The role of ATM signalling and its mediator proteins in DNA double strand break repair by Kakarougkas, Andreas David William
   
 
A University of Sussex DPhil thesis 
Available online via Sussex Research Online: 
http://sro.sussex.ac.uk/   
This thesis is protected by copyright which belongs to the author.   
This thesis cannot be reproduced or quoted extensively from without first 
obtaining permission in writing from the Author   
The content must not be changed in any way or sold commercially in any 
format or medium without the formal permission of the Author   
When referring to this work, full bibliographic details including the 
author, title, awarding institution and date of the thesis must be given 
Please visit Sussex Research Online for more information and further details   
! 
 
 
 
 
THE ROLE OF ATM SIGNALLING AND ITS 
MEDIATOR PROTEINS IN DNA DOUBLE 
STRAND BREAK REPAIR 
 
 
 
 
 
 
 
 
 
 
 
A thesis submitted to the University of Sussex for the degree of 
Doctor of Philosophy 
By Andreas David William Kakarougkas 
May 2012 
!!
"!
Declaration 
 
I hereby declare that this thesis has not been and will not be, submitted in whole or in 
part to another university for the award of any other degree. 
 
 
 
Signature  …………………………… 
 
 
Andreas David William Kakarougkas 
  
!!
#!
Acknowledgements 
 
I would like to express my sincerest gratitude to Professor Penny Jeggo for giving me 
the opportunity to carry out my doctoral studies in her laboratory and for her invaluable 
support and guidance throughout this period. I would also like to thank the Medical 
Research Council for funding my doctoral studies. Special thanks go out to all the 
members of the Jeggo laboratory for their help over the past four years and for making 
the GDSC an amazing place to work. I am particularly grateful to Atsushi Shibata for 
supervising aspects of this work.    
 
I would like to thank our families for helping and supporting us in many different ways. 
 
Finally I would like to dedicate this thesis to the women in my life. To Amani, for her 
constant support and encouragement without which this work would not have been 
possible, and to Nadia, whose smile always helps me keep things in perspective. 
  
!!
$!
UNIVERSITY OF SUSSEX 
 
ANDREAS DAVID WILLIAM KAKAROUGKAS 
 
DOCTOR OF PHILOSOPHY IN BIOCHEMISTRY 
 
THE ROLE OF ATM SIGNALLING AND ITS MEDIATOR PROTEINS IN DNA 
DOUBLE STRAND BREAK REPAIR 
 
SUMMARY 
 
Although most DNA double strand breaks (DSBs) are repaired by DNA non-
homologous end!joining (NHEJ), DSBs at heterochromatin (HC) regions undergo repair 
by homologous recombination (HR) in G2 phase. Repair of DSBs at HC regions 
requires ATM-dependent KAP1 phosphorylation and subsequent HC relaxation. The 
mediator proteins facilitate DSB repair at HC in G1 phase by retaining ATM and hence 
pKAP1 at DSBs until the completion of repair. In this thesis, I investigated the role of 
the mediator proteins in enabling DSB repair in G2 phase. I demonstrate that the 
mediator proteins are required for the slow component of DSB repair in G2, which 
represents HR. They also promote ATM-dependent pKAP1 formation in G2 as in G1. 
In addition, I have described a role for MDC1 in Rad51 loading and for RNF8 in DNA 
resection. Moreover, I demonstrate that BRCA1 overcomes an inhibitory barrier by 
53BP1 to resection by promoting a G2!specific enlargement in 53BP1 foci during HR 
that involves 53BP1 repositioning to the foci periphery and vacation from the central 
core. RPA foci form in the core devoid of 53BP1. 53BP1 has opposing roles in HR; it 
creates a restrictive barrier to resection but promotes pKAP1 and HC relaxation. RAP80 
also inhibits resection by binding to ubiquitylated histones at DSBs. I demonstrate that 
the DUB enzyme, POH1, is required to overcome the barrier posed to resection by 
RAP80 since its depletion leads to deficient 53BP1 vacation of the central core and 
deficient resection. BRCA1 and POH1 cooperate during G2 phase to promote resection 
and DSB repair by HR. Additionally; I investigated the role(s) of the chromatin 
remodelers BAF180 and CHD7 in transcriptional silencing following DSB induction, a 
process that requires ATM, RNF8 and RNF168. I demonstrate that deficient 
transcriptional silencing leads to a DSB repair defect at early times post IR. 
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Plk1 Polo-like kinase 1 
PNK Polynucleotide kinase 3$-phosphatase 
POH1 Pad1 homologue 
Pol I Polymerase 1 
Pol II Polymerase 2 
PTM Post translational modification 
PUMA p53 up-regulated modulator of apoptosis 
Rad18 RAD18 homolog (S. cerevisiae) 
Rad50 RAD50 homolog (S. cerevisiae) 
Rad51 RAD51 homolog (S. cerevisiae) 
Rad51c RAD51 homolog C (S. cerevisiae) 
RAP80 Receptor associated protein 80 
RIDDLE Radiosensitivity, immunodeficiency, dysmorphic features and 
learning difficulties 
RING Really Interesting New Gene 
RNA Ribonucleic acid 
RNF168 Ring finger protein 168 
RNF169 Ring finger protein 169 
RNF8 Ring finger protein 8 
RPA Replication protein A 
RPA2 Replication protein A2 
RS-SCID Severe Combined Immunodeficiency with Sensitivity to 
Ionizing Radiation 
RSC Chromatin structure remodelling 
SAE1 SUMO-activating enzyme subunit 1 
SAE2 SUMO-activating enzyme subunit 2 
SCE Sister chromatin exchange 
SCF Skp1, Cul1, F-box ubiquitin ligase complex 
Ser Serine 
siRNA Small interfering RNA 
Skp1 S-phase kinase- associated protein 1 
SMC1 Structural maintenance of chromosomes protein 1 
Spo11 SPO11 meiotic protein covalently bound to DSB homolog (S. 
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cerevisiae) 
SSB Single strand break 
ssDNA Single stranded DNA  
Thr Threonine 
Tip60 Tat interacting protein, 60kDa 
TOPBP1 Topoisomerase (DNA) II binding protein 1 
Ub Ubiquitin 
UBC9 Ubiquitin conjugating enzyme 9 
UBC13 Ubiquitin conjugating enzyme 13 
uH2A Ubiquitylated histone H2A 
UIM Ubiquitin interacting motif 
USP16 Ubiquitin-specific processing protease 16 
UV Ultraviolet 
UVA Ultraviolet A 
V(D)J Variable (V), Diversity (D) and Joining (J) genes 
VCP Valosin containing protein 
XLF XRCC4-like factor 
XP Xeroderma pigmentosum 
XPB Xeroderma pigmentosum group B-complementing protein 
XPD Xeroderma pigmentosum D 
XPF Xeroderma pigmentosum, complementation group F 
XRCC1 X-ray repair complementing defective repair in Chinese 
hamster cells 1 
XRCC4 X-ray repair complementing defective repair in 
YFP Yellow fluorescent protein 
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CHAPTER 1 
 
Introduction 
  
!!
""!
1   Introduction  
 
 
1.1: Significance of research in the field of the DNA Damage Responses. 
 
DNA is the blue print of life. Every function of every living organism is carried out 
using information contained in the DNA molecule. It is therefore imperative that the 
integrity of DNA is maintained so it can be faithfully passed on to further generations. 
However, this is a major challenge for cells since DNA exists in a hostile environment, 
and its integrity is constantly under threat due to exposure to endogenous and 
exogenous DNA damaging agents. Endogenous agents include reactive oxygen species, 
which are by-products of normal cellular metabolism, while exogenous agents include 
ionising and UV radiation.  
 Loss of ability to deal with DNA damage can have severe consequences for the 
cell. Cellular proliferation in the presence of DNA damage can lead to loss of genomic 
stability, which is a hallmark of malignant transformation. The importance of the DNA 
damage responses (DDR) in preventing malignant transformation is evident in 
individuals afflicted with syndromes leading to a defective DDR, as many display 
elevated cancer incidence (Table 1.1) (Jackson & Bartek, 2009). Moreover, components 
of the DDR pathways are frequently lost or supressed in malignant cells thus allowing 
them to overcome these protective mechanisms.   
 Scientific research in the DDR field is important in order to gain understanding 
of the molecular mechanisms underlying cancer development. Moreover, targeting the 
DDR in cancer therapy has emerged as a powerful tool in sensitising cells to existing 
cancer treatments (Lord & Ashworth, 2012). It is paradoxical that deficient DNA repair 
is the primary cause of cancer development yet cancer treatment involves introducing 
DNA damage through radiotherapy and chemotherapy. However, the alterations in 
DDR pathways that promote carcinogenesis can be manipulated for therapeutic benefit. 
By identifying which DNA repair pathways are suppressed in a given tumour, drugs can 
be used to inhibit the remaining pathway(s) upon which the tumour cells become 
reliant, thus selectively sensitising the tumour cells to DNA damaging agents. 
Therefore, gaining insight into the complex molecular mechanisms of the DDR is 
important not only for understanding malignant transformation but also for finding 
ways to improve cancer treatment.  
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Table 1.1: Human diseases with DDR defects (Jackson & Bartek, 2009). 
  
            
  
            
 
Syndrome Phenotypes Mutated Genes 
GGR/NER deficiency 
Xeroderma pigmentosum Neurodegeneration and microcephaly, 
Photosensitivity, skin cancer 
XPA-XPG 
Pol ? 
Cockayne syndrome Microcephaly, neuron demyelination and stunted 
growth 
CSA, CSB, XPB, 
XPD, XPG 
Trichothiodystrophy Neurodevelopmental defects, dysmyelination 
(abnormal myelin), brittle hair and nails  
XPD, XPB,  
TTD-A 
Cerebro-oculo-facio-
skeletal (COFS) syndrome 
Demyelination (loss of myelin), dysmyelination, 
brain calcification, microcephaly 
XPD, XPG, CSB, 
ERCC1 
DNA helicase deficiency 
Bloom’s syndrome Microcephaly, short stature, dysmorphic features, 
mild/moderate mental retardation, susceptible to 
infections, Elevated predisposition to all cancers 
BLM 
Werner’s syndrome Premature ageing, cancer predisposition WRN 
Rothmund–Thompson 
syndrome 
Stunted growth, skeletal abnormalities, early 
cataracts, accelerated ageing, chromosomal 
instability and cancer predisposition 
RECQL4 
Ataxia with oculomotor 
apraxia 2 
Ataxia, neurodegeneration and oculomotor 
apraxia 
SETX 
Exonuclease deficiency 
Aicardi-Goutières 
syndrome (AGS) 
De/dysmyelination, brain calcification, 
microcephaly, elevated CSF (cerebrospinal fluid) 
IFN-?, CSF lymphocytosis (CSF lymphocytes 
increased) 
TREX1, 
RNASEH2 
NHEJ/V(D)J recombination deficiency 
Inactivation of Ku70 or 
Ku80 in mouse models 
Premature ageing, cancer predisposition, 
lymphomas 
Ku70 
Ku80 
Lig4 syndrome/Human 
immunodeficiency with 
microcephaly 
Microcephaly, leukemia, immunodeficiency, and 
developmental and growth delay 
DNA Ligase IV, 
XLF/Cerunnos 
RS-SCID (radiosensitive-
SCID)  
Severe-combined immunodeficiency, lymphomas 
and hypersensitivity to ionizing radiation 
Artemis 
HR deficiency 
Breast cancer 1, early onset Breast and ovarian cancer BRCA1 
Breast cancer 2, early onset Breast and ovarian cancer; predisposition to 
pancreatic, prostate and gastric cancer and 
melanoma 
BRCA2 
DNA SSB repair deficiency 
Spinocerebellar ataxia with 
axonal neuropathy 
(SCAN1) 
Ataxia, neurodegeneration, peripheral axonal 
motor and sensory neuropathy, muscle weakness 
TDP1 
Ataxia with oculomotor 
apraxia 1 (AOA1) 
Ataxia, neurodegeneration, oculomotor apraxia 
and peripheral neuropathy 
APTX 
DNA cross-link repair deficiency 
Fanconi anaemia Congenital abnormalities, progressive bone 
marrow failure, prone to AML, squamous 
carcinomas of head, neck or gynaecological 
system. 
FANCA-FANCM, 
BRCA2 
(FANCD1) 
Mismatch repair deficiency 
Hereditary non-polyposis 
colorectal cancer (HNPCC) 
Colon and gynaecologic cancers MSH2, MSH3, 
MSH6, MLH1, 
PMS2 
DNA DSB-repair and signal-transduction deficiency 
Li-Fraumeni syndrome Soft tissue sarcomas, breast cancer, brain tumours p53 
Familial breast cancer  
(non BRCA1/2) 
Predisposition to medium/late-onset breast cancer Chk2, MRN, ATM 
BRIP1, PALB2, 
Ataxia telangiectasia Cerebellar ataxia, telangiectases, immune defects, 
predisposition to malignancy (mainly lymphomas 
but also breast cancer) 
ATM 
Ataxia telangiectasia-like 
disorder 
Mild A-T like features, possibly cancer 
predisposed 
MRE11 
Nijmegen breakage 
syndrome (NBS) 
Microcephaly, growth retardation, mental 
retardation, immunodeficiency, cancer 
predisposition 
NBS1 
NBS-like syndrome NBS-like phenotype RAD50 
RIDDLE syndrome Radiosensitivity, immunodeficiency, dysmorphic 
features and learning difficulties 
RNF168 
(RIDDLIN) 
Seckel syndrome Marked microcephaly, primordial dwarfism, 
dysmorphic facial features and mental 
retardation, possibly AML 
ATR, SCKL2, 
SCKL3 
Primary microcephaly 1 Microcephaly, mental retardation MCPH1/BRIT1 
Hutchinson-Gilford 
progeria syndrome (HGPS) 
and restrictive 
dermopathy(RD) 
Accelerated ageing (HGPS); neonatal lethality 
(RD) 
Lamin-A 
DNA-damage-response impairment and defective DNA repair 
Down syndrome Mental retardation, progeria Trisomy of 
chromosome 21 
Alzheimer’s disease Progressive neurodegeneration leading to 
dementia, memory loss and cognitive decline 
Increased oxidative 
stress and damage 
Parkinson’s disease Tremor, bradykinesia, posture rigidity and 
postural instability, degeneration of dopaminergic 
neurons in substantia nigra area 
Mutations in ?-
Synuclein and 
Parkin variants 
Huntington’s disease Progressive chorea and dementia, severe neuronal 
loss in the striatum and cerebral cortex 
CAG repeat 
expansion in 
huntingtin (HD)  
Several spinocerebellar 
ataxias 
Problems with bodily movements (similar to 
Huntington’s disease), progressive neuron loss 
Expanded CAG 
repeats in various 
genes 
Friedreich’s ataxia Limb ataxia, cerebellar dysarthria, sensory loss, 
skeletal deformities 
GAA expanded 
repeats in frataxin 
(FXN) 
Myotonic dystrophy types 
1 and 2 
Muscle weakness and wasting, cataracts, 
testicular atrophy, cognitive decline 
CTG expansion 
(type 1), CCTG 
expansion (type 2) 
Triple-A syndrome Adrenal insufficiency, achalasia, alacrima, 
neurodegeneration, autonomic dysfunction 
Mutation in AAAS 
gene 
Amyotrophic lateral 
sclerosis 
Progressive degeneration of motor neurons, 
muscle weakness and atrophy, leading to fatality 
Defective Cu-Zn 
superoxide 
dismutase (SODC, 
SOD1); 
mitochondrial 
DNA 
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 The introductory chapter of this thesis will provide an overview of the DDR 
with particular emphasis on the response to DNA double strand breaks (DSBs). This 
will lay the ground for the choice of topics covered in subsequent chapters. The aims of 
this thesis are outlined at the end of the introductory chapter. 
 
1.2: DNA damage responses. Overview of the mechanisms that cells have evolved 
to prevent genomic instability. 
 
To combat the effect of DNA damage and to maintain genomic stability, cells have 
evolved a vastly complicated collection of processes termed the DNA damage responses 
(DDR) (Harper & Elledge, 2007). These processes function to monitor DNA status 
integrity, to safeguard and to ensure that a complete and error free copy of the entire 
DNA molecule is passed on to the daughter cells following cell division. Owing to the 
frequency of genomic insult and to the size and complexity of their genome, this is a 
formidable challenge for mammalian cells. However, through sensors, mediators, 
transducers and effectors, mammalian cells repair DNA damage with incredible 
efficiency. Moreover, when DNA repair is not possible, the damaged cells are able to 
undergo apoptosis or enter senescence, thereby ensuring that damaged DNA is not 
passed on to further generations. Here I will summarise the processes responding to 
DNA damage.  
 
1.2.1: Cell cycle checkpoints 
 
Following the detection of DNA damage, cells activate a signalling cascade that leads to 
a halt of cell cycle progression (Diagram 1.1). Cell cycle checkpoints prevent cells from 
undertaking processes such as DNA replication and mitosis in the presence of DNA 
damage. Moreover, by inhibiting cell cycle progression, cell cycle checkpoints provide 
the cells with valuable time in which to attempt DNA repair before DNA replication or 
mitosis ensue (Jeggo & Löbrich, 2006). Cell cycle checkpoints function by inhibiting 
the activity of cyclin- dependent kinases (CDK), which drive cells through the cell 
cycle. In the presence of DNA damage, cells can inhibit entry into S-phase via the G1/S 
checkpoint and entry into mitosis via the G2/M checkpoint. In addition, if DNA damage 
is detected in S-phase, the intra-S-phase checkpoint causes a transient, reversible  
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Diagram 1.1: Cell cycle checkpoint overview.  
Detection of DNA damage leads to the activation of cell cycle checkpoints at the G1/S and G2/M boundaries, but 
also in S-phase. The PIKK kinases, ATM and ATR regulate the activation of the checkpoints by phosphorylating the 
effector kinases Chk2 and Chk1, respectively. The G1/S and G2/M checkpoints can both be rapidly activated by 
phosphorylation of the CDC25 phosphatases. This modification leads to their degradation and prevents the removal 
of inhibitory phosphorylations from the CDKs that promote cell cycle progression. When a more sustained 
checkpoint response is required, p53 is hyper-accumulated and drives the up regulation and accumulation of the 
effector p21, which is an inhibitor of the CDKs. In S-phase, DNA synthesis can be inhibited via the ATM/ATR and 
Chk2/Chk1 pathway which prevents origin firing. Alternatively, activation of the intra-S-phase checkpoint can be 
achieved via NBS1 and the cohesion protein SMC1. The mediator proteins are thought to facilitate these pathways by 
promoting the amplification and maintenance of the ATM/ATR signalling cascades. Adapted from (Kastan & Bartek, 
2004). 
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inhibition of DNA replication by slowing on-going DNA synthesis and by preventing 
new origin firing (Zhou & Elledge, 2000). 
 The PIKK kinases, ATM and ATR, lie at the heart of the signalling cascades 
that make up the DDR. As will be discussed in more detail later, these kinases function 
in every facet of the DDR including cell cycle arrest, chromatin remodelling, DNA 
repair, and apoptosis (Shiloh, 2003). They carry out these functions via regulatory 
modification of a large numbers of downstream mediators and effectors. In the case of 
cell cycle regulation, the key effector kinases are Chk2 and Chk1, which are 
phosphorylated in response to DNA damage by ATM and ATR, respectively. Here an 
overview of the ATM-ATR co-ordination of DNA damage induced arrest at different 
cell cycle stages is provided (Diagram 1.1). 
 
1.2.1a: G1/S checkpoint.  
 
Following the activation of a checkpoint response, cell cycle progression can be halted 
in a transient way, or in a more sustained or even permanent way.  This depends on 
which signalling pathway leading to a checkpoint response it utilised by the cell. In G1, 
the signalling pathway involving the phosphatase Cdc25A results in a transient 
response, while the signalling pathway involving the transcription factor p53 leads to a 
more sustained arrest. The Cdc25A signalling pathway can rapidly halt progression 
from G1 into S-phase in response to DNA damage, thus allowing time for the synthesis 
and accumulation of the factors required for the sustained p53 dependent arrest. 
 Under normal physiological conditions, entry into S-phase is driven by the 
removal of an inhibitory phosphorylation on the Cdk2 cyclin kinases by the Cdc25A 
phosphatase. However, following the detection of DNA damage in G1 phase, ATM and 
ATR phosphorylate Chk2 or Chk1, respectively, which in turn phosphorylate Cdc25A 
on several residues. This phosphorylation promotes further ubiquitylation of Cdc25A by 
the Skp1, Cul1, F-box ubiquitin ligase complex (SCF), which targets Cdc25A for 
proteasomal degradation (Sørensen et al, 2003; Busino et al, 2004). The 
dephosphorylation of the Cdk2 cyclin kinases (Cyclin E/A) is required for the 
recruitment of the pre-replication complexes to chromatin and for the initiation of DNA 
synthesis. Therefore the degradation of Cdc25A prevents this process by maintaining 
Cdk2 phosphorylation (Mailand et al, 2000; Falck et al, 2001). This branch of the G1/S 
checkpoint functions independently of p53 and rapidly inhibits cell cycle progression. 
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However, since Cdc25A normally functions to promote S-phase entry by 
dephosphorylating the Cdk2 cyclin kinases, its expression levels peak in late G1. 
Moreover, Cdc25A mediated cell cycle arrest is transient and can only prevent entry 
into S-phase for several hours. It appears that this is a fast acting response that is able to 
block late G1 phase cells from entering S-phase until the p53 branch of the checkpoint 
becomes active.  
 The expression levels of p53 under normal conditions are negatively regulated 
by the ubiquitin ligase, Mdm2, which binds and ubiquitylates p53 thus targeting it for 
degradation. However, following DNA damage induction, ATM or ATR phosphorylate 
Mdm2 thereby inhibiting its interaction with p53 (Maya et al, 2001). In addition, p53 is 
phosphorylated by Chk2 and directly by ATM and ATR leading to its stabilisation and 
hyper-accumulation (Hirao et al, 2000). As a result, p53 drives the up regulation and 
accumulation of the effector p21, which is an inhibitor of the Cdk2 cyclin kinases(Sherr 
& Roberts, 1999).  Although this response requires several hours for the critical levels 
of p21 to be reached, the resulting inhibition of cell cycle progression is more sustained 
and even permanent. In conclusion, the Cdc25A and p53 branches of the G1/S 
checkpoint arrest cooperate to ensure that cells do not enter S-phase harbouring 
unrepaired DNA damage. 
 
1.2.1b: Intra-S-phase checkpoint. 
  
During DNA replication, cells are particularly vulnerable to genotoxic exposure. This is 
in part due to changes in chromatin structure that facilitate DNA replication, but mainly 
due to the consequences of active replication forks encountering damaged DNA 
regions. Stalled and collapsed replication forks can have devastating effects on the 
maintenance of genomic stability and, as a result, cells have evolved elegant 
mechanisms to attempt replication fork restoration (Petermann & Helleday, 2010). In 
addition, to prevent replication forks from encountering damaged DNA regions, cells 
activate an intra-S-phase checkpoint response. Similar to the G1/S checkpoint, the intra-
S-phase checkpoint is comprised of two signalling branches, which cooperate to delay 
replication fork progression and to prevent the firing of new replication origins (Kastan 
& Bartek, 2004). 
   The first signalling pathway is identical to the transient branch of the G1/S 
checkpoint and involves ATM/ATR and Chk2/Chk1. By promoting the degradation of 
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Cdc25A, Cdk2 remains phosphorylated and inhibited. In turn, this prevents the loading 
of CDC45 onto chromatin, which is required for the recruitment of DNA polymerase % 
to the pre-replication complexes. Under these conditions, origin firing cannot take place 
and DNA synthesis is inhibited (Bartek et al, 2004). 
 The second branch of the intra-S-phase checkpoint response involves the 
phosphorylation of the MRN component NBS1 and the cohesin protein SMC1 by ATM 
(Lim et al, 2000; Yazdi et al, 2002). In this pathway, NBS1 functions as an adaptor 
protein and promotes the phosphorylation of SMC1, which is required for the intra-S 
phase checkpoint activation after IR. This branch of the S-phase checkpoint is distinct 
to the ATM/Chk2/Cdc25A pathway, but is clearly important since NBS cells display 
checkpoint defects in S-phase (Yazdi et al, 2002). 
 
 
 1.2.1c: G2/M checkpoint.  
 
The G2/M checkpoint functions to prevent cells harbouring DNA damage from entering 
mitosis and attempting cell division. Entry into mitosis in the presence of DNA damage 
can lead to cell death by mitotic catastrophe or to genetic rearrangements and/or 
deletions, that contribute to the loss of genomic stability. Similar to the other cell cycle 
checkpoints, cell cycle arrest in G2 can be achieved transiently via post-translational 
modification of adaptor and effector proteins, or in a sustained way via the 
transcriptional regulation of such factors. 
 The transient activation of the G2/M checkpoint is mechanistically similar to the 
equivalent responses in the G1 and S phases of the cell cycle. Following activation of 
ATM/ATR, Chk1/Chk2 are phosphorylated and in turn go on to phosphorylate 
phosphatases (CDC25A-C). This phosphorylation initially impairs their activity and 
subsequently targets them for degradation (Lukas et al, 2004b). Degradation of the 
phosphatases prevents dephosphorylation of the Cdk1 kinase cyclin B, which is 
required to drive cells into mitosis (Kastan & Bartek, 2004).  
 Following exposure to IR in G2 phase, ATM and ATR co-operate in the 
transient G2/M checkpoint response, while the sustained checkpoint response is 
primarily ATR dependent (Brown & Baltimore, 2003). This is likely due to cells 
damaged in S-phase progressing to the G2/M boundary where the presence of ssDNA, 
due to erroneous or incomplete replication, maintains ATR activation and leads to a 
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sustained G2/M checkpoint response. Moreover, cells damaged in G2 phase can 
undergo repair by Homologous Recombination (HR), which involves the generation of 
ssDNA that activates ATR. The generation of ssDNA by resection appears to be a 
molecular switch that activates ATR and leads to a sustained G2/M checkpoint response 
(Shiotani & Zou, 2009).  
 The sustained G2/M checkpoint response is less well understood and is distinct 
to the G1/S checkpoint. Although the activation and maintenance of the G1 checkpoint 
is p53 and p21 dependent, cells lacking p53 are still able to activate the G2/M 
checkpoint indicating that p53 is not essential for this process (Taylor & Stark, 2001). 
On the other hand, p53 appears to play a role in the maintenance of the G2/M 
checkpoint via transcriptional regulation of GADD45 and 14-3-3" (Taylor & Stark, 
2001). GADD45 inhibits entry into mitosis by impacting on Cdk1 cyclin B and Cdc25A 
activity, since overexpression of either of these factors can overcome the GADD45 
block on mitotic entry (Wang et al, 1999). 14-3-3" is also thought to impact on Cdk1 
cyclin B and Cdc25A activity and has been shown to be upregulated in a p53 dependent 
manner in response to DNA damage, leading to G2 arrest (Hermeking et al, 1997).  
 The importance of a proficient checkpoint response on the maintenance of 
genomic stability is highlighted by the fact that p53 is frequently downregulated in 
tumours. However, despite their importance, both the G1/S and G2/M checkpoints have 
limitations. The G1/S checkpoint is highly sensitive and can be activated by a single 
DSB, however, the initial ‘rapid’ response is leaky and some damaged cells are able to 
progress into S-phase. Moreover, and particularly following higher radiation doses, the 
G1/S checkpoint is not maintained efficiently thus allowing cells with residual damage 
to progress into S-phase (Deckbar et al, 2010). The G2/M checkpoint is less sensitive 
than the G1/S checkpoint meaning that there is a threshold of DNA damage that is 
required for its activation. Moreover, G2/M checkpoint maintenance is also not 
complete thus allowing cells with unrepaired DNA damage to enter mitosis (Deckbar et 
al, 2007; 2011; Stewart et al, 2009). Another limitation of the checkpoint response to 
DNA damage is the ability of certain cells to inactivate the checkpoint via a process 
termed ‘checkpoint adaptation’. The process of checkpoint adaptation involves the 
inactivation of a sustained checkpoint in cells harbouring DNA damage thus allowing 
them to enter mitosis (Syljuâsen, 2007). In this process, polo kinase 1 (Plk1) overcomes 
Chk1 dependent checkpoint maintenance by promoting its de-phosphorylation, while at 
the same time it promotes mitotic entry by phosphorylating and activating Cdc25C 
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(Syljuâsen, 2007). The process of checkpoint adaptation might be activated during 
malignant transformation thus allowing cells with DNA damage to continue dividing.   
Under normal physiological conditions, cell cycle checkpoints efficiently 
prevent genomic instability but their function alone is not sufficient. They form an 
important part of the DDR and are coordinated with other components of the response 
such as DNA repair, apoptosis and senescence.  
 
1.3: DNA repair. 
 
DNA repair forms an integral part of the DDR. Following the detection of damage and 
activation of cell cycle arrest, components of the DNA repair machinery are recruited to 
the damage sites and attempt to repair the damaged region(s). Owing to the variety of 
types of DNA damage that can arise, cells have evolved several different repair 
mechanisms to deal with this damage. Here I will provide a brief overview of these 
repair processes and will then focus on DSB repair in a separate section. 
  
1.3.1: Nucleotide excision repair. 
 
Nucleotide excision repair (NER) is the repair mechanism that responds to DNA 
damage affecting base pairing or general helical structure. Such damage normally arises 
following exposure to exogenous agents such as UV light and bulky lesions caused by 
chemical mutagens. NER can be divided into global genome-NER (GG-NER) and 
transcription coupled repair (TCR), which specifically responds to DNA damage that 
interferes with elongating RNA polymerases. The mechanisms of GG-NER and TCR 
are identical and require the same factors, except that in TCR when a polymerase-
blocking lesion is detected, the affected polymerase is first removed by CSB and CSA. 
Next, in both pathways, the helicases XPB and XPD unwind and open up a DNA region 
of ~30bp around the damage site and RPA rapidly binds the exposed region to stabilise 
the molecule. The endonucleases XPG and ERCC1/XPF cleave either side of the 
generated flap on the DNA strand that contains the damage (Svejstrup, 2002) . Finally, 
polymerase(s) are recruited to fill in the excised region by using the undamaged strand 
as a template (Ogi et al, 2010). 
 The importance of the NER pathway in the maintenance of genomic stability is 
highlighted by human disorders resulting from mutations in factors of the NER 
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pathway. Xeroderma pigmentosum (XP) results from mutations in the XP genes and 
results in a 1000 fold increase in the incidence of skin cancer as a direct result of 
defective UV induced DNA damage repair (Friedberg, 2001). Cockayne syndrome, 
results from mutations in the CSA and CSB genes and consequently only affects the 
TCR branch of the NER pathway (Hoeijmakers, 2001).  
 
1.3.2: Base excision repair. 
 
As with NER, base excision repair (BER) responds to and repairs lesions affecting only 
one strand of the DNA molecule. BER mainly deals with endogenous DNA damage that 
arises as a consequence of normal cellular metabolism. By-products of these metabolic 
processes include reactive oxygen species, which damage DNA with high frequency on 
a daily basis. The BER pathway responds to small chemical alterations, abasic sites and 
single-strand DNA breaks (SSB) and repairs them by a core reaction followed by a 
short or long-patch version of the BER pathway. Base alterations are detected and 
excised by a family of glycosylases resulting in the formation of an abasic site. Abasic 
sites are then processed by the core BER reaction, which involves incision of the DNA 
strand at the abasic site by the endonuclease APE1 (Almeida & Sobol, 2007). The 
resulting SSB is then processed by short or long-patch BER. In a parallel pathway 
responding to SSBs, XRCC1, PARP1 and PNK process the SSB ends into a substrate 
that can be repaired by the BER machinery (Caldecott, 2003). The small patch BER 
pathway, involves the removal of the baseless sugar residue, followed by a gap filling 
reaction by polymerase & and ligation by the XRCC1-ligase 3 complex. The long patch 
BER pathway, involves the generation of a 2-10 base pair flap that is excised by the 
endonuclease FEN1. The excised region is filled in by polymerases (&,',() using the 
undamaged strand and ligase 1 carries out the ligation step (Fortini & Dogliotti, 2007). 
 Recently, a hereditary neurodegenerative disorder in which SSBs are defectively 
repaired indicates that the BER pathway might have a neuroprotective function (El-
Khamisy et al, 2005).  
 
1.4: Apoptosis. 
 
Following the completion of DNA repair, cell cycle checkpoints are deactivated and cell 
cycle progression resumes. However, there are cases when attempts to repair DNA fail. 
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When such a situation arises, cells either permanently halt their cell cycle progression 
(senescence), or they undergo programmed cell death (apoptosis). There are many 
factors that determine which of these outcomes take place, including cell type and the 
extent of DNA damage. 
There are several lines of evidence indicating that an inability to repair DNA 
damage is a strong trigger of apoptosis. Indeed, human cells defective for the NER, 
BER and DSB repair pathways all show elevated levels of apoptosis in response to 
DNA damage (Christmann et al, 2003). Moreover, cells that are transfected with 
restriction enzymes that induce DSBs also trigger an apoptotic response (Lips & Kaina, 
2001). However, the induction of apoptosis does not always coincide with an inability 
to repair DNA damage. Certain cell types trigger apoptosis following the induction of 
low number of DSBs despite being proficient in DNA repair. An example of such a cell 
type are neuronal and progenitor cells, which during embryonic neuronal development 
are hypersensitive to radiation induced apoptosis (Gatz et al, 2011).  
 ATM and ATR play a critical role in the signalling response leading to 
apoptosis. As mentioned earlier, following the induction of DSBs, ATM and ATR are 
activated and phosphorylate downstream targets including p53. This leads to cell cycle 
arrest via p53 dependent transcriptional upregulation of factors such as p21. However, 
following the induction of large amounts of DNA damage or in the presence of 
persistent DNA damage, p53 can also drive the expression of pro-apoptotic factors such 
as BAX, PUMA and the FAS receptor (Lane, 1992). BAX interaction with 
mitochondria leads to the release of pro-apoptotic factors such as cytochrome c which 
leads to the activation of caspases whose protein degradation function leads to cell death 
(Tafani et al, 2002). The dual role of p53 in checkpoint and apoptotic signalling makes 
it hard to decipher whether it is a pro or anti-apoptotic factor. In some cell types, loss of 
p53 leads to resistance to DNA damage due to a supressed apoptotic response, whereas 
in other cell types loss of p53 sensitises cells to apoptosis (Roos & Kaina, 2006). 
 The ATM-ATR-p53 signalling pathway is important for the initiation of 
apoptosis, but the fact that ATM and p53 deficient cells are able to undergo apoptosis 
suggests that backup pathways exist. One pathway leading to apoptosis independently 
of p53 involves the activation of E2F1 by Chk1/Chk2. E2F1 activation drives the 
expression of the p53 homologue p73 whose pro-apoptotic function drives the 
expression of PUMA and BAX, thus leading to apoptosis (Melino et al, 2004). Another 
p53 independent pathway leading to apoptosis involves NF-#B, which can induce the 
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expression of the FAS receptor. The FAS receptor is expressed on the cellular surface 
but when activated and internalised it leads to caspase activation and subsequently 
apoptosis (Huang et al, 1996). Finally, apoptosis can be triggered by the degradation of 
BCL-2. However, the details of this pathway are not fully understood (Roos & Kaina, 
2006). 
 In combination with the other components of the DDR, apoptosis plays an 
important role in the preservation of genomic stability. Eliminating cells harbouring 
DNA damage prevents cells from carrying out processes, such as replication or mitosis, 
in the presence of DNA damage, which can lead to genomic rearrangements and 
ultimately malignant transformation. 
 
1.5: Senescence. 
 
Replicative senescence is the process whereby cells undergo permanent arrest and no 
longer progress through the cell cycle. One way to trigger senescence is by telomere 
shortening which occurs progressively as a result of incomplete telomere replication in 
S-phase. With each cell cycle, telomeres become progressively shorter until replicative 
senescence is induced and cells stop cycling to protect the cells from loss of genomic 
material (Harley et al, 1990). This phenomenon can be counteracted by the function of 
telomerase, which is a reverse transcriptase able to restore telomere ends using 
telomeric RNA as a template. Cells with a high replicative potential such as stem cells 
and tumour cells, display high levels of telomerase activity (Cong et al, 2002). By the 
same mechanism, cultured cells such as fibroblasts that enter senescence after a set 
number of passages can escape this process and continue dividing when overexpressing 
telomerase.   
 In addition to replicative senescence, cells can also enter senescence as a result 
of DNA damage. It is thought that when cells accumulate DNA damage above a certain 
threshold, they enter senescence despite normal telomere length. This hypothesis is 
supported by the finding that cells lacking components of the DSB repair pathways 
display accelerated senescence (Lombard et al, 2005).  
 DNA damage induced and replicative senescence are induced by similar 
mechanisms. As discussed earlier, the detection of DNA damage leads to activation of 
ATM/ATR and cell cycle arrest via the Chk1/Chk2-p53/p21 signalling pathway. 
Interestingly, cells entering replicative senescence are positive for DNA damage 
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markers indicating that shortened telomeres activate the DDR (Takai et al, 2003). 
Indeed, shortened telomeres are recognised by the DSB repair machinery and trigger a 
DDR leading to senescence that is similar to the checkpoint response following DNA 
damage (Dimitrova et al, 2008). Consistent with this, cells with mutated p53 display 
extended lifespan while senescent cells in which ATM/ATR and/or Chk1/Chk2 is 
depleted are able to escape senescence and begin DNA synthesis (Herbig & Sedivy, 
2006; Herbig et al, 2004).     
 Cellular senescence represents a protective mechanism whereby cells that have 
accumulated DNA damage, undergo a permanent checkpoint response. In addition, 
aging cells that have undergone a set number of passages enter senescence by activating 
a similar pathway, presumably as a way of protecting the cells from attempting DNA 
replication and mitosis in the presence of accumulated DNA damage. The importance of 
these mechanisms in preventing genomic instability is highlighted by tumour cells, 
which circumvent these protective mechanisms by blocking p53 function and 
upregulating the expression of telomerase. 
 
1.6: Double strand break repair. 
 
DNA double strand breaks (DSBs) are the most challenging DNA lesion that a cell can 
be faced with owing to the fact that both DNA strands are damaged. In addition, DSBs 
are the most toxic type of DNA damage as a single DSB can potentially lead to cell 
death. DSBs can be induced directly in all cell cycle phases by exposure to agents such 
ionising radiation (IR) or can result from replication forks encountering SSBs in S-
phase. Cell have evolved two main repair pathways to deal with DNA damage, Non 
Homologous End Joining (NHEJ) and Homologous Recombination (HR).  
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Diagram1.2: Classical non homologous end joining 
In Non-Homologous End Joining (NHEJ) DSBs are recognized by the Ku 70/80 heterodimer that binds to the strand 
ends, which tethers them and leads to the recruitment of other proteins. The catalytic subunit of the DNA-dependent 
protein kinase, DNA- PKcs, then binds to the strand ends and activates the nuclease Artemis by autophosphorylation. 
Artemis then processes the ends possibly leading to loss of genetic information thus making NHEJ an error prone 
pathway of DSB repair. Finally XLF, Ligase IV and XRCC4 ligate the strands back together. 
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1.6.1: Classical Non Homologous End Joining. 
 
NHEJ is the DSB repair pathway that repairs the majority of DSBs in the G1 and G2 
cell cycle phases (Beucher et al, 2009). There are several factors that determine whether 
a DSB can be accurately repaired by NHEJ, but following exposure to IR approximately 
80% of induced DSBs undergo efficient end processing (most likely without involving 
resection) and are repaired by classical NHEJ (C-NHEJ) (Diagram 1.2). 
 The first step of the NHEJ pathway involves the recruitment of the Ku70/Ku80 
heterodimer which binds to the broken DNA ends and prevents their resection (Mimori 
& Hardin, 1986). Next, the Ku heterodimer translocates along the DNA molecule and 
recruits the DNA-dependent protein kinase catalytic subunit (DNA-PKcs) (Gottlieb & 
Jackson, 1993). DNA-PKcs is a key kinase in the DDR and regulates many downstream 
substrates. In classical NHEJ where CtIP dependent resection of DNA ends is not 
required prior to ligation, DNA-PKcs regulates the interaction of Ku with the DNA end 
ligation complex which is comprised of XRCC4, Ligase IV and XLF (Costantini et al, 
2007). DNA-PKcs enhances the interaction between the heterodimeric form of Ku and 
the BRCT domain of Ligase IV (Costantini et al, 2007). In turn, ligase IV directly 
interacts with XRCC4 via two BRCT domains that are present in the C-terminal region 
of DNA ligase IV (Critchlow et al, 1997). The final component of the ligation complex 
is XLF which has been shown to directly interact with DNA ligase IV-XRCC4 and may 
function to tether the DSB ends (Ahnesorg et al, 2006). The DNA ligase IV-XRCC4-
XLF complex is then able to ligate the DNA ends and seal the lesion. The ligation 
reaction involves the transfer of an AMP moiety by the DNA ligase IV/XRCC4 
complex to the 5’ phosphate of the DNA molecule leading to a donor DNA-adenylate 
complex. The reaction is then completed by the formation of a phosphodiester bond 
between the 5’ phosphate donor and the 3’ hydroxyl of the acceptor.  XLF functions to 
re-adenylate the DNA ligase IV/XRCC4 complex thus allowing it to carry out further 
ligation reactions (Riballo et al, 2009). 
 The reaction described above repairs approximately 80% of IR induced DSBs 
with fast kinetics in the G1 and G2 phases of the cell cycle. However, approximately 
15-20% of IR induced DSBs are repaired with slow kinetics and require additional 
repair factors for their efficient repair (Riballo et al, 2004). These factors include ATM, 
Artemis and the mediator proteins. The role of ATM and the mediator proteins in 
promoting the repair of this subset of DSBs will be discussed in detail in a later section. 
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There seems to be several contributing factors that determine whether a DSB requires 
additional processing prior to ligation. These include the chromatin structure 
surrounding the DSB as well as the complexity of the DNA lesion and whether the DSB 
end termini require additional processing prior to ligation (Riballo et al, 2004; Goodarzi 
et al, 2008). The endonuclease Artemis has been shown to be required for the efficient 
repair of this subset of breaks but the mechanism of how it achieves this has remained 
elusive. ATM and the NHEJ machinery also function in V(D)J recombination which is 
a process of genetic recombination that takes place during the production of the immune 
system. In this process, Artemis cleaves DNA hairpin structures in an DNA-PK 
dependent manner (Ma et al, 2002). The endonuclease activity of Artemis is facilitated 
by DNA-PK autophosphorylation, which is thought to remodel the DNA ends thus 
making them compatible for nucleolytic cleavage. The requirement for the 
endonuclease activity of Artemis in DSB repair is unclear (Goodarzi et al, 2006). As 
will be discussed later, the role of Artemis in the repair of a subset of DSBs is required 
in both the G1 and G2 phases of the cell cycle and is independent on the chromatin 
structure surrounding the DSB. 
 
1.6.2: Micro Homology Mediated End Joining 
 
Micro homology mediated end joining (MMEJ) is a backup end joining repair pathway 
that is thought to function when C-NHEJ is inhibited (Liang et al, 1996) (Diagram 1.3). 
This pathway of DSB re-joining is thought to be error prone due to deletions resulting 
from excessive DNA degradation (Liang & Jasin, 1996). Moreover, MMEJ is 
associated with the formation of chromosomal translocations (Bennardo et al, 2008). 
The mechanism of MMEJ is poorly understood but is thought to involve 5’ to 3’ DNA 
end resection of both DNA ends to generate 3’ DNA tails containing regions of 
microhomology that can then be used to ligate the break (McVey & Lee, 2008). The 
resected regions are not recovered, and it is this 5’ to 3’ resection that is thought to 
result in the deletions associated with MMEJ. The mechanism that carries out the re-
joining remains unclear. However, the Lobrich and Jeggo laboratories have evidence 
that this can arise via a process dependent upon NHEJ proteins. There is also evidence 
that re-joining can occur via a process involving DNA ligase I/III and XRCC1 and 
PARP1 (described as Alt-NHEJ). 
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Diagram 1.3: Micro homology mediated end joining. 
In order for the DNA ends to be ligated, they must be processed into substrates that are compatible with the ligation 
reaction. In order for the DNA ends to be complementary, microhomology regions are generated at DNA ends via the 
insertion or deletion of nucleotides. Alternatively, when microhomology regions are present further from the DNA 
ends, DNA resection can take place in order to expose the microhomology regions that allow the DNA ends to be 
ligated. This repair pathway is termed micro homology mediated end joining (MMEJ) and is thought to be error 
prone due to deletions resulting from excessive DNA degradation. 
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 As will be discussed in detail later, DNA resection is the first step of DSB repair 
by HR in the G2 phase of the cell cycle and requires CtIP and the nuclease MRE11 
(Shibata et al, 2011). Recent findings indicate that these factors also operate in resection 
associated with MMEJ suggesting a similar mechanism (Rahal et al, 2010). Moreover, 
the notion that CtIP and MRE11 function in the resection step of MMEJ is supported by 
recent findings showing that the increased translocations of Ku70 deficient cells are 
suppressed by CtIP depletion (Zhang & Jasin, 2010).  
 Ku is recruited to DSBs with very fast kinetics where it binds to DNA ends with 
high affinity (Smith et al, 1999). Ku appears to compete with PARP, another DNA 
binding factor. When DNA ends become bound by Ku, they are protected from DNA 
end resection and C-NHEJ ensues. When Ku is absent, PARP-1 is able to bind to DNA 
ends and initiate MMEJ (Alt-NHEJ) leading to deletions and chromosomal 
translocations (Wang et al, 2006). It is not clear whether Alt-NHEJ has a normal 
physiological function or whether it is an erroneous backup pathway that is only 
employed when NHEJ is compromised. There is strong evidence however, that by 
binding to DNA ends, Ku modulates DSB pathway choice and in the majority of cases 
promotes C-NHEJ in both G1 and G2 (Fattah et al, 2010). 
 
1.6.3: Homologous Recombination. 
 
HR is a repair pathway that utilises homologous sequences on the sister chromatid and 
uses them as a template for repair. Consequently, HR can only be utilised once the DNA 
region containing damage has been replicated. HR is considered an error free pathway 
that accurately repairs DNA lesions without loss of genetic information. The HR 
pathway plays an important role in the repair of one-ended DSBs arising at collapsed 
replication forks and appears to be the repair pathway predominantly used in S-phase 
(Petermann & Helleday, 2010) (Diagram 1.4). Work from our laboratory has indicated 
that HR is not as extensively used to repair two-ended DSBs following IR (X or !-rays) 
exposure in G2 phase, where it functions to repair ~20% of induced DSBs (Beucher et 
al, 2009; Jeggo et al, 2011). Similar to the fraction of DSBs in G1 that require ATM, 
Artemis and the mediators proteins, this subset of DSBs in G2 also requires ATM and 
Artemis and is repaired with slow kinetics (Beucher et al, 2009). One of the major aims 
of this thesis was to investigate the role(s) of the mediator proteins in the repair of these 
DSBs in G2. 
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Diagram 1.4: Homologous recombination repair of one-ended and two-ended DSBs. 
Homologous recombination (HR) repairs one ended DSBs arising in S-phase, but also two ended DSBs in G2 phase. 
In G2 phase HR, the DSB break is recognized by the MRN complex (Rad 50, Mre11 and NBS1), which then recruits 
ATM to the DSB site. Following ATM mediated resection and coating of single stranded DNA by RPA, members of 
the ‘Rad’ family together with BRCA1 and BRCA2, search the intact sister chromatid for a homologous region. Once 
the region has been located on the sister chromatid it is used as a template and the gaps are filled in by a polymerase 
without lose of genetic information. Finally the strands are ligated. In S-phase, the HR pathway is thought to be 
utilised for the restoration of collapsed replication forks that lead to the formation of one-ended DSBs. This process 
requires the core HR components (Rad family, BRCA1, BRCA2) and leads to the formation of a D-loop that can lead 
to the formation of an SCE upon resolution. Adapted from (Jeggo et al, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
replication fork
stalling/collapse
S-phase
one-ended DSB
replication fork recovery
S-/G2-phase
two-ended DSB
D-loop
formation
DSB repair
ionizing
irradiation
  
 
 
 
 
!!
$*!
 The HR pathway is initiated by extensive 5’to3’ resection of the DNA ends to 
generate single stranded DNA overhangs (Elgin & Grewal, 2003). The process of 
resection is regulated by many factors and will be discussed in more detail in chapter 4. 
Briefly, the nuclease activity of MRE11 is thought to initiate resection while CtIP and 
ATM have also been shown to be required for this process (Mimitou & Symington, 
2009b; Shibata et al, 2011). Recent evidence from yeast studies indicates that this first 
step functions to remove Ku and the MRN complex from DNA ends, thus allowing 
further nucleases to access the break and extend the resected regions (Langerak et al, 
2011). The extension step of resection seems to involve the function of further 
nucleases and helicases such as Exo1 and BLM (Nimonkar et al, 2008; Mimitou & 
Symington, 2009a). In addition, multiple factors function to ensure that extensive 
resection does not take place as this could have deleterious consequences for the cell 
(Hu et al, 2011). How the process of resection is regulated and the interplay between 
key factors of the process is a main aim of this thesis and is analysed in chapter 4. 
 Once the ssDNA overhangs have been generated, they are quickly bound to and 
coated by RPA which protects the overhangs from further degradation and prevents the 
formation of secondary structures (Fanning et al, 2006). In addition, RPA coated DNA 
leads to ATR activation, which is important for the checkpoint response. Next, RPA 
becomes displaced and Rad51 is loaded onto the ssDNA region. BRCA2 has been 
shown to be an important factor for loading Rad51 on RPA coated DNA and for 
initiating the homology search on the sister chromatid (Liu et al, 2010; Jensen et al, 
2010). The exact mechanism of how the homology search step is completed in not fully 
understood but recent evidence suggests that the process is facilitated by increasing the 
mobility of the damaged chromosomes thus enabling them to locate their homologous 
pair (Miné-Hattab & Rothstein, 2012). Next, Rad51 dependent strand invasion of the 
homologous region takes place which is then used as a template for filling in the 
resected regions (Holthausen et al, 2010). Finally, the strands are separated and restored 
via Holliday junction resolution in a process that requires the endonucleolytic function 
of Mus81 and GEN1 (Rass et al, 2010). 
 
1.7: Relevance of the DDR in human disease. 
 
Efficiently dealing with DNA damage and maintaining genomic stability plays an 
important role in the prevention of human disease. DNA damage and loss of genomic 
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stability is a hallmark of malignant transformation indicating that the DDR has an 
important role in preventing cancer formation. In addition, defects in the response to 
DNA damage also results in microcephaly and/or neurodegeneration suggesting that 
efficient DNA repair processes are important during embryonic neuronal development 
and/or the maintenance of a functional nervous system. Further still, the DDR 
machinery function in a diverse range of biological functions including the generation 
of immune system diversity, and the production of gametes. Consequently, inherited 
DDR defects can lead to increased cancer incidence, neurodegeneration, immune 
deficiency and infertility (Jackson & Bartek, 2009).  
 The human disorders associated with mutations in genes that function in the 
DDR are summarised in table 1.1, but below I will focus on human disorders associated 
with defective DSB repair.  
 
1.8: Human disorders associated with defective DSB repair.  
  
Ataxia Telangiectasia (AT) is an early onset autosomal recessive neurodegenerative 
disorder resulting from mutated ATM. AT is characterised by progressive ataxia but it 
is currently unclear whether ATM prevents this via its role in the DDR. AT patients also 
display increased cancer incidence and clinical radiosensitivity which are attributed to 
the central role of ATM in the DDR (Chun & Gatti, 2004). 
The progressive neurodegeneration of AT patients is due to Purkinje cell loss, 
but it is not clear whether this results from a defective DSB response. Evidence that this 
might be the case comes from another human disorder resulting from mutated MRE11. 
MRE11 is a member of the MRN complex that is required for ATM activation in 
response to DSB induction and functions in the ATM dependent DSB repair pathway 
(Lee et al, 2010). Inheritance of defective MRE11 results in ataxia telangiectasia-like 
disorder (ATLD) which presents as a mild form of AT (Taylor et al, 2004). ATLD 
patients display neurodegeneration similar to AT patients, indicating that this phenotype 
might result from a deficient DNA DSB response. Cultured cells from AT and ATLD 
patients display radiosensitivity and a defective checkpoint response (Lavin, 2008). In 
addition, cultured cells from AT and ATLD patients display a similar DSB repair defect 
following IR exposure indicating that these proteins function in the same pathway 
responding to DNA DSBs (Goodarzi et al, 2008; Lee et al, 2010).  
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Nijmegen breakage syndrome (NBS) is another disorder resulting from a 
defective component of the MRN complex. In this syndrome, mutations in NBS1 result 
in a disorder characterised by microcephaly, clinical radiosensitivity and increased 
cancer predisposition (Saar et al, 1997). The cellular features of NBS cells are similar to 
those of AT cells, consistent with findings that NBS1 is involved in the activation and 
recruitment of ATM to DSBs where they directly interact via the C terminus of NBS1 
(Berkovich et al, 2007). Importantly however, the clinical features of NBS and AT 
patients are very different. Although microcephaly is seen in NBS patients, they do not 
display ataxia and are therefore distinct to AT patients.  
Another human disorder associated with defective DSB repair is LIG4 
syndrome. LIG4 syndrome is a disorder that arises from mutation in the DNA ligase IV 
gene, which, as discussed earlier, is a component of the ligation complex that functions 
in NHEJ. The clinical features of LIG4 syndrome patients include microcephaly, a 
global developmental delay and immunodeficiency (O'Driscoll et al, 2001).  Unlike 
ATM, MRE11 and NBS1 whose role in NHEJ is limited, ligase IV plays an important 
role in the ligation step of all DSBs and consequently LIG4 knockout MEFs display a 
severe DSB repair defect (Riballo et al, 2004). In contrast, ligase IV is dispensable for 
ATM signalling and as a result LIG4 deficient cells have a normal checkpoint response 
(O'Driscoll et al, 2004). Moreover, since NHEJ functions in V(D)J recombination, 
LIG4 patients also display immunodeficiency (O'Driscoll et al, 2001). Another 
distinction is that unlike AT patients where neurodegeneration is progressive, LIG4 
patients are microcephalic but display no neurodegeneration post birth, indicating a role 
for ligase IV in embryonic neuronal development. Recent work from our laboratory 
using a LIG4 syndrome mouse model, suggests that the microcephaly in LIG4 
syndrome, results from apoptosis triggered by unrepaired DSBs that arise in rapidly 
proliferating cells during neurogenesis (Gatz et al, 2011). 
  As discussed earlier, Artemis is a nuclease that functions in the repair of a 
subset of DSBs but also functions to cleave hairpin structures during V(D)J 
recombination (Riballo et al, 2004; Ma et al, 2002).  As a result of these functions, 
radiosensitive severe combined immunodeficiency (RS-SCID) patients, who have 
mutated Artemis, are severely immunodeficient and cells from these patients display 
radiosensitivity in culture (Moshous et al, 2001; O'Driscoll et al, 2004). However, 
Artemis deficient cells are distinct to LIG4 deficient cells as Artemis is only required 
for the repair of a subset of DSBs. They are also distinct to AT cells as they display a 
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proficient checkpoint response and RS-SCID patients are not microcephalic (Riballo et 
al, 2004). 
Seckel Syndrome is an autosomal recessive disorder with clinical features that 
include severe microcephaly, developmental delay and characteristic facial features 
(Goodship et al, 2000). Seckel Syndrome results from defective ATR which, as 
discussed previously, is a key component of the signalling response to DNA damage 
(O'Driscoll et al, 2003). ATR is activated by ssDNA and is the primary kinase 
responding to UV damage that leads to replication stalling in S-phase. ATR-Seckel cells 
display deficient ATR signalling resulting in a defective G2/M checkpoint following 
UV exposure as well as elevated micronuclei formation and nuclear fragmentation 
(Alderton et al, 2004). However Seckel Syndrome cells do not display increased 
sensitivity to IR because the ATM-dependent signalling transduction pathway responds 
directly to induced DSBs. 
In summary, the DDR signalling pathways play important roles in limiting 
malignant transformation by preventing the accumulation of DNA damage and 
maintaining genomic stability. In addition, important roles for components of the DDR 
exist in the development of the neuronal and immune systems as well as in the 
prevention of neurodegeneration.  
 
1.9: The DDR in cancer and cancer therapy. 
 
The importance of the DDR in preventing genomic instability and malignant 
transformation is highlighted in the syndromes described above and others such as 
Fanconi anaemia and Bloom’s syndrome where radiosensitivity and elevated cancer 
incidence are observed due to defective DSB repair (Lord & Ashworth, 2012). 
Moreover, several tumour types exist where DDR defects have been identified in a 
proportion of sporadic tumours and are believed to have contributed to the malignant 
transformation of these tumours. Examples of such tumour types include colorectal 
tumours and ovarian adenocarcinomas where loss of function mutations and epigenetic 
silencing lead to defective mismatch repair and HR, respectively (Lord & Ashworth, 
2012; Cancer Genome Atlas Research Network, 2011).  
 In addition to defects identified in sporadic tumours, several familiar cancers are 
associated with defective HR with a prime example being hereditary breast cancer. The 
HR defect in familial breast cancers most frequently results from mutations in the 
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BRCA1 and BRCA2 genes, which as discussed earlier function in the HR pathway 
responding to DSBs (Powell & Kachnic, 2008). Individuals with BRCA associated 
breast cancer predisposition carry heterozygous mutations in the germ line and during 
their lifetime have an 80% risk of developing breast cancer. This malignant 
transformation entails loss or inactivation of the active wild type allele (Clarke et al, 
2006).   
 There is substantial evidence indicating that the DDR is defective in the majority 
of cancers, resulting in the genetically unstable phenotype of tumour cells. One model 
as to how this arises suggests that the first step to malignant transformation is the 
activation of oncogenes. Activation of these genes leads to rapid proliferation, which is 
associated with DNA damage in S-phase. Uncontrolled replication can lead to the 
formation of DSBs when replication forks collide or when the dNTP pool is depleted 
leading to fork stalling and/or collapsing (Halazonetis et al, 2008). In support of this 
model, elevated levels of endogenous damage have been detected in precancerous 
lesions using DSB markers such as !-H2AX foci (Halazonetis et al, 2008). However the 
intact DDR responses should be able to halt cell cycle progression and ensure that these 
lesions are efficiently repaired. It appears that the progression of precancerous lesions to 
malignant tumours is marked by the inactivation of DDR mechanisms that allow these 
cells to rapidly proliferate in the presence of DNA damage (Halazonetis et al, 2008). 
 The inactivation of DDR components allows tumour cells to proliferate in the 
presence of DNA damage, but also sensitises them to cancer treatments where DNA 
damaging agents such as platinum salts are used. For example, ovarian cancers with 
BRCA defects are sensitive to cross linking agents since there is a requirement for the 
HR pathway in the repair of the induced DNA damage (Lord & Ashworth, 2012). A 
greatly promising research area in cancer therapy is the development of drugs that can 
selectively target the intact DDR pathways of tumour cells. Using such drugs in 
conjunction with DNA damage inducing radiotherapy/chemotherapy can greatly 
increase the effectiveness of these treatments. Topoisomerase and PARP inhibitors are 
examples of drugs that target aspects of the DDR (Pommier et al, 2010; Rouleau et al, 
2010). In both cases, these drugs lead to defective repair of SSBs that upon entry into S-
phase can be converted to toxic DSBs when replication forks encounter these lesions. 
There is a great requirement for the HR pathway for the repair of these DSBs, thus 
making tumours with defective/suppressed HR particularly sensitive to these drugs. 
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 There are several on-going clinical trials where DDR targeting drugs such as the 
PARP inhibitors are used for the treatment of cancers with known HR defects (Lord & 
Ashworth, 2012). However, since the proportion of cancers with known DDR defects is 
relatively small, these drugs do not have widespread use. To increase the usage of DDR 
inhibitors, the DDR defect of individual tumours needs to be identified and advances in 
whole-genome sequencing is making this possible. By identifying the DDR defect of a 
given tumour, the appropriate DDR inhibitor can then be used to sensitise the tumour to 
therapy. There is a long way to go and many obstacles to overcome, but these studies 
highlight the great potential of targeting components of the DDR for therapeutic gain. 
  
 
1.10: Post-translational modifications in the DDR. 
 
Many cellular processes are regulated via post-translational modifications (PTMs) as 
they can lead to the activation, deactivation, degradation, recruitment and interaction of 
factors functioning in these processes. In the DDR, PTMs play a key role in the 
orchestration of the multitude of factors that function to repair and/or respond to DNA 
damage (van Attikum & Gasser, 2009). There are numerous PTMs but here I will 
provide an overview of those that have been demonstrated to function in the DDR.  
 
1.10.1: Poly(ADP-ribosyl)ation. 
 
ADP-ribosylation involves the addition of ADP-ribose moieties to a protein. In a 
process termed PARylation, poly (ADP-ribose) polymerases (PARPs) can add multiple 
moieties to form poly (ADP-ribose) chains, which are the earliest PTM detectable at 
DNA damage sites (Polo & Jackson, 2011).  Histone PARylation leads to the 
recruitment of downstream DNA repair factors including XRCC1 and APLF, which are 
particularly important for single-strand DNA repair (Okano et al, 2003; Rulten et al, 
2008). PARylation is also likely to play a role in DSB repair as it has been reported to 
lead to the recruitment of chromatin remodelling factors and the MRN complex to 
DSBs (Polo et al, 2010; Haince et al, 2008). 
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1.10.2: Phosphorylation.  
 
Protein phosphorylation, involves the post-translation modification of a target protein 
through the addition of a phosphate group. This modification is carried out by a protein 
kinase, which transfers the !-phosphate from ATP to a serine, threonine or tyrosine 
residue on the target protein. There are a vast number of protein kinases in eukaryotic 
cells, which together with protein phosphatases regulate many cellular processes 
through reversible phosphorylation (Johnson, 2009; Barford, 1996). ATM, ATR and 
DNA-PKcs are key protein kinases in the DDR and are members of the 
phosphoinositide 3-kinase related kinase (PIKK) family (Abraham, 2004). These 
kinases can phosphorylate either serine (S) or threonine (T) residues, but show strong 
affinity for sites followed by a glutamine (Q) residue i.e. SQ/TQ sites. Interestingly, 
related kinases that are not involved in the DDR do not show the same affinity for these 
regions. Therefore identification of SQ/TQ sites on proteins can be indicative of 
involvement in the DDR (Matsuoka et al, 2007). Many such targets have been 
identified and implicated in the DDR where their modification by phosphorylation can 
directly regulate their structure and activity. Moreover, phosphorylation of DDR 
components can act as docking sites for the recruitment of downstream components that 
possess phospho-binding motifs such as BRCT and FHA domains (Mohammad & 
Yaffe, 2009).  
 
 
1.10.3: Ubiquitylation. 
 
Ubiquitylation involves the attachment via an isopeptide bond of a 76 amino acid 
polypeptide called ubiquitin to a target protein. Ubiquitin is bound to the target protein 
via its C-terminus and usually to the amino group of a lysine residue on the target 
protein in a three-step process. First, ubiquitin is adenelated on its C-terminus in an 
ATP dependent process by an enzyme known as an E1 ubiquitin ligase. Adenelated 
ubiquitin is then transferred to an E2 ubiquitin ligase before being ligated to the target 
protein in a process catalysed by an E3 ubiquitin ligase. E3 ubiquitin ligases may have 
direct enzymatic activity or may catalyse the ligation of ubiquitin by promoting the 
interaction of the E2 ligase and the target protein (Al-Hakim et al, 2010). 
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Ubiquitylation is similar to phosphorylation in that both utilise ATP hydrolysis. 
In addition, like phosphorylation, the process of ubiquitylation is involved in many 
cellular processes including cell cycle regulation, transcription, protein degradation and 
DNA repair (Trempe, 2011). The involvement in such an array of processes is due to 
the versatility in the formation of the ubiquitin conjugates on target proteins resulting 
from a variety of E2 and E3 complexes. Depending on the desired outcome, a single 
ubiquitin moiety may be attached (monoubiquitylation) or several ubiquitin moieties at 
different lysine residues (poly-monoubiquitylation). Furthermore, ubiquitin itself 
possesses seven lysine residues which themselves can be ubiquitylated resulting in the 
formation of ubiquitin chains (polyubiquitylation). These chains may lead to the cellular 
relocalisation of the target protein or may act as a recruitment platform for other 
proteins possessing ubiquitin interacting motifs. Finally, cells utilise de-ubiquitin 
enzymes to make the process reversible therefore adding a further layer of regulation 
(Ulrich & Walden, 2010).  
 
1.10.4: Sumoylation.  
 
Sumoylation is another post-translational modification that has been implicated in 
aspects of the DNA damage response (Gareau & Lima, 2010). Similar to the ubiquitin 
pathway, sumoylation involves the conjugation of sumo moieties (sumo 1 and sumo 
2/3) onto target proteins via the cooperation of E1, E2 and E3 sumo ligases. However 
unlike the ubiquitin pathway, the sumo pathway only involves two E1 ligases, SAE1 
and SAE2, and one E2 ligase, UBC9. There are however several E3 sumo ligases 
including the PIAS1-4 family.  
 
1.10.5: Methylation. 
 
Methylation is the addition of methyl group(s) to target proteins. When methylation is 
carried out on a lysine residue by a methyltransferase, it can involve the addition of one 
(mono) two (di) or three (tri) methyl groups. Methylated histones have been reported to 
play a role in the DDR where they function as recruitment sites for factors that contain 
TUDOR, PHD or chromodomains all of which can bind to methylated residues (Polo & 
Jackson, 2011). Such factors include 53BP1 and Tip60, which contain TUDOR and 
chromodomains, respectively. There are currently conflicting reports on whether de 
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novo histone methylation is carried out at DNA damage sites or whether existing 
methylated histones become exposed as a result of other PTMs such as ubiquitylation 
(Pei et al, 2011; Botuyan et al, 2006; Stewart, 2009). A recent study indicated that 
JMJD2A, a factor that binds methylated histones via its tandem TUDOR domain, 
competes with 53BP1 for methylated residues. However, upon the induction of DSBs, 
JMJD2A is ubiquitylated by RNF8 and RNF168 and targeted for proteasomal 
degradation thus allowing 53BP1 to bind to the exposed methylated histones and 
accumulate at DSB sites (Mallette et al, 2012).  
 
1.10.6: Acetylation. 
 
Histone acetylation at DSBs has been well studied by many different groups (Polo & 
Jackson, 2011). Through the joint function of histone acetyltransferases (HATs) and 
histone deacetylases (HDACs), histones at DSBs are modified to facilitate DNA repair. 
It is not currently clear whether HATs and HDACs cooperate at all DSBs or whether the 
function of one or the other is required depending on factors such as chromatin 
compaction and transcriptional status at the damaged DNA site. HDACs have been 
implicated in DSB repair by NHEJ as their depletion leads to defective DSB repair 
(Miller et al, 2010). This is believed to contribute to the radio sensitising effects of 
HDAC inhibitors which are being developed for cancer treatment.  
Histone acetylation is associated with transcription, where it promotes chromatin 
remodelling leading to chromatin relaxation. Similarly, the HAT Tip60 has been 
reported as an important factor in facilitating DSB repair by HR by acetylating histones 
at DNA damage sites and thus increasing chromatin accessibility (Murr et al, 2006).   
 
 
1.11: Chromatin structure. 
 
In cells, DNA does not exist as a naked linear molecule but is rather packaged in a 
highly organised protein-DNA complex called chromatin. Cellular metabolic processes 
in which access to DNA is required need to contend with the highly compact structure 
of chromatin. Chromatin modifications that enable processes such as transcription and 
DNA repair, are generally achieved via histone post-translational modifications and 
chromatin remodellers (Bannister & Kouzarides, 2011; Berger, 2007; Clapier & Cairns, 
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2009). Chromatin can be broadly divided into euchromatin (EU) and heterochromatin 
(HC) (Diagram 1.5).  
 EU represents genomic areas that are relatively decondensed and which are 
frequently transcriptionally active.  However, EU is still heterogeneous in nature with 
different areas enriched for particular modifications at any given time. There are 
numerous PTMs that can occur on chromatin including methylation, acetylation, 
phosphorylation, ubiquitylation, sumoylation and more (Bannister & Kouzarides, 2011). 
These modifications play an important role in transcriptional regulation by acting as 
recruitment platforms for proteins containing domains that bind to the different 
modifications (Bannister & Kouzarides, 2011). The regulation of transcription is highly 
complex as a given modification can act either as an activator or repressor of 
transcription depending on which residue of a given histone it is bound to (Berger, 
2007). Moreover, the possibility of multiple modifications on a single residue as well as 
cross-talk between histone PTMs provide further regulatory layers (Bannister & 
Kouzarides, 2011).  
 Histone modifications and chromatin remodelling in EU are important 
components of the DDR to DSBs arising in EU (van Attikum & Gasser, 2009; Xu & 
Price, 2011). However, ATM, Artemis and mediator proteins appear to be dispensable 
for DSB in EU following exposure to X or gamma radiation. As will be discussed later, 
these components are important for the repair of DSBs that arise within HC regions 
(Goodarzi et al, 2008). 
 
1.11.1: Heterochromatin.   
 
HC reflects areas of the genome that remain particularly condensed throughout the cell 
cycle. HC was first distinguished from EU by its darker nuclear staining patterns and it 
was hypothesised that it corresponds to transcriptionally inactive areas (Trojer & 
Reinberg, 2007). In higher eukaryotes, HC is mainly made up of repetitive DNA, while 
specifically in humans, HC accounts for approximately 10-25 % of the genome (Miklos 
& John, 1979). HC can be divided further into constitutive and facultative HC. 
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Diagram 1.5: Overview of chromatin structure. 
Chromatin can be divided into euchromatin (EU) and heterochromatin (HC). EU represents genomic areas that are 
relatively decondensed and which are transcriptionally active. Moreover, these regions are enriched for epigenetic 
marks that are associated with transcription, such as histone acetylation. These epigenetic marks can act as 
recruitment platforms for transcriptional factors. 
Heterochromatin reflects areas of the genome that remain particularly condensed throughout the cell cycle. These 
areas enriched for epigenetic marks that are associated with transcriptional silencing, such as histone methylation. 
These epigenetic marks recruit repressors, which in turn interact with co-repressors and together these factors lead to 
the formation of the dense HC superstructure. 
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 Constitutive HC corresponds to genomic areas that are transcriptionally inactive 
and are permanently silenced, such as the telomeres and centromeres (Grewal & Jia, 
2007). In addition to permanently silenced genes, these regions contain repetitive and 
non-coding sequences known as satellite DNA. The highly repetitive nature of satellite 
DNA enables the formation of secondary structures that are thought to be important for 
the establishment of constitutive HC (Metzler-Guillemain et al, 2003). 
 Facultative HC is dynamic in nature and provides regulatory control over gene 
expression. Genomic areas that are normally in EU and transcriptionally active, can 
become heterochromatinised and transcriptionally silenced. This is particularly 
prevalent during development and a prime example is the inactive X-chromosome in 
female mammalian cells, which is silenced by the establishment of HC (Yunis & 
Yasmineh, 1971). Another example is the silencing of genomic regions during cellular 
differentiation thus leading to functional specificity in differentiated cells (Trojer & 
Reinberg, 2007).  
 The formation of HC is a highly regulated process that involves the function of 
(i) transcriptional repressors and their associated corepressors,  (ii) histone PTM 
modifiers such as histone deacetylases (HDACs) and histone methyltransferases 
(HMTs), (iii) adapter molecules such as HP1 and Polycomb and (iv) accessory factors 
such as ATP-dependent chromatin remodellers (Craig, 2004; Grewal & Jia, 2007). The 
first step in the process involves the recruitment of transcriptional repressors to gene 
promoters via their DNA-binding motifs, most commonly zinc finger domains (Urnov, 
2002). Next, via protein-protein interaction domains, repressors recruit corepressors, 
which in turn recruit further HC components. An example of such an interaction which 
is particularly important in the DDR, is the interaction of the transcriptional corepressor 
Kruppel-associated box (KRAB)-associated protein (KAP-1) with zinc finger repressors 
containing a KRAB domain (Craig, 2004). In turn, transcriptional corepressors such as 
KAP-1 interact with modifiers including HDACs and HMTs as well as accessory 
factors such as ATP-dependent chromatin remodellers. The combined function of 
HDACs and HMTs lead to HC areas becoming enriched for chromatin modifications 
associated with transcriptional silencing such as H3K9me3 and diminished for 
transcription associated histone acetylation (Trojer & Reinberg, 2007; Berger, 2007). 
These histone modifications lead to the recruitment of adapter molecules including HP1 
and Polycomb that further establish and maintain the HC superstructure by promoting 
nucleosome interactions (Maison & Almouzni, 2004).  
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The combined action of the factors outlined above lead to the establishment and 
maintenance of the HC superstructure. However, there are instances when chromatin 
accessibility is required, such as following the induction of DNA damage. In such cases, 
ATP-dependent chromatin remodellers can be recruited to DNA damage sites via 
interactions with transcriptional repressors or corepressors where they use the energy 
from ATP hydrolysis to remodel nucleosomes and increase chromatin accessibility 
(Craig, 2004; Goodarzi et al, 2011). In recent years, chromatin remodelling has 
emerged as an important aspect of the DDR and a major aim of this thesis is to 
investigate how repair of DSBs associated with HC is achieved in G2 phase (Downs et 
al, 2007).  
 
 
1.12: The ATM signalling cascade to DSBs.  
 
Following DSB induction, a complex signalling cascade is initiated that involves 
sensors, mediators, transducers, and effectors. These factors cooperate to carry out DNA 
repair within the context of chromatin and to interface DNA repair with other cellular 
processes such as transcription and DNA replication (Diagram 1.6). 
 Sensor proteins including the Ku70/80 heterodimer and the MRN complex 
detect DSBs following IR exposure and mark the first step in the DDR to DSB 
induction (Mimori & Hardin, 1986; Lavin, 2007). The recruitment of these factors is 
thought to stabilise the break and prevents the DNA ends from drifting apart. The MRN 
complex binds to DSBs as a heterotetramer, and tethers the DNA ends by direct 
interaction between the two Rad50 molecules (Moreno-Herrero et al, 2005). The MRN 
complex also plays an important role in the recruitment of ATM to DSB sites via a 
direct interaction between the C-terminal region of NBS1 and ATM (Berkovich et al, 
2007; You et al, 2005).  
 ATM is recruited to DSBs as a dimer, where it undergoes autophosphorylation 
on serine 1981 leading to dimer disassociation and activation of its kinase activity 
(Bakkenist & Kastan, 2003). Following activation of its kinase activity, ATM 
phosphorylates many downstream substrates including the histone variant H2AX on 
serine 139 (!-H2AX) (Rogakou et al, 1998). This phosphorylation triggers a cascade of 
events leading to the recruitment of an ever-expanding family of proteins that enable 
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efficient DSB repair by mediating chromatin remodelling, DSB repair pathway choice, 
checkpoint maintenance and more (Harper & Elledge, 2007). 
 Following the phosphorylation of histone H2AX, MDC1 is recruited to DSBs 
where it directly binds to the C-terminal region of !-H2AX via its BRCT domains 
(Stucki et al, 2005). In addition to BRCT domains, MDC1 also possesses an FHA 
domain capable of phosphospecific interactions but this is dispensable for its 
association with !-H2AX. The formation of !-H2AX and the recruitment of MDC1 
occur with fast kinetics and are visible within minutes following DSB induction 
(Bekker-Jensen & Mailand, 2010). Binding of MDC1 to !-H2AX prevents !-H2AX 
from being dephosphorylated, but also allows MDC1 to act as a binding platform for 
the recruitment of downstream factors. NBS1, which directly binds ATM, interacts with 
MDC1 via its FHA domain and this interaction retains ATM, leading to the spread of !-
H2AX over megabases (Lukas et al, 2004a; Stucki & Jackson, 2006; Rogakou et al, 
1999). MDC1 also possesses conserved T-Q-X-F clusters, which as discussed earlier, 
are ATM/ATR substrate motifs (Mailand et al, 2007). Phosphorylated MDC1 is 
recognised and bound by the E3 ubiquitin ligase, RNF8, via RNF8’s FHA domain 
(Mailand et al, 2007). This initiates the component of the ATM signalling cascade that 
is controlled by ubiquitin signalling. 
 RNF8 possesses a RING finger domain as well an FHA domain. The RING 
finger domain of RNF8 is dispensable for focal accumulation but is required for its 
ubiquitin ligase activity (Mailand et al, 2007). Following RNF8 recruitment, its 
ubiquitin ligase activity is stimulated by HERC2 (Bekker-Jensen et al, 2010). HERC2 is 
phosphorylated in response to DNA damage by either ATM, ATR or DNA-PK on Thr 
48227 and this triggers its recruitment to DSB sites via an interaction with the FHA 
domain of RNF8 (Bekker-Jensen et al, 2010). HERC2 is thought to catalyse and 
stabilise the interaction between the RING finger domain of RNF8 and the E2 enzyme 
UBC13, an interaction that is required for the ubiquitin ligase activity of RNF8 
(Bekker-Jensen et al, 2010). As mentioned previously, ubiquitin chains can form on a 
number of lysine residues, but only interaction with the E2 ligase UBC13 results in 
RNF8 mediated K63 linked ubiquitin chains (Plans et al, 2006). Therefore HERC2 
catalyses the interaction between UBC13 and RNF8 and promotes K63 linked ubiquitin 
chain formation (Bekker-Jensen et al, 2010). 
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Diagram 1.6: The ATM signalling cascade to DSBs leading to HC relaxation 
Upon the induction of a DSB, the lesion is detected by the MRN complex, which then recruits inactive dimer ATM to 
the DSB site. Once at DSB sites, ATM undergoes autophosphorylation, leading to its monomerisation and activation. 
Upon activation, ATM phosphorylates downstream targets including histone H2AX. Phosphorylated H2AX is 
recognised and bound to by MDC1, which then acts as a scaffold for the recruitment of further repair factors 
including RNF8 and RNF168. RNF8 ubiquitylates downstream substrates such as histone H2A and JMJD2A, leading 
to the formation of K63 and K48 ubiquitin chains respectively. RNF168 amplifies the RNF8 signal and catalyses the 
formation of K63 linked polyubiquitin chains which are then recognised and bound to by factors such as RNF169 and 
RAP80 which contain UIM motifs. RNF8 catalysed K48 linked ubiquitylation, targets substrates such as the methyl 
binding factor JMJD2A for proteasomal degradation, thus exposing methylated histones and leading to the 
recruitment of 53BP1 to these regions. 53BP1 interacts with the MRN complex via a direct interaction between its 
BRCT domains and the Rad50 subunit of the MRN complex (Lee et al, 2010). This interaction results in tethering of 
activated ATM at DSBs since ATM interacts with NBS1, another subunit of the MRN complex (You et al, 2005). 
53BP1 dependent tethering of ATM at DSBs leads to concentrated and localised KAP1 phosphorylation (pKAP1), 
which leads to HC relaxation and allows the repair machinery to access the DSB. Original diagram by A.A Goodarzi. 
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 Following the activation of its E3 ligase activity, RNF8 ubiquitylates chromatin 
surrounding the DSB predominantly on histones H2A and H2AX (Mailand et al, 2007; 
Huen et al, 2007). This results in the accumulation of K63 linked ubiquitin conjugates 
at DSBs (Kolas et al, 2007; Wang & Elledge, 2007; Zhao et al, 2007). Interestingly, the 
ubiquitin pathway appears to function in parallel to the SUMO pathway since the E3 
SUMO ligases PIAS1 and PIAS4 also accumulate at DSBs and form SUMO1 and 
SUMO2/3 conjugates (Galanty et al, 2009). PIAS1 and PIAS4 are dispensable for 
RNF8 recruitment to DSBs but their depletion compromises the formation of ubiquitin 
conjugates, suggesting that SUMOylation might regulate RNF8 ubiquitin ligase activity 
(Galanty et al, 2009). The formation of ubiquitin conjugates at DSBs is required for the 
recruitment of downstream factors via motifs capable of interacting with ubiquitin. One 
such factor is the ubiquitin ligase RNF168, which is mutated in RIDDLE syndrome 
(Stewart et al, 2009). RNF168 possesses a RING finger domain but also two interacting 
with ubiquitin (UIM) motifs which target it to the ubiquitylated histones flanking DSBs 
(Doil et al, 2009). Once at DSB sites, RNF168 interacts with UBC13 and amplifies the 
RNF8 initiated ubiquitin response by further ubiquitylating histones H2A and H2AX 
leading to the recruitment of 53BP1 and BRCA1 (Doil et al, 2009; Stewart et al, 2009). 
Interestingly, a recent study demonstrated that RNF169, another E3 ubiquitin ligase 
paralogous to RNF168, is recruited to DSBs downstream of RNF8 and RNF168 
(Poulsen et al, 2012). RNF169 is recruited to RNF8/RNF168 catalysed ubiquitin chains 
via its UIM and appears to compete with BRCA1 and 53BP1 for ubiquitin modified 
chromatin at DSBs (Poulsen et al, 2012). Since 53BP1 has been described as a factor 
that is inhibitory to HR, it is suggested that by delaying its accumulation to DSBs, 
RNF169 inhibits NHEJ and promotes repair by HR (Poulsen et al, 2012). The ubiquitin 
ligase activity of RNF169 appears to be dispensable for this function, as well as for the 
formation of the ubiquitylation products that lead to the recruitment of 53BP1 and 
BRCA1 (Poulsen et al, 2012). 
 The recruitment of BRCA1 to DSB sites is promoted via its interaction with 
RAP80, a factor that possesses a UIM capable of binding to ubiquitin chains (Sobhian 
et al, 2007). However, recent studies have suggested that RAP80 is enhancing but not 
essential for BRCA1 recruitment to DSBs (Hu et al, 2011). Conversely, the mechanism 
of 53BP1 recruitment to DSBs has remained elusive although RNF8/RNF168 and the 
upstream signalling response are clearly important (Stewart, 2009). The mystery 
surrounding the recruitment of 53BP1 to DSBs stems from the fact that 53BP1 does not 
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possess a motif capable of interacting with ubiquitin but rather binds to histone H4 
dimethylated on lysine 20 (H4K20me2) via its TUDOR domain (Botuyan et al, 2006). 
Moreover, there have been conflicting reports on whether this modification increases 
following DNA damage, or whether other modifications such as histone ubiquitylation 
lead to the exposure of the methylated histones to which 53BP1 binds (Pei et al, 2011; 
Botuyan et al, 2006). The results of three recent studies, support a model whereby 
53BP1 recruitment is facilitated via the disassociation or degradation of factors bound 
to H4K20me2 at DSBs, thus allowing 53BP1 recruitment (Acs et al, 2011; Meerang et 
al, 2011; Mallette et al, 2012). Acs et al demonstrate that the VCP-NPL4 complex is 
recruited to DSBs via the interaction of NPL4 with ubiquitylated histones. Once at DSB 
sites, this complex interacts with ubiquitylated L3MBTL1, a Polycomb protein that 
binds H4K20me1/2. The ATPase activity of VCP then promotes the disassociation of 
L3MBTL1 from chromatin thus exposing H4K20me2 and allowing 53BP1 assembly 
(Acs et al, 2011). Interestingly, Meerang et al indicated that the recruitment of the VCP-
NPL4 to DSBs depends on RNF8 mediated K48 and not K63 ubiquitylated chains 
(Meerang et al, 2011). Moreover this study demonstrates that the ATPase activity of 
VCP is required to extract K48 ubiquitylated proteins from DSBs and that this is 
required for the accumulation of 53BP1 and BRCA1 (Meerang et al, 2011). Given this, 
it is likely that the ubiquitylation of L3MBTL1 results in K48 linked ubiquitin chains 
resulting in its disassociation from chromatin by VCP. Finally, Mallette et al 
demonstrated that JMJD2A, a factor that possesses a TUDOR domain, binds to 
H4K20me2 and competes with 53BP1 for these sites. However, following DNA 
damage, JMJD2A is ubiquitylated by RNF8/RNF168 leading to the formation of K48 
linked ubiquitin chains (Mallette et al, 2012). This modification targets JMJD2A for 
proteasomal degradation thus leading to its removal from chromatin and allowing 
53BP1 to bind the vacant H3K20me2 sites. In summary, these studies provide a model 
for the recruitment of 53BP1 to DSB sites but also highlight the significance of both 
K63 and K48 linked RNF8/RNF168 mediated ubiquitin modifications in the DDR. 
 Once recruited to DSBs, 53BP1 interacts with the MRN complex via a direct 
interaction between its BRCT domains and the Rad50 subunit of the MRN complex 
(Lee et al, 2010). This interaction results in tethering of activated ATM at DSBs since 
ATM interacts with NBS1, another subunit of the MRN complex (You et al, 2005). 
53BP1 dependent tethering of ATM at DSBs is important for the maintenance of G2/M 
checkpoint arrest following IR exposure >3Gy, but also for the repair of DSBs at HC 
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regions (Shibata et al, 2010; Noon et al, 2010). DSBs at HC regions require 
concentrated and localised KAP1 phosphorylation (pKAP1) for HC relaxation and 
53BP1 mediates this process by concentrating active ATM at these sites (Noon et al, 
2010). During heterochromatin formation, SUMOylated KAP1 interacts with the 
nucleosome remodeller CHD3 which promotes nucleosome compaction. However, 
KAP1 phosphorylation on Ser 824 following DNA damage, generates a motif that 
disturbs the CHD3-KAP1 interaction leading to the disassociation of CHD3 from 
chromatin, which in turn results in chromatin relaxation (Goodarzi et al, 2011).  
 Several of the factors described in this signalling response to DSBs have 
additional roles in the DDR and do not simply function to mediate ATM dependent HC 
relaxation.  In addition, other factors such as BRCA1 are recruited as part of this 
signalling cascade but are, in fact, dispensable for pKAP1 formation (see chapter 4). 
Nevertheless, the ATM signalling cascade resulting in HC relaxation is an important 
part of the DDR and is required for the repair of DSBs residing at HC regions. Such 
DSBs account for ~20% of X and gamma ray induced DSBs. 
 Chromatin decondensation is particularly important for the repair of DSBs 
localised at HC regions, but this is not to say that it does not take place in EU also. 
Indeed, chromatin structure has been shown to be inhibitory to processes such as 
transcription, and large-scale chromatin decondensation is required to facilitate these 
processes (Müller et al, 2001). Similarly, chromatin remodelling at DSBs appears to be 
important for the recruitment of repair factors such as RNF168 and BRCA1. 
Interestingly, a recent study demonstrated that RNF8 functions together with the 
chromatin remodeller CHD4 to promote the extensive chromatin decondensation that is 
required for the recruitment of downstream repair factors (Luijsterburg et al, 2012). 
RNF8 recruits CHD4 to DSB sites via its FHA domain where the chromatin 
remodelling activity of CHD4 functions to decondense chromatin in a manner 
dependent upon its ATPase activity (Luijsterburg et al, 2012). Although the recruitment 
of CHD4 and the associated chromatin decondensation does not depend upon the 
ubiquitin ligase activity of RNF8, the ATPase activity of CHD4 promotes the RNF8 
mediated ubiquitin modifications required for the accumulation of downstream factors 
(Luijsterburg et al, 2012). Therefore, it appears that chromatin decondensation is 
important for DSB repair both in HC and EU, although ATM function appears to be 
dispensable for RNF8-CHD4 mediated chromatin remodelling. 
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1.13: DSB repair pathway choice.  
 
As discussed previously, cells have evolved two main mechanisms for repairing DSBs, 
NHEJ and HR. However, the presence of multiple repair pathways raises an important 
question. What are the factors that determine DSB repair pathway choice, and how is 
the choice of repair pathway regulated? Recent work has provided insight into these 
questions but several unanswered questions remain. There appear to be two main 
determinants of DSB repair pathway choice. The first is the position of the cell in the 
cell cycle, and the second is whether or not DNA resection is initiated (Symington & 
Gautier, 2011). The regulation of resection has emerged as an intricately controlled 
process that affects DSB repair pathway choice in all cell cycle phases (Shibata et al, 
2011; Mimitou & Symington, 2011; Yun & Hiom, 2009; Zhang & Jasin, 2010). 
 Until recently, the only known determining factor of DSB repair pathway choice 
was cell cycle phase. The general view was that G1 cells utilise the NHEJ pathway 
while in S/G2 phase, HR is the predominant repair pathway since the presence of a 
homologous template on the sister chromatid can be used for accurate repair. However, 
in light of recent findings, this is an oversimplified model that does not take into 
account the effect on pathway choice of parameters such as DNA damage complexity 
and chromatin structure at the damaged site (Shibata et al, 2011). Moreover, despite HR 
being functional in G2 phase, NHEJ is still the dominant repair pathway in G2, as only 
~20% of X and gamma ray induced DSBs are repaired by HR (Beucher et al, 2009). 
Therefore, although cell cycle phase does impact on DSB repair pathway choice, it is 
not the determining factor. 
 Recent work from our laboratory indicated that in mammalian cells, both the 
complexity of DNA damage and the chromatin complexity surrounding the DSB are 
determining factors in DSB repair pathway choice (Shibata et al, 2011). High LET 
carbon-ion induced DSBs are more ‘complex’ than etoposide induced DSBs as they 
lead to the formation of clustered damaged sites containing multiple DSBs and other 
forms of damage. Such lesions are more likely to undergo resection and repair by HR. 
On the other hand, etoposide induced DSBs are predominantly repaired with fast 
kinetics by NHEJ also in G2 phase. However, when etoposide induced DSBs are 
located at HC regions, they undergo resection and are repaired by HR (Shibata et al, 
2011). Therefore, at least in G2 phase, DNA damage complexity and chromatin 
structure surrounding the DSB are determining factors in DSB repair pathway choice. 
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 Following the induction of DSBs, Ku and the MRN complex rapidly bind all 
DSBs (Mimori & Hardin, 1986; Lavin, 2007). It appears that Ku binding to DSBs and 
the subsequent recruitment of DNA-PK promote fast re-joining of the DNA ends by 
NHEJ. However, when repair by NHEJ is not possible, DNA end resection is initiated 
leading to DSB repair by HR in G2 phase and by MMEJ in G1 phase (Shibata et al, 
2011; Yun & Hiom, 2009). However, prior to the initiation of resection, Ku must 
disassociate from the DNA ends since its presence is inhibitory to resection (Fattah et 
al, 2010; Shao et al, 2012; Sun et al, 2012; Langerak et al, 2011). Although the removal 
of Ku from DNA ends appears to be critical for the initiation of resection, the 
mechanism of how this is achieved is still unclear. Work in Schizosaccharomyces 
pombe demonstrated a role for the nuclease activity of Mre11 and Ctp1/CtIP in the 
disassociation of Ku70/Ku80 and the MRN complex from DSB ends (Langerak et al, 
2011). Another study monitoring the removal of the meiotic transecterase, Spo11, from 
meiotic DSBs in Saccharomyces cerevisiae also described an important role for MRE11 
in this process (Garcia et al, 2011). This study revealed that MRE11 endonuclease 
activity introduces nicks up to 300 nucleotides from the DNA end, which initiates 
bidirectional resection by Exo1 in the 5’-3’ direction and by the exonuclease activity of 
MRE11 in the 3’-5’ direction (Garcia et al, 2011). This bidirectional resection leads to 
the disassociation of Spo11 from the DNA but also creates a ssDNA overhang. It is not 
yet clear whether Ku is removed from DSB ends by a similar mechanism. An 
alternative model is that Ku disassociates from DNA ends following PTM. Work using 
Xenopus laevis egg extract, demonstrated that Ku80 is ubiquitylated following DSB 
induction and that the formation of K48 linked ubiquitin chains on Ku80 is required for 
its removal from DSB ends (Postow et al, 2008). Similarly, a study using human cells 
demonstrated that Ku80 is ubiquitylated by RNF8 following DNA damage leading to 
the formation of K48 linked ubiquitin chains on Ku80. This leads to its disassociation 
from the DNA ends and targets it for degradation (Feng & Chen, 2012). Although the 
precise mechanism leading to the removal of Ku from DSB ends is not fully 
understood, it is an important step in the resection process and reveals important roles 
for MRE11 and RNF8 in the regulation of DSB repair pathway choice. 
 Another key factor in DSB repair pathway choice via its role in DNA resection 
is CtIP (Huertas & Jackson, 2009; Sartori et al, 2007; You et al, 2009; Yun & Hiom, 
2009; Shibata et al, 2011). Specifically in the S and G2 phases of the cell cycle, CtIP is 
phosphorylated by CDK on Ser 327 which promotes its interaction with the BRCT 
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domain of BRCA1 (Yu & Chen, 2004; Huertas & Jackson, 2009). This interaction is 
important for an efficient checkpoint response to the induction of DNA damage and for 
efficient repair by HR (Yu & Chen, 2004; Yun & Hiom, 2009). During HR, CtIP is 
required for the initiation of resection and its function in this process is modulated by 
CDK dependent phosphorylation on Thr 847 (Sartori et al, 2007; Huertas & Jackson, 
2009). Furthermore, recent work has demonstrated that in the G2 phase, ATM regulates 
resection via direct phosphorylation of CtIP on Ser 644/745 (Shibata et al, 2011). These 
findings demonstrate roles for CtIP, CDK and ATM in DSB pathway choice via the 
regulation of resection. Surprisingly, following exposure to IR in G2, if the initiation of 
resection is abolished via depletion of CtIP or the inhibition of ATM, then repair can 
ensue with faster kinetics by NHEJ (Shibata et al, 2011). This demonstrates that the 
initiation, or not, of resection is a key event in DSB repair pathway choice. 
    CtIP also functions in resection during MMEJ in G1 phase, but this role does 
not depend on its interaction with BRCA1 (Yun & Hiom, 2009). It is also not currently 
clear whether CDK and ATM regulate CtIP function during G1 phase resection. The 
slow component of repair in G1 phase is thought to correspond to DSBs that undergo 
resection and repair by MMEJ. A recent study demonstrated that this alternative re-
joining pathway leads to chromosomal translocations that can be prevented by the 
depletion of CtIP, which prevents the initiation of resection and promotes repair by C-
NHEJ (Zhang & Jasin, 2010). These findings suggest that in both the G1 and G2 cell 
cycle phases, the regulation of resection determines DSB repair pathway choice.  
 
 
1.14: Interfacing DSB repair with transcription. 
 
 Collision of DNA polymerases with DNA damage during S-phase, can be 
particularly deleterious to the cell as this can lead to collapsed replication forks and the 
formation of DSBs. To prevent this happening, cells are able to block entry into S-phase 
via the G1/S checkpoint but are also able to slow down actively replicating cells via the 
intra-S-phase checkpoint. Similarly, when RNA polymerases encounter DNA damage 
such as bulky lesions they can become stalled. Cells are able to overcome this by 
transcription-coupled repair which involves the ubiquitylation and degradation of the 
stalled polymerase (O'Connell & Harper, 2007). The presence of DSBs can also affect 
the transcription machinery and conversely, the presence of the transcription machinery 
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at DSBs might interfere with the repair machinery. However, since transcription is 
active in interphase cells, cell cycle checkpoints cannot prevent this from happening. As 
will be discussed here, accumulating evidence suggests that through PTMs and 
chromatin remodelling, cells actively inhibit transcription in cis to DSBs and only 
restore it following the completion of repair. 
 One of the earliest events following DSB induction is the PARylation of 
histones by PARPs (Polo & Jackson, 2011). This modification leads to the recruitment 
of repair factors as well as the recruitment of the polycomb group (PcG) of 
transcriptional repressors, and chromatin remodellers such as the NuRD complex (Chou 
et al, 2010). As discussed earlier, these factors are associated with transcriptional 
repression and heterochromatinisation. Components of the NuRD complex include 
HDAC1/HDAC2 and the ATPases, CHD3/CHD4, all of which have been implicated in 
gene regulation and various aspects of the DDR (Denslow & Wade, 2007; Smeenk et al, 
2010; Polo et al, 2010; Goodarzi et al, 2011; Larsen et al, 2010; Luijsterburg et al, 
2012). It is thought that rapid accumulation of these factors to DSBs via PARylation of 
histones flanking DSBs, leads to the transient formation of an HC like structure that is 
inhibitory to transcription. In support of this model, the PARP dependent recruitment of 
PcG and NuRD components to UV laser microirradiation tracks is associated with the 
loss of nascent RNA and elongating RNA polymerases from these regions (Chou et al, 
2010). 
 The mechanism whereby the PcG and NuRD complexes achieve transcriptional 
repression following DSB induction seems to involve histone ubiquitylation. The 
polycomb repressive complex 1 (PRC1) contains BMI1, RING1 and RING2 and 
functions as an E3 ubiquitin ligase (Ismail et al, 2010). Following its rapid recruitment 
to DSBs, the PRC1 factor BMI1 ubiquitylates histones H2A and !-H2AX which has 
been shown to be important for transcriptional repression and accurate DSB repair 
(Wang et al, 2004; Ismail et al, 2010). On the other hand, the RING1b/RNF2 ubiquitin 
ligase that is the canonical ubiquitin ligase of H2A was recently shown to mediate 
chromatin compaction independently of its ubiquitin ligase activity (Eskeland et al, 
2010). It is therefore currently debatable how the PRC1 complex promotes chromatin 
compaction and transcriptional silencing and whether this involves histone 
ubiquitylation. Interestingly, the recruitment of PcG and NuRD to DSBs is ATM, ATR 
and histone H2AX independent, indicating that the initial transient inhibition of 
transcription is independent of these factors (Chou et al, 2010). 
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 Rapid recruitment of the NuRD chromatin-remodelling complex to DSBs has 
been reported to promote histone ubiquitylation. In particular the CHD4 subunit is 
required for RNF168 recruitment by promoting RNF8 catalysed histone ubiquitylation 
(Larsen et al, 2010; Luijsterburg et al, 2012). Similarly, the p400 SWI/SNF ATPase, is 
recruited to DSBs where it destabilises nucleosomes, a process that is required for 
RNF8 to ubiquitylate histones flanking DSBs (Xu et al, 2010). The recruitment of 
RNF8 and RNF168 leads to localised histone H2A ubiquitylation and to the formation 
of K63 ubiquitin chains. This event seems to represent a switch from the transient 
inhibition of transcription conferred by the PcG and NuRD complexes, to a more 
sustained response that is dependent on RNF8/RNF168 and histone H2A ubiquitylation 
(Wang et al, 2004; Shanbhag et al, 2010). Consequently, RNF8/RNF168 depletion 
leads to reduced H2A ubiquitylation and defective transcriptional silencing in cis to 
DSBs (Huen et al, 2007; Mailand et al, 2007; Doil et al, 2009; Stewart et al, 2009; 
Shanbhag et al, 2010). Importantly, although the transient response is ATM 
independent, the more sustained response is ATM dependent, since ATMi leads to 
defective transcriptional silencing (Shanbhag et al, 2010). Mechanistically ATM 
appears to inhibit both RNA Pol I transcriptional initiation and RNA Pol II 
transcriptional elongation. In a pathway involving NSB1 and MDC1, ATM appears to 
inhibit Pol I transcription by interfering with the assembly of the Pol I initiation 
complex (Kruhlak et al, 2007). In parallel, ATM is required for H2A ubiquitylation and 
the formation of K63 ubiquitin chains but is also required for the maintenance of H2A 
ubiquitylation (Shanbhag et al, 2010). ATM therefore prevents H2A DUBing in cis to 
DSBs and inhibits the chromatin decondensation associated with transcription 
(Shanbhag et al, 2010). 
 In summary, a complex signalling network involving chromatin remodelling and 
PTMs leads to a transient inhibition of transcription following DNA damage that may 
or may not require histone ubiquitylation. If necessary, a more sustained response is 
activated via RNF8/RNF168 histone H2A ubiquitylation. This response is maintained 
by ATM and is reversed only following the completion of repair by USP16 mediated 
histone DUBing (Shanbhag et al, 2010).  
Interestingly, ATM and RNF8/RNF168 are required to prevent transcription 
associated chromatin decondensation in cis to DSBs which is distinct to their role at HC 
where they promote chromatin relaxation (Shanbhag et al, 2010; Noon et al, 2010). 
Moreover, RNF8 can also promote chromatin relaxation via its interaction with the 
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CHD4 ATPase (Luijsterburg et al, 2012). It therefore appears that these factors are able 
to manipulate chromatin structure in several ways depending on the organisation and 
transcriptional status of the chromatin surrounding a DSB. 
 
 
1.15: Aims of this thesis. 
 
Work from our laboratory has demonstrated that ATM, Artemis and the mediator 
proteins are required for the repair of a subset of IR induced DSBs in G1 phase (Riballo 
et al, 2004). Subsequent work demonstrated that these DSBs are repaired with slow 
kinetics and represent DSBs arising at HC regions. The repair of such DSBs requires 
ATM and mediator protein dependent localised KAP1 phosphorylation to relax 
chromatin surrounding these DSBs (Goodarzi et al, 2008; Lee et al, 2010; Noon et al, 
2010; Goodarzi et al, 2011). Similarly, in G2 phase ATM and Artemis are also required 
for slowly repaired DSBs, but in G2 phase these lesions are repaired by HR (Beucher et 
al, 2009). During G2 phase DSB repair, ATM promotes HC relaxation as in G1 phase, 
but also has an additional role in initiating DNA resection via CtIP (Shibata et al, 2011). 
The major aim of chapter 3 in this thesis was to investigate whether the mediator 
proteins are also required for G2 phase HR and if so, how they function to facilitate this 
process. 
 The mediator proteins encompass a heterogeneous family of factors with a wide 
array of functional domains. These domains can promote protein-protein interactions or 
enable direct PTM of downstream substrates. Ubiquitin signalling is a PTM that has 
emerged as an important regulatory component of the DDR (Thomson & Guerra-
Rebollo, 2010; Ulrich & Walden, 2010; Ramaekers & Wouters, 2011). In chapter 4 of 
this thesis I investigated the role of the ubiquitin signalling network in HR with 
particular emphasis on the role(s) of the ubiquitin ligases RNF8, RNF168 and BRCA1. 
 As discussed earlier in this chapter, the initiation of resection plays an important 
role in DSB repair pathway choice. The major aim of chapter 5 of this thesis was to 
unravel the mechanistic regulation of this process. To this end, I investigated the role of 
BRCA1 and its interacting proteins in positively and negatively regulating resection. 
Moreover, I addressed how BRCA1 and its interacting proteins interface with 53BP1 
during G2 phase HR to regulate resection and facilitate DSB repair at HC. 
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 In chapter 6, I aimed to build on recent findings demonstrating that ATM and 
RNF8/RNF168 are required for transcriptional silencing in cis to DSBs (Shanbhag et al, 
2010). I aimed to test whether failure to silence transcription leads to defective DSB 
repair. Finally, I aimed to assess whether ATP-dependent chromatin remodellers are 
required for this process, as was previously suggested for NuRD (Chou et al, 2010).  
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CHAPTER 2 
 
Materials and Methods 
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2   Materials and Methods 
 
 
2.1: Cell lines and culturing conditions 
 
 The cell lines that were used in this thesis are: 
• A549: Human lung adenocarcinoma epithelial cell line 
• Hela: Human cervical cancer cell line 
• 1Br hTERT: Immortalised human fibroblasts 
• Wild type and 53BP1-/- mutant mouse embryonic fibroblast (MEF) cell lines 
• Wild type and BRCA1 mutant (RING and BRCT) mouse embryonic fibroblast 
(MEF) cell lines (Brca1FH-WT/FH-WT, BRCA1FH-I26A and BRCA1FH-S1598F MEFs) 
• NIH3T3: Mouse embryonic fibroblast cell line  
• U2OS: Human osteosarcoma cell line 
• U20S 3-6-3: Human osteosarcoma cell line containing DSB and transcription 
reporter system 
• HEK293: Human embryonic kidney cell line 
  
 
A549, Hela, U2OS and HEK293 cell lines were complemented with MEM Complete 
medium made up of: ‘Minimum Essential Medium’ (MEM) (Gibco, UK) supplemented 
with 10% Foetal bovine serum (FBS) (Gibco, UK) and 1% Penicillin and Streptomycin 
(PEST) (Gibco, UK). MEF and 1BrhTERT cells were complemented with DMEM 
Complete medium. U20S reporter cells were cultured in DMEM (GIBCO) containing 
10% Tet-system approved FBS (Clontech), 1% Penicillin/Streptomycin, 200 mg/ml 
G418, and 100 mg/ml hygromycin B. All cells were incubated at 37°C in a humidified 
95% air and 5% CO2 atmosphere. 
 
2.2: Drug treatment and irradiation 
 
Cells were irradiated by exposure to a 137Cs source at a dose rate of 1Gy/8 seconds. For 
G2 phase experiments 4µM Aphidicolin was added to prevent S-phase cells from 
progressing into G2. Where indicated, 10 µM ATM inhibitor (Calbiochem) was added 
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30 minutes before IR. For flow cytometry experiments camptothecin was used at a 
concentration range of 2-4 µM. 
 
2.3: Small interfering RNA (siRNA) knockdown conditions 
 
siRNA-mediated knockdown was achieved using HiPerFect Transfection Reagent 
(Qiagen, Hilden, Germany) using the following transfection conditions. 
Per 2 x 10^5 cells in 2ml media the following was made up and added to suspended 
cells after a 15m incubation: 
• 50-100 pmol of 25 mM stock siRNA solutions 
• 6µl of Hiperfect transfection reagent 
• OptiMEM to a final volume of 100 µl 
 
The cells were then grown for 24 hours and the transfection process was repeated. The 
cells were then grown for an additional 48h prior to IR.  Table 1 indicates the siRNA 
oligos used in this thesis. 
 
 
 
siRNA Manufacturer Sequence 
MDC1 Invitrogen 5 !AAAUCCUGAGACCUCCUAAGGUUUU!
3 ! (nucleotides 736!760) 
RNF8 A Invitrogen 5’-GGACAA UUAUGGACAACAA-3’ 
RNF8 B Invitrogen 5’ -UGCGGAGUAUGAAUAUGAA-3’ 
53BP1 Invitrogen 5´-AGAACGAGGAGACGGUA 
AUAGUGGG-3´ (nucleotides 229–252) 
KAP-1  Invitrogen 5’CAGUGCUGCACUAGCUGUGA 
GGAUA- 3’ (human cDNA nt 450–475) 
BRCA1 
  
Invitrogen  5'-GGAACCUGUCUCCACAAAG-3' 
BRCA1 Dharmacon 
SMARTpool 
siRNA 
 
Ku70 Dharmacon 
SMARTpool 
siRNA 
 
DNAPK Dharmacon 
SMARTpool 
siRNA 
 
Artemis Dharmacon 
SMARTpool 
siRNA 
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BRCA2 Dharmacon 
SMARTpool 
siRNA 
 
MRE11 Dharmacon 
SMARTpool 
siRNA 
 
CtiP Dharmacon 
SMARTpool 
siRNA 
 
H2AX Dharmacon 
SMARTpool 
siRNA 
 
RAP80 Dharmacon 
SMARTpool 
siRNA 
 
BRCC36 Dharmacon 
SMARTpool 
siRNA 
 
Abraxas Invitrogen 5’-
UAUAUAAGGAAUGUUCCAGUCGAUG 
POH1 Dharmacon 
SMARTpool 
siRNA 
 
POH1 Invitrogen 5’- AGAGUUGGAUGGAAGGUUU-3’ 
BRG1 Dharmacon 
SMARTpool 
siRNA 
 
CHD7 Dharmacon 
SMARTpool 
siRNA 
 
BAF180 Dharmacon 
SMARTpool 
siRNA 
 
ATR Dharmacon 
SMARTpool 
siRNA 
 
 
Table 2.1: siRNA oligonucleotides used in this thesis 
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2.4: Immunofluorescence for foci enumeration and analysis. 
 
Cells plated on glass slides were fixed for 10 min with fixative (3% (w/v) PFA, 2% 
(w/v) sucrose, 1X PBS) and permeabilized for 1 min with 0.2 % Triton X-100 in PBS. 
When staining for RPA or Rad51 foci, pre extraction was performed by treating the 
cells with 0.2 % Triton X-100 in PBS for 0.5-1 min prior to PFA fixation. Pre- 
extraction allows the removal of non-chromatin bound protein and thus allows clear 
visualisation of remaining protein. This is important for visualisation of abundant 
proteins such as RPA and Rad51. 
Cells were rinsed with PBS and incubated with primary antibody diluted in PBS 
+ 2%  (w/v) BSA for 1 hour at 37°C. Cells were washed three times, incubated with 
secondary antibody (diluted in PBS + 2% (w/v) BSA) for 30 min at RT in the dark, 
incubated with 4’,6-diamidino-2-phenylindole (DAPI) for 10 min and washed three 
times with PBS. Slides were mounted using Vectasheild and visualized using a Zeiss 
Axioplan microscope and Simple-PCI software or a Nikon e400 microscope. In each 
sample a minimum of 30 cells was scored blindly and error bars represent the s.d 
between three independent experiments. 
 For immunofluorescence on flow cytometry analysis, the following antibodies 
were used in this thesis. 
 
 
Primary Antibodies: 
Antibody Manufacturer Catalogue No. Concentration 
!H2AX Upstate Technology 05636 1:800 
53BP1 Upstate Technology 05726 1:800 
53BP1 Bethyl A300-272A 1:800 
RPA Calbiochem NA 18 1:800 
RPA Lifespan Biosciences LS-C38952 1:100 
Rad51 Santa-Cruz Biotechnology SC8349 1:200 
BRCA1 Home made Freire et al 1:400 
pATM Epitomics 21521 1:200 
pATM Millipore 05-740 1:200 
PCNA Abcam PC10 1:500 
CENPF Abcam Ab5 1:1000 
pKAP1 pS824 Bethyl A300-767A 1:200 
p-Histone H3 Ser 10 Upstate Biotechnology SC8349 1:500 
FK2 Millipore 04-263 1:400 
 
Table 2.2: Primary antibodies used in this thesis 
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Secondary Antibodies: 
Antibody Manufacturer Catalogue No. Concentration 
FITC Sigma F0257 1:200 
CY3 Sigma C2306 1:200 
Alexa 488 Invitrogen A21208 1:400 
Alexa 647 Invitrogen A 31634 1:400 
Alexa 555 Invitrogen A21422 1:400 
 
Table 2.3: Secondary antibodies used in this thesis 
 
2.5: Sister Chromatid Exchanges. 
 
2 x 105 logarithmically cells were grown for 48 h in 10 µM BrdU before IR. 0.2µg/ml 
Colcemid (plus 1mM caffeine to overcome the G2/M arrest) was added from 8 -12 h 
post-IR to collect mitotic cells. The cells were harvested and collected by trypsinisation 
and centrifugation before undergoing hypotonic treatment by being resupsended in 
75mM KCl pre-warmed to 37 °C. Following 30 minutes incubation at 37 °C, the cells 
were centrifuged and re-suspended in fixative solution made up of 3 parts methanol and 
1 part glacial acetic acid. Following three rounds of centrifugations and re-suspension in 
fixative solution, the cells were dropped on ethanol treated glass slides from a height of 
30cm to allow good cell spreading. 
Once the slides were dry, they were stained in the dark for 20m with 
bisbenzimide solution (Hoescht) (10)g/ml in milliQ H2O). The cells were then dipped 
in SSC buffer (2M NaCl, 0.3M tri-sodium citrate, pH7) to remove excess Hoescht stain 
and were then covered by 1ml of SSC buffer and a coverslip. The cells were then placed 
under a UV lamp for 1 hour at a wavelength that excited the Hoescht stain (355nm). 
The slides were then rinsed and incubated in 60 °C SSC buffer for 1 hour. 
Finally the slides were stained for 10 minutes in 6% giemsa-solution in Sörensen 
buffer ( 1:1 mixture of 0,067M Na2HPO4 + 0,067M KH2PO4; pH 7,2) and visualised 
and scored using a Nikon e400 light microscope. SCEs were scored in at least 800 
chromosomes from 3 independent experiments per data point. Note that the 
modifications from standard protocols i.e addition of aphidicolin, addition of caffeine 
and time of harvest, meant that only cells that were in the G2 phase of the cell cycle at 
the time of irradiation were scored. 
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2.6: Flow cytometry. 
 
A549 cells with or without siRNA oligo were seeded in 6cm dishes at a density of 6 x 
105 cells/4ml. Forty eight hours later cells were either treated with 10Gy IR or with 2-4 
µM camptothecin for 1h. Next the cells were washed with PBS containing 1mM EDTA 
(to prevent cellular clumping), trypsinised and collected in universal tubes containing 
complete MEM. The cells were collected by centrifugation and washed two further 
times with EDTA containing PBS. 1ml ice cold Triton was added to the cells to 
permeabilise the cellular membranes and the cells were transferred to eppendorf tubes. 
 Following a 5-minute incubation on ice the cells were washed with PBS once 
more before being fixed with PFA for 10 minutes at room temperature. Following PFA 
fixation, the cells were washed twice with PBS. 
 The fixed cells were then centrifuged at 10000 rpm for 10 minutes and were 
then resuspended in 2% BSA containing the desired antibody (RPA 1:20) (Rad51 1:10) 
and incubated at room temperature for 1 hour. Next the cells were washed with PBS and 
then the secondary antibody was added (Alexa 488 1:200) for 1 hour at room 
temperature. Finally, a PI mix (180)l PBS + 20 )l PI + 2 )l RNAse) was added and 
following a twenty minute incubation, the cells were analysed by a flow cytometer 
FACS CANTO flow cytometer. For each condition a minimum of 10000 events was 
recorded.  
 
 
2.7: Plasmid transfection and expression parameters. 
 
The following plasmid constructs were transfected and transiently overexpressed in this 
thesis: 
• pLPC-puro vector containing amino acids 1220–1711 of 53BP1 fused to 
the fluorescent label mCherry (Dimitrova et al, 2008) 
• GFP vector containing histone H2B 
• M-Cherry vector containing the FOK1 endonuclease 
• EGFP-vector containing full length BAF180 cDNA 
• EGFP vector containing BAF180 cDNA with site directed mutations 
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Transient expression of the above constructs was achieved by transfecting the indicated 
cell lines using the Hiperfect transfection reagent. 1µg of DNA was added to optiMEM 
to a final volume of 100 )l. After a 5 minute incubation, 6 )l of Hiperfect was added 
and the mixture was incubated for 15 minutes before being added to 2 x 105 adherent 
cells in 2ml of media. Depending on which construct was used, the cells were then 
allowed to express the construct for 24-48 hours. 
  
2.8: Live cell imaging. 
 
Live cell imaging was carried out on a Applied Precision® Delta Vision®  
RT Olympus IX70 deconvolution microscope and softWoRx® Suite software fitted 
with an environmental chamber. The environmental chamber kept the cells at 37 °C 
whilst the cells were kept in CO2 independent medium (Gibco UK) for the duration of 
the experiment. Analysis of the live cell imaging data was carried out using the BitPlane 
Imaris software. 
 
 
2.9: 3D rendering and foci volume quantification. 
 
For 3D foci analysis, Z-stack imaging was carried out using an Applied Precision® 
Delta Vision® RT Olympus IX70 deconvolution microscope and softWoRx® Suite 
software. Z-stacks were set at 2 µm and individual nuclei imaged using 100x 
magnification. Following image acquisition, deconvolution was carried out using the 
Huygens Professional image processing software. The deconvolution parameters were 
set as follows: PSF- Theoretical Max iterations- 400 Quality change threshold- 0.01.  
Following deconvolution by the Huygens Professional image processing 
software package, Z-stack images were imported into softWoRx® Suite software for 
3D representation. This was achieved using the model function (A) and then selecting 
the 2D Polygon finder (B). Within the 2D polygon finder, the desired channels (e.g. 
RPA, 53BP1) were selected and then the software detected the 2D representation in 
each Z-stack for each channel (B). The 3D object builder was then selected (B), and the 
2D polygons were combined to create a three dimensional model (C). The 3D model 
was then viewed by selecting the model function (C). By opening the options window 
found within the ‘view’ tab individual channels could be selected and there attributes 
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altered (E). In the example shown in (E), the attributes of the 53BP1 signal are changed 
to ‘wireframe’, from ‘solid’ which they were in (D), allowing visualisation of the 
underlying structure of the 3D objects by making them transparent. In addition this 
allows visualisation of enclosed objects, in this case RPA foci.  
 
 
A) 
 
B) 
 
 
C) 
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D) 
 
 
E) 
 
 
Figure 2.1:  Foci 3D imaging parameters 
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2.10: Foci quantifications Parameters. 
 
Following deconvolution by the Huygens Professional image processing software 
package, Z-stack images were imported into BitPlane Imaris software for foci volume 
quantitation. The Z-stack images were represented in 3D using the ‘Surpass’ option, 
whilst the channels to be analysed were selected from the display adjustment function 
(A). Next, the ‘surfaces’ tool was used to detect the foci in the selected channels (B).  
Finally, statistical parameters (e.g. volume) for the detected objects were exported and 
analysed (C).  In each sample a minimum of 10 cells were analyzed and quantified and 
error bars represent the s.d between three independent experiments. Error bars represent 
the minimum values and maximum valid values. Maximum valid values, determined as 
the highest datum still within 1.5 the interquartile range of the upper quartile, were used 
to eliminate abnormally large values arising from foci ‘clumping’ and resolution 
limitations. 
 
 
 
A) 
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B) 
 
 
 
 
C) 
 
 
 
Figure 2.2:  Foci 3D volume quantification parameters 
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2.11: Site directed mutagenesis. 
 
The phosphomimic and phosphomutant BAF180-GFP constructs were generated using 
the QuikChange® Multi Site-Directed Mutagenesis Kit following the manufacturers 
protocol. The following mutagenic primers were designed and used in these 
experiments. 
 
BAF180 S115 to A: 5'-aggcttacatcgcacatacgcccaggactgtagctttaaa-3' 
BAF180 S115 to E: 5'-ctcaggcttacatcgcacatacgagcaggactgtagctttaaaaaca-3' 
 
The region where the mutations were introduced was sequenced to ensure that the 
mutational changes were successfully introduced. This was achieved using the 
following primers and conditions: 
 
Forward primer: G C C A G G A C T G T A G C T T T A A A A A C A 
Reverse primer: T T C T A G A A A T T T T C G T G T A G C C A G 
 
 
2.12: Laser microirradiation. 
 
Exponentially growing human HEK293 cells were plated onto 35mm glass-bottom 
dishes (MatTek) and transfected with EGFP-BAF180 constructs using Hiperfect 
according to the manufacturers protocol. The cells were allowed to express the 
constructs for 24h and were then incubated with 10 µg/ml Hoechst 33285 for 1 h at 37 
°C before irradiation. EGFP positive cells were irradiated with a 351nm ultraviolet A 
(4.36 J/m2) laser channeled through a *40/1.2-W objective using a Zeiss ConfoCor 
2/LSM510 combi meta point scanning confocal microscope. Ultraviolet A was focused 
to an area of approximately 12 µm*0.1µm, and images were captured at 15s intervals 
following laser damage for a total time of 200s. EGFP signal intensity along the 
irradiation track was quantified using the LSM 520 Meta software. 
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2.13: Transcription reporter system. 
 
Transcription reporter U2OS cells (Shanbhag et al, 2010), were treated with siRNA 
oligonucleotide where indicated. 48h later, the cells were transfected, or not, with the 
mCherry-FOK1 endonuclease plasmid. 24h later, 1 µg/ml doxycycline was added to the 
cells to drive transcription and the cells were harvested 4h later. The cells were then 
visualized on a fluorescent microscope. Doxycycline driven transcription was visualized 
as YFP-MS2 protein binding to MS2 nascent transcript. In cells expressing FOK1, 
DSBs were visualized by FOK1 focal accumulation and transcription in these cells was 
monitored by YPF-MS2. Where indicated, ATMi was added 30m prior to doxycycline 
treatment. The presence or absence of nascent transcripts was analysed in a minimum of 
30 cells per condition and the data represent the mean and standard deviation of three 
independent experiments. 
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CHAPTER 3 
 
The role of the mediator proteins in 
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3   The role of the mediator proteins in Homologous Recombination 
 
 
3.1: Introduction. 
 
Homologous Recombination (HR) functions in the repair of DSBs in the S and G2 
phases of the cell cycle by using the intact sister chromatid as a template for repair. 
However, contrary to the widely held view that HR is the predominant DSB repair 
pathway in G2 phase, HR only repairs 20% of the X and ! ray induced DSBs (Beucher 
et al, 2009). These lesions require ATM and Artemis function for their efficient repair 
and are thought to arise at HC regions (Beucher et al, 2009; Shibata et al, 2011). 
However it is not clear whether other members of the ATM signalling response are also 
required to mediate HR at HC regions in G2 phase. Moreover, ATM appears to have 
distinct roles in facilitating DSB repair at HC in G1 and G2 phase.  In G1 ATM 
facilitates HC repair via KAP1 phosphorylation and although ATM also has this 
function in G2 phase HR, it also functions to initiate resection (Goodarzi et al, 2008; 
Shibata et al, 2011). It is therefore important to establish whether the mediator proteins, 
which promote HC DSB repair in G1 phase, also promote this process in G2 phase and 
whether like ATM they also have additional functions. In this chapter I examine the role 
of the mediator proteins 53BP1 and MDC1 in facilitating DSB repair by HR in G2 
phase. 
 In addition to repairing a fraction of DSBs in G2 phase, the HR pathway is also 
employed to restore replication forks that have stalled/collapsed during S-phase 
(Saintigny et al, 2001). Replication forks can become stalled and ultimately collapse 
when they encounter obstacles such as SSBs or secondary DNA structures (Petermann 
& Helleday, 2010). Agents such as topoisomerase poisons and PARP inhibitors prevent 
the repair of SSBs thus leading to the formation of toxic one-ended DSBs when 
replication forks encounter these lesions (Lundin et al, 2002; Saleh-Gohari et al, 2005). 
HR appears to be the dominant repair pathway of one ended DSBs since HR deficient 
cells are highly sensitive to agents that lead to replication fork stalling/collapse (Groth 
et al, 2012). HR at collapsed replication forks involves the 5’-3’ resection of the one 
ended DSB to produce a ssDNA overhang that becomes coated initially by RPA and 
subsequently by Rad51 (Lundin et al, 2003). Similar to HR repair of two ended DSBs 
in G2 phase, this triggers the invasion of the sister chromatid which is used as a 
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template for the repair of the resected regions (Helleday, 2003). The resulting Holliday 
junction is resolved in a Mus81 dependent manner that may or may not lead to 
crossovers and the formation of an SCE (Roseaulin et al, 2008; Helleday, 2003).  
 The requirement of core HR components such as BRCA2 for the repair of one-
ended DSBs is demonstrated by the sensitivity of cells deficient for these factors to 
drugs such as PARP inhibitors (Bryant et al, 2005). However, the role(s) of the 
mediator proteins in the repair of one-ended DSBs by HR has not been previously 
assessed. In this chapter I examine the role of the mediator proteins 53BP1, and MDC1, 
in DNA resection in S-phase cells following camptothecin treatment. Moreover, I 
examine the requirement of CtIP and ATM for this process as well as the requirement 
for the other PIKK kinases, DNA-PK and ATR. 
 As mentioned previously, HR defective cells are highly sensitive to one-ended 
DSBs that arise following replication fork collapse. One model for this sensitivity, is 
that it results from erroneous re-joining of distant one-ended DSBs by NHEJ (Helleday 
et al, 2007). Here I use live cell imaging (LCI) to monitor the repair of methyl 
methanesulfonate (MMS) induced DSBs in HR proficient and deficient S-phase cells. In 
addition, I assess whether 53BP1 has a role in the distant rejoining of one-ended DSBs. 
53BP1 has previously been shown to facilitate long range rejoining events in telomere 
end to end fusions, during V(D)J recombination and in Class Switch Recombination 
(CSR) (Dimitrova et al, 2008; Difilippantonio et al, 2008; Bothmer et al, 2011). 
Therefore, establishing whether long-range rejoining events during S-phase contribute 
to the genomic instability of HR defective cells, and if 53BP1 is required for these 
events, are important outstanding questions. 
   
 
3.1.2: Monitoring HR in G2 phase. 
 
Traditional plasmid assays have been predominately used to monitor repair of DSBs by 
HR. These involve the integration of a reporter substrate containing an I-SCE1 site 
within one of two defective GFP genes. Following transfection of the I-SCE1 
endonuclease and DSB induction, if the homologous region of the second GFP gene is 
used for repair, this leads to restoration of GFP functionality. Flow cytometry can then 
be used to estimate the frequency of these events within a population of cells and the 
requirement of genetic factors for the process can be determined (Pierce et al, 2001; 
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Stark et al, 2002; Moynahan et al, 2001). However, the limitation of such systems is 
that chromatin structure at the cutting site is defined and does not emulate the 
heterogeneity of chromatin structure and its impact on DSB repair pathway choice and 
outcome. 
 One goal of this chapter was to investigate the role of the mediator proteins in 
homologous recombination in G2 phase. However, since experiments in G1 had 
indicated that the function of these proteins in DSB repair is to modify HC structure, I 
could not use the traditional I-SCEI based assays to assess these functions.  
 First, I needed to ensure that I was able to monitor HR specifically in G2 phase 
cells. Since HR also functions in S-phase it was important to prevent cells irradiated in 
S-phase from progressing into G2. I achieved this by adding aphidicolin to cells prior to 
irradiation. As previous work from our laboratory has shown, this reversible DNA 
polymerase inhibitor leads to S-phase arrest and to a characteristic !-H2AX panuclear 
staining probably due to DSBs from collapsed or stalled replication forks (Beucher et 
al, 2009). In order to identify G2 phase cells, I used a CENP-F antibody. CENP-F 
protein levels peak in G2 phase and are then rapidly degraded after completion of 
mitosis. Subsequently it is a good G2 marker as protein levels are low in G1 and high in 
G2 phase (Liao et al, 1995). Additionally, I was also able to use the !-H2AX pattern 
after aphidicolin treatment to exclude S-phase cells from analysis, which would be 
identified by their panuclear staining for !-H2AX. 
 DNA end resection resulting in the formation of single stranded DNA is the first 
step of HR (Symington & Gautier, 2011) . There appear to be several nucleases and 
other proteins that are involved in this process that has at least two distinct steps 
(Mimitou & Symington, 2011). The first step, is the initiation of resection that seems to 
require the MRE11 nuclease and CtIP whose function is seems to be required to remove 
Ku from DNA ends (Langerak et al, 2011; Sartori et al, 2007). The second step 
involves CtIP and Exo1 which is the 5’-3’ exonuclease that carries out the elongation 
step of resection in HR (Nimonkar et al, 2008; Shibata et al, 2011). The resulting single 
stranded DNA is then rapidly coated by RPA to stabilize the molecule, to protect it from 
further degradation and potentially to prevent it from forming secondary structures 
(Fanning et al, 2006). RPA coated single stranded DNA can be visualized is G2 phase 
by immunostaining with an RPA antibody (Shibata et al, 2011). By two hours after 
exposure to IR in G2, DSBs undergoing repair by HR have accumulated sufficient 
levels of RPA protein for distinct IRIF to be visualized. These foci can be enumerated 
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and provide a clear indication of the efficacy with which this HR intermediate is 
formed. No RPA foci are observed in the absence of CtIP suggesting that RPA foci are 
a good read out for resection (Shibata et al, 2011). 
 Similarly, Rad51 foci also form in G2 phase at DSBs that are repaired by HR 
(Forget & Kowalczykowski, 2010). Following single strand DNA formation and RPA 
coating, Rad51 displaces RPA and initiates the homology search on the undamaged 
template. As for RPA, cells that are deficient in HR fail to form Rad51 foci correctly 
indicating a defect in the process (Yuan et al, 1999) . However, use of Rad51 foci 
allows analysis of a specific HR intermediate and provides insight into which step of the 
process a given factor functions. An example of this is the comparison of BRCA1 and 
BRCA2. Mutant cells for either BRCA1 or BRCA2 display defective HR when 
measured by plasmid based systems (Moynahan et al, 1999; 2001). However, when 
RPA foci are specifically measured, only BRCA1 mutant cells display an RPA foci 
formation defect (Schlegel et al, 2006; Shibata et al, 2011). In contrast, when Rad51 
foci are measured both BRCA1 and BRCA2 mutant cells are defective (Schlegel et al, 
2006; Shibata et al, 2011; Beucher et al, 2009). These assays allow a distinction to be 
made as to where in the HR pathway specific factors function. BRCA2 seems to 
function downstream of BRCA1 and is dispensable for resection while BRCA1 is 
required for both these processes.  
 Finally as readout of the completion of HR, I monitored sister chromatid 
exchange (SCE) formation. SCEs form following Holliday junction resolution and 
represent successful recombination events (Conrad et al, 2011). This is a useful tool as 
different factors display varying degrees of dependency for RPA or Rad51 foci 
formation. Therefore if cells defective for a given protein display a minor RPA foci 
defect, looking at SCEs can monitor the impact of this on the overall outcome of HR. I 
used these assays to assess the direct role(s) of the mediator proteins in G2 phase DSB 
repair by HR, as well as their indirect role in the process via chromatin modifications. 
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3.2: Results 
 
 
3.2.1: IR induced DSBs associated with HC are repaired via HR in G2 phase. 
 
 
We have previously demonstrated that the mediator proteins are required for ATM 
dependent DSB repair in the G1 phase of the cell cycle. The orchestrated accumulation 
of these proteins at DSB sites results in the tethering of activated ATM and the 
subsequent robust phosphorylation of KAP1 at HC DSBs (Noon et al, 2010). Localised 
phosphorylation of KAP1 results in chromatin relaxation, which is important for repair 
of DSBs at dense HC regions. In G1 phase, such DSBs are repaired with slow kinetics 
and, in addition to ATM and the mediator proteins, they also require the nuclease 
Artemis for efficient repair (Riballo et al, 2004). We recently demonstrated that as in 
G1, a fraction of IR induced DSBs in G2 (~20%), also require ATM and Artemis 
(Beucher et al, 2009). 
 DSB repair in G2 phase is also biphasic consisting of a fast and slow 
component. Interestingly however, the slow component of repair in G2 corresponds to 
DSBs being repaired by HR whilst the fast component corresponds to those repaired by 
NHEJ. The observation that ATM and Artemis are required for the slow component of 
DSB repair in G2 raised the interesting possibility that these factors may also function 
in HR. This notion gained favour when analysis was carried out using core components 
of the HR pathway (BRCA2, Rad51) and an epistatic relationship to ATM and Artemis 
was observed (Beucher et al, 2009). We have subsequently demonstrated that ATM is a 
key regulator of DSB repair pathway choice in G2 phase by initiating the process of 
DNA end resection through phosphorylation of the nuclease CtIP (Shibata et al, 2011).  
 In addition to its role in initiating resection, ATM function is also required for 
chromatin de-condensation at DSB sites in G2 and, as in G1, this role can be overcome 
by KAP1 depletion (Beucher et al, 2009). It therefore appears that IR induced DSBs in 
G2 that are associated with HC are specifically repaired by HR. To further substantiate 
this finding, I aimed to show that late repairing DSBs in G2 colocolise with RPA foci 
(depicting ongoing HR) and pKAP1 foci (depicting HC) (Figure 3.1a). Due to changes 
in chromatin superstructure following DNA replication, G2 phase cells have low 
chromatin bound KAP-1 making pKAP1 foci analysis difficult. To visualise pKAP-1 in  
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Figure 3.1: Co-localization analysis of 53BP1, pATM, RPA and pKAP1 IRIF in G2 phase 1BRhTERT 
cells.  
1BRhTERT cells were harvested 8 h post exposure to 3 Gy IR and immunostained with the indicated 
antibodies. Aphidicolin was added to prevent S phase cells progressing into G2 during analysis. Analysis was 
undertaken in G2 phase cells. S phase cells were excluded from analysis by their pan-nuclear RPA staining 
which arises as a consequence of aphidicolin addition. G1 cells do not show RPA foci. Co-localization 
between pKAP1 and 53BP1 (a) and pATM (b) was carried out using softWoRx® Suite software. The Pearson 
Coefficient of Correlation indicates how closely the two intensities are colocalised on a pixel-by-pixel basis 
(full colocalisation is 1.0). RPA foci overlapped with all the above IRIF indicating that these lesions are 
repaired by homologous recombination. G2 phase cells have low chromatin bound KAP-1 making pKAP1 
foci analysis difficult. To visualize pKAP-1 in G2 cells, the cells were subjected to MeCP2 siRNA, which as 
previously observed allows greater foci expansion and visualization of pKAP1 in G2. 
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G2 cells, the cells were subjected to MeCP2 siRNA, which as previously observed, 
allows greater foci expansion and subsequently allowed visualisation of pKAP1 foci 
(Brunton et al, 2011). At late time points (8h) post damage induction, DSB sites marked 
by 53BP1 foci strongly colocalise with pKAP1 foci and RPA foci (Figure 3.1a). 
Additionally, and consistent with previous data, pATM was also retained at DSB sites 
and strongly colocolised with pKAP1 and RPA foci (Figure 3.1b).  
 To further substantiate the notion that HR in G2 phase repairs only HC DSBs, I 
decided to artificially increase the fraction of breaks repaired by HR. To achieve this I 
co-depleted Ku80 and DNA-PKcs by siRNA treatment. Ku80 is a component of the Ku 
heterodimer that rapidly and efficiently binds DNA ends whilst DNA-PKcs is a core 
component of the NHEJ pathway. By depleting Ku80, which is believed to be a barrier 
to DNA resection and by inhibiting NHEJ via DNA-PKcs depletion I was able to 
increase the fraction of breaks repaired by HR in G2 (Langerak et al, 2011). Following 
Ku80 and DNA-PKcs co-depletion I observed a significant increase in the number of 
RPA and Rad51 foci as wells as SCEs compared to control cells (Figure 3.2a-c). 
Significantly, although very high co-localisation is observed between pKAP1 and RPA 
foci in control cells, this decreases following Ku80 and DNA-PKcs depletion (Figure 
3.2d). I interpret this to suggest that euchromatic DSBs that would normally be repaired 
by NHEJ undergo resection and are repaired by HR when Ku80-DNA-PKcs is lost. This 
confirms that pKAP1 does not form at all DSBs and that in normal cells most HR 
occurs at DSBs harbouring pKAP1 foci. 
In conclusion, this data provides strong evidence that IR induced DSBs in G2 
phase located at HC regions are repaired by HR. It is conceptually plausible that the 
highly repetitive sequences of HC may be favourable to the HR pathway in which a 
homology search on the sister chromatid needs to be carried out.       
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Figure 3.2: SCEs, RPA and Rad51 foci enumeration in G2 phase A549 cells.  
(a-c) SCEs as well as RPA and Rad51 foci were enumerated in control cells and in cells depleted for Ku80 and DNA-
PKcs. In G2 phase control cells RPA and Rad51 foci reach maximum numbers at approximately two hours post IR 
and represent DSBs repaired by HR. For SCEs, the cells were grown in BrdU for forty-eight hours and aphidicolin 
was added prior to IR to prevent S-phase from progressing to G2. The cells were harvested twelve hours post IR and 
SCEs were scored in colcemid arrested mitotic cells. Exposing G2 phase cells to 2Gy leads to a two-fold increase in 
the number of SCEs.  
Cells depleted for Ku80 and DNA-PKcs have elevated numbers of RPA and Rad51 foci in G2 as well as increased 
numbers of radiation induced SCEs (a-c) compared to control cells. This is a consequence of impaired NHEJ 
resulting in euchromatic DSBs undergoing repair by HR. Consistently there is a reduction in the co-localisation of 
RPA and pKAP1 signals as resection in no longer restricted to HC regions (d). Enumerated data represent the mean 
and standard deviation of three independent experiments. 
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3.2.2: 53BP1, MDC1 and H2AX are required for IR induced HR in G2 phase. 
 
As a first step in determining whether the mediator proteins function in HR, I decided to 
investigate whether they are required for efficient DSB repair in G2 phase. To achieve 
this, I monitored the loss of !-H2AX foci at defined times (2h,8h) following exposure to 
3Gy IR. Timpeoints beyond 8h can not be analysed in G2 since cells start to enter 
mitosis, particularly in ATMi or mediator siRNA treated cells due to a defective G2/M 
checkpoint (Shibata et al, 2010).  Foci were only scored in G2 phase cells which were 
identified by CENP-F staining (Figure 3.3a). Addition of aphidicolin prior to irradiation 
prevented S-phase cells from progressing to G2 and ensured that only cells in G2 at the 
time of irradiation were analysed.  
siRNA mediated depletion of either 53BP1 or MDC1 led to a mild DSB repair 
defect  in G2, similar to that observed in G1 phase cells (Figure 3.3b). Importantly, as in 
G1, depletion of 53BP1 or MDC1 only affected the slow component of repair since the 
number of !-H2AX foci at two hours post IR was indistinguishable to that in control 
cells (Figure 3.3b). This result suggested that 53BP1 and MDC1 function in the slow, 
ATM dependent repair pathway in both G1 and G2. To verify this I carried out epistasis 
analysis by adding the ATM inhibitor to 53BP1 and MDC1 depleted cells and 
monitoring loss of !-H2AX foci (Figure 3.3b). As expected, addition of ATMi did not 
lead to an additive repair defect indicating that these proteins function in an ATM-
dependent DSB repair pathway in G2. 
The role of ATM in G2 is distinct to that of G1, since in G2 ATM also regulates 
the initiation of resection through phosphorylation of CtIP. Resection, the first step of 
HR, appears to be (at least) a two-step process with an initial incision step followed by 
an elongation step (Symington & Gautier, 2011). The ATM damage dependent 
phosphorylation of CtIP has been shown to be indispensable for the initiation of 
resection as loss of this phosphorylation leads to complete loss of RPA foci following 
IR in G2 (Li et al, 2000; Shibata et al, 2011). Strikingly however, loss of ATM and/or 
CtIP allows unresected DSBs to be repaired by NHEJ with faster kinetics and without 
obvious deleterious consequences to the cells (Shibata et al, 2011). It should be noted 
however that ATMs function in facilitating HC relaxation is indispensable in G2 
regardless of which repair pathway is used. ATM therefore has two distinct functions in 
G2. As in G1, it promotes HC relaxation via KAP1 phosphorylation but it also enables 
resection through CtIP phosphorylation. Given this I wanted to ask whether 53BP1 and 
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Figure 3.3: 53BP1 and MDC1 and required for IR induced DSB repair in G2. 
a) A549 cells were treated with control, 53BP1 or MDC1 siRNA and were irradiated with 3Gy IR. Prior to irradiation 
aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then harvested at two 
and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. G2 phase cells were identified by 
positive CENP-F staining and the cell nuclei were visualized by DAPI (a). !-H2AX foci were enumerated 
specifically in CENP-F positive cells (b). Where indicated the ATMi was added 30 minutes prior to IR. (b) !-H2AX 
foci were enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three 
independent experiments. c) Knockdown efficiency in A549 cells following treatment with a pool or single siRNA 
oligonucleotides. Per knockdown, 100 pmol of siRNA duplexes per 2 x 105 logarithmically growing cells were used. 
Cells were then grown for 72 h prior to fixation and immunostaining with the indicated antibodies.  
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MDC1 mediate both of these functions and whether they themselves have distinct roles 
during HR. 
 First I decided to look at whether RPA foci formation in G2 cells was 
compromised following siRNA depletion of either 53BP1 or MDC1 (Figure 3.4b). As a 
positive control and to ask whether an epistatic relationship existed between these 
proteins and ATM, I also monitored cells in which ATMi was added. As observed 
previously, all cells (control, si53BP1,siMDC1) in which ATMi was added were 
completely impaired in RPA foci formation and no foci were visible two hours post 
3Gy IR (Figure 3.4b). Surprisingly however, in the mediator depleted cells only a mild, 
but reproducible decrease in the level of RPA foci was observed (Figure 3.4b). This 
result strongly suggests that ATM dependent initiation of resection does not require 
53BP1 and MDC1 function. The mild resection defect observed in mediator depleted 
cells could not explain the DSB repair defect which is identical to that observed in 
ATMi treated cells, so I considered whether these proteins function in HR downstream 
of resection. To ask this I monitored whether Rad51 loading was proficient in G2 cells 
following 53BP1 and MDC1 depletion (Figure 3.5). As for RPA foci, at two hours post 
3Gy IR I observed no increase in Rad51 foci numbers when ATMi was added (Figure 
3.5). Following 53BP1 or MDC1 siRNA, a two-fold reduction was observed in Rad51 
foci, which was reproducibly greater than the reduction observed for RPA foci 
formation (Figure 3.5b). This result suggests that although not essential for the initiation 
of resection both 53BP1 and MDC1 are required for efficient progression through the 
HR pathway. 
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Figure 3.4: 53BP1 and MDC1 are partially required for RPA foci formation in G2. 
a) A549 cells were treated with control, 53BP1 or MDC1 siRNA and were irradiated with 3Gy IR. Prior to 
irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two hours post IR and immunostained with RPA and CENP-F antibodies. G2 phase cells were 
identified by positive CENP-F staining and the cell nuclei were visualized by DAPI (a). RPA foci were 
enumerated specifically in CENP-F positive cells (b). Where indicated the ATMi was added 30 minutes prior to 
IR. (b) RPA foci were enumerated in 30 cells per time-point and the data represent the mean and standard 
deviation of three independent experiments. 
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Figure 3.5: 53BP1 and MDC1 are partially required for Rad51 foci formation in G2. 
a) A549 cells were treated with control, 53BP1 or MDC1 siRNA and were irradiated with 3Gy IR. Prior to 
irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two hours post IR and immunostained with Rad51 and CENP-F antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI (a). Rad51 foci 
were enumerated specifically in CENP-F positive cells (b). Where indicated the ATMi was added 30 
minutes prior to IR. (b) Rad51 foci were enumerated in 30 cells per time-point and the data represent the 
mean and standard deviation of three independent experiments. 
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Next I wanted to know whether the cells attempting to repair DSBs by HR in the 
absence of 53BP1 and MDC1 were able to complete the process. To achieve this I 
utilised our modified assay in which SCEs are monitored as a read out of HR 
completion specifically in G2 phase cells (Conrad et al, 2011). BrdU labelled cells were 
irradiated with 2Gy and metaphase cells were collected 12h post IR so that all G2 phase 
cells at the time of IR are in mitosis. Aphidicolin was used to prevent S-phase cells 
from progressing into G2, caffeine was used to overcome the G2/M checkpoint and 
colcemid was used to arrest cells in mitosis. As expected, ATMi treated cells showed no 
IR induced increase in the number of SCEs (Figure 3.6b). Strikingly however, a 
complete loss of IR induced SCEs was also observed in 53BP1 and MDC1 depleted 
cells. This result indicates that although cells are able to initiate resection and form 
some Rad51 foci in the absence of 53BP1 and MDC1 this is not sufficient to complete 
HR resulting in a DSB repair defect. 
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Figure 3.6: ATM, 53BP1 and MDC1 are required for IR induced SCEs in G2. 
(a-b) A549 cells were treated with 53BP1 and MDC1 siRNA, grown for 48 hours in BrdU and irradiated with 2Gy 
IR. Prior to irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. Eight hours after 
irradiation, colcemid was added to the cells to arrest them in mitosis and caffeine was added to overcome the G2/M 
checkpoint. Where indicated the ATMi was added 30 minutes prior to IR. SCEs were scored in at least 800 
chromosomes from 3 independent experiments per data point and error bars represent the standard deviation amongst 
experiments.  
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3.2.3: Distinct functions of 53BP1 and MDC1 in G2 phase HR. 
 
In previous work, our laboratory has demonstrated that 53BP1 and MDC1 function to 
promote ‘concentrated’ phosphorylation of KAP1 via the retention of active ATM at 
DSB sites (Noon et al, 2010). The requirement for ATM and the mediator proteins in 
G1 phase DSB repair can be alleviated via KAP1 depletion, which leads to sufficient 
relaxation of HC to bypass the need for ATM-dependent modifications. In G2 phase 
DSB repair, the requirement of ATM can also be overcome by KAP1 depletion but this 
leads to DSBs being repaired by NHEJ since resection cannot be initiated (Beucher et 
al, 2009; Shibata et al, 2011). Based on these findings I examined whether KAP1 
depletion impacted on the outcome of DSBs repaired by HR in the absence of the 
mediator proteins 53BP1, MDC1 and H2AX (Figure 3.7).  
Phosphorylation of histone H2AX is one of the earliest events in the DDR to 
DSBs and is required for the recruitment of downstream factors such as MDC1 
(Bekker-Jensen & Mailand, 2010). I decided to monitor the requirement of H2AX in 
HR as an indirect method of assessing the importance of MDC1 focal accumulation on 
the process. As in G1, depletion of KAP1 had no effect on the repair kinetics of control 
cells and rescued the repair defect of 53BP1-depleted cells (Figure 3.7a). Strikingly 
however and distinct to repair in G1, KAP1 depletion did not rescue the repair defect of 
MDC1 depleted cells (Figure 3.7a). This result suggested that 53BP1 facilitates G2 
phase HR via mediating KAP1 phosphorylation whilst MDC1 has an additional and 
distinct role. To try to elucidate at which step MDC1 functions I decided to look at the 
different HR intermediates. 
 KAP1 depletion in control cells has no effect on the number of RPA foci formed 
two hours post 3Gy IR in G2 (Figure 3.8b). However KAP1 depletion in 53BP1 
knockdown cells restores the number of RPA foci to that of control cells (Figure 3.8b). 
Therefore the mild resection defect seen in 53BP1 knockdown cells likely results from 
inefficient HC remodelling and relaxation. Surprisingly however, the RPA foci numbers 
of H2AX and MDC1 knockdown cells also return to control levels following KAP1 co-
depletion (Figure 3.8b). This result is not consistent with the DSB repair defect that 
persists in H2AX and MDC1 knockdown cells following KAP1 co-depletion (Figure 
3.7a).  
 A possible explanation for this unexpected result is that MDC1 and H2AX may 
function in an HR step downstream of resection. I postulated that this might be a  
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Figure 3.7: The role of 53BP1 in G2 phase DSB repair is overcome by KAP1 depletion but those of MDC1 and 
H2AX are not. 
a) A549 cells were treated with control, 53BP1,MDC1 or H2AX siRNA and KAP-1 was co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at two and eight hours post IR and immunostained 
with !-H2AX and CENP-F antibodies. G2 phase cells were identified by positive CENP-F staining and the cell nuclei 
were visualized by DAPI. !-H2AX foci were enumerated specifically in CENP-F positive cells. Where indicated 
KAP1 was co-depleted by siRNA. !-H2AX foci were enumerated in 30 cells per time-point and the data represent the 
mean and standard deviation of three independent experiments. 
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Figure 3.8: The requirement for 53BP1, MDC1 and H2AX in G2 phase RPA foci formation is overcome by 
KAP1 depletion. 
a) A549 cells were treated with control, 53BP1,MDC1 or H2AX siRNA and KAP-1 was co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at two hours post IR and immunostained with RPA 
and CENP-F antibodies. G2 phase cells were identified by positive CENP-F staining and the cell nuclei were 
visualized by DAPI. b) RPA foci were enumerated specifically in CENP-F positive cells. Where indicated KAP1 was 
co-depleted by siRNA. RPA foci were enumerated in 30 cells per time-point and the data represent the mean and 
standard deviation of three independent experiments. 
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requirement  for Rad51 loading and set out to test this. As expected, KAP1 depletion 
had no effect on Rad51 foci numbers in control cells but was able to rescue the Rad51 
foci defect seen in 53BP1 knockdown cells (Figure 3.9b). Again this is consistent with 
the notion that 53BP1 only facilitates this process via HC modification. Importantly 
however, the Rad51 foci defect seen in MDC1 and H2AX knockdown cells was not 
rescued following co-depletion of KAP1 (Figure 3.9b). This finding indicates that 
MDC1 has a role in Rad51 loading that is distinct to that of 53BP1 and that goes 
beyond its role in HC modification. To further verify this I decided to see whether 
MDC1 is required for HR repair of DSBs located in EU.  
 As described earlier, co-depletion of Ku80 and DNA-PKcs in G2 leads to an 
increase in the number of euchromatic DSBs repaired by HR. It also leads to slower 
repair kinetics with a significantly greater number of !-H2AX foci persisting compared 
to control cells. This delay in repair corresponds to a greater proportion of remaining 
breaks (!-H2AX foci) at four hours post IR undergoing resection (RPA foci) (Figure 
3.10a). When Ku80/DNA-PKcs are co-depleted in either 53BP1 or MDC1 knockdown 
cells, more RPA foci are observed than in cells where Ku80/DNA-PKcs are present. 
This suggests that the increased resection seen following co-depletion of Ku80/DNA-
PKcs is in EU and is mediator protein independent. Significantly however, the number 
of RPA foci in cells depleted for 53BP1 or MDC1 + Ku80/DNA-PKcs is less than in 
Ku80/DNA-PKcs knockdown cells (Figure 3.10a). This is due to the inability of 
mediator protein deficient cells to remodel HC into the relaxed confirmation needed for 
efficient resection. However when KAP1 is also depleted then the number of RPA foci 
increases to the level of Ku80/DNA-PKcs knockdown cells as the mediator proteins 
become redundant (Figure 3.10b).  This data supports the model whereby 53BP1 and 
MDC1 facilitate resection via HC remodelling but have no direct role in the process per 
se.    
 Next I repeated these experiments but this time I analysed the Rad51 loading 
step of HR. As for RPA foci, the number of Rad51 foci seen four hours post IR in G2 
increases following co- depletion of Ku80/DNA-PKcs (Figure 3.11a). This time 
however, when I co-depleted Ku80/DNA-PKcs in 53BP1 and MDC1 knockdown cells I 
only observed an increase in Rad51 foci in 53BP1 depleted cells (Figure 3.11a). This 
result indicates that the increased Rad51 foci seen following co-depletion of 
Ku80/DNA-PKcs are in EU and their formation is 53BP1 independent but MDC1 
dependent. Furthermore, when KAP1 was also depleted, the number of Rad51 foci  
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Figure 3.9: The requirement for 53BP1 in G2 phase Rad51 foci formation is overcome by KAP1 depletion but 
those of MDC1 and H2AX are not. 
a) A549 cells were treated with control, 53BP1,MDC1 or H2AX siRNA and KAP-1 was co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at two hours post IR and immunostained with 
Rad51 and CENP-F antibodies. G2 phase cells were identified by positive CENP-F staining and the cell nuclei were 
visualized by DAPI. b) Rad51 foci were enumerated specifically in CENP-F positive cells. Where indicated KAP1 
was co-depleted by siRNA. Rad51 foci were enumerated in 30 cells per time-point and the data represent the mean 
and standard deviation of three independent experiments. 
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Figure 3.10: 53BP1 and MDC1 are dispensable for RPA foci formation in euchromatin. 
a) A549 cells were treated with control, 53BP1 or MDC1 siRNA and Ku80 and DNA-PKcs were co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at 0.5 and 4 hours post IR. Next one set of samples 
was immunostained with RPA and CENP-F and the other with !-H2AX and CENP-F antibodies. G2 phase cells were 
identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. RPA and !-H2AX were 
enumerated and plotted on the same graph with hashed bars indicating !-H2AX foci and solid bards indicating RPA 
foci. 
b) As for a) but KAP-1 was co-depleted in all samples. Foci were enumerated in 30 cells per time-point and the data 
represent the mean and standard deviation of three independent experiments. 
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Figure 3.11: 53BP1 is dispensable for Rad51 foci formation in euchromatin but MDC1 is not. 
a) A549 cells were treated with control, 53BP1 or MDC1 siRNA and Ku80 and DNA-PKcs were co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at 0.5 and 4 hours post IR. Next one set of samples 
was immunostained with Ra51 and CENP-F and the other with !-H2AX and CENP-F antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. Rad51 and !-H2AX were 
enumerated and plotted on the same graph with hashed bars indicating !-H2AX foci and solid bards indicating Rad51 
foci. b) As for a) but KAP-1 was co-depleted in all samples. Foci were enumerated in 30 cells per time-point and the 
data represent the mean and standard deviation of three independent experiments. 
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observed in 53BP1 + Ku80/DNA-PKcs knockdown cells increased to that observed in 
Ku80/DNA-PKcs depleted cells (Figure 3.11b). In contrast, when KAP1 was depleted 
in MDC1 + Ku80/DNA-PKcs knockdown cells, no increase was observed in Rad51 foci 
numbers indicating an important role for MDC1 in Rad51 filament formation (Figure 
3.11b). 
Finally I looked at whether KAP1 depletion could alleviate the defect in IR 
induced SCEs following mediator protein depletion. Consistent with the above, KAP1 
depletion did not affect the number of SCEs seen in control cells but increased the 
number of SCEs seen in 53BP1 knockdown cells to control levels (Figure 3.12). 
However the SCE formation defect of ATMi and MDC1 knockdown cells was not 
rescued by KAP1 knockdown. ATM inhibited cells are unable to initiate resection and 
therefore KAP1 depletion has no effect on their ability to carry out HR whilst MDC1 
depleted cells are unable to efficiently form Rad51 filaments and are therefore unable to 
complete HR even after KAP1 depletion. Importantly however, ATMi cells show no 
repair defect in G2 following KAP1 depletion, whilst MDC1 and H2AX knockdown 
cells do (Figure 3.12). It appears that failure to initiate resection in ATMi treated cells 
allows these breaks to be repaired by NHEJ as long as chromatin structure is favourable. 
In contrast, MDC1 knockdown cells in which resection is initiated but Rad51 loading 
fails are unable to return to NHEJ and thus a DSB defect is observed even following 
KAP1 depletion (Figure 3.12). 
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Figure 3.12: The requirement for 53BP1 in G2 phase IR induced SCE formation is overcome by KAP1 
depletion but those of MDC1 and H2AX are not. 
a) A549 cells were treated with control, 53BP1,MDC1 or H2AX siRNA and KAP-1 was co-depleted where 
indicated. The cells were grown for 48 hours in BrdU and irradiated with 2Gy IR. Prior to irradiation aphidicolin was 
added to the cells to prevent S-phase cells from entering G2. Eight hours after irradiation, colcemid was added to the 
cells to arrest them in mitosis and caffeine was added to overcome the G2/M checkpoint. SCEs were scored in at least 
800 chromosomes from 3 independent experiments per data point and error bars represent the standard deviation 
amongst experiments.  
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3.2.4: The requirement of MDC1 for 53BP1 and FK2 IRIF formation cannot be 
relieved by siRNA KAP1. 
 
The data so far indicates that the requirement for MDC1 in resection (RPA foci) but not 
in Rad51 foci formation can be relieved by KAP1 depletion in contrast to 53BP1 
depleted cells where both processes are rescued. I postulated that a factor(s) acting 
downstream of MDC1 but upstream of 53BP1 may be required for efficient Rad51 
filament formation. MDC1 is one of the earliest factors to be recruited to DSBs where it 
binds to !-H2AX via its BRCT domain (Stucki et al, 2005). Once there it acts as a 
scaffold protein for the recruitment of downstream factors including the ubiquitin 
ligases RNF8 and RNF168 (Doil et al, 2009). Once at DSB sites, RNF8/RNF168 
ubiquitylate downstream targets including the histone variant H2A (Mailand et al, 
2007). Via its role in the recruitment of these ligases, MDC1 has also been shown to be 
required for these ubiquitylation events, detected via FK2 foci that mark polyubiquitin 
chains. I decided to test whether siRNA depletion of KAP1 had any impact on MDC1s 
ability to form ubiquitin chains or recruit 53BP1. As expected, 53BP1 depletion had no 
impact on FK2 foci formation at DSB sites whilst MDC1 depleted cells failed to form 
53BP1 and FK2 foci irrespective of KAP1 status (Figure 3.13a-b).  
These findings verify that KAP1 depletion does not impact upon ubiquitin chain 
formation or 53BP1 recruitment. It is therefore plausible that the inability of MDC1 
knockdown cells to form Rad51 foci may result from their inability to recruit the 
ubiquitin ligases. In support of this model, the ubiquitin ligase Rad18 has previously 
been shown to be required for Rad51c and subsequently Rad51 foci formation (Huang 
et al, 2009). The role of the ubiquitin system and in particular the ubiquitin ligases 
RNF8/RNF168 is the focus of my work in chapter 4. 
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Figure 3.13: The requirement of MDC1 for 53BP1 and FK2 IRIF formation cannot be relieved by 
siRNA KAP1. 
a-b) A549 cells were treated with control, 53BP1 or MDC1 siRNA and KAP-1 was co-depleted were 
indicated. Two hours post 3Gy IR the cells were harvested and immunostained with 53BP1 and CENP-F 
(a) or FK2 and CENP-F (b) antibodies. DAPI was used to visualize cell nuclei.  
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3.2.5: S-phase resection requires CtIP and the PIKK kinases. 
 
Exposure to ionizing radiation leads to the formation of DSBs in all cell cycle phases. In 
the G1 and G2 phases of the cell cycle these lesions arise when a duplex DNA molecule 
is fractured into two parts. Such DSBs are two ended and are repaired by NHEJ or HR. 
In addition to the direct formation of two ended DSBs, exposure to ionizing radiation 
also leads to the formation of single stranded DNA breaks. Single stranded DNA breaks 
form at a twenty fold greater frequency than DSBs and are mainly repaired by the base 
excision repair pathway (Caldecott, 2007). If unrepaired, single strand DNA breaks can 
be converted into the more toxic DSBs during replication. 
When a replication fork encounters a single strand break, it can collide with the 
lesion leading to replication fork collapse and the formation of a one-ended DSB 
(Helleday et al, 2007). These lesions are distinct to two ended DSBs and are normally 
repaired by homology directed repair leading to restoration of the replication fork 
(Figure 3.17a). Although distinct to G2 phase HR, homology directed repair at the 
replication fork requires the core HR components including Rad51 and BRCA2 
(Helleday et al, 2007). 
In addition to IR other cytotoxic agents can lead to replication fork collapse and 
the formation of one-ended DSBs. Camptothecin is a topoisomerase 1 poison that 
stabilizes the normally transient interaction between topoisomerase 1 and DNA (Shao et 
al, 1999). Topoisomerase 1 functions to relieve DNA tension during processes such as 
DNA replication, transcription and repair, and does this by introducing nicks that are re-
ligated once reduction of DNA supercoiling is achieved (Pommier, 1996). Following 
camptothecin treatment, when an incoming replication fork encounters a topoisomerase-
DNA complex, it leads to replication fork collapse and the formation of one-ended 
DSBs (Helleday et al, 2007). These lesions are sensed and activate a DDR that includes 
the activation of the PIKK kinases ATM, ATR and DNA-PK. 
Following the finding that ATM has a direct role in G2 phase HR I postulated 
that this role might also be required during S-phase homology directed repair of one-
ended DSBs. This hypothesis seemed plausible as homology directed repair involves 5’-
3’ resection which in G2 phase HR necessitates ATM function (Petermann & Helleday, 
2010). DNA resection in S-phase also leads to extensive ssDNA regions that are coated 
by RPA and hence activation of ATR. To test this, I used a flow cytometry approach to 
measure RPA signal intensity in S-phase cells following exposure to different 
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concentrations of CPT (Figure 3.15). I decided to use this approach because, unlike the 
situation in G2 where distinct RPA foci can be seen and enumerated, CPT exposure in 
S-phase leads to pan-nuclear RPA staining. Flow cytometry thus allowed me to measure 
changes in overall RPA signal intensity whilst DNA content quantification by 
Propidium Iodide staining enabled me to distinguish cell cycle phases (Figure 3.15).  
Exposure to 4µM CPT for one hour, led to a reproducible increase in RPA signal 
intensity so this dose was selected. Propidium Iodide co-staining indicated that this 
increase was most pronounced in S-phase cells consistent with previous findings that 
CPT leads to DNA lesions in cells where DNA replication in on-going (Figure 3.15).  
Next I used the ATMi inhibitor to test whether the increase in RPA signal 
intensity was dependent upon ATM. As a positive control and to ensure that the flow 
cytometry assay was working, I irradiated cycling cells with 15Gy and measured RPA 
signal intensity in the presence and absence of ATMi (Figure 3.14). In control cells, 
exposure to 15Gy IR led to an increase in RPA signal intensity, while PI staining 
indicated that this was primarily in G2 phase cells (Figure 3.14). Consistent with the 
data described earlier, addition of ATMi thirty minutes prior to irradiation led to no 
detectable changes in RPA signal intensity following 10Gy IR (Figure 3.14). Strikingly 
however, when the same experiment was repeated using CPT, addition of ATMi had no 
impact on RPA signal intensity in S-phase cells (Figure 3.15a). This result indicates that 
in S-phase, unlike the situation in G2, resection can proceed independently of ATM 
status. Since CtIP is required for resection in G2, I then decided to ask whether CtIP is 
required for S-phase resection following CPT treatment. 
In G2 phase HR, CtIP undergoes regulatory phosphorylation by ATM at 
S664/S745 (Li et al, 2000). This phosphorylation in response to DNA damage is 
required for CtIP recruitment to damage sites and for the initiation of resection (Shibata 
et al, 2011). Consistently, when CtIP was depleted, no increase in RPA signal intensity 
was observed in G2 cells following 10Gy IR. Interestingly however and distinct to 
ATMi treated cells, no increase in RPA signal intensity was seen in S-phase CtIP 
knockdown cells following CPT treatment (Figure 3.16). This result suggests that CtIP 
is required for S-phase and G2 phase resection but that ATM regulates this only in G2. 
This finding raised the question of how S-phase resection is regulated and whether it 
requires DNA-PK or ATR. 
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Figure 3.14: ATM is required for a G2 phase specific RPA intensity increase after IR. 
a) Cycling A549 cells were treated with 10Gy IR. Irradiated and non-irradiated cells were harvested four hours 
post IR and immunostained with an RPA antibody and propidium iodide. In the lower panels populations p2, p3 
and p4 correspond to G1,S and G2 phase cells respectively as determined by DNA content following propidium 
iodide staining. Populations p5,p6 and p7 represent cells of each cell cycle phase in which a radiation induced 
increase in RPA intensity was detected after IR treatment. The upper panels show the cell cycle profile for each 
condition as determined by propidium iodide staining.  
  
' ?
*? !"#$%"&'()*' !"#$%"&'+()*',-' !"#$%"&'.'/012'+()*',-'
+,' +-' +.' +/' +)' +0'
)+' 3' )4'
567' .67' 567' .67' 567' .67'
!!
**+!
 
 
Figure 3.15: S-phase resection requires the PIKK kinases. 
a) Cycling A549 cells were treated with 4µM CPT for one hour. Treated and non-treated cells were harvested 
and immunostained with an RPA antibody and propidium iodide. In the lower panels populations p2, p3 and p4 
correspond to G1,S and G2 phase cells respectively as determined by DNA content by propidium iodide 
staining.  Population p5 represents cells in which an increase in RPA intensity was observed. The far right 
panel indicate cells in which the ATMi was added thirty minutes prior to CPT treatment. 
b) Quantification of RPA signal intensity after CPT treatment measured in A549 cells by flow cytometry. The 
cells were treated with ATMi, DNAPKi and caffeine where indicated. Results represent the average of three 
experiments and the standard deviation among these. 
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When a replication fork collapses as a result of colliding with a topoisomerase 
induced single strand nick, ssDNA is formed that is coated by RPA and leads to ATR 
activation (Shechter et al, 2004). In addition, DNA-PK is activated and phosphorylates 
RPA2 (Shao et al, 1999). To assess whether these kinases are required for single strand 
DNA formation at collapsed replication forks, I inhibited their function and monitored 
RPA signal intensity in response to CPT treatment. First I used ATM and DNA-PK 
inhibitors but in both cases I observed an increase in RPA intensity one-hour post CPT 
that was indistinguishable to control cells (Figure 3.15b). Next I used caffeine to inhibit 
ATR function. Interestingly, when caffeine was added at a 4mM concentration, a partial 
reduction in RPA signal intensity was observed relative to the control. It is important to 
note however that at this caffeine concentration, ATM function is also inhibited 
although DNA-PK is not (Sarkaria et al, 1999). This result indicates that there might be 
some redundancy amongst these kinases so I decided to inhibit them in conjunction. 
First I used both the ATM and DNA-PK inhibitors and monitored RPA signal intensity 
after CPT treatment. Although use of the inhibitors alone had no effect, when used 
together they led to a significant decrease in RPA intensity relative to control cells 
(Figure 3.15b). Finally I inhibited ATM, DNA-PK and ATR at the same time by using 
the two inhibitors and adding caffeine and observed an even greater reduction in RPA 
signal intensity (Figure 3.15b). This result indicates that the PIKK kinases are required 
for ssDNA formation and RPA loading at collapsed replication forks but that there is 
functional redundancy amongst them. Moreover the mechanism by which they regulate 
resection in S-phase is unclear but is unlikely to be via CtIP. This is because 
phosphorylation of CtIP in G2 is ATM specific and cannot be performed by DNA-PK 
or ATR. CtIP is also a CDK substrate and CtIP phosphorylation by CDK has been 
shown to be required for resection both in S and G2 cell cycle phases (Huertas & 
Jackson, 2009). It is possible that CtIP function at replication forks is regulated by CDK 
activity whilst ATM, ATR and DNA-PK enable this process indirectly via activation of 
intra S-phase checkpoint arrest.    
 
 
 
 
 
 
!!
**"!
3.2.6: The mediator proteins are dispensable for S-phase resection. 
 
As discussed above, the mediator proteins MDC1, 53BP1 and H2AX are required for 
efficient resection at two ended DSBs in G2. However this is not due to a direct role of 
these proteins in the process but through ATM dependent chromatin remodelling. ATM 
dependent chromatin remodelling appears to be dispensable for resection in S-phase 
probably due to the de-condensed chromatin configuration during replication. Here I 
wanted to ask whether mediator protein function is required for ssDNA formation and 
RPA coating following CPT treatment. To achieve this I used the flow cytometry assay 
described above and monitored RPA signal intensity following one hour 4µM CPT 
treatment. siRNA knockdown of 53BP1, MDC1 or H2AX had no impact on the 
increase in RPA signal intensity seen after CPT treatment (Figure 3.16a). This result 
indicates that the mediator proteins are dispensable for ssDNA formation and RPA 
coating at stalled/collapsed replication forks. 
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Figure 3.16: S-phase resection requires CtIP but not ATM or the mediator proteins. 
a) Quantification of RPA signal intensity after CPT treatment measured in A549 cells by flow 
cytometry.  Cycling A549 cells were treated with 4µM CPT for one hour. Treated and non-treated 
cells were harvested and immunostained with an RPA antibody and propidium iodide. Where 
indicated, cells were treated with ATMi or siRNA prior to CPT exposure.  
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3.2.7: Repair pathway choice of collapsed/stalled replication forks might affect 
genomic stability. 
 
HR has an evolutionarily conserved role in the maintenance of genomic stability 
following replication stress. Whilst only functioning to repair a small subset of IR 
induced DSB breaks in G2, it has a critical role in preventing the genomic instability 
that can arise when a lesion is encountered at the replication fork (Lundin et al, 2003; 
Arnaudeau et al, 2001; Lundin et al, 2002). Consistent with this, cell lines deficient in 
HR display only modest radiation sensitivity but marked genomic instability and 
sensitivity to agents such as PARP inhibitors and MMS, which lead to enhanced 
replication fork stalling/collapse (Jasin, 2002; Kass et al, 2010).  
It is unclear whether sites of DNA damage that are marked by !-H2AX foci in 
S-phase are indeed DSBs or just stalled replication forks, but fork restoration is crucial 
for maintenance of chromosomal stability. BRCA1/2 and certain FA mutant cells are 
HR deficient and display sensitivity to replication stress and have increased 
chromosome breakage, radial chromosomes and other cytogenetic abnormalities 
(D'Andrea & Grompe, 2003). This cellular phenotype is a direct result of these cells 
failure to restore replication forks due to impaired HR. It is currently unclear why there 
is such a high dependence on HR in S-phase and why NHEJ can’t repair these lesions as 
in G1 and G2. One explanation is that this is due to the difference in nature of DSBs in 
G1 and G2 versus S-phase. DSBs arising in G1 and G2 are two ended and can be 
accurately repaired by tethering the broken ends and re-joining them by NHEJ (Shibata 
et al, 2011). DSBs at the replication fork however are one ended and there is no 
adjacent DNA end for it to be ligated to (Helleday et al, 2007). If NHEJ is used to repair 
such a lesion, then DNA joining will occur between two distinct one-ended DSBs 
resulting in genomic rearrangements. It is plausible that repair of one ended DSBs by 
NHEJ in HR deficient cells results in the chromosomal abnormalities seen in BRCA 
and FA mutant cells following replication stress (Figure 3.17). 
The mediator protein 53BP1 promotes ATM dependent DSB repair in G1 and 
G2 via HC remodelling (Noon et al, 2010). As discussed in the introductory chapter, 
53BP1 also has ATM independent functions in V(D)J recombination, CSR, and 
telomere end fusions (Difilippantonio et al, 2008; Bothmer et al, 2011; Dimitrova et al, 
2008). Intriguingly, in all three processes, 53BP1 functions to facilitate long-range re-
joining events. In V(D)J recombination 53BP1 brings together recombination  
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Figure 3.17: Model for replication fork recovery. 
a) Following replication fork collapse one-ended DSBs are created. In wild type cells homology directed repair is 
utilized to restore the collapsed replication fork and DNA replication can ensue. However in FA and BRCA mutant 
cells homology directed repair is defective. A model for the complex cytogenetic abnormalities seen in these cells is 
that one-ended DSBs arising following replication fork collapse are repaired erroneously by NHEJ. In this model two 
distinct and possibly distant one-ended DSBs are joined resulting in chromosomal re-arrangements.  
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signal sequences of distally separated V, D or J segments while in CSR it is required for 
the re-joining of AID cleavage sites when they are separated by more than 100kb. In 
uncapped telomere re-joining 53BP1 enables telomere fusions by bringing telomere 
ends close enough to each other so that re-joining by fusion takes place. The mechanism 
by which 53BP1 carries out these functions is unclear but 53BP1 accumulation and foci 
formation appear to be important as is its ability to oligomerise. From the above I 
reasoned that 53BP1 might enable the deleterious long range re-joining of one ended 
DSBs in HR deficient cells in S-phase. To test this I decided to monitor repair foci 
fusions by live cell imaging (LCI) following DNA damage in S-phase. 
MMS treatment results in replication fork stalling/collapse in S-phase and 
restoration of these forks requires the HR pathway (Löbrich et al, 2010). Sites of MMS 
induced damage lead to the accumulation of !-H2AX and intermediates of the HR 
pathway such as Rad51. To see whether 53BP1 may have a role in the processing of 
such lesions, I decided to look whether 53BP1 foci form following exposure to MMS. 
In order to detect 53BP1 foci and for later use in LCI experiments, I acquired the 
mCherry-BP1 construct used by the Titia de Lange group to study end fusions of 
uncapped telomeres (Dimitrova et al, 2008). In this construct, mCherry is fused to a 
truncated form of 53BP1 that lacks most functional domains of the protein but that 
maintains its TUDOR and !-H2AX binding domains important for 53BP1 foci 
formation (Figure 3.18a). 
Hela cells were transfected with the mCherry-BP1 construct and allowed to 
express it for twenty four hours prior to exposure to 1mM MMS for 30 minutes. Cells 
were then harvested and immunostained for !-H2AX (Figure 3.18b). The twenty-four 
hour expression led to a panuclear distribution of the mCherry-BP1 protein, while cells 
that were treated with MMS formed distinct nuclear foci. These foci completely 
colocolised with !-H2AX foci suggesting the fusion protein was able to accumulate at 
DNA damage sites (Figure 3.18b). Next I wanted to know whether or not the foci 
formed after MMS treatment were restricted to S-phase cells. To test this I exposed cells 
to the same concentration of MMS but this time stained with PCNA. In S-phase cells 
PCNA has a distinct, granular nuclear appearance with many small foci visible (Figure 
3.18c) (van Dierendonck et al, 1991). Following MMS exposure mCherry-BP1 foci 
only formed in S-phase cells as determined by PCNA staining pattern (Figure 3.18c). I 
concluded that MMS was a suitable agent for inducing S-phase specific DNA damage  
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Figure 3.18: mCherry-BP1 construct forms foci that overlap with !-H2AX foci specifically in S-
phase. 
a) Schematic representation of the mCherry-BP1 construct. The C-terminal BRCT domains are present, as 
are the TUDOR binding and !-H2AX binding domains required for focal accumulation. The functional 
domains of 53BP1 are absent. 
b) Hela cells were transfected with the mCherry-BP1 construct and allowed to express it for twenty-four 
hours. The cells were then exposed to 1mM MMS for one hour and then harvested and immunostained with 
a !-H2AX antibody.  
c) As for b), but this time the cells were immunostained with a PCNA antibody. 
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and that the mCherry-BP1 construct would allow me to test foci movement and fusions 
by LCI. 
NHEJ repairs DSBs with fast kinetics with the majority of lesions repaired 
within two hours post damage induction (Riballo et al, 2004). I decided to monitor foci 
movement by LCI for three hours post MMS exposure, as this would allow ample time 
to detect any differences arising from 53BP1 status. Additionally, when monitoring 
telomere fusions by NHEJ in the presence or absence of 53BP1 a significant difference 
in telomere distance travelled was observed within twenty minutes of LCI (Dimitrova et 
al, 2008). Following transfection and transient expression of the mCherry-BP1 
construct, I treated the cells with 1mM MMS and monitored foci movement by LCI. I 
also transfected the cells with a plasmid containing GFP tagged histone variant H2B 
and used this to visualize the cell nuclei (Figure 3.19a). 
The experimental setup worked well and as predicted from IRIF foci behaviour 
in G1, MMS induced mCherry-BP1 foci expanded over time and were dynamic and 
mobile (Figure 3.19). Additionally, the number of foci that remained after three hours of 
LCI were significantly reduced indicating that repair was taking place (Figure 3.19b). 
The image processing software suite Imaris was used to quantify foci movement over 
the LCI period. When comparing the total distance travelled by individual foci a clear 
discrepancy became apparent (Figure 3.20b). If any given focus persisted for long, then 
it would likely travel further than one that disappeared in a shorter time. Therefore 
comparing the distance travelled over time i.e. the speed of each focus seemed a more 
appropriate parameter to compare. Control cells displayed uniform foci speed without 
substantial differences between the entire population (Figure 3.20c). Importantly, no 
obvious foci fusion events were observed in control cells. Next I repeated this 
experiment following BRCA1 depletion by siRNA. Following BRCA1 depletion I 
expected to see an increase in 53BP1 IRIF mobility since HR was compromised and 
repair would need to occur between distant one-ended DSBs. However following 
BRCA1 depletion, no significant changes in foci speed were observed and foci fusions 
were not detected (Figure 3.20b-c). This result was unexpected as HR defective cells 
were predicted to show an increase in foci speed or total distance travelled and 
increased foci fusions. Next I assessed the effect of 53BP1 on foci movement in an HR 
deficient background by co-depleting BRCA1 and 53BP1. However, co-depletion of 
BRCA1 and 53BP1 did not have a significant effect on foci speed compared to control  
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Figure 3.19: mCherry-BP1 construct foci that form after MMS treatment expand over time and 
decrease in number as repair ensues. 
a) Hela cells were transfected with the mCherry-BP1 construct and with a plasmid expressing histone H2B-
GPF. They were allowed to express these for twenty-four hours. The cells were then exposed to 1mM 
MMS for one hour and were then monitored for three hours by LCI. Images where take every 5 minutes but 
images here show twenty minute intervals. 
b) Quantitative analysis of mCherry-BP1 foci size and number from LCI images. LCI images obtained 
using an Applied Precision® Delta Vision® RT Olympus IX70 deconvolution microscope were 
deconvolved by the Huygens Professional image processing software. The BitPlane Imaris image 
processing software suite was then used to quantify the foci number and size over time. The right Y-axes 
represents arbitrary units for foci size. 
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Figure 3.20: BRCA1 depletion does not affect the mobility of the mCherry-BP1 construct foci that form after 
MMS treatment. 
a) Representative images of mCherry-BP1 foci detection and track measurement over time by the BitPlane Imaris 
image processing software suite. b) Quantification of the distance travelled by the mCherry-BP1 foci in control cells 
and in cells treated with BRCA1 and 53BP1 + BRCA1 siRNA. c) Quantification of the speed of the mCherry-BP1 
foci in control cells and in cells treated with BRCA1 and 53BP1 + BRCA1 siRNA. In b) and c), the data represent the 
median and lower and upper quartiles from at least 10 nuclei from each of three experiments. Error bars represent the 
minimum and maximum valid values determined as the highest datum still within 1.5 the interquartile range of the 
upper quartile. These were used to eliminate abnormally large values (depicted as single points) arising from foci 
‘clumping’ and resolution limitations. Statistical analysis was carried out using the Mann-Whitney rank sum test. 
Data were not deemed to be significant when a p value > 0.05 was obtained.   
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cells and neither did it increase the number of foci fusions formed (Figure 3.20b-c).  
Due technical difficulties in LCI experimental setup and data analysis, these studies 
were not taken further. Determining whether the increased sensitivity of HR and FA 
mutant cells to genotoxic exposure in S-phase results from aberrant re-joining of one-
ended DSBs is an important future question. 
 
 
3.3: Discussion  
 
IR induced DSBs associated with HC are repaired via HR in G2 
 
Traditionally, DSB repair has been separated into NHEJ and HR with one pathway 
repairing breaks in G1 and the other in G2. In recent years however this simplistic view 
has been overturned and the true complexity of DSB repair is becoming apparent. The 
regulation of repair pathway choice is still to be fully understood but appears to be 
influenced by cell cycle phase, chromatin structure and DNA damage complexity 
amongst other factors (Shibata et al, 2011; Symington & Gautier, 2011; Bothmer et al, 
2010). In addition, an ever-growing number of proteins with a wide range of functional 
and interacting motifs are found to play a role in the DNA damage response 
(Mohammad & Yaffe, 2009). The tightly regulated orchestration of these factors by 
post-translational modification allows cells to perform the complex but vital task of 
repairing potentially lethal DSBs.  
   The influence of chromatin structure on DSB repair in G1 has been the subject 
of recent work from our laboratory. Chromatin structure at DSB sites was found to play 
a pivotal role in repair kinetics and the requirement, or not, of localized chromatin 
remodelling. Specifically breaks at HC were found to require localized chromatin 
relaxation that depended upon ATM and the mediator proteins and culminate in HC 
relaxation via KAP1 phosphorylation (Noon et al, 2010).  
 Subsequently, these experiments were extended to the G2 phase of the cell cycle 
that is distinct to G1 as HR is also functional. DSB repair in G2 was also found to be 
biphasic and there was a requirement for HC modification via ATM dependent KAP 
phosphorylation. Unexpectedly the slow component of repair in G2 was found to 
represent the DSBs undergoing repair by HR, with ATM and Artemis being required for 
the resection step (Beucher et al, 2009). The role of Artemis in resection is still unclear 
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but ATM was found to be required for the initiation of resection through 
phosphorylation of CtIP (Shibata et al, 2011). Consistent with the situation in G1, the 
DSBs that require ATM are located at HC regions. ATM dependent KAP1 
phosphorylation is required for the repair of these breaks and the requirement for ATM 
can be overcome by KAP1 depletion. However, in such a scenario the HC DSBs are 
then repaired by NHEJ and we believe this is because resection cannot be initiated 
independently of ATM. 
 The major focus of this chapter lies in determining the requirement for the 
mediator proteins 53BP1, MDC1 and H2AX in G2 phase HR. 53BP1 has been 
described as a pro-NHEJ factor with an inhibitory role on HR (Xie et al, 2007). In stark 
contrast however, my experiments in G2 indicate that 53BP1 is required for HR that 
occurs at HC-DSBs. As in G1, 53BP1 enables the repair of HC DSBs by retaining 
activated ATM through its interaction with the MRN complex and leads to the localized 
robust KAP1 phosphorylation needed for HC relaxation. However, experiments in 
which KAP1 was depleted indicated that 53BP1 has no direct role in the HR process 
and is dispensable for all HR steps when chromatin configuration is favourable. 
Collectively, experiments in G1 and G2 indicate that 53BP1 does not appear to function 
in or regulate any given repair pathway but rather functions to promote the changes in 
HC superstructure that are a prerequisite for HC-DSB repair. Previous studies in which 
53BP1 was described as a pro-NHEJ factor used I-Sce1 induced DSBs (Xie et al, 2007). 
However such systems may not monitor roles in chromatin modifications as the 
construct integration site is most likely not in HC regions. More recently an inhibitory 
role for 53BP1 in DNA end resection has been described and BRCA1 function is 
required to overcome this (Bunting et al, 2010; Bouwman et al, 2010). The interplay 
between 53BP1 and BRCA1 in DNA end resection will be the focus of chapter 5. 
 MDC1 and H2AX were also found to be required for G2 phase HR that occurs 
at HC-DSBs. Since H2AX functions upstream of MDC1 and is required for MDC1 
recruitment I conclude that this is how H2AX mediates this process. As for 53BP1, 
MDC1 also has a role in HC-relaxation in G2 that is required for HR. However 
although the role of MDC1 in resection can be overcome by KAP1 depletion, its 
requirement for Rad51 foci formation and completion of HR (measured by SCEs) 
cannot. These findings indicate that MDC1 has two distinct roles in promoting G2 
phase HR. Firstly, MDC1 is required to localize 53BP1, which is necessary for HC 
relaxation. Additionally MDC1 has a role in Rad51 loading although the precise 
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mechanism of how this occurs is currently unclear. One possibility is that MDC1 
directly interacts with Rad51 and promotes filament formation while another possibility 
is that it facilitates the process via recruitment of downstream factors. There are 
currently data in the literature in support of both of these models (Zhang et al, 2005; 
Huang et al, 2009). 
 
ATM is dispensable for MMS induced HR in S-phase. 
 
In addition to its role in G2 phase DSB repair, HR is utilised in replication fork 
restoration following stalling or collapse in S-phase. In order to address the role of the 
ATM and mediator proteins in resection at the replication fork I monitored ssDNA 
formation following exposure to CPT. In S-phase chromatin is thought to be 
decondensed in preparation for replication and consistent with this, I found no effect on 
ssDNA formation by CPT in 53BP1, MDC1 and H2AX knockdown cells. This result 
indicates that HC modification in S-phase in not required for DNA end resection. 
Surprisingly however, the role of ATM was also found to be indispensable which is 
distinct to the situation in G2. It appears that the single stranded regions present at 
stalled/collapsed replication forks are a substrate for CtIP and therefore ATM function 
is no longer required. However as in G2, CtIP is required for resection in S-phase and 
CtIP depletion leads to a reduction in ssDNA formation after CPT. 
 
MDC1 but not 53BP1 is required for HR following MMS treatment. 
 
In collaboration with our work investigating the role of the mediator proteins in G2 
phase HR, the laboratory of Markus Lobrich has monitored the role of the mediator 
proteins in HR in S-phase. They first showed that MMS induced lesions are repaired 
almost exclusively by HR in contrast to IR DSBs in G2, where the majority of breaks 
are repaired by NHEJ. By using MMS and IR doses that resulted in similar numbers of 
!-H2AX foci and then monitoring SCEs, they found almost four times more SCEs after 
MMS treatment. They then went on to investigate the requirement of ATM and the 
mediator proteins, 53BP1 and MDC1, in HR repair of MMS induced damage. 
Consistent with my data showing that ATM is dispensable for resection in S-
phase, they observed normal Rad51 foci formation and SCEs in an A-T cell line after 
MMS treatment. This finding is also consistent with the notion that due to chromatin 
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restructuring in S-phase, ATM dependent chromatin decondensation is not a 
prerequisite for repair. 
Next they monitored the requirement for 53BP1 and MDC1 in HR following 
MMS treatment. Consistent with the G2 phase data and the notion that 53BP1 has no 
direct role in HR, they observed normal repair (!-H2AX) in 53BP1 knockdown cells 
after MMS treatment. Moreover they observed no impact on the formation of Rad51 
foci or SCEs after MMS treatment. In contrast however, when they depleted MDC1, 
they observed persisting !-H2AX foci, reduced Rad51 foci and reduced SCEs after 
MMS treatment. These observations indicate that following MDC1 depletion, HR 
cannot progress due to deficient Rad51 loading. This stalling of repair does not allow 
completion of HR (SCEs) and leads to a DSB repair defect (!-H2AX). Taken together 
with the data in G2, these results strengthen the conclusions that MDC1 has a direct role 
in HR at the Rad51 filament formation stage while 53BP1 does not have a direct role in 
HR.  
 
S-phase resection requires CtIP and the PIKK kinases. 
 
The PIKK kinases ATM, ATR and DNA-PK have a prominent role in the DNA damage 
response to DSBs in all cell cycle phases. However elucidating the individual roles of 
these kinases can be difficult as there is often functional redundancy amongst them. 
Such an example is the phosphorylation of histone H2AX, where DNA-PK is able to 
substitute for ATM and carry out this modification after damage in the absence of ATM 
(Stiff et al, 2004). On the other hand, however, there are certain functions for each of 
these kinases that cannot be substituted. 
 In G2-phase HR, ATM phosphorylates CtIP and this phosphorylation is required 
for CtIP focal accumulation and the initiation of resection (Shibata et al, 2011). In the 
absence of ATM function, neither ATR nor DNA-PK is able to carry out this 
phosphorylation and a resection defect in observed. Paradoxically however, this 
phosphorylation appears to be dispensable in S-phase HR as RPA, Rad51 and SCEs 
form normally in the absence of ATM. One explanation for this is that CtIP is able to 
bind to ssDNA and initiate resection without modification by ATM. At stalled/collapsed 
replication forks there is single stranded DNA to which CtIP could bind whereas at Ku 
bound G2 phase DSBs there is not (Shechter et al, 2004; Langerak et al, 2011). It is 
important to note however that although the mechanism of CtIP regulation is S-phase is 
!!
*"%!
unclear, as in G2, resection cannot proceed in the absence of CtIP. Consistently when 
CtIP is depleted in S-phase RPA signal intensity is reduced compared to control siRNA 
treated cells. 
 The extent of modifications to chromatin but also to target proteins that are 
required to facilitate resection are currently unclear. For example in G2 phase, 
chromatin relaxation via KAP1 phosphorylation is important for efficient resection and 
HR. In S-phase, the function of the PIKK kinases also appears to be required for S-
phase resection. Although dispensable when inhibited individually, when inhibited in 
conjunction a reduction in RPA signal intensity is observed. The function of the PIKK 
kinases in facilitating resection in S-phase is unlikely to occur via CtIP modification but 
this has not been shown and their roles are currently unknown. 
 
 
Repair pathway choice of collapsed/stalled replication forks can affect genomic 
stability. 
 
The cause of the chromosome breakage, radial chromosomes and other cytogenetic 
abnormalities seen in BRCA and FA mutant cells is not understood. It is suggested 
however that these abnormalities result from an inability to properly respond to 
replication stress (D'Andrea & Grompe, 2003). As discussed previously, HR is a repair 
pathway that is frequently used to respond to replication fork stalling/collapse and is 
defective in both FA and BRCA mutant cells. One model for the cytogenetic 
abnormalities seen in these cells is the inappropriate repair of one-ended DSBs arising 
in S-phase by NHEJ (Helleday et al, 2007).   
 Since 53BP1 has been shown to function in long range re-joining events in 
V(D)J recombination, telomere fusions and CSR, I reasoned that it may play a role in 
NHEJ of distant one ended DSBs (Difilippantonio et al, 2008; Dimitrova et al, 2008; 
Bothmer et al, 2011). To test this, I depleted BRCA1 in Hela cells and monitored foci 
movement and re-joining in the presence and absence of 53BP1 by LCI.  
 However, following BRCA1 depletion I observed no increase in 53BP1 foci 
movement or increased re-joining compared to control cells. Additionally, co-depletion 
of 53BP1 and BRCA1 had no effect on foci movement and re-joining. These 
inconclusive results indicate that the experimental setup may need to be modified in 
order to detect any changes or that there is in fact no role for 53BP1 in the process. One 
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obvious difference between re-joining in V(D)J and CSR and the situation at one-ended 
DSBs in S-phase is the distance that separates the DSBs. In V(D)J and CSR there is a 
defined and measurable distance whereas in S-phase another one ended DSB could be 
relatively close or far. 
 Investigating the effect of 53BP1 on the cytogenetic abnormalities of FA and 
BRCA mutant cells may provide a clearer picture. Strikingly a recent study showed that 
the increased number of radial chromosomes observed in BRAC1 mutant cells return to 
normal when 53BP1 is co-depleted (Bunting et al, 2010). The authors propose a model 
whereby 53BP1 functions to block resection and promote NHEJ while BRCA1 
functions to overcome the barrier posed by 53BP1 and enable HR. When the two are 
co-depleted, HR can ensue and the radial chromosomes are no longer observed. 
However, whether the repair of S-phase damage by NHEJ leads to radial chromosomes, 
whether these result from re-joining of distant one-ended DSBs and whether this 
requires 53BP1 function are all questions which need to be addressed.     
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CHAPTER 4 
 
The role of ubiquitin signalling in 
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4   The role of ubiquitin signalling in Homologous recombination 
 
 
4.1: Introduction 
 
Following the induction of DSBs, a DDR is initiated that involves the function of 
multiple factors. The recruitment, interactions, and function(s) of these factors are 
highly regulated through PTMs that include phosphorylation and ubiquitylation. As 
discussed in the introductory chapter, the PIKKs ATM, ATR and DNA-PK are key 
regulatory components of the DDR, with important roles in cell cycle checkpoint 
initiation as well as in the DSB repair pathways (Lavin, 2008; Stiff et al, 2004). These 
kinases orchestrate the initial, rapid DDR via phosphorylation of downstream targets. 
Phosphorylation is a signalling PTM that can be carried out rapidly, and the first wave 
of DDR factor recruitment to DSBs is controlled by phosphorylation (Bekker-Jensen & 
Mailand, 2010). The recruitment and phosphorylation of these factors can activate their 
function, which might be required for repair, or might act as a binding platforms for 
downstream factors via phospho-specific interactions (Mohammad & Yaffe, 2009). 
 The second wave of DDR factor recruitment to DSBs involves ubiquitin 
signalling (Bekker-Jensen & Mailand, 2010). This signalling cascade is initiated by the 
recruitment of RNF8 to DSBs via the interaction of the FHA domain of RNF8 with 
phosphorylated MDC1 (Mailand et al, 2007). Once recruited to DSBs, RNF8 
ubiquitylates downstream targets that include histones H2A, H2AX and H2B (Thomson 
& Guerra-Rebollo, 2010). The E3 ubiquitin ligase activity can lead to the formation of 
K48 and K63 linked ubiquitin chains, but HERC2 promotes the formation of K63 
linked chains by catalysing the interaction between RNF8 and the E2 ligase UBC13 
(Bekker-Jensen et al, 2010). RNF168 is subsequently recruited to DSBs via the 
interaction of its UIM with ubiquitylated histones, where it amplifies the ubiquitin 
response by interacting with UBC13 and carrying out further histone ubiquitylation 
(Doil et al, 2009; Stewart et al, 2009). The ubiquitin signalling pathway at DSBs is 
critical for the recruitment of 53BP1 and BRCA1. 
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 As discussed in the previous chapter, 53BP1 functions in the repair of DSBs in 
G2 phase by mediating HR repair at HC. However, 53BP1 does not have a direct role in 
the HR pathway and is dispensable when HC is artificially relaxed via KAP-1 
knockdown, or during HR in S-phase where chromatin is decondensed for DNA 
replication. In addition to 53BP1, ubiquitin signalling events at DSBs also lead to the 
recruitment of BRCA1 via the interaction of its binding partner RAP80 with 
ubiquitylated histones (Sobhian et al, 2007). Unlike 53BP1, BRCA1 is essential for 
DSB repair via HR although the details of BRCA1 function in this pathway have 
remained elusive (Baldeyron et al, 2002; Moynahan et al, 1999; Stark et al, 2004; 
Zhong et al, 2002; Huen et al, 2009). The position of BRCA1 in the HR pathway and its 
interplay with 53BP1 will be the focus of chapter 5 of this thesis. The requirement for 
RNF8, RNF168 and the ubiquitin signalling pathway in the recruitment of BRCA1, 
raise the possibility that these E3 enzymes might also function in the HR pathway. 
Moreover, a recent study demonstrated that RNF8/RNF168 catalysed histone 
ubiquitylation recruits RNF169 to DSBs, where it supresses 53BP1 recruitment and 
promotes repair by HR (Poulsen et al, 2012). In this chapter I examine whether 
ubiquitin signalling is required for HR in G2 phase following IR, and in S-phase 
following CPT treatment. In addition, I examine whether the E3 ubiquitin ligases RNF8 
and RNF168 have distinct or overlapping roles in the formation of HR intermediates in 
G2 phase and also assess their requirement for resection in S-phase. Finally, since 
BRCA1 is itself an ubiquitin ligase, I test whether the ubiquitin ligase activity of 
BRCA1 is required for HR in G2 phase.  
 
 
4.2: Results 
4.2.1: RIDDLE patient cells are defective in G2 phase homologous recombination 
 
RIDDLE (radiosensitivity, immunodeficiency, dysmorphic features and learning 
difficulties), is a recently discovered human disorder with a defective DDR due to 
mutated RNF168 resulting in defective 53BP1 focal recruitment (Stewart et al, 2007; 
2009). Previous work from our laboratory investigated the role of RNF168 in G1 phase 
DSB repair by using cultured RIDDLE syndrome fibroblast cells (Noon et al, 2010). 
Following treatment with IR, ATM activation is normal in these cells however a DSB 
repair defect is observed that is identical to AT cells. This is because although RIDDLE 
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cells do not have defective ATM activation, they are unable to tether active ATM at 
DSB sites and do not form pKAP-1 foci (Noon et al, 2010). This results from their 
inability to form 53BP1 foci, which are important for ATM tethering via the MRN 
complex (Lee et al, 2010). Ultimately the radiosensitivity of RIDDLE patients appears 
to result from an inability to carry out the chromatin modifications necessary for 
efficient DSB repair. 
As described in the previous chapter, HR in G2 preferentially repairs slowly 
repaired HC DSBs after IR. The process requires ATM and the mediators H2AX, 
MDC1 and 53BP1 that function to relax chromatin structure at DSB sites via KAP-1 
phosphorylation. Additionally however, ATM is also required for the initiation of 
resection while MDC1 function is necessary for Rad51 foci formation. The role of 
53BP1 in G2 phase HR is limited to chromatin relaxation.  
 In the choreographed recruitment of the DDR factors to DSB sites, the ubiquitin 
ligases RNF8 and RNF168 function downstream of MDC1 but upstream of 53BP1 
(Huen et al, 2007; Mailand et al, 2007; Doil et al, 2009). Since MDC1 is required for 
all HR while 53BP1 is not, I reasoned that the ubiquitin ligases might have a direct role 
in DSB repair by HR and that the HR defect of MDC1 cells results from an inability to 
recruit the ubiquitin ligases. To test this I utilised cultured RIDDLE patient fibroblast 
cells and carried out the HR assays described in chapter 3. Additionally by using cells 
stably complemented with an empty HA vector or an HA vector with human wild type 
RNF168 (HA-RNF168) I could verify whether any effect observed was due to RNF168 
function. 
As in G1 phase, G2 phase RIDDLE fibroblasts stably expressing the empty HA 
vector display a repair defect specifically in slowly repaired DSBs (Noon et al, 2010) 
(Figure 4.1a). As a control, immortalised wild type human fibroblasts were used 
(1BrhTERT). At two hours post IR the number of !-H2AX foci remaining in the 
RIDDLE fibroblasts was indistinguishable to that in wild type cells, but by eight hours a 
significant repair defect was observed (Figure 4.1a). Importantly, RIDDLE cells stably 
complemented with HA-RNF168 showed normal repair suggesting that the repair defect 
in RIDDLE cells results from mutated RNF168. Moreover the fact that RNF168 
deficiency only affected slowly repaired DSBs indicated a role in HR.  
To test whether RNF168 might indeed have a role in HR, I decided to monitor 
DNA end resection (RPA foci) and Rad51 filament formation (Rad51 foci) in RIDDLE 
patient cells (Figure 4.1b-c). Two hours following 3Gy IR, G2 phase RIDDLE cells had  
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Figure 4.1: RIDDLE patient cells are deficient in G2 phase DSB repair by HR. 
a) RIDDLE patient cells stably complemented with either HA or HA-RNF168 were irradiated with 3Gy IR. Prior to 
irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. !-H2AX foci were 
enumerated specifically in CENP-F positive cells. b) As for a) but here RPA foci were enumerated two hours post 
3Gy IR. c) Enumeration of Rad51 foci two hours post 3Gy IR in G2 phase RIDDLE patient cells stably 
complemented with either HA or HA-RNF168. In a-c, foci were enumerated in 30 cells per time-point and the data 
represent the mean and standard deviation of three independent experiments. 
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Figure 4.2: KAP-1 depletion alleviates the HR defect of RIDDLE patient cells. 
a) RIDDLE patient cells stably complemented with either HA or HA-RNF168 were treated or not with KAP-1 
siRNA and irradiated with 3Gy IR. Prior to irradiation aphidicolin was added to the cells to prevent S-phase cells 
from entering G2. The cells were then harvested at two and eight hours post IR and immunostained with CENP-F and 
!-H2AX antibodies. G2 phase cells were identified by positive CENP-F staining and the cell nuclei were visualized 
by DAPI. !-H2AX foci were enumerated specifically in CENP-F positive cells. b) As for a) but here RPA foci were 
enumerated two hours post 3Gy IR. c) Enumeration of Rad51 foci two hours post 3Gy IR in G2 phase RIDDLE 
patient cells stably complemented with either HA or HA-RNF168. In a-c, foci were enumerated in 30 cells per time-
point and the data represent the mean and standard deviation of three independent experiments. 
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significantly fewer RPA foci than wild type cells although the defect was only partial. 
However, RIDDLE cells stably expressing HA-RNF168 had normal RPA foci numbers 
two hours post IR (Figure 4.1b). Similarly, a partial Rad51 foci formation defect was 
observed in RIDDLE cells but not in RNF168 complemented cells (Figure 4.1c). These 
results indicate that RNF168 function is required for resection and Rad51 loading and 
that the DSB repair defect observed in G2 phase RIDDLE cells results from defective 
HR repair. 
In G1, RNF168 mediates DSB repair via HC relaxation however its role is 
overcome by KAP-1 depletion indicating that it is not a core repair component (Noon et 
al, 2010). To test whether RNF168 is a core HR component or whether it mediates 
repair via HC relaxation, I repeated the experiments outlined above with or without 
KAP-1 depletion. As predicted, KAP-1 depletion in 1BrhTERT cells had no effect on 
the speed or fidelity of DSB repair in G2 cells monitored by !-H2AX foci (Figure 4.2a). 
However depletion of KAP-1 in G2 phase RIDDLE patient cells rescued the repair 
defect and the number of !-H2AX foci remaining eight hours post IR was 
indistinguishable to control cells (Figure 4.2a). Similarly, KAP-1 depletion did not 
impact on control cells but rescued the RPA and Rad51 foci formation defect of 
RIDDLE patient cells (Figure 4.2b-c). These results indicate that RNF168 does not have 
a direct role in HR but like 53BP1 promotes the process by mediating the necessary 
localised chromatin relaxation. Importantly, the requirement of MDC1 for RNF168 
recruitment cannot explain its role in HR as it is distinct to that of RNF168 and cannot 
be overcome by KAP-1 depletion. 
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4.2.2: RNF8 is required for IR induced HR in G2. 
 
RNF8 is the second E3 ubiquitin ligase that is recruited to DSB sites in an MDC1 
dependent manner. Previous work has shown that RNF8 functions together with 
RNF168 in the formation of the K63 polyubiquitin chains required for 53BP1 IRIF 
(Huen et al, 2007; Mailand et al, 2007; Kolas et al, 2007). To test whether the HR 
defect seen in MDC1 depleted cells results from an inability to recruit RNF8, I 
investigated the role of RNF8 in G2 phase HR.  
 As in G1, when !-H2AX foci were monitored in G2 phase cells depleted for 
RNF8, a DSB repair defect affecting slow repairing DSBs was observed after IR  
(Figure 3a). Strikingly however and distinct to the situation in G1, when KAP-1 was co-
depleted in these cells there was no rescue of the repair defect (Figure 4.3a). This 
finding indicates that RNF8 function in G2 phase DSB repair is distinct to that of 
RNF168 and goes beyond mediating the recruitment of 53BP1. To further investigate 
the involvement of RNF8 in HR repair I monitored RPA and Rad51 foci in G2 phase 
cells. Surprisingly, a severe RPA and Rad51 foci formation defect was observed in 
RNF8 knockdown cells and this was unaffected by KAP-1 depletion (Figure 4.3b-c). 
The magnitude of these defects are greater that those seen in MDC1 knockdown cells 
and suggest an important role for RNF8 in these processes. As discussed previously, 
ATM functions in the initiation of resection in G2 via phosphorylation of CtIP which is 
also required for resection (Shibata et al, 2011). As these two components are essential 
for resection, no repair by HR can take place in their absence. However, under these 
conditions, the DSB ends are still an end joining substrate and repair can ensue with 
faster kinetics by NHEJ and no repair defect is observed (Shibata et al, 2011). Distinct 
to the situation in ATM and CtIP depleted cells, RNF8 depleted cells display a 
persistent DSB repair defect in G2 even after KAP-1 depletion (Figure 4.3a). I interpret 
this as suggesting that resection is initiated but likely stalls at an early stage, thus not 
allowing HR progression or returning to repair by NHEJ.  
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Figure 4.3:RNF8 is required for IR induced HR in G2 irrespective of KAP-1 status. 
a) A549 cells were treated with control +/- KAP-1 and RNF8 +/- KAP-1 siRNA and were irradiated with 3Gy IR. 
Prior to irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. b) As for a) but here RPA 
foci were enumerated two hours post 3Gy IR. c) Enumeration of Rad51 foci two hours post 3Gy IR in G2 phase 
A549 cells treated with control +/- KAP-1 and RNF8 +/- KAP-1 siRNA. In a-c, foci were enumerated in 30 cells per 
time-point and the data represent the mean and standard deviation of three independent experiments. 
 
0 
5 
10 
15 
20 
25 
30 
35 
40 
45 
0 2 
R
PA
 fo
ci
 
Time post IR (h) 
RPA foci in G2 phase A549 cells after 3Gy IR 
siControl 
siControl + siKAP1 
siRNF8 
siRNF8 + siKAP1 
0 
5 
10 
15 
20 
25 
30 
0 2 
R
ad
51
 fo
ci
 
Time post IR (h) 
Rad51 foci formation in G2 A549 cells after 3Gy IR 
Control 
Control + KAP1 
RNF8 
RNF8 + KAP1 
0 
10 
20 
30 
40 
50 
60 
0 2 4 8 
!-
 fo
ci
 p
er
 c
el
l 
Time post IR (h) 
!-H2AX foci in G2 phase A549 cells after 3Gy 
Control 
Control + siKAP1 
siRNF8 
siRNF8 + siKAP1 
!"
#"
$"
!!
*#&!
4.2.3: RNF8 and RNF168 have distinct roles in G2 phase HR. 
 
The initial experiments carried out in RNF8 and RNF168 depleted/mutant cells 
indicated distinct roles for these E3 ubiquitin ligases in G2 phase HR. To gain further 
insight and in an attempt to verify that RNF8 is a core HR component I artificially 
increased the fraction of IR induced DSBs repaired by HR. As in chapter 3, I achieved 
this by inhibiting NHEJ through siRNA mediated depletion of Ku80 and DNA-PKcs.  
In control cells this led to an increase in the number of RPA foci observed four hours 
post IR treatment (Figure 4.4a). As expected, increased RPA foci numbers were also 
observed in RNF168 depleted cells although not to the level of control cells (Figure 
4.4a). However, when KAP-1 was also depleted, the RPA foci in RNF168 depleted 
cells returned to control levels (Figure 4.4b). In summary, these results support the 
notion that RNF168 enables HR by mediating KAP-1 dependent HC relaxation but 
itself has no direct role in HR. In contrast, RNF8 depleted cells displayed an RPA foci 
defect that persisted even after KAP-1 depletion (Figure 4.4b). However, Ku80 and 
DNA-PK depletion did increase RPA foci numbers in RNF8 depleted cells (Figure 
4.4a-b). This was surprising given the severe RPA foci defect seen in Figure 3b and 
suggests that RNF8 might be dispensable for resection in EU but not at HC. Another 
possibility is that the depletion of Ku80 and DNA-PK creates DSB ends that are 
favourable to resection even in the absence of RNF8. 
Next I monitored Rad51 foci in RNF168 and RNF8 depleted cells following co-
depletion of Ku80 and DNA-PKcs (Figure 4.5a-b). RNF168 knockdown cells showed 
only a partial reduction in Rad51 foci numbers compared to Ku80 + DNA-PKcs 
knockdown cells (Figure 4.5a). Moreover this defect was completely overcome by 
KAP-1 depletion again consistent with the notion that RNF168 is dispensable for HR 
when chromatin structure is relaxed (Figure 4.5b). In stark contrast, RNF8 depleted 
cells displayed a severe Rad51 foci formation defect even following Ku80 and DNA-
PKcs knockdown (Figure 4.5a). KAP-1 depletion had no effect on the phenotype of 
RNF8 depleted cells and a severe Rad51 foci formation defect persisted (Figure 4.5a). 
These results indicate that some resection can take place at EU DSBs in the absence of 
RNF8, however Rad51 loading remains severely compromised and it is unlikely that 
repair by HR would be completed. It is plausible to suggest that the HR defect seen in 
MDC1 depleted cells in G2 phase, results from an inability to recruit RNF8. 
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Figure 4.4: RNF168 is dispensable for RPA foci formation in euchromatin while RNF8 is partially required. 
a) A549 cells were treated with control, RNF8 or RNF168 siRNA and Ku80 and DNA-PKcs were co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at 0.5 and 4 hours post IR. Next one set of samples 
was immunostained with RPA and CENP-F and the other with !-H2AX and CENP-F antibodies. G2 phase cells were 
identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. RPA and !-H2AX were 
enumerated and plotted on the same graph with hashed bars indicating !-H2AX foci and solid bards indicating RPA 
foci. b) As for a) but KAP-1 was co-depleted in all samples. Foci were enumerated in 30 cells per time-point and the 
data represent the mean and standard deviation of three independent experiments. c) A549 cells were treated RNF8 
and RNF168 siRNA oligonucleotides. Per knockdown, 100 pmol of siRNA duplexes per 2 x 105 logarithmically 
growing cells were used. Cells were then grown for 72 h, irradiated with 3Gy IR and fixed 4h later. 53BP1 
immunostaining revealed that RNF8 and RNF168 siRNA treated cells failed to form 53BP1 IRIF indicating efficient 
knockdown. 
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Figure 4.5: RNF168 is dispensable for RPA foci formation in euchromatin but RNF8 is not. 
a) A549 cells were treated with control, RNF168 or RNF8 siRNA and Ku80 and DNA-PKcs were co-depleted where 
indicated. The cells were treated with 3Gy IR and then harvested at 0.5 and 4 hours post IR. Next one set of samples 
was immunostained with Ra51 and CENP-F and the other with !-H2AX and CENP-F antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. Rad51 and !-H2AX were 
enumerated and plotted on the same graph with hashed bars indicating !-H2AX foci and solid bards indicating Rad51 
foci. b) As for a) but KAP-1 was co-depleted in all samples. Foci were enumerated in 30 cells per time-point and the 
data represent the mean and standard deviation of three independent experiments. 
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4.2.4: Proteasome inhibition affects G2 phase DSB resection. 
 
RNF8 and RNF168 are E3 ubiquitin ligases that are required for the formation of K63 
polyubiquitin chains during the DDR (Doil et al, 2009). However to date not many 
targets for this modification have been identified and histone H2A is the best 
characterised (Panier & Durocher, 2009). Due to the large discrepancy in the 
requirement for RNF8 and RNF168 in RPA and Rad51 foci formation I decided to 
investigate the role of ubiquitin modifications in these processes.  To achieve this I 
utilised the potent proteasome inhibitor epoxomicin (Meng et al, 1999). The post-
translational modification of ubiquitylation is primarily used to target proteins for 
proteasomal degradation (Ramadan & Meerang, 2011). By treating cells with 
proteasome inhibitors, ubiquitylated proteins are not degraded leading to deficient 
ubiquitin turnover and a depletion of the ubiquitin pool. 
 To monitor the effect of epoxomicin on K63 polyubiquitin chain formation in 
response to IR I used an FK2 antibody to detect these chains. In control cells, a 
significant increase in FK2 nuclear signal was observed by thirty minutes after exposure 
to 3Gy IR (Figure 4.6a). This increase reached maximum levels by four hours after IR 
treatment and was still evident at eight hours after IR. Cell cycle stage, determined by 
CENPF staining, had no effect on the intensity of the FK2 signal (Figure 4.6a). In cells 
treated with 100µM epoxomicin for four hours prior to IR exposure, there was a clear 
reduction in nuclear FK2 signal compared to control cells (Figure 4.6b). Although there 
was an increase in cytoplasmic FK2 signal, nuclear signal was inhibited even at eight 
hours post IR (Figure 4.6b). 
 Next I monitored RPA foci in cells treated with 100µM epoxomicin for four 
hours prior to IR exposure. The number of RPA foci in epoxomicin treated cells was 
significantly reduced at two hours post IR compared to control cells (Figure 4.7a). In 
control cells, the number of RPA foci reached maximum numbers at two hours post IR 
and then gradually decreased over the eight-hour time course. In contrast, epoxomicin 
treated cells failed to efficiently form RPA foci by two hours and then displayed 
delayed RPA foci clearance during the eight hour time course (Figure 4.7a). These 
results indicate that epoxomicin is a potent proteasome inhibitor that prevents the 
formation of FK2 foci following IR exposure. Additionally ubiquitin modifications 
appear to be important for DNA resection as treatment with epoxomicin leads to 
decreased RPA foci numbers in response to IR. It is important to note that the  
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Figure 4.6: Epoxomicin treatment leads to reduced FK2 nuclear staining after IR. 
a) A549 cells were treated with 3Gy and harvested 0.5, 4 and 8 hours after IR. The cells were then immunostained 
with FK2 and CENPF antibodies while DAPI stain was used to visualise cell nuclei. b) A549 cells were treated with 
50µM epoxomicin for four hours prior to being irradiated with 3Gy. The cells were then harvested 0.5, 4 and 8 hours 
after IR and immunostained with FK2 and CENPF antibodies while DAPI stain was used to visualise cell nuclei. 
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Figure 4.7: Proteasome inhibition effects G2 phase DSB resection. 
A549 cells were treated or not with 50µM epoxomicin for four hours prior to being irradiated with 3Gy. The cells 
were then harvested 2, 4, 6 and 8 hours after IR and immunostained with RPA and CENPF antibodies while DAPI 
stain was used to visualise cell nuclei. Foci were enumerated in 30 cells per time-point and the data represent the 
mean and standard deviation of three independent experiments. 
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reduction in RPA foci number after epoxomicin treatment was similar in magnitude to 
RNF168 deficient/depleted cells but smaller than that observed in RNF8 depleted cells.  
 
4.2.5: Neither proteasome inhibition nor RNF8 depletion affect S-phase resection. 
 
The magnitude of the resection defect in RNF8 depleted cells and the fact that it could 
not be overcome by KAP-1 depletion indicated a role in the process that went beyond 
mediating the process via HC relaxation. In order to further assess the role of RNF8 in 
DNA resection I decided to use a flow cytometry approach to differentially assess 
resection in G2 versus S-phase. In S-phase chromatin structure is thought to be in a 
decondensed configuration and as discussed in chapter 3 resection can ensue in the 
absence of ATM, MDC1 or 53BP1. 
 First I assessed the effect of RNF8 depletion and epoxomicin treatment on RPA 
signal intensity in G2 cells four hours post 15 Gy (Figure 4.8a). Both epoxomicin 
treatment and RNF8 depletion led to a significant reduction in RPA signal intensity 
compared to control cells and was comparable to ATMi treated cells (Figure 4.8a). 
Surprisingly however when RPA signal intensity was monitored in S-phase cells 
following a one-hour exposure to 4µM camptothecin, no reduction in RPA intensity was 
observed compared to control cells (Figure 4.8b). This unexpected result indicated that 
RNF8 function and the formation of polyubiquitin chains are required for DNA 
resection in G2 phase but not in S-phase. 
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Figure 4.8: RNF8 depletion and proteasome inhibition effect RPA signal intensity after IR in G2 but not in S-
phase.  
a) Cycling A549 cells were treated with ATMi, epoxomicine, CtIP siRNA or RNF8 siRNA and irradiated with 15Gy 
IR. Irradiated cells were harvested four hours post IR and immunostained with an RPA antibody and propidium 
iodide. RPA signal intensity was measured by flow cytometry and the quantification is shown. Propidium iodide 
staining was used to detect G2 phase cells based on DNA content. b) As for a) but here RPA signal intensity was 
measured by flow cytometry after one hour exposure to 4µM camptothecin. Propidium iodide staining was used to 
detect S-phase cells based on DNA content. In a-b 10,000 cells were analysed per condition and the results represent 
the average of three experiments and the standard deviation among these. 
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4.2.6: BRCA1 is also required for G2 phase HR. 
 
As discussed in chapter 3, CtIP phosphorylation by ATM is response to DNA damage is 
a pre-requisite for DNA resection in G2 (Shibata et al, 2011). However is S-phase, 
although CtIP is still required for resection, its function is ATM independent. I 
postulated that a similar scenario may be true for ubiquitylation i.e. it is required for 
resection in G2 but dispensable for resection in S-phase. CtIP has previously been 
reported to be ubiquitylated in response to DNA damage (Yu et al, 2006). This 
ubiquitylation does not target CtIP for degradation but rather promotes the association 
of CtIP with chromatin. BRCA1, another E3 ubiquitin ligase, is thought to directly 
ubiquitylate CtIP is response to DNA damage although the recruitment of BRCA1 
depends on RNF8 function (Wang & Elledge, 2007). Interestingly, the ubiquitylation of 
CtIP by BRCA1 requires prior phosphorylation of CtIP and interaction with the BRCT 
domains of BRCA1. It therefore appears that at least in G2 phase, phosphorylation and 
ubiquitylation of CtIP cooperate to target CtIP to DSB sites so that resection can take 
place and repair by HR can ensue.  
 To test this hypothesis I decided to investigate the role of BRCA1 in the 
formation of HR intermediates in G2 following IR. BRCA1 has long been known as a 
vital component of homology directed repair (Moynahan et al, 1999; Schlegel et al, 
2006; Huen et al, 2009). However, its role(s) in the process are not fully understood. 
First, I tested whether depletion of BRCA1 by siRNA affects DSB repair in G2 phase 
cells (Figure 4.9a). Indeed BRCA1 depletion led to a DSB repair defect that specifically 
affected the slow component of repair in G2 phase (Figure 4.9a). The number of !-
H2AX foci at two hours post 3Gy was similar to the control cells but by eight hours a 
significant repair defect was observed (Figure 4.9a). Importantly KAP-1 co-depletion 
did not rescue the BRCA1 repair defect suggesting that its role in HR is not due to a 
role in HC relaxation (Figure 4.9a). 
 Next I monitored RPA foci formation in G2 phase BRCA1 depleted cells 
following IR treatment. A substantial reduction in RPA foci number two hours post IR 
was observed and this could not be rescued by KAP-1 co-depletion (Figure 4.9b).  This 
finding indicates that BRCA1 has a direct role in resection that is not dependent on 
chromatin compaction. Finally, I monitored Rad51 foci in G2 phase BRCA1 depleted 
cells following IR treatment. I observed a significant reduction in Rad51 foci number 
two hours post IR that could not be rescued by KAP-1 co-depletion (Figure 4.9c). 
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Figure 4.9: BRCA1 is required for IR induced HR in G2 irrespective of KAP-1 status. 
a) A549 cells were treated with control +/- KAP-1 and BRCA1 +/- KAP-1 siRNA and were irradiated with 3Gy IR. 
Prior to irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. G2 phase cells 
were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. b) As for a) but here RPA 
foci were enumerated two hours post 3Gy IR. c) Enumeration of Rad51 foci two hours post 3Gy IR in G2 phase 
A549 cells treated with control +/- KAP-1 and BRCA1 +/- KAP-1 siRNA. In a-c, foci were enumerated in 30 cells 
per time-point and the data represent the mean and standard deviation of three independent experiments. 
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These findings indicate a direct role for BRCA1 in G2 phase HR that is important for 
both RPA and Rad51 foci formation. Significantly this role(s) appear to be independent 
of chromatin compaction as KAP-1 co-depletion rescued neither the !-H2AX, RPA nor 
Rad51 foci formation defects. All the above are consistent with a model whereby 
BRCA1 enables resection by ubiquitylating CtIP in response to DNA damage and 
targeting it to DSB sites. To test this model I acquired BRCA1 MEFs with a mutated 
RING finger domain, responsible for its ubiquitin ligase activity. 
 
 
4.2.7: The BRCT domain but not the RING domain of BRCA1 is required for G2 
phase HR. 
 
 When amino acid twenty-six of BRCA1 is mutated from an isoleucine to an 
alanine (I26A), it results in a ubiquitin ligase dead version of the protein (Sankaran et 
al, 2006). However, this mutation does not affect the ability of BRCA1 to interact with 
its binding partners or its ability to localise to DNA damage sites. I used MEFs isolated 
from mice carrying this mutation to test whether BRCA1 ubiquitin ligase activity is 
required for resection in G2 phase (Figure 4.10a) (Shakya et al, 2011). Surprisingly and 
contrary to the model suggested above, G2 phase BRCA1-I26A MEFs formed RPA foci 
to the same level as wild-type MEFs. Additionally, Rad51 foci formation in these cells 
was also normal and indistinguishable to wild-type cells (Figure 4.10b). In contrast, 
when these experiments were carried out using BRCA1 MEFs in which the BRCT 
domain is mutated (S1598F), a two-fold reduction in both RPA and Rad51 foci was 
observed (Figure 4.10 a-b). In summary, these results indicate that BRCA1 has a direct 
role in resection and Rad51 loading which is independent of chromatin compaction. 
Furthermore, the role of BRCA1 in HR appears to depend on the BRCT domain of the 
protein while its RING domain and ubiquitin ligase activity are dispensable. 
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Figure 4.10: The BRCT domain but not the RING domain of BRCA1 is required for G2 phase HR. 
a) BRCA1 FH-WT/FH-WT, BRCA1 FH-I26A/FH-I26A and BRCA1 S1598F/S1598F MEF cells were irradiated with 3Gy IR. Prior to 
irradiation aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and RPA antibodies. G2 phase cells were 
identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. RPA foci were enumerated 
specifically in CENP-F positive cells. b) As for a) but here Rad51 foci were enumerated two hours post 3Gy IR. In a-
b), foci were enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three 
independent experiments. 
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4.3: Discussion. 
 
RIDDLE patient cells are defective in G2 phase HR. 
 
RIDDLE patient cells have previously been described as radiosensitive and deficient in 
DNA DSB repair due to mutated RNF168 (Stewart et al, 2007; 2009). Work from our 
laboratory using confluence arrested G1 RIDDLE patient cells, identified a defect in 
ATM dependent robust and localised KAP-1 phosphorylation, resulting in deficient 
DSB repair of HC DSBs (Noon et al, 2010).  RNF168 is an ubiquitin ligase that is able 
to form the K63 polyubiquitin chains that are required for 53BP1 IRIF. In the absence 
of RNF168, 53BP1 foci do not form which in turn in a failure of activated ATM to be 
tethered at DSB sites (Doil et al, 2009; Lee et al, 2010). Since RNF168 deficient cells 
are unable to form 53BP1 foci in all cell cycle phases and given the role of 53BP1 in 
mediating HR (described in chapter 3), I predicted that RNF168 deficient cells would be 
impaired in DSB repair by HR. Indeed this was the case as RIDDLE patient cells 
displayed a mild !-H2AX, RPA and Rad51 foci defect in G2 that was similar to that 
seen in 53BP1 depleted cells. 
 To consolidate the notion that RNF168 mediates HC DSB repair by HR in G2 
by enabling 53BP1 IRIF, I depleted KAP-1 in RIDDLE cells and monitored the same 
endpoints. Following KAP-1 depletion, !-H2AX, RPA and Rad51 foci numbers 
returned to control levels. These results strongly suggest that RNF168 also enables HR 
by mediating KAP-1 dependent HC relaxation but does not have a direct role in the 
process per se. 
 
RNF8 is required for IR induced HR in G2. 
 
As demonstrated in chapter 3, the mediator protein MDC1 has a role during Rad51 
loading that is independent of its ability to mediate HR via KAP-1 HC relaxation. 
Consequently, the requirement for MDC1 in Rad51 loading cannot be bypassed by 
KAP-1 depletion where as that of 53BP1 can. The ubiquitin ligases RNF8 and RNF168 
fall between MDC1 and 53BP1 in the DSB repair signalling cascade and this led me to 
investigate their role in HR. However, the results from this chapter indicate that the 
Rad51 phenotype of MDC1 depleted cells cannot be explained by their failure to recruit 
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RNF168. This is because unlike MDC1 depleted cells, RNF168 depleted cells have a 
defect in !-H2AX, RPA and Rad51 foci that can be rescued by KAP-1 depletion.  
 Next I looked at the role of RNF8 in G2 phase DSB repair by HR. I was 
surprised to find that the phenotype of RNF8 depleted cells was distinct to that of 
RNF168 depletion and much greater in magnitude. RNF8 depleted cells had a severe 
RPA and Rad51 foci formation defect that could not be overcome by KAP-1 depletion. 
This phenotype was also distinct to that of MDC1 depleted cells in which the RPA foci 
defect can be overcome by KAP-1 depletion. This finding suggested that RNF8 
mediated ubiquitylation may be critical for G2 phase HR while RNF168 mediated poly-
ubiquitylation is dispensable when HC is relaxed. Consistent with this possibility, a 
recent study looking at replication fork recovery by homology directed repair found a 
direct role for RNF8 in Rad51 recruitment (Sy et al, 2011). RNF168 function, however, 
was not required, further indicating that the roles of these E3 ubiquitin ligases in HR are 
distinct. The role of RNF8 in resection appears to be less critical than its role in Rad51 
loading. Consistent with this, when I inhibited NHEJ and increased the fraction of 
DSBs repaired by HR, there was a partial increase in RPA foci in RNF8 depleted cells. 
On the other hand, the number of Rad51 foci that formed in RNF8 depleted cells under 
the same conditions remained severely impaired. 
 The function of RNF8 and RNF168 is important for the recruitment of a ‘second 
wave’ of factors important for accurate completion of the DNA repair pathways. The 
mediator 53BP1 and the E3 ubiquitin ligases Rad18 and BRCA1 are all recruited with 
slower kinetics downstream of RNF8 and RNF168. Interestingly however, Rad18 focal 
accumulation was recently shown to depend on RNF8 function but not on RNF168 (Sy 
et al, 2011). Rad18 is recruited to DNA damage sites where it directly interacts with 
Rad51c and is required for Rad51 loading and completion of DSB repair by HR (Huang 
et al, 2009). One explanation therefore is that the severe Rad51 foci formation defect of 
RNF8 depleted cells results from an inability to recruit Rad18. In the case of RNF168 
depleted cells, Rad18 recruitment and Rad51 loading take place normally but an HR 
defect is observed resulting from an inability to recruit 53BP1. Finally, since MDC1 is 
required for RNF8 recruitment, the Rad51 foci formation defect seen in MDC1 depleted 
cells likely results from loss of the RNF8-Rad18-Rad51c pathway. It must be noted 
however that RNF8 depleted cells also display an RPA foci formation defect that 
indicates a role for RNF8 in resection.  
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 The role of the non-proteolytic ubiquitin signalling pathway that is regulated by 
K63 linked ubiquitin chains is well established in the DDR, but recent evidence 
indicates that the formation of K48 linked ubiquitin chains also function in the DDR 
(Meerang et al, 2011; Mallette et al, 2012; Feng & Chen, 2012). The formation of K48 
linked ubiquitin chains on a target substrate target it for degradation by the 26S 
proteasome. The proteasome has previously been implicated in the DDR, but these 
recent findings have begun to decipher distinct requirements for the ubiquitin ligases 
involved in the DDR for the formation of proteasomal and non-proteasomal ubiquitin 
conjugates. Two independent studies have demonstrated that RNF8 but not RNF168 is 
required for the formation of K48 linked ubiquitin chain IRIF at DSB sites and for 
accumulation of these ubiquitin conjugates at laser induced DNA damage tracks (Feng 
& Chen, 2012; Meerang et al, 2011). The removal of factors modified by K48 linked 
ubiquitin chains from DSB sites by the proteasome appears to be important for 53BP1, 
BRCA1 and Rad51 recruitment (Meerang et al, 2011; Mallette & Richard, 2012). 
Strikingly, the depletion of RNF8 but not RNF168 supressed HR as measured by a 
GFP-reporter assay, supporting the data from this chapter depicting distinct roles for 
RNF8 and RNF168 in HR (Ramadan & Meerang, 2011). RNF8 was recently shown to 
target Ku80 for proteasomal degradation through K48 ubiquitylation (Feng & Chen, 
2012). As demonstrated in this chapter and in chapter 3, the removal of the Ku 
heterodimer from DSB ends is an important step in the initiation of resection. 
Consistent with this, depletion of Ku leads to increased resection as measured by RPA 
foci. It is therefore possible that during G2 phase HR, RNF8 function promotes 
resection through Ku80 K48 ubiquitylation, which triggers its removal and degradation, 
while RNF168 is dispensable for this process. Moreover, the requirement of RNF8 for 
resection is at least partially overcome by Ku80 depletion. These findings highlight that 
ubiquitin signalling plays an important role in the regulation of HR through the timely 
recruitment of 53BP1, BRCA1 and Rad51. Moreover, RNF8 appears to have an 
additional role in the regulation of resection by promoting the removal of Ku80 from 
DNA ends. 
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Proteasome inhibition effects G2 phase DSB resection. 
 
The ubiquitin ligases RNF8, RNF168, Rad18, BRCA1 and HERC2 have all been 
implicated in the cellular response to DNA DSBs (Doil et al, 2009; Huang et al, 2009; 
Huen et al, 2009; Bekker-Jensen et al, 2010). However, the mechanism of their function 
is still to be elucidated. It is likely that there is some functional redundancy amongst 
these ligases resulting from common ubiquitylation targets. In addition, it is likely that 
there are distinct functions for each of the above as demonstrated by the distinct and 
overlapping functions of RNF8 and RNF168 in HR.   
I wanted to gain insight into the overall requirement of the ubiquitin pathway in HR and 
in particular its requirement for the initial resection step, as this seems to be the process 
that determines which repair pathway is used. If resection is not initiated then repair can 
ensue by NHEJ, while following the initiation of resection repair must take place by HR 
as NHEJ can no longer repair the DSB. To investigate the role of the ubiquitin pathway 
in resection I used the proteasome inhibitor epoxomicin. Epoxomicin inhibits 
ubiquitylated protein degradation by covalently binding to the catalytic subunits of the 
proteasome. This inhibition leads to a depletion of the ubiquitin pool resulting in 
inhibition of further ubiquitylation events (Meng et al, 1999). When 1BrhTERT cells 
were treated with 50µM epoxomicin for four hours prior to exposure to IR, they stained 
negatively for nuclear FK2 up to eight hours after IR (Figure 6b). The FK2 antibody 
detects K63 monoubiquitylated proteins and polyubiquitin chains that form following 
DSB induction (Fujimuro et al, 1994) . Consistent to this, control cells treated with IR 
showed an increase in nuclear FK2 signal intensity (Figure 6a). Since there was no 
increase in nuclear FK2 signal following IR in cells treated for four hours with 50µM 
epoxomicin, I reasoned that ubiquitylation events were efficiently inhibited (Figure 6a). 
 Treatment of cells with the proteasome inhibitor epoxomicin prior to exposure 
to IR, led to a significant reduction in the formation of RPA foci in G2 phase cells 
(Figure 7). However the reduction was partial and smaller in magnitude that that seen in 
RNF8 depleted cells (Figure 3). One possibility is that the smaller effect on resection 
seen in epoxomicin treated cells compared to RNF8 depleted cells results from 
inefficient proteasomal inhibition. Another possibility is that the role of RNF8 in G2 
phase resection is independent of its ubiquitin ligase activity however this seems 
unlikely. 
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Proteasome inhibition and RNF8 depletion do not affect S-phase resection. 
 
The role of RNF8 in G2 phase resection cannot be overcome by KAP-1 depletion 
(Figure 4.3). This indicates a role for RNF8 in this process that goes beyond chromatin 
structure and is likely to be required in all HR events. To test this, I investigated the role 
of RNF8 in replication fork recovery following CPT treatment. As discussed in chapter 
3, HR is utilised for replication fork restoration and CtIP function is required for this 
process. As in G2, CtIP is also required for resection in S-phase and CtIP depletion 
leads to deficient resection after CPT (Figure 4.8a). However, unlike in G2 where CtIP 
needs to be phosphorylated by ATM in order to be recruited to DSB sites, in S-phase, 
CtIP function is ATM independent (Figure 4.8b). Consequently ATMi treated S-phase 
cells show a normal increase in RPA signal intensity following CPT treatment (Figure 
4.8b). 
 When RNF8 is depleted, G2 phase cells treated with IR show reduced RPA 
signal intensity compared to control cells indicating deficient resection (Figure 4.8a). 
Strikingly however, when RNF8 depleted cells are treated with CPT, there is no 
reduction in the RPA signal intensity in S-phase cells compared to the control (Figure 
4.8b). This finding indicates that as for ATM, RNF8 function is required for resection in 
G2 phase but dispensable for resection in S-phase. The most plausible explanation for 
this is that ATM and RNF8, function to recruit CtIP to DSB sites in G2 but that this is 
dispensable in S-phase. This model is consistent with data showing that CtIP is 
ubiquitylated in response to DNA damage and that this modification is required for its 
association with chromatin. I propose a model whereby DSB induction in G2 leads to 
CtIP phosphorylation by ATM that in turn leads to its association with its binding 
partner BRCA1 via the BRCA1 BRCT domains. BRCA1 then targets CtIP to chromatin 
where it functions in the resection step of HR. BRCA1 directly ubiquitylates CtIP in 
response to DNA damage however this event could be dispensable for resection since 
the ubiquitin ligase activity of BRCA1 is not required for HR (Yu et al, 2006; 
Greenberg, 2011). However, although BRCA1 ubiquitin ligase activity is dispensable 
for HR, there might be redundancy amongst the E3 ubiquitin ligases and another 
member of this family could carry out CtIP ubiquitylation when BRCA1 is mutated. 
RNF8 might also directly ubiquitylate CtIP or may promote CtIP ubiquitylation by 
recruiting BRCA1. In S-phase however, CtIP is recruited to sites of stalled replication 
forks independently of ATM and RNF8 function. The most likely explanation for this is 
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the difference between stalled replication forks and two ended DSBs in G2. Stalled 
replication forks have some ssDNA which may act as a substrate for direct CtIP binding 
thus making ATM and RNF8 function redundant.        
 RNF8 function may be dispensable for resection in S-phase, but experiments in 
G2 indicated that RNF8 function is critical for Rad51 filament formation (Figure 4.3-
4.5). It is highly probable that RNF8 function is required for Rad51 loading also in S-
phase and for replication fork recovery by HR. The mechanism whereby RNF8 leads to 
Rad51 loading likely involves its role in recruiting Rad18 which has been shown to 
interact with Rad51c and is required for HR. In support of this model, there is evidence 
showing that RNF8 depletion compromises Rad18 and Rad51 recruitment to damage 
sites following hydroxyurea treatment. In addition replication fork recovery after 
hydroxyurea, which has been shown to depend on HR, is severely compromised in 
RNF8 depleted cells. In summary, the role of RNF8 in S-phase and G2 phase DNA 
repair goes far beyond its role in G1 repair as a result of its involvement in HR. In 
contrast RNF168 functions in G2 as in G1 and promotes efficient DSB repair by 
mediating KAP-1 dependent chromatin relaxation. 
 
 
The BRCT domain but not the RING domain of BRCA1 is required for G2 phase 
HR. 
 
BRCA1 is the ubiquitin ligase thought to ubiquitylate CtIP in response to DNA damage. 
As discussed previously, CtIP function is required for DNA resection during HR in G2 
and in S-phase. However experiments in this chapter using the proteasome inhibitor 
epoxomicin indicate that ubiquitylation events are required for resection in G2 phase 
but dispensable in S-phase (Figures 4.7-4.8). I decided to investigate whether BRCA1 
function is required for resection in G2 phase and whether this depends on its function 
as a ubiquitin ligase. Consistent with its well-characterised role in HR, BRCA1 depleted 
cells displayed a defect in RPA and Rad51 foci in G2 after IR resulting in a DSB repair 
defect (Figure 4.9). This defect could not be overcome by KAP-1 depletion indicating 
that BRCA1 function in G2 phase HR is not dependent on chromatin status.  
 Next I used MEFs isolated from mice with mutated or wild type BRCA1 to test 
the role of BRCA1 as ubiquitin ligase in resection. One set of MEFs carried a mutation 
that leads to a ubiquitin ligase dead version of the protein (I26A), while the other had a 
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deletion in the BRCT region (S1598F). Strikingly, the I26A MEFs showed normal RPA 
and Rad51 foci numbers indicating that BRCA1 function as a ubiquitin ligase is 
dispensable for G2 phase HR. This is a highly surprising result given its function in 
CtIP ubiquitylation following DNA damage. One possible explanation is that there is 
functional redundancy amongst the ubiquitin ligases in G2 and that another ligase can 
ubiquitylate CtIP in MEFs carrying the I26A mutation. In contrast, the MEFs in which 
the BRCA1 BRCT domains are deleted showed a significant defect in both RPA and 
Rad51 foci formation compared to the wild type cells. The BRCT domains of BRCA1 
are important for its interaction with its binding partners CtIP, BACH1, Abraxas and 
RAP80. BRCA1 interacts with phosphorylated Abraxas via its BRCT domain and forms 
a complex with Abraxas and RAP80. The ubiquitin interacting motif of RAP80 binds to 
RNF8-RNF168 ubiquitylated sites and targets the complex to DNA damage sites. The 
BRCT domains of BRCA1 are therefore important for its recruitment to DSB sites 
although its function when it gets there does not require its ubiquitin ligase activity. 
Moreover, the overall role of BRCA1 as a tumour suppressor and its function in 
maintenance of genomic stability was recently shown to depend on the BRCT but not 
the RING domain of the protein. 
 The results from this chapter indicate that BRCA1 function is required for 
efficient resection and Rad51 filament formation during DSB repair by HR in G2. In the 
next chapter the role of BRCA1 in G2 phase HR will be studied in more detail. 
 
   
       
  
 
   
 
 
 
 
 
 
 
 
!!
*%%!
 
 
 
 
 
CHAPTER 5 
 
BRCA1 repositions 53BP1 during 
Homologous Recombination in G2 to 
enable resection at heterochromatin 
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5   BRCA1 repositions 53BP1 during Homologous Recombination in G2 to enable 
resection at heterochromatin 
 
 
 
5.1: Introduction. 
  
DSB repair pathway choice is a highly regulated process, the details of which are not 
fully understood. As discussed in the introductory chapter, the initiation of DNA 
resection appears to be the key event that determines whether NHEJ or HR repairs a 
DSB. The removal of Ku from DSB ends is a pre-requisite for the initiation of resection 
as is the recruitment of Mre11 and CtIP (Fattah et al, 2010; Shao et al, 2012; Sun et al, 
2012; Langerak et al, 2011; Shibata et al, 2011). In addition, the mediator proteins 
MDC1, 53BP1, RNF8, and BRCA1 have all been demonstrated as having an impact on 
DSB repair pathway choice (Xie et al, 2007; Feng & Chen, 2012; Yu et al, 2006; 
Schlegel et al, 2006). 
 Previous findings and my results from chapter 4 indicate that MDC1 is an 
important mediator of HR (Xie et al, 2007). In addition to its role in recruiting 
important downstream factors such as RNF8 and BRCA1, MDC1 also appears to have a 
direct role in Rad51 loading (Zhang et al, 2005). Conversely, 53BP1 has been described 
as a factor that promotes repair by NHEJ (Xie et al, 2007). More recently, the interplay 
between 53BP1 and BRCA1, both factors that are recruited by the MDC1, RNF8, 
RNF168 pathway, has been shown to determine DSB repair pathway choice by 
regulating DNA resection (Bouwman et al, 2010; Bunting et al, 2010). Loss of BRCA1 
is embryonic lethal, however MEFs and ES cells harbouring the hypomorphic 
BRCA1+11/+11 mutation are viable. This mutation does not impact on the BRCT or 
RING finger domains of BRCA1 but disrupts its phosphorylation and interaction with 
Rad50, and leads to impaired HR (Huber et al, 2001). Moreover, 98% of BRCA1+11/+11 
embryos die between days 12 and 18 of development indicating that BRCA1 function is 
critical in these stages of embryonic development (Xu et al, 2001). Interestingly, the 
embryonic lethality of BRCA1+11/+11 can be rescued by loss of ATM, Chk2 or p53 (Cao 
et al, 2006). However, BRCA1+11/+11 animals lacking p53 display cancer susceptibility 
and premature aging, while BRCA1+11/+11 animals lacking Chk2 or ATM have a greater 
lifespan but also develop tumours (Cao et al, 2006). More recently, the senescence and 
cell death seen in BRCA1+11/+11 MEFs was shown to also be rescued by deleting 53BP1 
(Cao et al, 2009). Moreover, 53BP1 deletion also rescued the embryonic lethality of the 
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BRCA1+11/+11 mutation, and the BRCA1+11/+11 53BP1-/- mice have a normal lifespan 
and do not display elevated tumour formation (Cao et al, 2009). These findings 
suggested that 53BP1 function antagonises the tumour suppressor function of BRCA1.  
Two independent studies reported that 53BP1 antagonises BRCA1’s function in 
HR by promoting XRCC4/LigIV dependent NHEJ (Bunting et al, 2010; Bouwman et 
al, 2010). Bunting et al, demonstrated that increased cytogenetic abnormalities are 
observed in BRCA1+11/+11 cells but that these are rescued by deleting 53BP1. Moreover, 
they demonstrated that 53BP1 deletion leads to increased ATM/CtIP dependent DNA 
resection and rescues the HR defect of BRCA1+11/+11 cells (Bunting et al, 2010). 
Consistently, 53BP1 deletion rescued the sensitivity of BRCA1+11/+11 cells to PARPi 
and CPT treatment. The authors concluded that in S-phase, where HR is the primary 
DSB repair pathway, BRCA1 functions to overcome the inhibitory function of 53BP1 
on resection. However, when BRCA1 function is compromised, 53BP1 blocks resection 
and promotes erroneous XRCC4/LigIV dependent NHEJ leading to the cytogenetic 
abnormalities seen in BRCA1 mutant cells (Bunting et al, 2010). Bouwman et al, 
demonstrated that 53BP1 loss rescues the hypersensitivity of BRCA1 null ES cells to 
DNA damaging agents such as cisplatin and mitomycin C and partially restores the HR 
defect of these cells (Bouwman et al, 2010). Importantly, the authors also demonstrated 
that 53BP1 is more frequently lost or aberrantly expressed in BRCA1/2 associated 
breast cancers and in triple negative sporadic breast cancers compared to sporadic 
tumours (Bouwman et al, 2010). This finding indicates that 53BP1 could serve as a 
biomarker for the effectiveness of PARPi and platinum drugs for the treatment of 
BRCA associated cancers (Bouwman et al, 2010). 
These studies demonstrating that 53BP1 is inhibitory to repair by HR are 
contradictory to my findings in chapter 3, where 53BP1 was shown to be required for 
G2 phase HR by mediating HC relaxation via KAP-1 phosphorylation. A possible 
explanation for this discrepancy is that the studies showing that 53BP1 depletion 
overcomes the requirement for BRCA1 in HR, monitored HR is S-phase where 
chromatin is decondensed in preparation for DNA replication. In this chapter I assess 
whether 53BP1 and BRCA1 co-depletion can restore HR also in the G2 phase of the 
cell cycle. 
 Currently little is known about where BRCA1 functions in the HR pathway and 
how it mechanistically overcomes the inhibitory function of 53BP1 on resection. As 
discussed earlier, the removal of Ku from DNA ends requires CtIP and Mre11 but also 
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ubiquitylation by RNF8 which leads to the degradation of Ku by the proteasome (Feng 
& Chen, 2012). One possibility is that BRCA1 promotes 53BP1 disassociation from 
chromatin via ubiquitylation. However, this seems unlikely since the ubiquitin ligase 
activity of BRCA1 is dispensable for HR, while my data from chapter 4 demonstrated 
that it is also dispensable for resection (Reid et al, 2008). Moreover, the tumour 
suppressor function of BRCA1 also does not appear to dependent on its function as a 
ubiquitin ligase (Shakya et al, 2011). Recently, the E3 ubiquitin ligase activity of 
BRCA1 was shown to be required for heterochromatin-mediated silencing (Zhu et al, 
2011). Work from the Jeggo laboratory has previously observed normal DSB repair 
rates in other human syndromes having disordered heterochromatin (e.g. Rett 
Syndrome) but such cells display a diminished requirement for ATM for HC-DSB 
repair (Brunton et al, 2011; Goodarzi et al, 2008). However, unlike Rett syndrome cells, 
BRCA1-depleted cells display the anticipated DSB repair defect following ATMi 
addition in G1 and G2. Thus, any change in HC structure caused by BRCA1 depletion 
does not impact upon the need for ATM for HC-DSB repair. 
Interestingly, the tumour suppressor function of BRCA1 is dependent on its 
BRCT domain, while this domain is also required for resection (chapter 4) and HR 
(Shakya et al, 2011). However, unlike the depletion of CtIP, which leads to complete 
loss of RPA foci formation, the BRCT domain mutant MEFs used in chapter 4 only 
displayed a partial RPA foci formation defect. This finding suggests that BRCA1 
functions downstream of CtIP and that the disassociation of Ku from DSB ends might 
precede that of 53BP1. 
 The tandem BRCT domains on the C-terminus of BRCA1 enable it to bind to 
phosphorylated proteins with which it forms three distinct complexes, all of which 
function in the DDR (Huen et al, 2009) (Diagram 5.1).  BRCA1 exists in all three 
complexes as a stable heterodimer with BARD1, which regulates the ubiquitin ligase 
activity of BRCA1 (Wu et al, 1996). The BRCA1c complex contains CtIP and the 
MRN complex, and it is through this complex that BRCA1 is thought to be involved in 
the regulation of resection. The BRCT domains of BRCA1 interact with  
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Diagram 5.1: Schematic of the three BRCA1 complexes and the cellular processes in which they function. 
BRCA1 exists in all three complexes as a stable heterodimer with BARD1, which regulates the ubiquitin ligase 
activity of BRCA1 (Wu et al, 1996). The BRCA1a complex consists of RAP80, Abraxas, BRCC36, BRCC45 and 
MERIT40. This complex is important for the localisation of BRCA1 to DNA damage sites via the binding of RAP80 
to ubiquitylated histones flanking DSBs (Sobhian et al, 2007). The BRCA1a complex is also involved in the G2/M 
checkpoint response. The BRCA1b complex consists of BACH1 and TOPBP1 and the formation of the complex 
involves the interaction between phosphorylated BACH1 and the BRCT domains of BRCA1 (Huen et al, 2009). This 
complex has been implicated in DNA replication but also in the intra-S-phase and G2/M checkpoint responses (Huen 
et al, 2009). The BRCA1c complex contains CtIP and the MRN complex, and it is through this complex that BRCA1 
is thought to be involved in the regulation of resection. The BRCT domains of BRCA1 interact with phosphorylated 
CtIP, a modification that is carried out by both ATM and CDK in response to DNA damage (Huertas & Jackson, 
2009; Shibata et al, 2011). This interaction promotes CtIP dependent resection specifically in the S and G2 phases of 
the cell cycle 
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phosphorylated CtIP, a modification that is carried out by both ATM and CDK in 
response to DNA damage (Huertas & Jackson, 2009; Shibata et al, 2011). This 
interaction promotes CtIP dependent resection specifically in the S and G2 phases of the 
cell cycle, but how BRCA1 modulates this process is not clear although the ubiquitin 
ligase function of BRCA1appears to be dispensable (Yun & Hiom, 2009).   
 The BRCA1b complex consists of BACH1 and TOPBP1 and the formation of 
the complex involves the interaction between phosphorylated BACH1 and the BRCT 
domains of BRCA1 (Huen et al, 2009). This complex has been implicated in DNA 
replication but also in the intra-S-phase and G2/M checkpoint responses (Huen et al, 
2009). Finally, the BRCA1a complex consists of RAP80, Abraxas, BRCC36, BRCC45 
and MERIT40. This complex is important for the localisation of BRCA1 to DNA 
damage sites via the binding of RAP80 to ubiquitylated histones flanking DSBs 
(Sobhian et al, 2007). The BRCA1a complex is involved in the G2/M checkpoint 
response where BRCA1 is thought to impact on the checkpoint proficiency by 
regulating CHK1 kinase phosphorylation and activation (Yarden et al, 2002). More 
recently, the BRCA1a complex has also been described as a negative regulator of 
resection (Coleman & Greenberg, 2011; Hu et al, 2011). It is thought that by binding to 
ubiquitylated histones via its UIM domain, RAP80 forms an inhibitory barrier to 
resection and prevents excessive nucleolyitc processing. Consistent with this, depletion 
of RAP80 or any of the other BRCA1a complex components, leads to increased 
resection (Hu et al, 2011). 
 It is becoming evident that DNA end resection is regulated by the simultaneous 
action of factors that either promote or inhibit the process. There appear to be at least 
three negative regulators that need to be overcome for the process to progress. Firstly, 
Ku needs to be removed from DNA ends so nucleases can access the DSB and so that 
resection can be initiated. Secondly, the inhibitory barrier posed to the process by 
53BP1 needs to be overcome, and thirdly, the elongation step of resection requires the 
disassociation of RAP80 from ubiquitylated histones. In this chapter I address where 
BRCA1 functions in the series of events that regulate resection, with particular 
emphasis on its interplay with CtIP and MRE11. Moreover, I assess how BRCA1 
together with the DUB POH-1 overcome the barriers posed by 53BP1 and RAP80 
respectively. 
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5.2: Results 
 
5.2.1: BRCA1 is required for HR at HC-DSBs in G2 but is dispensable for HC 
relaxation. 
 
The function of BRCA1 in DSB repair is distinct to that of ATM and the mediator 
proteins (H2AX, 53BP1, MDC1, RNF8, RNF168) as it is specifically required for 
repair in G2 but not in G1 (Figure 5.1). When I monitored !-H2AX foci loss post IR in 
G1 and G2, a characteristic repair defect specifically affected the slow repair component 
of G2 phase cells was observed (Figure 5.1). Furthermore the repair defect seen in G2 
phase cells could not be alleviated by KAP-1 knockdown. BRCA1 depletion does not 
affect pKAP-1 foci formation in G2, in contrast to the defect observed following 53BP1 
siRNA (Figure 5.2). Taken together these results support the notion that BRCA1 
functions specifically in HR in a way that is not affected by KAP-1 status.  
 
5.2.2: BRCA1 functions in HR downstream of CtIP/MRE11. 
 
Previous studies and my data from chapter 4 have shown that CtIP is required for 
resection in both the S and G2 cell cycle phases. Consist with this, CtIP depletion leads 
to a complete loss of RPA foci following IR exposure in G2 phase (Figure 5.5a). 
Importantly however, CtIP depletion does not lead to a DSB repair defect in G2, as 
when resection is not initiated repair can take place by NHEJ. This notion is 
consolidated by previous work from our laboratory where CtIP and XLF co-depletion 
led to an additive defect since under these conditions both HR and NHEJ are 
compromised (Shibata et al, 2011). In contrast, BRCA1 loss leads to a DSB repair 
defect in G2 indicating that NHEJ cannot repair DSBs in G2 that have reached the HR 
stage where BRCA1 function is needed (Figure 5.1). This circumstantial evidence 
indicates that BRCA1 functions in an HR step that is downstream of CtIP and post 
commitment to repair by HR. To verify in which order BRCA1 and CtIP function 
during G2 phase HR, I examined whether CtIP depletion could rescue the repair defect 
of BRCA1 knockdown cells. As observed previously, CtIP depletion did not lead to a 
DSB repair defect in G2 cells but rather led to faster repair kinetics indicating that repair 
was taking place by NHEJ (Figure 5.3a). On the other hand, BRCA1 depletion led to a 
repair defect that affected the slow component of repair (Figure 5.3a). Strikingly, cells 
!!
*&"!
 
 
Figure 5.1. BRCA1 is specifically required for DSB repair in G2 and its role cannot be overcome by KAP-1 
knockdown. 
a-b) A549 cells were exposed to 3 Gy IR in G1 and G2 with or without BRCA1 and KAP-1 siRNA. The cells were 
then harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. G2 phase 
cells were identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. !-H2AX foci were 
enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three independent 
experiments. 
c) Knockdown efficiency in A549 cells following treatment with a pool of BRCA1 siRNA oligonucleotides. Per 
knockdown, 100 pmol of siRNA duplexes per 2 x 105 logarithmically growing cells were used. Cells were then 
grown for 72 h prior to fixation and immunostaining with the indicated antibodies.  
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Figure 5 2: pKAP1 IRIF analysis in G2 phase 1BRhTERT cells after 53BP1 or BRCA1 knockdown. 
1BRhTERT cells were treated with the indicated siRNA for 72h. Next they were irradiated with 3 Gy IR, harvested 8 
h post exposure and immunostained with the indicated antibodies. Aphidicolin was added to prevent S phase cells 
progressing into G2 during analysis. Analysis was undertaken in G2 phase cells. S phase cells were excluded from 
analysis by their pan-nuclear RPA staining that arises as a consequence of aphidicolin addition. 53BP1 knockdown 
cells are unable to form pKAP-1 IRIF leading to an HR defect in G2 due to defective HC relaxation. BRCA1 
knockdown cells form normal pKAP-1 IRIF indicating that their HR defect in G2 is not due to defective HC 
relaxation. 
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 in which CtIP and BRCA1 were co-depleted showed normal repair (Figure 5.3a). This 
finding indicates that CtIP functions upstream of BRCA1 to initiate resection, 
committing to repair by HR. BRCA1 seems to function downstream of CtIP and is 
required for the efficient completion of resection. Importantly, if resection is not 
initiated then BRCA1 function is dispensable since repair ensues by NHEJ.  
 To substantiate this model further, I tested whether CtIP or BRCA1 knockdown 
could overcome the DSB repair defect seen in BRCA2 depleted cells. BRCA2 functions 
downstream of resection and is required for Rad51 loading. BRCA2 knockdown cells 
show normal resection but fail to load Rad51. I expected that if BRCA1 functions 
downstream of the CtIP-dependent initiation of resection then BRCA1 depletion would 
not rescue the repair defect of BRCA2 knockdown cells. On the other hand CtIP 
depletion should rescue the repair defect of BRCA2 knockdown cells since under these 
conditions repair would ensue by NHEJ and therefore be independent of BRCA2. As 
previously reported, when I depleted BRCA2 and monitored !-H2AX foci loss after IR 
in G2 cells I observed a repair defect at late times post IR (Figure 3c) (Beucher et al, 
2009). Importantly and consistent with the proposed model, CtIP depletion rescued the 
repair defect caused by BRCA2 siRNA, while joint BRCA1 and BRCA2 knockdown 
resulted in defective DSB repair (Figure 5.3c). 
 The regulation of resection and DSB repair pathway choice are highly complex 
processes involving many factors including MRE11.MRE11 is a nuclease that is 
required for the initiation of resection (Mimitou & Symington, 2011). However, 
MRE11 is part of the MRN complex that has previously been shown to be required for 
efficient HC-DSB repair via KAP-1 phosphorylation. As discussed previously, Rad50 
bridges the interaction between 53BP1 and pATM resulting in pATM retention at DSB 
sites and the robust localised KAP-1 phosphorylation needed for HC-DSB repair (Lee et 
al, 2010). When I depleted MRE11 by siRNA, I observed a repair defect in the slow 
repair component of G2 phase cells that was similar in magnitude to that seen in 
BRCA1 or BRCA2 depleted cells (Figure 5.4). However when MRE11 and KAP-1 
were co-depleted normal repair ensues (Figure 5.4). This finding indicates that either 
MRE11 is dispensable for HR when chromatin structure is relaxed, or that it also 
functions in the initiation of resection and repair can ensue by NHEJ in MRE11- KAP-1 
co-depleted cells. To test which of the above is correct I carried out triple knockdown of 
BRCA1, MRE11 and KAP-1 (Figure 5.4). Under these conditions the repair defect 
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Figure 5.3. CtIP depletion rescues the G2 phase repair defect of BRCA1 and BRCA2 deficient cells by 
channelling DSBs into NHEJ. 
a-b) A549 cells were treated with the indicated siRNA and then exposed to 3 Gy IR in G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. !-H2AX foci 
were enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three 
independent experiments. 
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Figure 5.4. MRE11 + KAP-1 depletion also rescues the G2 phase repair defect of BRCA1 and BRCA2 deficient 
cells by channelling DSBs into NHEJ. 
a) A549 cells were treated with the indicated siRNA and then exposed to 3 Gy IR in G2. The cells were then 
harvested at two and eight hours post IR and immunostained with CENP-F and !-H2AX antibodies. !-H2AX foci 
were enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three 
independent experiments. 
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of BRCA1 depleted cells was rescued and !-H2AX foci returned to control levels. 
These findings strongly suggest that MRE11, like CtIP, functions upstream of BRCA1 
and is required for the initiation of resection. MRE11 and CtIP function commits to 
repair by HR whereas BRCA1 has a downstream role promoting resection post the 
initiation step.  
 To gain further insight into the position at which BRCA1 functions in the 
different steps of HR, I monitored RPA and RAD51 foci formation. As predicted, G2 
phase cells in which BRCA1 was depleted showed a significant reduction in RPA foci 
number two hours following IR treatment compared to control cells (Figure 5.5b). 
Importantly, BRCA1 depleted cells were also severely compromised in Rad51 foci 
formation indicating that inefficient or incomplete resection in the absence of BRCA1 
impacts on downstream Rad51 loading (Figure 5.5b). In contrast to BRCA1 and 
consistent with previous findings, BRCA2 depleted cells showed normal RPA foci 
formation after IR treatment but showed a complete loss of Rad51 foci (Figure 5.5a-b). 
When BRCA1 and BRCA2 where co-depleted, a two-fold reduction in RPA foci 
number and a complete loss of Rad51 foci was observed (Figure 5.5a-b). These findings 
strongly indicate that BRCA1 functions upstream of BRCA2 in resection while BRCA2 
functions during Rad51 loading. 
 Next, I tested the impact of CtIP depletion on these two endpoints. As expected, 
CtIP depletion completely abrogated the formation of both RPA and Rad51 foci 
formation indicating that resection was not initiated and HR did not take place (Figure 
5.5a-b). In addition, CtIP + BRCA1 and CtIP + BRCA2 again led to a complete loss of 
RPA and Rad51 foci indicating that CtIP functions upstream of these HR factors 
(Figure 5.5a-b). Under these conditions BRCA1 and BRCA2 are dispensable for repair, 
since DSBs are repaired by NHEJ.  
 Finally, I tested the impact of MRE11 depletion on RPA and Rad51 foci 
formation in G2 phase cells. Depletion of MRE11 leads to a reduction in RPA foci 
consistent with the notion that its exonuclease activity plays a role in resection (Figure 
5.5a). Surprisingly however, the magnitude of the resection defect was smaller than that 
of CtIP depleted cells. One interpretation is that MRE11 functions downstream of CtIP 
in resection, but inefficient siRNA is also possible. The MRE11 resection defect was 
not rescued by KAP-1 knockdown unlike the situation in 53BP1 and MDC1 knockdown 
cells (Figure 5.5a). This suggests that MRE11 has a direct role in resection and does not 
facilitate the process via KAP-1 mediated HC relaxation. 
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Figure 5.5. BRCA1 functions downstream of CtIP/MRN in G2 to promote resection and Rad51 loading during 
HR repair of HC-DSBs.  
a-b) A549 cells were treated with the indicated siRNA and then exposed to 3 Gy IR in G2. Prior to irradiation 
aphidicolin was added to the cells to prevent S-phase cells from entering G2. The cells were then harvested at two 
hours post IR and immunostained with RPA (a) ,Rad51 (b) and CENP-F antibodies. G2 phase cells were identified 
by positive CENP-F staining and the cell nuclei were visualized by DAPI. Foci were enumerated specifically in 
CENP-F positive cells. RPA and Rad51 foci were enumerated in 30 cells per time-point and the data represent the 
mean and standard deviation of three independent experiments. 
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 Importantly however, KAP-1 knockdown does rescue the repair defect of MRE11 
depleted cells (Figure 5.4). This result strongly indicates that in MRE11 + KAP-1 co-
depleted cells repair takes place by NHEJ since RPA and Rad51 foci formation is 
compromised. This result is somewhat surprising since the presence of some RPA foci 
following MRE11 siRNA suggests that resection has been initiated at least at a fraction 
of DSBs. Although normally the initiation of resection commits to repair by HR and 
does not allow repair by NHEJ, under these conditions (MRE11 + KAP1) repair takes 
place since no DSB repair defect is observed (Figure 5.4). It is highly likely that these 
DSBs are repair by NHEJ since RPA and Rad51 foci are compromised, but another HR 
endpoint such as SCEs is needed to confirm this. Triple siRNA knockdown of MRE11, 
BRCA2 and KAP-1 led to reduced RPA and Rad51 numbers (Figure 5.5 a-b) consistent 
with the notion that the DSB repair observed in Figure 4 occurs by NHEJ not HR. The 
fact that repair can take place by NHEJ implies that MRE11 functions in the initiation 
of resection or at a stage prior to commitment to repair by HR.  
 Collectively these findings show that CtIP/MRE11 function early in HR, with a 
role in the initiation of resection that commits to repair by HR. If the initiation of 
resection is prevented then DSBs that would normally be repaired by HR undergo repair 
by NHEJ. In contrast BRCA1 functions in a downstream step of resection possibly in 
the elongation or completion of the CtIP/MRE11 initiation. The HR phase in which 
BRCA1 functions is post commitment to HR which is consistent with the severe HR 
defect seen in BRCA1 depleted/mutant cells. 
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5.2.3: 53BP1 depletion rescues the HR defect of BRCA1 knockdown cells in G2. 
 
In chapter 3 I described a novel function for 53BP1 in mediating G2 phase HR via 
KAP-1 dependent HC relaxation. This was an unexpected finding as the general 
consensus in the literature is that MDC1 functions to promote HR while 53BP1 
promotes NHEJ (Xie et al, 2007; Minter-Dykhouse et al, 2008). Subsequently, two 
independent studies monitoring HR in S-phase reported that 53BP1 not only promotes 
NHEJ but actively supresses HR by inhibiting resection (Bunting et al, 2010; Bouwman 
et al, 2010). The authors went on to show that BRCA1 function is required to overcome 
the inhibitory function of 53BP1 on resection and that HR could be restored in BRCA1 
mutant cells by depleting 53BP1. As these findings were contradictory to my findings, I 
set out to investigate the interplay between 53BP1 and BRCA1 during HR repair of two 
ended DSBs in G2 phase. 
 As indicated previously in this chapter and in chapter 3, depletion of either 
53BP1 or BRCA1 leads to a repair defect in G2 phase cells that is similar in magnitude 
and effects slowly repaired DSBs (Figure 5.5a). However the repair defect of 53BP1 
knockdown cells but not that of BRCA1 knockdown cells can be overcome with KAP-1 
depletion (Figure 5.6a). This is consistent with the notion that 53BP1 is dispensable for 
HR but mediates the process via HC relaxation while BRCA1 has a direct role in HR. 
When 53BP1 and BRCA1 were co-depleted and repair was monitored in G2 phase cells 
a repair defect persisted at later time points (Figure 5.6a). This was contradictory to the 
studies showing that 53BP1 depletion could overcome the need for BRCA1 in HR. 
Strikingly however, triple knockdown of 53BP1, BRCA1 and KAP-1 lead to normal 
repair in G2 phase cells (Figure 5.6a). This unexpected finding showed that 53BP1 
depletion could overcome the BRCA1 repair defect but that 53BP1’s function in 
relaxing the HC structure is a requisite for repair. 
 Next I decided to investigate whether repair ensued by NHEJ or HR following 
53BP1 and BRCA1 co-depletion in G2. As shown previously in this chapter and in 
chapter 3, depletion of either 53BP1 or BRCA1 leads to a defect in RPA and Rad51 foci 
formation (Figure 5.6b-c). However, the resection and Rad51 loading defect of 53BP1 
knockdown cells but not that of BRCA1 knockdown cells can be overcome by KAP-1 
depletion (Figure 5.6b-c). As was the case when monitoring !-H2AX foci, the RPA and 
Rad51 foci defect of G2 phase BRCA1 knockdown cells could not be overcome by 
53BP1 depletion (Figure 5.6b-c). Importantly however, triple knockdown of 53BP1,  
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Figure 5.6. Combined loss of BRCA1, 53BP1 and KAP1 allows DSB repair by HR. 
A549 cells were treated with the indicated siRNAs, exposed to 3 Gy IR and examined for RPA (a), RAD51 (b) or 
g-H2AX (c) foci at the indicated times. Prior to irradiation aphidicolin was added to the cells to prevent S-phase cells 
from entering G2. G2 phase cells were identified by positive CENP-F staining and the cell nuclei were visualized by 
DAPI. Results are shown in samples with or without siRNA KAP1 to expose the necessity to have relaxed HC to 
observe HR in G2 phase. In all panels results represent the mean of 3 experiments and error bars are the s.d. 
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BRCA1 and KAP-1 lead to normal RPA and Rad51 foci formation suggesting that 
under these conditions repair ensues by HR (Figure 5.6b-c). 
 There are several important conclusions that can be drawn from these findings. 
Firstly, 53BP1 appears to have two contrasting roles during DSB repair by HR in G2 
phase. On one hand it inhibits HR by blocking resection while on the other hand it 
enables the accurate completion of HR by mediating KAP-1 dependent HC relaxation. 
Secondly, the function of BRCA1 in HR appears to be the removal of the barrier caused 
to resection by 53BP1. It seems that 53BP1 forms a barrier to resection downstream of 
the initiation step which is where BRAC1 function is required. Overcoming the barrier 
that 53BP1 poses to the completion of resection is very important, as repair can no 
longer ensue by NHEJ. The significance of this is demonstrated in BRCA1 
depleted/mutated cells where a severe HR defect exists. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!!
*'#!
5.2.4: 53BP1 undergoes repositioning at IRIF during HR. 
 
The unexpected finding that 53BP1 depletion can overcome the HR defect of BRCA1 
depleted/mutant cells suggests that this is the only role for BRCA1 during HR. In order 
to elucidate the role of BRCA1 in HR I wanted to investigate how 53BP1 poses a 
barrier to resection and how BRCA1 overcomes this. 
 While examining the effect of 53BP1 and BRCA1 on the formation of HR 
intermediates, I also used immunofluorescence to test the knockdown efficiencies of the 
different siRNA oligos. Interestingly, when staining with a 53BP1 antibody in order to 
test 53BP1 siRNA efficiency, I observed that in control cells 53BP1 IRIF expanded 
over time. Previous studies have shown that the expansion of !-H2AX signal can spread 
over megabases of DNA away from a DSB (Rogakou et al, 1999). I reasoned that the 
same could be true for the 53BP1 signal. However when monitoring 53BP1 IRIF 
expansion at later times (eight hours) after IR treatment, I observed that 53BP1 foci size 
was not uniform amongst all cells. Strikingly, when using CENP-F staining as a cell 
cycle marker I observed that the increase in 53BP1 foci size seemed to be restricted to 
G2 phase cells.  
To examine this further I used enhanced-resolution imaging and 3D processing 
software to measure the volume of 53BP1 IRIF at different times after IR in G1 and G2. 
By taking Z-stacked images I was able to use the image processing software Imaris to 
reconstruct a 3D model of the 53BP1 IRIF and quantitatively measure their volume. 
Importantly, the 3D model of the foci accurately represented the Z-stacked 
immunofluorescence images acquired on the high-resolution microscope (Figure 5.7). 
Using these conditions, no substantial increase in 53BP1 foci volume in G1 cells over 
an eight-hour time course was observed (Figure 5.8a). In contrast, a doubling in 53BP1 
IRIF volume was observed in G2 phase cells over an eight-hour time course (Figure 
5.8a and Figure 5.14). What struck me about this result is that 53BP1 IRIF did not 
expand in G1 where BRCA1 function is dispensable, whereas they expanded in G2 
where BRCA1 is required for efficient DSB repair. I reasoned that BRCA1 function 
may be required for 53BP1 IRIF expansion and that this may be important for repair by 
HR. Strikingly, when BRCA1 was depleted 53BP1 IRIF expansion was impeded 
resulting in foci that resembled those of G1 phase cells (Figure 5.7, 5.8b and 5.15). 
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Figure 5.7. 3D modelling of 53BP1 IRIF accurately depicts the BRCA1 dependent G2 phase specific increase 
of 53BP1 IRIF volume as seen by IF. 
a) A549 cells were treated with the indicated siRNA and then exposed to 3 Gy IR in G2. The cells were then 
harvested at eight hours post IR and immunostained with CENP-F and 53BP1 antibodies. G2 phase cells were 
identified by positive CENP-F staining and the cell nuclei were visualized by DAPI. 53BP1 foci were imaged using 
an Applied Precision® Delta Vision® RT Olympus IX70 deconvolution microscope and softWoRx® Suite software 
at eight hours post IR in G1 and G2 phase cells. The immunofluorescence images (IF) indicate a two dimensional 
projection of the acquired Z-stacked images while the 3D panels show a snapshot of the 3D model constructed from 
the Z-stacks. Please see the materials and methods section for a detailed description of the image acquisition and 
processing parameters.  
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Figure 5.8. Analysis of 53BP1 IRIF in G1 and G2 phase cells using enhanced resolution microscopy. 
a-b) Analysis of the volume of 53BP1 foci in A549 cells following exposure to 3 Gy IR. The volume of 53BP1 foci 
was assessed by 3 dimensional imaging using an Applied Precision® Delta Vision® RT Olympus IX70 
deconvolution microscope and softWoRx® Suite software at the indicated times in G1 and G2 phase cells (see 
materials and methods for details of image processing).  G2 phase cells were identified by CENPF staining. Analysis 
was carried out in untreated cells (a) and following treatment with siRNA BRCA1 (b). The data represent the median 
and lower and upper quartiles from at least 10 nuclei from each of three experiments. Error bars represent the 
minimum and maximum valid values determined as the highest datum still within 1.5 the interquartile range of the 
upper quartile. These were used to eliminate abnormally large values (depicted as single points) arising from foci 
‘clumping’ and resolution limitations. Statistical analysis was carried out using the Mann-Whitney rank sum test. 
Data were not deemed to be significant when a p value > 0.05 was obtained.   
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Following the observation that 53BP1 IRIF expansion in G2 was BRCA1 
dependent, I postulated that this might be related to BRCA1’s function in overcoming 
the barrier 53BP1 poses to resection. I examined the behaviour of 53BP1, RPA and 
BRCA1 IRIF at different time-points by high-resolution microscopy to gain insight into 
the BRCA1-53BP1 interplay during HR. When a 3D model of 53BP1 foci was made 
from a 0.5 and 8-hour time-point there was a significant difference in volume due to 
53BP1 foci expansion (Figure 5.9a). In addition however, when the 3D model of an 
individual 53BP1 focus was visualised as a wireframe structure I observed that by 8 
hours post IR, they had become hollow structures (Figure 5.9a and Figure 5.15). This 
interesting result made me question whether the 53BP1 IRIF expansion as well as the 
central core devoid of 53BP1 could be important for resection. To test this I repeated 
the high resolution and 3D modelling experiments but this time co-stained with 53BP1 
and RPA. When both 53BP1 and RPA were visualised together, only the 53BP1 signal 
was apparent (Figure 5.9b). Strikingly however, when the 53BP1 IRIF was visualised as 
a wireframe structure, the RPA foci became visible. Intriguingly, the RPA foci had 
formed in the central core of the 53BP1 IRIF, in the area devoid of 53BP1 signal 
(Figure 5.9b). This finding strongly indicated that 53BP1 IRIF expansion is a pre-
requisite to RPA foci formation and that BRCA1 function is required to drive this 
repositioning of 53BP1. 
To test this further I repeated the high resolution and 3D modelling experiments 
using 53BP1, BRCA1 and RPA triple staining. At four hours post 3Gy, the 
immunofluorescence signal of RPA, 53BP1 and BRCA1 all overlapped  (Figure 5.10a). 
However the size of the 53BP1 foci appeared greater than that of BRCA1 foci. 
Strikingly, when the IRIF were visualised as a 3D model of the Z-stacked images the 
53BP1 signal appeared on the periphery (Figure 5.10b). Visualising the 53BP1 IRIF as 
a wireframe structure revealed that BRCA1 foci form internally to 53BP1. Finally by 
visualising the BRCA1 IRIF as a wireframe structure revealed that RPA foci form 
internally to BRCA1 (Figure 5.10b and Figure 5.15).  
In summary these findings indicate that 53BP1 becomes relocated as DSB repair 
by HR ensues. This relocation is dependent upon BRCA1 function and is required for 
resection and the formation of RPA foci. BRCA1 foci form internally to 53BP1 and 
RPA foci form in the centre. Next, I tested whether the reduced expansion of 53BP1 
IRIF observed in BRCA1 depleted cells resulted from the reduced resection in these 
cells. To do this, I monitored 53BP1 IRIF expansion in Artemis depleted  
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Figure5. 9. 53BP1 is relocalised during G2 phase HR creating a core devoid of 53BP1 where RPA foci form. 
a) A549 cells were exposed to 3 Gy IR in G2, harvested at eight hours post IR and immunostained with 53BP1 (a) or 
53BP1 + RPA antibodies (b). Z-stacked images were acquired using an Applied Precision® Delta Vision® RT 
Olympus IX70 deconvolution microscope and softWoRx® Suite software. A 3D model of the Z-stacked images was 
then produced and visualised as either ‘solid’ or ‘wireframe’ to reveal the internal space of the IRIF. 
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Figure 5.10. BRCA1 foci form internally to 53BP1 and RPA foci form in the core devoid of 53BP1. 
a-b) A549 cells were exposed to 3 Gy IR in G2, harvested at eight hours post IR and immunostained with 53BP1, 
BRCA1 and RPA antibodies. Z-stacked images were acquired using an Applied Precision® Delta Vision® RT 
Olympus IX70 deconvolution microscope and softWoRx® Suite software. a) The immunofluorescence images (IF) 
indicate a two dimensional projection of the acquired Z-stacked images while the 3D panels (b) show a snapshot of 
the 3D model constructed from the Z-stacks. The 3D model is displayed as either ‘solid’ or ‘wireframe’ to reveal the 
internal space of the IRIF. BRCA1 foci form internally to 53BP1 and RPA foci form in the core devoid of 53BP1. 
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cells. Artemis is an endonuclease that is required for resection in G2 phase HR (Beucher 
et al, 2009). Importantly, depletion of Artemis results in a resection defect in G2 that is 
similar in magnitude to that of BRCA1 knockdown cells. However when I used high-
resolution imaging and 3D modelling to assess 53BP1 IRIF volume in Artemis depleted 
cells, I observed normal IRIF expansion (Figure 5.11a). Therefore despite the resection 
defect seen in Artemis depleted cells (Figure 11b) normal 53BP1 IRIF expansion was 
observed. Furthermore, and distinct to BRCA1 depletion, co-depletion of 53BP1 and 
KAP-1 in Artemis knockdown cells failed to restore the resection and repair defects in 
these cells (Figure 5.11b-c). Taken together these findings indicate that the role of 
Artemis in G2 phase HR is distinct to that of BRCA1 and does not affect 53BP1 IRIF 
relocation. More importantly, however, these results indicate that BRCA1 actively 
promotes the relocation of 53BP1 to enable resection and HR and that the loss of this in 
BRCA1 depleted cells is not a consequence of reduced resection. 
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Figure 5.11. 53BP1 repositioning is not driven by resection while 53BP1 depletion does not alleviate the 
requirement of Artemis 
A549 cells were treated with the indicated siRNA and then exposed to 3 Gy IR in G2 and analysed for (a) 53BP1 foci 
volume, (b) RPA foci and (c) !-H2AX foci. In a) , 53BP1 foci volume quantification following Artemis siRNA was 
carried out as in Figure 8. Statistical analysis was carried out using the Mann-Whitney rank sum test. Data were not 
deemed to be significant when a p value > 0.05 was obtained. In b) and c), G2 phase cells were identified by positive 
CENP-F staining and the cell nuclei were visualized by DAPI. RPA and !-H2AX foci were enumerated in 30 cells 
per time-point and the data represent the mean and standard deviation of three independent experiments. 
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5.2.5: 53BP1 repositioning during HR is distinct to regular foci expansion. 
  
The IRIF that form during the DDR are dynamic in nature and tend to move and change 
in shape before eventually disappearing once repair is completed. As mentioned above, 
studies monitoring the expansion of the !-H2AX signal reported spreading over 
megabases of DNA (Rogakou et al, 1999). I wanted to verify that the 53BP1 
repositioning that I observed in G2 phase cells was distinct to the regular IRIF 
expansion seen with other DDR factors. I suspected that this was the case, as in my 
experiments I observed a G2 phase specific increase in 53BP1 IRIF volume that I had 
not observed for IRIF of other factors. 
 To test whether 53BP1 was specifically relocated during HR, I decided to 
compare 53BP1 IRIF to !-H2AX IRIF during G2 phase HR. At early time points (0.5h) 
following exposure to IR in G2, 53BP1 and !-H2AX foci where similar in size and 
strongly co-localised although !-H2AX IRIF appeared external to 53BP1 IRIF at these 
time points (Figure 5.12). Strikingly, from two hours onwards, a time that coincides 
with the appearance of RPA foci, 53BP1 IRIF continued to enlarge while the size of !-
H2AX foci remained unchanged. By eight hours following IR treatment, the 53BP1 foci 
were on the periphery of the IRIF and enclosed the !-H2AX and RPA foci (Figure 
5.12). By producing a 3D model of the IRIF and viewing the 53BP1 signal as a 
wireframe structure, I was able to confirm that 53BP1 is specifically relocated and 
forms a hollow structure that surrounds !-H2AX and RPA. Using the same method I 
observed that !-H2AX also expands but to a lesser extent and that RPA foci form in the 
centre. These results indicate that the relocation of 53BP1 is a BRCA1 dependent 
process that is required for resection and that is distinct to normal signal expansion seen 
for other IRIF.   
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Figure 5.12. !-H2AX foci form internally to 53BP1 and RPA foci form in the core devoid of 53BP1 and !-
H2AX . 
 As for Figure 9 but this time !-H2AX foci were visualised instead of BRCA1. At these time points (8h), 53BP1 IRIF 
have expanded significantly more that !-H2AX IRIF and are located on the IRIF periphery. !-H2AX foci form 
internally to 53BP1 and RPA foci form in the core devoid of 53BP1 and !-H2AX. 
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5.2.6: pATM and ubiquitin chains re-localise with 53BP1 in G2. 
 
The formation of 53BP1 IRIF requires RNF8-RNF168- dependent ubiquitylation at 
DSBs(Huen et al, 2007; Mailand et al, 2007; Doil et al, 2009). I predicted that 53BP1 
relocation to the periphery of IRIF might necessitate the repositioning of the 
polyubiquitin chains required for 53BP1 IRIF formation.  To test this, I used an FK2 
antibody to detect ubiquitylation events and polyubiquitin chains and repeated the high 
resolution and 3D modelling experiments described above. I observed that in G2 cells 
the FK2 IRIF expand over time and like 53BP1 vacate the central core and strongly co-
localise with 53BP1 (Figure 5.13 and Figure 5.14a). Similarly to 53BP1 IRIF, the RPA 
foci formed internally to FK2 in the vacated central core. 
 As discussed previously, 53BP1 functions during HC DSB repair in G1 and G2 
by tethering activated ATM at DSB sites and therefore mediating the robust localised 
KAP-1 phosphorylation needed for repair (Noon et al, 2010). Using the high resolution 
and 3D imaging assay I tested whether pATM IRIF also become relocated during HR. 
Strikingly, pATM signal also expanded over time and relocated to the periphery of  
IRIF and strongly co-localised with 53BP1 (Figure 5.14b and 5.15b). siRNA mediated 
knockdown of BRCA1 ablated the expansion and repositioning of 53BP1, FK2 and 
pATM (Figure 5.15c).  
Previous studies have suggested that during HR there is a handover from ATM 
to ATR since ATM is not efficiently activated at resected DSBs (Shiotani & Zou, 
2009). However, other studies have demonstrated that in G1 53BP1 tethers pATM at 
DSB sites via interactions between 53BP1-RAD50 and NBS1-ATM (Noon et al, 2010; 
Lee et al, 2010). Importantly, the high resolution imaging in this chapter specifically 
looking at G2 phase HR indicates that pATM is tethered at DSBs even up to 8 hours 
post IR. However, the specificity of pATM antibodies has been questioned so as an 
alternative way of assessing the requirement of pATM, I decided to test whether its 
retention at later times (4-8h) post IR is important for the completion of the HR 
pathway. To achieve this, I irradiated cells with 3Gy and then added the ATMi at 
different times post IR to test whether ATMi function was still required. Significantly, 
addition of the ATMi at two or even four hours post IR led to a similar repair defect at 
eight hours to that seen in cells where ATMi was added prior to IR (Figure 5.15d). 
When ATMi was added 6 hours post IR the effect was not substantial but this may have 
resulted from the time needed for the drug to diffuse and take effect. 
!!
*($!
 
 
Figure 5.13. FK2 IRIF are also relocalised during G2 phase HR creating a core devoid of 53BP1 and FK2 
where RPA foci form. 
a-b) A549 cells were exposed to 3 Gy IR in G2, harvested at eight hours post IR and immunostained with 53BP1, 
FK2 and RPA antibodies. Z-stacked images were acquired using an Applied Precision® Delta Vision® RT Olympus 
IX70 deconvolution microscope and softWoRx® Suite software. a) The immunofluorescence images (IF) indicate a 
two dimensional projection of the acquired Z-stacked images while the 3D panels (b) show a snapshot of the 3D 
model constructed from the Z-stacks. The 3D model is displayed as either ‘solid’ or ‘wireframe’ to reveal the internal 
space of the IRIF. FK2 foci form internally to 53BP1 and RPA foci form in the core devoid of 53BP1 and FK2. 
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Figure 5.14. 53BP1, FK2 and pATM all become relocalised during G2 phase HR and strongly colocolise 
a-b) A549 cells were immunostained with the indicated antibodies 8 h post 3Gy IR and colocalisation between 
53BP1 and pATM (b) and FK2 (a) was carried out using softWoRx® Suite software. The Pearson Coefficient of 
Correlation indicates how closely the two intensities are colocolised on a pixel-by-pixel basis (full colocalisation is 
1.0) 
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Figure 5.15: BRCA1 promotes relocalisation of 53BP1 in G2 phase creating a core devoid of 53BP1, ubiquitin 
chains and pATM.  
a-b) Analysis of G2 A549 cells at 0.5 (a) and 8 (b) hours post 3 Gy IR. Following immunostaining with the indicated 
antibodies (53BP1, BRCA1, RPA, FK2 and p1981-ATM), 3D IRIF analysis was undertaken using softWoRx® Suite. 
The red and green signals represent 53BP1 and RPA, respectively; the blue signal is as indicated. ‘Wireframe’ 
images are displayed allowing 3D visualization. Foci volume enlarges from 0.5- 8 h post IR generating an expanded 
core lacking 53BP1. BRCA1 localizes internally to 53BP1 and RPA lies within the core. c) Images following siRNA 
BRCA1 8 h post IR where no significant expansion in 53BP1, FK2 or pATM IRIF is observed. d) Addition of ATMi 
at varying times post IR. Cells were exposed to 3 Gy IR and !-H2AX foci enumerated 8 h later. ATMi was added 15 
min before IR or 2, 4 and 6 h post IR, as indicated. ATMi addition at 2 and 4 h caused a repair defect similar to that 
observed when ATMi was added prior to IR (which is similar to that observed in cells lacking ATM). Thus, ATM 
activity is required for HC-DSB repair for at least 4 h post IR. 
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These findings show that as in G1, the retention of pATM during DSB repair in G2 is 
also required for at least four hours post IR, a time when RPA foci numbers have 
become maximal. 
 
5.2.7: The BRCT but not the RING domain of BRCA1 is required for 53BP1 
repositioning during HR. 
 
Following the observation that BRCA1 function is required for 53BP1 IRIF 
repositioning during G2 phase HR, I wanted to gain some insight into the mechanism of 
this function. There is a multitude of studies in the literature investigating the role of 
BRCA1 in the DDR and this is discussed in the introductory chapter. What makes 
BRCA1 particularly versatile are its interacting domains that result in a plethora of 
complexes with wide ranging functions (Huen et al, 2009). In addition, BRCA1 also 
possesses enzymatic activity and acts as an ubiquitin ligase. The above characteristics of 
BRCA1 made the identification of a mechanism by which it promotes the relocation of 
53BP1 during HR challenging. 
 First I tested whether the ubiquitin ligase activity of BRCA1 was required for 
53BP1 relocation. I reasoned that this was a good place to start since the ubiquitin 
chains detected by the FK2 antibody where also repositioned as HR progressed. 
However, published evidence in the literature has suggested that the enzymatic activity 
of BRCA1 is dispensable for HR (Shakya et al, 2011; Greenberg, 2011; Reid et al, 
2008). Nevertheless I decided to pursue these experiments, as the finding that BRCA1 
E3 ligase activity was dispensable for HR was not widely accepted and the model 
suggesting that 53BP1 repositioning depends on BRCA1 E3 ligase activity was 
appealing. Concurrently I also tested whether the BRCT domains of BRCA1 were 
required for its function in 53BP1 relocation. This would provide insight as to whether 
the interaction of BRCA1 with its phosphobinding partners is important for this 
function. 
 Initially, I developed a strategy involving BRCA1 depletion by siRNA and 
complementation using BRCA1 cDNA. I acquired full length human BRCA1 and 
mutant BRCA1 in a plasmid that also contained an HA tag. The mutant versions of 
BRCA1 included the I26A mutation that leads to a ligase dead version of the protein 
and a BRCT domain delete. Next I designed primers and used site directed mutagenesis 
to introduce silent mutations in the region that was targeted by the siRNA oligo thus 
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creating siRNA resistant constructs. Following verification of the site directed 
mutagenesis by sequencing, I transfected and transiently expressed the constructs in 
cells treated with BRCA1 siRNA. I aimed to specifically pick out the transfected cells 
by an HA antibody and then measure 53BP1 IRIF volume in these cells. 
Complementation using the different BRCA1 mutants would provide insight into the 
requirement of the BRCA1 domains for 53BP1 IRIF expansion and relocation. 
However, these experiments proved technically challenging and were ultimately 
unsuccessful. Treatment with BRCA1 siRNA is highly toxic in mammalian cells since 
BRCA1 function is essential and BRCA1 loss is embryonic lethal (Gowen et al, 1996). 
In these experiments, in addition to the BRCA1 siRNA treatment I also carried out an 
additional transfection with BRCA1 cDNA followed by a 24-hour overexpression. This 
additional step is also not well tolerated by cells. The end result of these combined 
treatments was high levels of cell death and not sufficient cells to carry out the 53BP1 
imaging analysis. 
 While optimising these experiments, a study was published from the Ludwig 
and Baer laboratories, investigating the role of BRCA1 E3 ubiquitin ligase activity on 
BRCA1’s function as a tumour suppressor (Shakya et al, 2011). This work involved the 
generation of homozygous mice expressing BRCA1FH-I26A resulting in ligase dead 
BRCA1. Intriguingly, the BRCA1 mutated mice prevented tumour formation to the 
same degree as wild-type mice in three different mouse models of cancer. This was an 
unexpected finding that suggested that BRCA1 function as an ubiquitin ligase is 
dispensable for its role as a tumour suppressor. In addition the authors also showed that 
MEFs isolated from these animals had no evidence for an abnormal response to 
genotoxic damage. Next, the authors investigated the requirement of the BRCT motifs 
of BRCA1in its function as a tumour suppressor. They generated homozygous 
BRCA1FH-S1598F mice that express mutant BRCA1 that is unable to interact via its 
BRCT domain with its binding partners, Abraxas, BACH1 and CtIP. Importantly, 
tumours were observed in all three of the mouse cancer models whilst isolated MEFs 
displayed hypersensitivity to genotoxic stress and defective homology directed repair 
(Shakya et al, 2011). 
 I contacted the authors and requested MEFs isolated from the mice expressing 
mutated BRCA1 so that I could carry out my 53BP1 IRIF analysis in these cells. The 
advantage of using these cells was that it did not necessitate doing knockdown of 
BRCA1 nor selection for transfected cells. Importantly, following irradiation of cultured 
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wild-type MEFs, an enlargement in 53BP1 IRIF volume was observed over time 
(Figure 16). Strikingly however, the MEFs expressing BRCA1FH-I26A also showed an 
increase in 53BP1 IRIF volume over time that was indistinguishable from that seen in 
wild type cells. On the other hand the MEF’s expressing BRCA1FH-S1598F were 
compromised in their ability to reposition 53BP1 IRIF and a significant difference in 
IRIF volume was observed at eight hours post IR compared to wild-type cells (Figure 
5.16). These results are consistent with the findings from Shakeya et al showing that 
BRCA1 phosphoprotein recognition via its BRCT domains is important for its role in 
homology directed repair. More specifically here I demonstrate that the phosphoprotein 
interactions are required for 53BP1 IRIF relocation thus overcoming its inhibitory effect 
on resection. However, although BRCA1 is required to facilitate this relocation, it does 
not appear to drive this process via its ubiquitin ligase activity. 
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Figure 5.16. The BRCT but not the RING domain of BRCA1 is required for 53BP1 repositioning during HR. 
a) Analysis of 53BP1 foci volume in G2 phase Brca1FH-WT/FH-WT, BRCA1FH-I26A and BRCA1FH-S1598F MEFs following 
3Gy IR. 53BP1 foci analysis was carried out as in Figure 8. Statistical analysis was carried out using the Mann-
Whitney rank sum test. Data were not deemed to be significant when a p value > 0.05 was obtained.   
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5.2.8: The BRCA1 interacting proteins BACH1, RAP80 and BRCC36 are not 
required for 53BP1 repositioning during HR. 
 
As discussed earlier, BRCA1 forms distinct complexes that function in different aspects 
of the DDR (Huen et al, 2009). The BRCA1a complex consists of Abraxas, RAP80, 
BRCC36, BRCC45 and MERIT40. The BRCA1b complex comprises BACH1 and 
TOPBP1. Finally, the BRCA1c complex encompasses CtIP and the MRN complex. The 
finding that ablation of these interactions in the BRCA1FH-S1598F MEFs resulted in 
abnormal 53BP1 volume expansion indicated a possible role for these factors in this 
process. To examine, I depleted components of the different BRCA1 complexes and 
monitored their effect on 53BP1 IRIF volume.  
 First I monitored the impact of RAP80 and BRCC36 depletion on 53BP1 IRIF 
expansion. I reasoned that this complex might play a part in this process as it has 
previously been implicated in targeting BRCA1 to DSB sites (Sobhian et al, 2007). 
Additionally RAP80 and BRCC36 have been reported to play a role in ‘tuning’ BRCA1 
dependent resection (Hu et al, 2011). Finally since BRCC36 is a DUB, I postulated that 
it might play a role in the formation of the hollow core of 53BP1 IRIF by promoting 
53BP1 disassociation through histone de-ubiquitylation. However depletion of either of 
these factors had no impact on 53BP1 IRIF volume, since at eight hours post IR 53BP1 
IRIF volume was indistinguishable to that in control cells (Figure 5.17).  
 Next I investigated the role of BACH1 in 53BP1 repositioning during HR. 
BACH1 is a helicase that has a role in DNA replication and also functions to unravel 
DNA during resection. Consequently, depletion of BACH1 leads to a resection defect in 
G2 phase. However when I depleted BACH1, I again observed no impact on 53BP1 
IRIF volume, as at eight hours post IR they were indistinguishable to those in control 
cells.  
 The third complex that BRCA1 forms is with CtIP and the MRN complex. 
However the 53BP1 IRIF repositioning defect seen in the BRCA1FH-S1598F MEFs could 
not be attributed to loss of interaction with these factors as earlier in this chapter I 
demonstrated that they function upstream of BRCA1. CtIP/MRN dependent initiation of 
resection occurs independently of BRCA1 which functions in the later 
elongation/completion step. In addition 53BP1 repositioning during HR cannot be 
monitored in the absence of CtIP/MRN as when these factors are depleted repair ensues 
by NHEJ.   
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Figure 5.17. The BRCA1 interacting proteins BACH1, RAP80 and BRCC36 are not required for 53BP1 
repositioning during HR. 
a) Analysis of 53BP1 foci volume in A549 cells treated with the indicated siRNA, following 3Gy IR. 53BP1 foci 
analysis was carried out as in Figure 8. Statistical analysis was carried out using the Mann-Whitney rank sum test. 
Data were not deemed to be significant when a p value > 0.05 was obtained.   
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5.2.9: The deubiquitinating enzyme POH1 is required for resection and 53BP1 
repositioning in G2. 
 
The observations made so far in this chapter suggest that BRCA1 repositions 53BP1 is 
G2 to enable resection and DSB repair by HR. In addition to 53BP1 repositioning, a 
hollow core devoid of 53BP1 forms in the IRIF where RPA subsequently form. This 
hollow core also forms in FK2 and !-H2AX IRIF and is also likely to be important for 
resection. An attractive model is that on-going ubiquitylation away from the DSB drives 
53BP1 repositioning while histone deubiquitination in the IRIF core leads to 53BP1 
disassociation and possibly histone eviction/degradation to allow resection. Such a 
mechanism would necessitate the function of a deubiquitinating enzyme (DUB) for the 
formation of the hollow core, but depletion of the DUB BRCC36 led normal 53BP1 
volume expansion and resection (Figure 5.17). Indeed depletion of BRCC36 has been 
shown to lead to increased, not reduced resection (Hu et al, 2011).  
 Unpublished data from the Jo Morris laboratory indicates that the POH1 DUB 
enzyme also functions in the DDR. POH1, like BRCC36, is a JAMM domain 
containing protein that shows K63-Ub specific DUB activity (Cooper et al, 2009). 
POH1 is a member of the 19S portion of the 26S proteasome and like BRCC36; its 
DUB activity requires interaction with an MPN- domain-containing factor (Patterson-
Fortin et al, 2010; Cooper et al, 2009). As part of the BRCA1a complex responding to 
DNA damage, BRCC36 interacts with Abraxas, which contains an MPN- domain and 
this interaction is required for its DUB activity. (Patterson-Fortin et al, 2010). On the 
other hand, POH1 interacts with the MPN- domain of RPN8 as part of the proteasome 
and appears to be important for HR (Morris et al unpublished). I decided to test whether 
POH1 DUB activity is required for disassociation of 53BP1 from the IRIF core and 
therefore for RPA foci formation. POH1 depletion by siRNA did not prevent 53BP1 
foci from expanding in G2 from 0.5h to 8h after IR treatment. In addition, at 8h post IR 
in G2, the volume of 53BP1 IRIF in POH1 knockdown cells was indistinguishable from 
that in control cells (Figure 5.18a). As a control for redundancy among K63-Ub DUBs 
in this process I also co-depleted POH1 and BRCC36. Under these conditions 53BP1 
foci expansion was also normal and 53BP1 IRIF volume at 8h post IR was 
indistinguishable to control cells (Figure 5.18a). In addition, when I co-depleted POH1 
with either RAP80 or Abraxas I also observed normal 53BP1 foci expansion (Figure 
5.18a). 
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Figure 5.18. POH1 is dispensable for 53BP1 IRIF expansion in G2 but is required for RPA and Rad51 foci 
formation. Co-depletion of BRCC36, RAP80 or Abraxas alleviates the requirement of POH1 for RPA but for 
Rad51 foci formation. 
a) Analysis of 53BP1 foci volume in A549 cells treated with the indicated siRNA, following 3Gy IR. 53BP1 foci 
analysis was carried out as in Figure 8. Statistical analysis was carried out using the Mann-Whitney rank sum test. 
Data were not deemed to be significant when a p value > 0.05 was obtained. b-c)  A549 cells were treated with the 
indicated siRNA and then exposed to 3 Gy IR in G2. The cells were then harvested at two hours post IR and 
immunostained with RPA/Rad51 and CENP-F antibodies. G2 phase cells were identified by positive CENP-F 
staining and the cell nuclei were visualized by DAPI. Foci were enumerated specifically in CENP-F positive cells. 
RPA/Rad51 foci were enumerated in 30 cells per time-point and the data represent the mean and standard deviation 
of three independent experiments. c) Knockdown efficiency in A549 cells following treatment with a pool of POH1 
siRNA oligonucleotides. Per knockdown, 100 pmol of siRNA duplexes per 2 x 105 logarithmically growing cells 
were used.  
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This is consistent with other studies showing that loss of these proteins does not impair 
but enhances HR (Hu et al, 2011; Coleman & Greenberg, 2011). When carrying out 
these experiments, I also immunostained the cells with an RPA antibody to assess 
resection under these conditions. Strikingly, at 2h post IR, the number of RPA foci that 
formed in POH1 depleted cells were significantly reduced compared to control cells 
(Figure 5.18b). This is distinct to loss of BRCC36 where an increase in resection is 
observed (Hu et al, 2011). Importantly, cells in which POH1 and BRCC36, RAP80 or 
Abraxas were co-depleted showed normal levels of RPA foci indicating that POH1 
function in resection is redundant when these factors are depleted (Figure 5.18b). 
Binding of the BRCA1a complex to ubiquitylated histones at DSB sites via the UIM of 
RAP80, is inhibitory to resection (Coleman & Greenberg, 2011). I therefore interpret 
these findings to suggest that POH1 is required to overcome the inhibitory function of 
RAP80/BRCC36/Abraxas on resection. Importantly, POH1 depletion also led to a 
defect in Rad51 foci formation  (Figure 5.18c). However, the Rad51 foci formation 
defect of POH1 depleted cells could not be rescued by RAP80 or BRCC36 co-depletion 
indicating that POH1 might also have a direct downstream role in Rad51 loading 
(Figure 5.18c). Consistent with this, unpublished work from the Morris laboratory has 
shown that POH1 is required for the recruitment of the BRCA2-co-factor DSS1 to DSB 
sites. Moreover, POH1 was shown to form a complex with BRCA2 and BRC1 
following HU treatment. These findings suggest that the 19S proteasome, which 
contains POH1, interacts with factors that promote Rad51 loading. 
 Next, I used the 3D imaging assay described earlier to assess whether the IRIF 
core devoid of 53BP1 that is required for RPA foci can form when POH1 is depleted. 
At 8h post 3Gy in G2, the hollow core where RPA foci form is clearly visible in control 
cells in both immunofluorescence and 3D model images (Figure 5.19a). Remarkably, 
following POH1 depletion, the severe RPA foci formation defect seen in these cells 
coincides with a failure to form a hollow core in 53BP1 IRIF (Figure 5.19a). However, 
when BRCC36 is also depleted the resection defect of POH1 cells as well as their 
ability to form a hollow core in 53BP1 IRIF is rescued (Figure 5.19a).  
 Finally, I tested whether POH1 function is required for the formation of a 
hollow core in FK2 IRIF since in control cells this occurs at DSBs that undergo 
resection and repair by HR (Figure 5.15). Following POH1 depletion, G2 phase cells 
failed to form a hollow core in FK2 IRIF and this coincided with a severe RPA foci 
formation defect (Figure 5.19b). However, following POH1 and BRCC36 co-depletion, 
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Figure 5.19. POH1 promotes resection in G2 by overcoming the inhibitory barriers of 53BP1 and RAP80. 
A549 cells were immunostained with the indicated antibodies 8 h post 3Gy IR. G2 cells were selected by CENPF+ 
staining. The far left panels are a projection of the immunofluorescence (IF) Z-stacked images acquired on an 
Applied Precision® Delta Vision® RT Olympus IX70 deconvolution microscope. These images were converted into 
a 3D model using the softWoRx® Suite and are shown in the subsequent panels. Individual foci from cells treated 
with the indicated siRNA were magnified and displayed either as solid or wireframe structures. Wireframe images 
allow visualisation of the hollow core in 53BP1 and FK2 IRIF where RPA foci form. A devoid core does not form 
following siRNA POH1 in neither 53BP1 or FK2 IRIF but does form following siRNA BRCC36+POH1. 
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the RPA foci formation defect was rescued and the FK2 foci contained a hollow core 
where the RPA foci formed (Figure 5.19b). These findings indicate that the DUB 
enzyme POH1 is required for the formation of the hollow core in 53BP1 and FK2 IRIF 
that is required for RPA foci formation. The formation of the hollow core in FK2 IRIF 
likely represents the disassociation of the RAP80/Abraxas/BRCC36 complex, which is 
inhibitory to resection.  
 
 
5.3.1: Discussion 
 
BRCA1 functions in HR downstream of CtIP/MRE11. 
 
In this chapter I have investigated the role of BRCA1 in HR with particular emphasis on 
the process of resection. Following the contrasting findings that 53BP1 both mediates 
resection and HR as well as actively inhibiting the process, I aimed to gain insight into 
the interplay of BRCA1 and 53BP1 during G2 phase HR. 
 The requirement of BRCA1 for HR has long been established. However, the 
exact mechanism of its function has remained elusive. Here I initially show that the 
requirement of BRCA1 for DSB repair is dispensable in G1 where HR is inactive 
(Figure 5.1). In contrast, BRCA1 function is required for DSB repair in G2 where loss 
of BRCA1 leads to defective repair of slowly repaired DSBs (Figure 5.1). Importantly 
in chapter 3, I provide evidence showing that HR repairs DSBs in G2 that arise at HC 
regions. This is consistent with the widely accepted notion that BRCA1 specifically 
functions in DSB repair by HR. Moreover, the requirement of BRCA1 cannot be 
overcome by KAP-1 depletion indicating that its function in the process is distinct to 
that of 53BP1 (figure 5.1). Whereas 53BP1 depletion impacts upon pKAP-1 IRIF 
formation and HC relaxation, depletion of BRCA1 is dispensable for pKAP-1 IRIF. In 
conclusion the role of BRCA1 in G2 phase repair by HR is distinct to the mediator 
proteins 53BP1, and MDC1 and is not involved in ATM mediated HC relaxation. 
 To gain insight into the role of BRCA1 in HR, I first used the assays described 
in chapter 3 for monitoring the formation of HR intermediates to determine which 
step(s) of the process BRCA1 functions in. Interestingly, BRCA1 depletion leads to a 
modest defect in resection visualised as reduced RPA foci numbers in G2 cells 
following IR exposure (Figure 5.4). Additionally, BRCA1 knockdown cells also display 
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defective Rad51 loading with a marked reduction in foci numbers two hours post 3Gy 
IR in G2 (Figure 5.4).  However, BRCA1 depletion only leads to a twofold reduction in 
RPA and Rad51 foci unlike the complete loss observed following CtIP depletion (figure 
5.4). Moreover unlike CtIP depleted cells where repair can take place by NHEJ since 
resection is not initiated, BRCA1 depleted cells display a repair defect that likely results 
from stalled HR (Figure 5.3). This suggests that BRCA1 functions downstream of CtIP 
in HR. 
 To try to place BRCA1 function in the HR process, I investigated the impact of 
CtIP or MRE11 depletion on BRCA1 depleted cells. When CtIP is depleted no repair 
defect is observed. However MRE11 depletion leads to a repair defect since MRE11 has 
two functions during G2 phase repair by HR (Figure 5.3). An upstream role in the 
initiation of resection, and a downstream role as a mediator protein where it bridges the 
interaction between 53BP1 and pATM and enables pKAP-1 and HC relaxation (Lee et 
al, 2010). Consequently, when MRE11 and KAP-1 are co-depleted no repair defect is 
observed and repair ensues by NHEJ as resection is not initiated (Figures 5.3 and 5.4).  
Importantly, CtIP or MRE11/KAP-1 knockdown overcomes the requirement of BRCA1 
in G2 phase DSB repair (Figure 5.3). However under these conditions no RPA or Rad51 
foci were observed indicating that repair takes place by NHEJ (Figure 5.4). These 
findings strongly suggest that CtIP/MRN initiate resection and commit the cells to 
repair by HR. BRCA1 is not required for this initiation step but rather functions 
downstream to complete resection. A recent study has demonstrated that the E3 
ubiquitin ligase RNF169 is recruited to DSBs downstream of RNF8/RNF168 but 
upstream of 53BP1 and BRCA1. RNF169 inhibits the recruitment of 53BP1 and 
BRCA1 by binding to ubiquitylated histones and is thought to promote repair by HR 
(Poulsen et al, 2012). One possibility is that by delaying the recruitment of 53BP1, 
RNF169 enables the CtIP/MRE11 initiation of resection, while BRCA1 functions 
downstream in the elongation step of the process. 
 
53BP1 depletion rescues the HR defect of BRCA1 knockdown cells in G2. 
 
It was recently proposed that BRCA1 function in HR is to promote efficient resection 
by overcoming the inhibitory barrier that 53BP1 poses on this process (Bunting et al, 
2010; Bouwman et al, 2010). In these studies monitoring HR in S-phase, 53BP1 
depletion restored the HR defect of BRCA1 deficient cells. The notion that 53BP1 
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actively inhibits resection was surprising as my data from chapter 3 indicates that 
53BP1 mediates efficient HR by promoting pKAP-1 foci and HC relaxation. I tested 
whether in G2 depletion of 53BP1 could overcome the requirement for BRCA1 in HR 
(Figure 5.5). However, I also had to deplete KAP-1 since in G2, HC structure poses a 
barrier to HR unlike the situation in S-phase. Strikingly, under these conditions, the !-
H2AX, RPA and Rad51 foci formation defect of BRCA1 depleted cells were rescued 
indicating that proficient HR repair ensued (Figure 5.5). 53BP1 therefore has two 
opposing roles in G2 phase HR. On one hand, it inhibits HR by blocking resection 
while it also enables the accurate completion of HR by mediating KAP-1 dependent HC 
loosening. Perhaps more importantly, these findings indicate that the function of 
BRCA1 in HR is the removal of the barrier caused to resection by 53BP1. It seems that 
53BP1 forms a barrier to resection downstream of the initiation step which is where 
BRAC1 function is required. The barrier that 53BP1 poses is not complete since some 
RPA foci are observed in BRCA1 depleted cells. However the significance of 
overcoming the partial barrier that 53BP1 poses to resection is demonstrated in BRCA1 
depleted/mutated cells where a severe HR defect exists. 
 
BRCA1 promotes relocalisation of 53BP1 in G2 creating a core devoid of 53BP1. 
 
Using high resolution imaging and 3D image processing software I was able to gain 
insight into the role of BRCA1 in overcoming the inhibitory barrier posed by 53BP1 on 
resection. It appears that BRCA1 promotes a G2 phase specific relocalisation of 53BP1 
to the periphery of IRIF during HR, creating an internal core devoid of 53BP1 (Figure 
5.14). Similar results were recently obtained using super-resolution microscopy 
(Chapman et al, 2012). 53BP1 IRIF enlargement and relocalisation is specific to DSBs 
repaired by HR and is not observed in G1 phase (Figure 5.7). Significantly the 
formation of an internal core devoid of 53BP1 appears to be important for resection as 
this is where RPA foci form (Figure 5.14).  
 In addition to 53BP1, pATM signal is also repositioned and localises externally 
to 53BP1 on the IRIF periphery. It appears that the retention of activated ATM at DSB 
sites is important for the completion of resection as addition of the ATMi even up to 
four hours after damage induction leads to a repair defect in G2 (Figure 5.14). One 
explanation is that on-going ATM dependent HC relaxation is required until the 
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completion of HR. In BRCA1 depleted cells pATM IRIF also fail to relocalise although 
this likely results from deficient 53BP1 relocalisation. 
 
The BRCT but not the RING domain of BRCA1 is required for 53BP1 
repositioning during HR. 
 
An important question from the data described above is how BRCA1 mechanistically 
overcomes the barrier that 53BP1 poses to resection. I suspected that the ubiquitin 
ligase activity of BRCA1 might be important as FK2 IRIF depicting polyubiquitin 
chains also become relocalised as HR ensues in a BRCA1 dependent manner (Figure 
5.14). I postulated that BRCA1 might drive 53BP1 repositioning away from the DSBs 
ends by on-going ubiquitylation. Moreover, a recent study reported that BRCA1 can 
ubiquitylate H2A and carries out this modification during its role in HC maintenance 
(Zhu et al, 2011). To gain insight into this, I tested whether the BRCT or RING 
domains of BRCA1 are required for this function. The RING domain of BRCA1 is the 
catalytic domain of its ubiquitin ligase activity whereas the BRCT domains are 
responsible for its phosphoprotein interactions. I tested 53BP1 IRIF volume in MEFs 
expressing either RING or BRCT mutant BRCA1 and compared it to WT MEFs. 
Surprisingly, the ubiquitin ligase activity of BRCA1 was dispensable for this process 
whereas the BRCT mutant MEFs failed to relocalise 53BP1 to the same extent as the 
WT cells (Figure 5.15). These findings strongly suggest that BRCA1 does not directly 
promote 53BP1 relocalisation via its ubiquitin ligase activity but rather promotes the 
process via its interaction with one or more of its interacting factors.  
 To determine whether any of the BRCA1 interacting factors is required for 
53BP1 relocalisation, I depleted several of these factors. First I investigated the impact 
of BRCC36 or RAP80 depletion on 53BP1 IRIF foci volume (Figure 5.16). However 
BRCC36 depletion had no effect on 53BP1 IRIF relocalisation in G2 and the foci in 
these cells were indistinguishable to those in control cells (Figure 5.16). RAP80 is 
another factor that interacts with BRCA1 and targets it to ubiquitylated histones 
flanking DSBs via its ubiquitin interacting motif (UIM) (Sobhian et al, 2007). Since 
RAP80 impacts on BRCA1 recruitment and BRCA1 dependent resection I reasoned 
that it might also impact on BRCA1’s ability to relocalise 53BP1. However, depletion 
of RAP80 did not impact on 53BP1 IRIF volume in G2 and the foci in these cells were 
indistinguishable to those in control cells (Figure 5.16). 
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 Next I tested the effect of BACH1 knockdown on BRCA1’s ability to relocalise 
53BP1. BACH1 is a helicase that interacts with BRCA1 so it is plausible that BACH1 
mediated DNA unwinding might be necessary for resection and consequently 53BP1 
IRIF expansion (Huen et al, 2009). However BACH1 depletion by siRNA also did not 
impact on 53BP1 IRIF relocalisation in response to IR in G2 (Figure 5.16).    
 
The deubiquitinating enzyme POH1 is required for resection and 53BP1 
repositioning in G2. 
 
The BRCA1a complex is comprised of BRCA1, RAP80, Abraxas, BRCC36, NBA1 and 
BRCC45 (Huen et al, 2009). The complex is targeted to DSBs by RAP80 binding to 
ubiquitylated histones via its UIM (Sobhian et al, 2007). Previous studies have 
indicated that RAP80 binding to ubiquitylated histones is inhibitory to resection and 
functions to counteract BRCA1 function and prevent excessive resection (Hu et al, 
2011). Consistent with this, depletion of RAP80 leads to elevated levels of BRCA1 
mediated resection. Moreover, disruption of the BRCA1a complex by depletion of 
either Abraxas or BRCC36 also leads increased resection thought to result from loss of 
RAP80 from ubiquitylated histones. The inhibitory function of RAP80 on resection 
needs to be overcome for the process to ensue however how this is achieved is currently 
unclear. From my data in this chapter I propose a model whereby the DUB enzyme 
POH1 promotes RAP80 disassociation from ubiquitylated histones thereby enabling 
resection. Consistent with this model, siRNA depletion of POH1 leads to a marked 
defect in RPA foci formation following IR in G2 (Figure 5.18). Moreover, I propose 
that POH1 DUB activity is required to form the hollow core observed in 53BP1 and 
FK2 IRIF, which is required for RPA foci formation. POH1 deubiquitylation of histone 
H2A likely leads to disassociation of RAP80 and 53BP1 from these regions thus 
overcoming their inhibitory role on resection. Once RAP80 disassociation is achieved, 
then histone eviction/degradation or sliding can take place so resection can ensue. 
Interestingly, when RAP80 is depleted or when the BRCA1a complex is disrupted by 
Abraxas of BRCC36 depletion, POH1 function becomes redundant for RPA foci 
formation. This finding suggests that when ubiquitylated histones are not protected by 
RAP80 binding to them, they can be evicted/degraded and resection can take place. 
However, although RAP80/Abraxas/BRCC36 can overcome the requirement for POH1 
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in RPA foci formation, this is not the case for Rad51 foci. This suggests that POH1 has 
a direct role in Rad51 loading, possibly by recruiting the BRCA2-co-factor DSS1. 
In addition to being disassociated from the IRIF core, 53BP1 also needs to be 
repositioned away from DSB ends in order for resection and HR to ensue. My data from 
this chapter indicate that 53BP1 repositioning requires BRCA1 function, consistent with 
published data showing that BRCA1 overcomes the 53BP1 inhibition of resection 
(Bunting et al, 2010; Bouwman et al, 2010). More specifically, my data reveal that 
53BP1 repositioning requires the BRCT domain of BRCA1 but that the ubiquitin ligase 
activity of BRCA1 is dispensable for this process (Figure 5.16). However, despite the 
ubiquitin ligase activity of BRCA1 not being required for 53BP1 repositioning, in the 
absence of BRCA1, FK2 IRIF also fail to reposition. I interpret this finding to suggest 
that 53BP1 repositioning away from DSB ends is driven by on-going ubiquitylation that 
is driven by BRCA1 although it might not be the E3 ligase carrying out this 
modification. There are several ubiquitin ligases that function in the DDR including 
RNF8/RNF168, Rad18 and HERC2. One, or more, of these ligases might be involved in 
53BP1 repositioning but testing this is difficult since depletion of some of these ligases 
leads to loss of 53BP1 foci formation. It is currently unclear how the BRCT domain of 
BRCA1 functions to overcome the barrier posed by 53BP1, although an interaction with 
POH1 and an E3 ligase is likely. In support of this model, co-immunoprecipitation 
experiments carried out by the Morris laboratory revealed that POH1 and BRCA1 
interact following DSB induction (Morris et al unpublished). 
 Deciphering the mechanism behind BRCA1 dependent 53BP1 repositioning 
during HR is a difficult task. There are many factors that contribute to this. First it is 
highly likely that there are currently unidentified BRCA1 interacting factors that might 
play a role in this process. Secondly, even if these factors were to be identified there 
might be functional redundancy amongst them, which means that the requirement of 
one might be overcome by the function of another. Indeed this could well be the case 
for some of the BRCA1 interacting factors tested in this chapter. However, concurrent 
depletion of multiple factors especially in BRCA1 depleted cells makes analysis 
extremely difficult due to toxicity and a small G2 population. Recently, processes in the 
DDR that are regulated by multiple and simultaneous post-translational modifications 
including ubiquitylation and sumoylation have been described. Indeed both BRCA1 and 
53BP1 have been shown to be sumo-modified in response to DSB induction so it is 
possible that the factors responsible for these modifications are required to help 
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overcome the barrier that 53BP1 poses to resection (Galanty et al, 2009; Morris et al, 
2009). Given the central role that BRCA1 plays in HR it is unlikely that its sole 
function is to relocalise 53BP1. However, it is now clear that this is a necessary step and 
consolidating how BRCA1 achieves this is an important future question. 
 
 
 
Model for the roles of 53BP1, BRCA1 and POH1 in HR.  
 
 
The question of how 53BP1 becomes repositioned during HR is an important one, but 
equally important is understanding why the retention of 53BP1 on the IRIF periphery is 
required for efficient HR. Our findings indicate that following exposure to !-radiation in 
G2, DSBs at HC regions are predominantly repaired by HR with slow kinetics. ATM 
dependent pKAP-1 formation is required for HR repair of such DSBs as it leads to the 
HC relaxation required to make the chromatin region accessible. In HR, the undamaged 
template on the sister chromatid is used to fill in the resected regions and to accurately 
repair the break (Diagram 5.2a). However if a DSB is in an HC region it is likely that 
the homologous region on the sister chromatid will also be heterochromatic and access 
will necessitate chromatin relaxation. I propose that the G2 phase specific enlargement 
of 53BP1 and pATM during HR represents chromatin modifications on the undamaged 
template. The repositioning of the ubiquitin modifications likely drives the 53BP1 
repositioning although this process doesn’t require BRCA1’s RING domain. The ability 
of 53BP1 to oligomerise is likely important for its ability to encompass the damaged 
and undamaged templates and its BRCT domain is important for pATM retention and 
HC relaxation. In the core of the IRIF, the creation of a 53BP1 devoid region is BRCA1 
and POH1 dependent and necessary for the completion of resection (Diagram 5.2b). 
BRCA1 and 53BP1 therefore cooperate in G2 phase HR to ensure that resection is 
efficiently completed and to carry out the necessary chromatin modifications.  
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Diagram 5.2: Model showing the expansion of 53BP1 foci in G2 phase and the formation of an IRIF core 
devoid of 53BP1 and FK2 where RPA foci form. 
a) Model showing the requirement for 53BP1 to affect HC changes on the undamaged sister chromatid. The slowly 
repaired DSBs that arise within regions of heterochromatin (HC) undergo resection and repair by HR (HC is depicted 
in green). In early G2 phase (30 min post IR), 53BP1 foci form around the DSB on a single DNA molecule similar to 
the situation in G1 phase. 53BP1 is likely not located at the extreme DNA end. 53BP1 interacts with RAD50 of the 
a?
b?
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MRN complex; NBS1 of the MRN complex interacts with ATM. Thus, ATM tethering at the DSB is enhanced by the 
presence of 53BP1 foci (interactions between MRN and MDC1 or H2AX also enhance ATM tethering but 53BP1 
appears to be critical for the presence of  pATM foci at DSBs). ATM phosphorylates KAP-1 located at HC-DSBs in a 
concentrated manner producing pKAP-1 foci (note that pan-nuclear pKAP-1 also occurs at early times post IR but 
this is not 53BP1-dependent; in contrast the formation of pKAP-1 foci, which only form at HC-DSBs is 53BP1-
dependent). This causes HC-relaxation in the vicinity of the DSB (not depicted in the figure). HC forms a partial 
barrier to resection that is overcome by 53BP1-ATM pKAP-1 foci formation. The presence of 53BP1 on the DNA 
molecule also forms a partial barrier to the completion of resection and a bigger barrier to RAD51 loading. However, 
neither 53BP1 nor KAP1 prevent the initiation of resection by CtIP-MRN, since they function downstream of CtIP-
MRN dependent commitment to HR and since RPA foci numbers are only partially reduced. Later in G2 (evident at 2 
h), further resection ensues followed by the single stranded DNA overhang with bound RPA and/or RAD51 invading 
the undamaged sister template.  53BP1 foci formation expands to allow further resection and to encompass the 
undamaged DNA molecule, resulting in a two fold expansion in foci volume. The expansion of 53BP1 foci requires 
the BRCT but not the RING finger domain of BRCA1 and involves repositioning of ubiquitin modifications on 
histones. Thus, we propose that BRCA1 promotes deubiquitination and/or proteasome mediated protein degradation 
in the core region and new ubiquitin events on the damaged and, we propose, the undamaged molecule. For 
simplicity this has not been depicted in the figure. The presence of 53BP1 on the undamaged strand allows pKAP1 
formation and hence HC relaxation on this strand, which promotes the completion of resection and/or RAD51 
loading. We have depicted 53BP1 as entirely encircling the DNA molecule although its initial tethering involves 
interactions with methylated H4. This is consistent with evidence that 53BP1 undergoes oligomerisation and has a 
role in synapsis during long range V(D)J recombination (Adams et al, 2005; Difilippantonio et al, 2008). In G2 
phase, 53BP1 may also enhance synapsis but this does not appear to be essential since HR can ensue in the absence 
of 53BP1+BRCA1.  We suggest that the close association of sister chromatids in G2 phase via cohesin interactions 
can function redundantly to 53BP1-dependent synapsis in G2 phase.  Thus, 53BP1-dependent synapsis is only 
essential for long-range translocation events in G1 phase. 
b) Model showing the role of POH1 in removing 53BP1 from the foci core region. 
Previous studies have demonstrated that 53BP1 and RAP80 form a restrictive barrier to resection by binding to 
methylated and ubiquitylated histones at DSBs. The BRCT domain of BRCA1 is required for 53BP1 repositioning 
away from the DSB ends as well as for the formation of an IRIF core devoid of 53BP1 where resection occurs. 
Similarly, the BRCT domain of BRCA1 is also required for the formation of an IRIF central core devoid of ubiquitin 
modifications. We propose that BRCA1 achieves this via the recruitment of the deubiquitinating enzyme POH1which 
functions to promote the removal of 53BP1 and ubiquitin chains but is dispensable for 53BP1 repositioning to the 
foci periphery. POH1 DUBing might lead to histone degradation thus exposing DNA to the nucleases which carry 
out the elongation step in resection. 
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CHAPTER 6 
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6   Transcriptional silencing at DSBs requires ATM and RNF8 as well as the 
chromatin remodellers BAF180 and CHD7 
 
 
 
6.1: Introduction  
 
Repair of DNA damage occurs within the context of chromatin and it is becoming 
increasingly evident that the ability to modify chromatin can greatly impact on repair 
efficiency. As discussed in previous chapters, post translational modification of 
chromatin components (!-H2AX, uH2A, pKAP-1) are particularly important in dense 
HC regions where chromatin compaction poses a barrier to repair. Conversely, in EU 
regions, posttranslational modifications are also required for efficient DSB repair and 
for interfacing repair with other DNA metabolic processes such as transcription (Zhu et 
al, 2007; Zhou et al, 2009). The process of transcription, like other process where 
access to DNA is required, is associated with chromatin decondensation (Müller et al, 
2001). It has been suggested that chromatin decondensation at transcriptionally active 
EU regions needs to be inhibited in the presence of DNA damage but until recently no 
evidence existed for this model. In support of such a model, post-translational 
modifications such as histone H2A ubiquitylation have been shown to be important in 
both DNA repair and transcriptional repression(Ulrich & Walden, 2010; Wang et al, 
2004). This model suggests that transcription associated chromatin decondensation in 
the presence of DNA damage might lead to erroneous repair and is therefore inhibited.  
 The idea that transcription is inhibited in the presence of DNA damage is 
conceptually appeasing. However, how this inhibition is regulated is not clear. Until 
recently it was also not clear whether transcription is globally inhibited in the presence 
of DNA damage or whether this is restricted to DNA damage sites (Shanbhag et al, 
2010). Recently, the Greenberg laboratory developed an elegant reporter system that 
they used to gain insight into the regulation of transcription in cis to DSBs.  The authors 
hypothesised that there might be a link between the ubiquitylation events at DSB sites 
and the ubiquitylation events leading to the inhibition of transcription. They reasoned 
that since posttranslational modifications spread megabases from DSBs that these may 
lead to the inhibition of transcription within these regions (Rogakou et al, 1999). To 
address these questions they integrated a reporter system at a single site in the U2OS 
cell line.  
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 The reporter system provided concomitant read outs for DSB induction as well 
as active transcription. It consists of a lac operator array that is bound by the lac 
repressor protein following its expression. The lac repressor protein was tagged with the 
fluorescent protein mCherry thus allowing visualisation of the reporter site. A CMV 
promoter drives the expression of a CFP-tagged peroxisomal targeting peptide that 
accumulates in the cytoplasm and provides a read out for protein production. The 
expression of this protein can be controlled via a 4kb region of tandem tetracycline 
response elements located between the promoter and the operator sequences that bind a 
doxycycline-inducible transactivator. Following doxycycline treatment, the tetracycline-
controlled transcactivator binds to the tetracycline response elements and activates 
transcription. In addition to monitoring protein production, nascent transcript can also 
be visualised by YFP tagged MS2 viral coat protein. The reporter transcript contains 24 
repeats of stem loop structures that are bound to by YFP-MS2 thus allowing 
visualisation of the nascent transcript.  
 In order to assess the impact of DSB induction on transcription, the authors 
fused the nuclease domain of the FOK1 endonuclease to the mCherry-Lacl construct. 
Following expression of this construct, DSBs are produced in the lac operator sequence 
thus at a distance of 4-13 kb from the promoter. By simultaneous expression of the 
mCherry-Lacl-FOK1 construct and the tetracycline-controlled transactivator, the impact 
of DSBs on transcription within a 4-13 kb distance from the DSB sites could be 
assessed. Strikingly, a 4 to 10 fold reduction in nascent transcript levels was observed 
following DSB induction, compared to cells where transcription was induced but no 
DSBs were created. Importantly, enrichment of !-H2AX was observed across the 
reporter locus by ChIP, indicating that DSB induced chromatin modifications spread 
across the region separating the DSBs and the transcription sites.   
 Next the authors used radiation exposure and laser micro-irradiation to assess 
whether the inhibition of transcription following DSB induction is a global phenomenon 
or restricted to DSB sites. Perhaps surprisingly, they observed that nascent transcript 
levels from their reporter system were not affected by exposure to IR or micro-
irradiation strongly suggesting that transcriptional silencing only occurs in cis to DSBs. 
These results indicate that the expansion of chromatin posttranslational modifications 
away from DSBs lead to transcriptional silencing within these regions. By quantifying 
the FOK1 locus area following doxycycline induced transcription, the authors also 
demonstrated that chromatin is decondensed at transcription sites. However upon 
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induction of DSBs chromatin decondensation as well as well as transcription is 
inhibited. 
 
6.1.2: Histone H2A ubiquitylation and ATM are required for DSB associated 
transcriptional silencing. 
 
The ubiquitylation of histone H2A has previously been linked to transcriptional 
silencing (Wang et al, 2004). As mentioned above, using their reporter system 
Shanbhag et al observed !-H2AX spreading across the reporter locus located between 4-
13 kb from the sites of DSB induction (Shanbhag et al, 2010). To test whether DSB 
induced histone ubiquitylation also spreads over the same region, they used ubiquitin 
specific antibodies and observed an enrichment of ubiquitin modified H2A as well as 
K48 and K63 conjugate polyubiquitin chains at the reporter site. This finding indicates 
that the transcriptional repression observed in cis to DSB sites may be regulated via the 
spreading of ubiquitin modifications away from the DSB sites.  
 ATM has many roles in the DDR to DSBs that include the modification of 
chromatin topography to facilitate efficient repair (Lavin, 2008). Work from our 
laboratory has demonstrated that ATM plays a central role in regulating the chromatin 
decondensation that needs to occur for the repair of DSBs located within HC regions 
(Goodarzi et al, 2008). Following the observation that transcription associated 
chromatin decondensation in cis to DSB sites is inhibited, Shanbhag et al questioned 
whether ATM is required for this process. Remarkably, ATMi treatment led to defective 
inhibition of transcription following the induction of DSBs. In addition, the inhibition of 
transcription associated chromatin decondensation also failed following ATMi 
treatment. Although ATM activity is not directly required for histone H2A 
ubiquitylation, the maintenance of this modification was greatly defective in ATMi 
treated cells. The mechanism of ATM dependent transcriptional repression is not clear 
from these findings but ATM activity and histone H2A ubiquitylation appear to play a 
central role. 
 As discussed in chapter 4, RNF8 and RNF168 are two of the E3 ubiquitin 
ligases that carry out the ubiquitylation modifications at DSB sites (Mailand et al, 2007; 
Huen et al, 2007; Doil et al, 2009). Since histone H2A is a well-characterised target of 
these ligases, Shanbhag et al tested the effect of RNF8 and/or RNF168 depletion on 
transcriptional silencing using their reporter system. When they depleted each ligase 
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alone they did not a great effect, but joint depletion led to a significant defect in 
transcriptional silencing. Interestingly, the reversal of histone H2A ubiquitylation by the 
DUB USP16 led to the restoration of transcription.  
 Overall, Shanbhag et al demonstrated that transcription and chromatin 
decondensation are inhibited in cis to DSBs through histone H2A ubiquitylation. 
Moreover, ATM function is required to inhibit chromatin decondensation and to 
maintain the RNF8/RNF168 mediated H2A ubiquitylation until repair is completed. 
However, although great insight into the roles of these factors has been gained, many 
future questions remain. Firstly, it is not clear how ATM maintains histone H2A 
ubiquitylation or how it inhibits transcription associated chromatin decondensation. 
ATM might manipulate chromatin structure directly as in HC repair via KAP-1 
phosphorylation or indirectly via chromatin remodellers. Secondly, it is not clear 
whether there is an impact on the ability to repair DSBs when transcription is not 
efficiently inhibited. By using the reporter system acquired from the Greenberg 
laboratory, and other functional assays, I attempted to gain insight into the roles of 
ATM, RNF8 and chromatin remodellers in the inhibition of transcription in cis to DSBs 
and the repair of these lesions. 
 
6.1.3: Chromatin remodelling at DSBs 
 
The efficient formation of pKAP-1 foci following IR exposure is dependent upon ATM 
function and is a prerequisite for repair at HC regions. However until recently the 
mechanism by which pKAP-1 foci formation leads to HC relaxation was unclear. As 
discussed in the introductory chapter, chromatin structure impacts upon DNA metabolic 
processes and there are several lines of evidence indicating that facultative HC offers a 
level of control over gene expression (Dillon & Festenstein, 2002). This dense structure 
is assembled and maintained by the concomitant function of enzymes that remove 
transcription associated chromatin modifications and by chromatin remodellers that 
densely pack nucleosomes. Histone acetylation is associated with transcription while 
histone methylation is predominately associated with the repression of transcription. 
Consistently, HC regions are enriched for methylation associated posttranslational 
modifications (Dillon & Festenstein, 2002). 
Recent work from our laboratory investigated the changes in the histone 
posttranslational modification landscape specifically at HC DSBs (Goodarzi et al, 
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2011). Perhaps surprisingly; no changes in HC acetylation or methylation were detected 
following exposure to IR. This does not necessarily indicate that these changes do not 
take place as the high stoicheometric background of these modifications rendered the 
detection of IR induced changes by immunofluorescence difficult. In the same study the 
impact of pKAP-1 formation on chromatin remodellers leading to HC compaction was 
also investigated. The nucleosome remodelling and deacetylase complex (NuRD) is a 
well-characterised ATP-dependent complex that promotes heterochromatinisation via 
nucleosome compaction (Denslow & Wade, 2007). This function is achieved via the 
direct interaction of the NuRD complex with KAP-1 (Schultz et al, 2001). Specifically, 
the CHD3 component of the NuRD complex binds to autosumoylated KAP-1 via its 
SUMO interaction motif. Following exposure to IR, ATM phosphorylation of KAP-1 
leads to the generation of a motif that abolishes the CHD3 KAP-1 SIM-SUMO 
interaction and CHD3 becomes disassociated from HC (Goodarzi et al, 2011). This 
leads to a loss of HC compaction, which allows repair to take place and is only re-
established following the completion of repair and KAP-1 de-phosphorylation. 
 Following the observation that ATM is required for transcriptional silencing and 
the inhibition of the associated chromatin decondensation, I reasoned that this process 
might also be achieved via chromatin remodelling complexes.  
 The SWI/SNF chromatin remodelling complexes have been implicated in both 
the DDR and transcriptional regulation (Tang et al, 2010). These complexes alter 
chromatin structure by manipulating nucleosomes via their ATP-dependent nucleosome 
remodelling activity (Xu & Price, 2011). They are involved in a diverse set of processes 
by sliding and ejecting nucleosomes, but do not appear to function in chromatin 
assembly. The RSC complex is a yeast chromatin-remodelling complex that is 
homologous to mammalian SWI/SNF-b or PBAF  (Diagram 6.1) (Table 6.1) (Clapier & 
Cairns, 2009). RSC has an important role in transcriptional regulation but also functions 
in several DDR pathways (Kent et al, 2007). RSC exists as two isoforms that differ on 
whether Rsc1 or Rsc2 are present (Diagram 6.1). Mutant strains of both rsc1 and rsc2 
display defective NHEJ activity, while Rsc1 but not Rsc2 is required for nucleosome 
sliding at DSBs sites, a process that seems to require its bromo-adjacent homology 
(BAH) domain (Chambers et al, 2012). RSC utilises its ATPase activity to modify 
nucleosomes at DSBs but until recently little was known about the functional 
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Diagram 6.1: Schematic representation of the yeast RSC and human BAF/PBAF chromatin remodelling 
complexes.  
Yeast RSC comprises of 17 subunits and functions in DNA repair pathways as well as in transcriptional regulation. 
There are two isoforms of the RSC complex, one that contains Rsc1 and the other Rsc2. The homologous complex in 
humans is PBAF. PBAF contains BAF180, which is a fusion of yeast Rsc1, Rsc2 and Rsc4. The PBAF complex 
functions in transcriptional regulation but a role in DNA repair has not been described. Adapted from (Kasten et al, 
2011). 
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Table 6.1: Remodeller composition and orthologous subunits (Clapier & Cairns, 2009). 
 
 
 
 
  
 Organisms Family and 
composition  namuH ylF tsaeY
Complex SWI/SNF RSC BAP PBAP BAF PBAF 
ATPase Swi2/Snf2 Sth1 BRM/Brahma hBRM or BRG1 BRG1 
Swi1/Adr6  OSA/eyelid  BAF250/hOSA1  
   Polybromo 
BAP170 
 BAF180 
BAF200 
Swi3 Rsc8/Swh3 MOR/  071FAB ,551FAB 551PAB
 c ro b ro a06FAB 06PAB 6csR 37pwS
Snf5 Sfh1 SNR1/BAP45 hSNF5/BAF47/INI1 
  BAP111/  75FAB oalad
 b ro a35FAB 74PAB ro 55PAB
Noncatalytic 
homologous 
subunits 
Arp7, Arp9 
Actin β-actin 
SWI/
SNF 
Unique a b     
Complex ISW1a ISW1b ISW2 NURF CHRAC ACF NURF CHRAC ACF 
ATPase Isw1 Isw2 ISWI SNF2L SNF2Hc
Itc1 NURF301 ACF1 BPTF hACF1/WCRF180 
CHRAC14 hCHRAC17
CHRAC16 hCHRAC15
Noncatalytic 
homologous 
subunits 
NURF55/p55 RbAp46 or 48
ISWI 
Unique Ioc3 Ioc2, Ioc4  NURF38      
Complex CHD1 CHD1 Mi-2/NuRD CHD1 NuRD 
ATPase Chd1 dCHD1 dMi-2 CHD1 Mi-2α/CHD3, 
Mi-2β/CHD4 
dMBD2/  3DBM 3
 3,2,1ATM ATMd
 2,1CADH 3DPRd
 84 ro 64pAbR 55p
Noncatalytic 
homologous 
subunits 
p66/68 p66α,β
CHD
 ?1-COD     euqinU
Complex INO80 SWR1 Pho-dINO80 Tip60 INO80 SRCAP TRRAP/Tip60
ATPase Ino80 Swr1 dIno80 Domino hIno80 SRCAP p400 
2,1LBVUR nitnoP ,nitpeR 2,1bvR /Tip49a,b 
 a35FAB 6prA 8,5prA
Arp4, Actin1 
dArp5,8 
dActin1 
BAP55 
Actin87E Arp5,8 Arp6 Actin 
 14SAG  14SAGd 9faY 41faT
   6,2seIh   6,2seI
Swc4/  1PAMD 1PAMDd 2faE
Swc2/  1-LY 1-LYd 27spV
8drB  8drBd 1fdB /TRC/p120
H2AZ,H2B H2Av,H2B H2AZ,H2B
Swc6/  1TIH-FnZ  17spV
 PARRT 1arTd
 06piT 06piTd
 51GRM 51GRMd
MRGX
 03711JLF 6faEd
 PBGRM PBGRMd
 ,1CPE )cP(E
EPC-like 
Noncatalytic 
homologous 
subunits 
dING3 ING3 
INO80
Unique Ies1,Ies3-5,Nhp10 Swc3,5,7 Pho  d   
aSwp82, Taf14, Snf6, Snf11. 
bRsc1 or Rsc2, Rsc3-5, 7, 9, 10, 30, Htl1, Ldb7, Rtt102. 
cIn addition, SNF2H associates respectively with Tip5, RSF1, and WSTF to form NoRC, RSF, and WICH remodelers. 
dAmida, NFRKB, MCRS1, UCH37, FLJ90652, FLJ20309. 
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importance of its BAH domain. Work form the Downs laboratory recently described a 
mechanism whereby the RSC complex binds to chromatin (histone H3) via the (BAH) 
domain in the Rsc2 subunit. Importantly, site directed mutations in the BAH domain led 
to impaired Rsc2 chromatin association and compromised the function of RSC in rDNA 
silencing, transcriptional regulation and the DDR (Chambers et al unpublished). 
 The BAH domains of the yeast RSC complex are conserved in the mammalian 
PBAF homologue. However, the BAH domains of Rsc1, and Rsc2 exist on a single 
protein called BAF180, which appears to be a fusion of Rsc1, Rsc2 and Rsc4 (Goodwin 
& Nicolas, 2001; Mohrmann & Verrijzer, 2005). Site directed mutations in the 
conserved BAH domains of BAF180 also lead to a reduction in chromatin binding 
affinity (Chambers et al unpublished). It is not clear whether the roles of Rsc1, 2 and 4 
in transcriptional regulation and the DDR are functionally conserved in BAF180 and 
whether these require the BAH domains. Interestingly, BAF180 was previously 
identified as an ATM phosphorylation target in a large proteomics study (Matsuoka et 
al, 2007). However, the role of this modification in the DDR has not been characterised.  
 Functional studies examining the role of BAF180 in maintaining genomic 
stability are clinically significant as it is frequently mutated in cancer (Xia et al, 2008; 
Varela et al, 2011). It is currently unclear exactly how BAF180 functions to prevent 
carcinogenesis. BAF180 is thought to bind to promoter regions of genes involved in 
genome maintenance via its bromodomains, where, as part of the PBAF complex it 
regulates the expression of these genes (Brownlee et al, 2012). Consistent with this 
notion, disruption of the BAF180 or BRD7 subunits of the PBAF complex, lead to 
defective replicative senescence and checkpoint activation due to impaired p53 
transcriptional activity (Xia et al, 2008; Burrows et al, 2010). To date no published 
studies have addressed whether BAF180 has a direct role in DNA repair. Given the 
established role of RSC in the DDR and the fact that ATM phosphorylates BAF180 in 
response to DNA damage, I decided to investigate the role of BAF180 in DSB repair 
and in transcriptional repression in cis to DSBs. 
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6.2: Results 
 
6.2.1: RNF8 is required is for efficient DSB repair in euchromatin. 
 
In chapter 4, I investigated the role of RNF8 in the repair of HC DSBs by HR in G2. 
Previous work from our laboratory has also investigated the requirement for RNF8 in 
DSB repair in G1 (Noon et al, 2010). In both G1 and G2, RNF8 functions in the slow 
component of DSB repair that corresponds to DSBs located at HC regions. In G1 phase, 
RNF8 promotes the repair of these breaks by mediating ATM dependent HC loosening 
while in G2 it has an additional role in promoting RPA and Rad51 foci formation. 
Paradoxically, the work from Shanbhag et al suggests that RNF8 ubiquitin ligase 
activity also functions to silence transcription in cis to DSBs via a pathway that also 
involves ATM. However, DSBs in cis to transcriptionally active regions are likely to be 
located in EU not in HC. Following exposure to !-radiation, approximately 20% of 
induced DSBs are located at HC regions, which corresponds with approximately 20% 
of mammalian genomes being heterochromatic (Goodarzi et al, 2008). MEFs form 
distinct chromocenters in G1 that can be visualised by DAPI staining and are 
understood to represent dense HC regions (Guenatri et al, 2004). Using chromocenters 
as an HC marker we can visualise whether a break is in HC or EU by analysing the 
position of !-H2AX foci relative to the chromocenters (Figure 6.1a). Using this system, 
previous work from our laboratory has demonstrated that loss of ATM or any of the 
mediator proteins in G1 phase leads to a DSB repair defect in the slow component of 
repair and that these remaining foci co-localise with HC regions (Figure 6.1b) 
(Goodarzi et al, 2008). However, no requirement for the repair of EU breaks that are 
repaired with fast kinetics has been observed for ATM or the mediator proteins. 
Particularly in the first hour post DSB induction, no significant change in the number of 
breaks located at HC regions is observed, indicating that repair of DSBs at these early 
times only represent repair in EU (Figure 6.1c). 
 In the past, attempts were made to assess whether ATM is required for the repair 
of DSBs at very early times post irradiation. However, this was not possible by using !-
H2AX foci as a surrogate marker for DSBs. ATM directly phosphorylates histone 
H2AX at DSB sites and although DNA-PK can carry out this modification in ATM 
deficient cells, the foci that form are smaller and can not be accurately compared to 
those in ATM proficient cells (Stiff et al, 2004). Since RNF8 does not affect histone  
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Figure 6.1: DSB repair in EU and HC following IR exposure. 
NIH3T3 cells were seeded and allowed to enter G0 by contact inhibition. The cells were then irradiated with 1Gy IR 
and harvested at the indicated time points. Fixed cells were then immunostained with a !-H2AX antibody and DAPI 
and imaged on a fluorescent microscope. a) Representative immunofluorescence image of a cell harvested at 30m 
post 1Gy IR. Red arrows indicate !-H2AX foci associated with DAPI chromocenters depicting HC, while green 
arrows indicate !-H2AX in EU. b) Schematic of DSB repair over time after IR exposure. At early times post IR, EU 
DSBs are repaired with fast kinetics and their repair is completed by 4h post 3Gy IR. DSBs associated with HC are 
repaired with slower kinetics and require ATM and the mediators for efficient repair. c) During the first 60m post 
1Gy IR, predominantly DSBs in EU are repaired. !-H2AX foci were enumerated in 30 cells per time-point and the 
data represent the mean and standard deviation of three independent experiments. 
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H2AX phosphorylation but appears to function in the ATM pathway leading to 
transcriptional silencing at DSB sites, I decided to investigate the requirement of RNF8 
for repair of DSBs at very early time points post the induction of damage (Figure 6.2). 
Strikingly, RNF8 knockdown led to a repair defect at early times post 1.5Gy IR 
treatment with the biggest difference being observed at the 20 and 40-minute time 
points. However, by 60 minutes post IR treatment, the number of !-H2AX foci in RNF8 
knockdown cells were almost at the same level as that observed in control cells 
consistent with previous findings whereby no repair defect was observed in the fast 
component of repair. The repair defect/delay at the very early time points in RNF8 
knockdown cells was not previously observed and we considered might result from an 
inability to efficiently silence transcription in EU. 
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Figure 6.2: RNF8 is required for DSB repair at early times post IR. 
1BrhTERT cells were treated with control or RNF8 siRNA and were irradiated with 1.5Gy IR. The cells were then 
harvested at the indicated time points and immunostained with CENP-F and !-H2AX antibodies. G1 phase cells were 
identified by negative CENP-F staining and the cell nuclei were visualized by DAPI. !-H2AX foci were enumerated 
specifically in CENP-F negative cells. !-H2AX foci were enumerated in 30 cells per time-point and the data represent 
the mean and standard deviation of three independent experiments. 
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6.2.2: RNF8 functions in the same pathway as ATM leading to transcriptional 
silencing in cis to DSBs. 
 
Once I acquired the reporter system from the Greenberg laboratory, I first tested 
whether I could reproduce their transcriptional silencing defect following ATMi 
inhibition (Figure 6.3).  As expected, doxycycline treatment drove the expression of the 
CFP-tagged peroxisomal targeting peptide and nascent transcripts were detected by 
YFP in 80 – 90 % of cells (Figure 6.3). However, when the FOK1 endonuclease was 
activated by transfection, the resulting DSBs led to transcriptional silencing across the 
reporter region and an almost complete loss of nascent transcripts was observed (Figure 
6.3). 
 Next I assessed the effect of ATMi inhibition and/or RNF8 depletion on 
transcriptional silencing following DSB induction. Consistent with the data from 
Shanbhag et al, following ATMi treatment there was no significant reduction in the 
number of cells with nascent transcripts following DSB induction indicating deficient 
transcriptional silencing. Additionally, when RNF8 was depleted I observed a 
significant defect in the inhibition of transcription following DSB induction although 
this was not as severe as that of ATMi treated cells. The defect observed in RNF8 
depleted cells was greater however than that observed by Shanbhag et al where they 
only observed a significant defect after RNF8/RNF168 double knockdown. This 
difference can be attributed to greater knockdown efficiency as in my experiments a 
pool of RNF8 siRNA oligos were used. When the ATMi was added to RNF8 
knockdown cells, the transcriptional silencing defect increased to the level of ATMi 
treated cells (Figure 6.3). 
 
6.2.3: The PBAF chromatin-remodelling complex is required for transcriptional 
repression in cis to DNA DSBs. 
 
Depletion of BAF180 by siRNA was carried out in the U20S cells carrying the 
transcriptional reporter. The level of transcriptional read out after doxycycline treatment 
was not affected by the depletion of BAF180 indicating that BAF180 function is not 
required for the activation of transcription in this system. Remarkably however, 
depletion of BAF180 led to a significant defect in transcriptional silencing following 
FOK1 induced DSBs (Figure 6.4). This result indicates that BAF180 
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Figure 6.3: RNF8 is required for transcriptional silencing is cis to DSBs 
Transcription reporter U2OS cells were treated with control or RNF8 siRNA. 48h later, the cells were transfected, or 
not, with the mCherry-FOK1 endonuclease. 24h later, doxycycline was added to the cells to drive transcription and 
the cells were harvested 4h later. The cells were then visualized on a fluorescent microscope. Doxycycline driven 
transcription was visualized as YFP-MS2 protein binding to MS2 nascent transcript. In cells expressing FOK1, DSBs 
were visualized by FOK1 focal accumulation and transcription in these cells was monitored by YPF-MS2. Where 
indicated, ATMi was added 30m prior to doxycycline treatment. Y-axis indicates the fraction of YFP positive cells 
where 1=100%. The presence or absence of nascent transcripts was analysed in a minimum of 30 cells per condition 
and the data represent the mean and standard deviation of three independent experiments. b) Representative images 
of cells proficient and deficient in transcriptional silencing (determined by YFP-MS2 signal) is cis to DSBs 
(determined by FOKI signal) (adapted from (Shanbhag et al, 2010)). 
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Figure 6.4: The PBAF complex and its subunits are required for transcriptional silencing in cis to DSBs. 
Transcription reporter U2OS cells were treated with control, BRG1, BAF180 or combined BRG1 and BAF180 
(PBAF) siRNA. 48h later, the cells were transfected, or not, with the mCherry-FOK1 endonuclease. 24h later, 
doxycycline was added to the cells to drive transcription and the cells were harvested 4h later. The cells were then 
visualized on a fluorescent microscope. Doxycycline driven transcription was visualized as YFP-MS2 protein 
binding to MS2 nascent transcript. In cells expressing FOK1, DSBs were visualized by FOK1 focal accumulation and 
transcription in these cells was monitored by YPF-MS2. Where indicated, ATMi was added 30m prior to doxycycline 
treatment. Y-axis indicates the fraction of YFP positive cells where 1=100%. The presence or absence of nascent 
transcripts was analysed in a minimum of 30 cells per condition and the data represent the mean and standard 
deviation of three independent experiments. 
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function is required to silence transcription in cis to DSBs possibly by mediating 
chromatin compaction. Importantly, addition of ATMi to BAF180 depleted cells leads 
to a defect similar in magnitude to ATMi treated cells (Figure 6.4). 
BAF180 contains two BAH domains that appear to be important for the 
association of the PBAF complex with chromatin (Downs et al unpublished). However 
BAF180 is not the ATPase catalytic subunit of the complex. The ATPase catalytic 
subunits of the SWI/SNF complexes are either BRM or BRG1, but in SWI/SNF-b 
(PBAF) only BRG1 exists (Clapier & Cairns, 2009). To examine whether the ATP-
dependent chromatin remodelling activity of the PBAF complex is required for 
transcriptional silencing in cis to DSBs, I depleted BRG1 in the U20S reporter cells. As 
for BAF180, depletion of BRG1 did not lead to a reduction in doxycycline induced 
transcription of the reporter gene (Figure 6.4). However, following FOK1 induced 
DSBs there was impairment in transcriptional silencing in BRG1 depleted cells (Figure 
4). The observed defect was similar in magnitude to BAF180 depleted cells indicating 
that they function in the same pathway/complex (Figure 6.4). To confirm this I carried 
out joint BAF180, BRG1 depletion (PBAF) and monitored transcription after FOK1 
induced DSBs. As expected, the joint depletion of BAF180 and BRG1 did not lead to 
an additive defect indicating that they function in the same complex (Figure 6.4). 
Finally, addition of the ATMi to BAF180 depleted cells led to a defect similar in 
magnitude to ATMi treated cells (Figure 6.4). These results and the previous findings 
from the Downs and Jeggo laboratories, indicate that RSC – PBAF are important 
chromatin remodelling complexes in transcriptional regulation and the DDR. In the case 
of DSB associated transcriptional silencing, PBAF appears to play a pivotal role. The 
BAH domains of BAF180 appear to be important for the association of the complex 
with chromatin, while the ATPase activity of BRG1 is required for the chromatin 
remodelling leading to chromatin compaction.   
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6.2.4: The PBAF complex is required for efficient DSB repair in euchromatin. 
 
The results from figures 2-3 show that RNF8 is an important player in the cascade of 
events leading to transcriptional silencing is cis to DSBs via histone H2A 
ubiquitylation. In addition, loss of RNF8 leads to a DSB repair defect/delay at very 
early time points after IR specifically in transcriptionally active EU. I decided to test 
whether depletion of BAF180, BRG1 or both (PBAF) would also affect DSB repair at 
these early time points (Figure 6.5). Depletion of PBAF or either BAF180 or BRG1 led 
to a DSB repair defect at very early times post IR (Figure 6.5). This defect was 
observed as early as 10 minutes port IR and was most evident 20-40 minutes post IR. 
Importantly, the repair defect was identical in magnitude to that observed in RNF8 
depleted cells, consistent with the possibility that these factors function in the same 
pathway responding to DSBs at early times post IR (Figure 6.5). 
 
 
6.2.5: BAF180 is recruited to DSB containing laser tracks. 
 
Following the observation that depletion of BAF180 leads to a DSB repair defect/delay 
at very early times post IR, I decided to investigate whether BAF180 accumulates at 
DSBs and to test the kinetics of its focal accumulation. However, following treatment 
with IR and immunostaining with BAF180 antibodies no distinct foci were observed at 
DSB sites marked by !-H2AX. This is not uncommon, as other members of the DDR do 
not form IRIF. In the case of BAF180, the failure to form IRIF may be because not 
enough protein accumulates at DSBs or because it does not accumulate at all DSBs. 
Another method routinely used to assess the accumulation of a given factor tagged with 
a fluorescent protein to damaged chromatin is via laser induced chromatin damage 
(Kong et al, 2009).  
 The intact BAF180 cDNA was cloned into a GFP vector by a postdoc in the 
Jeggo laboratory (E. Riballo). I subsequently obtained the construct and transfected it 
into HEK293 cells. Following a 48h expression, the cells were incubated with Hoescht 
dye for 30 minutes before being micro irradiated with a 351 nm UVA laser. The laser 
was targeted so that a dose of 4.36 J/m2 was administered in a 0.1 µM wide track across 
the width of the nucleus. These conditions have previously been shown to generate 
DNA damage that includes DSBs along the laser track (Rulten et al, 2011). Only GFP-  
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Figure 6.5: The PBAF complex and its subunits are required for DSB repair at early times post IR. 
1BrhTERT cells were treated with control, BRG1, BAF180 or combined BRG1 and BAF180 (PBAF) siRNA and 
were irradiated with 1.5Gy IR. The cells were then harvested at the indicated time points and immunostained with 
CENP-F and !-H2AX antibodies. G1 phase cells were identified by negative CENP-F staining and the cell nuclei 
were visualized by DAPI. !-H2AX foci were enumerated specifically in CENP-F negative cells. !-H2AX foci were 
enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three independent 
experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!"
#"
$!"
$#"
%!"
%#"
&!"
&#"
!'" #'"" $!'" %!'" (!'" )!'"
!"
#$
%&
'(
)*+
&,
-&)
./
/&
0*1.&2(345&-67&,!89&:1*;<&
*+,"
,-./"
0123.$/!"
012,4$"
01523."
6"
!!
""%!
expressing cells were micro irradiated. The cells were then imaged at 15-second 
intervals for a total of three minutes. Strikingly, BAF180 was initially dispersed from 
the track but was then rapidly relocalised and concentrated along the path of the laser 
micro irradiation (Figure 6.6). BAF180-GFP was recruited to the laser track with very 
fast kinetics and a track was visible within a minute post damage induction in GFP 
expressing cells. Previous studies looking at DDR factor accumulation following DSB 
inducing laser micro irradiation have demonstrated that not all factors are accumulated 
with identical kinetics. There is an initial wave of recruitment that is initiated by the 
phosphorylation of H2AX and involves the recruitment of MDC1 and the MRN 
complex. This initial wave is very fast and the focal intensity of these factors peaks 
within a couple of minutes post damage induction. The second wave of recruitment 
depends upon the UBC13, RNF8 and RNF168 mediated ubiquitylation events at DSB 
sites (Strauss & Goldberg, 2011; Bekker-Jensen & Mailand, 2010). These modifications 
lead to the recruitment of BRCA1 and its phosphobinding partners as well as that of 
53BP1. There is a lag of approximately 1-2 minutes between the recruitment of the first 
and second wave of DDR factors at  DSBs. The data in Figure 6.6 indicate that BAF180 
is recruited to DSB sites with fast kinetics and is likely recruited upstream of the 
ubiquitylation events at DSBs. Consistent with this, the signal intensity of BAF180-
GFP along the laser induced damaged chromatin track peaked within 60s of damage 
induction (Figure 6.7).  
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Figure 6.6: BAF180 localises to UVA laser induced DNA damage regions. 
HEK293 cells were transfected with 1µg BAF180-GFP. 24h later the cells were 
preincubated with 10 µg/ml Hoechst 33258 at 37°C for 30m. Selected cells were then irradiated with a 351-nm UVA 
laser focused through a 40x/ 1.2-W objective using an LSM 510 Meta Zeiss Axiovert microscope. UVA (10.47 µJ) 
was targeted to a track of 2µm diameter that ran through the cell nucleus (approximately 0.35 µJ/µm2). Images of 
irradiated cells were taken at the indicated time points. 
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Figure 6.7: BAF180 localisation to UVA laser induced DNA damage regions reaches maximum intensity by 
60s post irradiation. 
HEK293 cells expressing BAF180-GFP were preincubated with 10 µg/ml Hoechst 33258 at 37°C for 30m and 
irradiated with a 351-nm UVA laser. Images of the irradiated cells were taken at 15s intervals up to 200s post 
irradiation. The Zeiss AIM software was then used to measure the signal intensity of BAF180-GFP along the laser 
track as well as in an unirradiated area. The background fluorescence level was subtracted from the measurement 
along the irradiated track. The increase in BAF180-GFP intensity along the laser track over time is shown here. 
Results indicate the mean and standard deviation of BAF180 signal intensity from a minimum of 30 cells imaged 
over three independent experiments. 
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6.2.6: BAF180 recruitment to DSB containing laser tracks does not depend on 
phosphorylation by ATM. 
 
Following the induction of DNA damage, ATM and ATR phosphorylate a myriad of 
factors thereby playing a key role in the coordination of the DDR (Matsuoka et al, 
2007). A single damage dependent phosphorylation site has been identified on BAF180 
(Matsuoka et al, 2007). However the function of phosphorylation of BAF180 on serine 
948 is currently unknown. In order to gain insight into the function of this modification, 
I performed site directed mutagenesis and mutated this site to either an Alanine (A) or a 
Glutamic acid (E). Mutation to Alanine leads to a non-phosphorylatable form of the 
protein while mutation to Glutamic acid acts as a phospho-mimic since phospho-Serine 
is structurally similar to Glutamic acid.  In Figure 6.8 the base pair and amino acid 
sequence in proximity to the BAF180 SQ phosphorylation site is shown. Additionally 
the mutational changes leading to the phospho-mutant and phosphor-mimic versions of 
BAF180 are shown. 
 The successful introduction of the described mutations was confirmed by 
sequencing and the constructs were then used in the UVA laser tracking experiments. 
The recruitment of BAF180 to the damaged DNA tracks was not affected by the 
mutation of S948 to either an Alanine or a Glutamic acid (Figure 6.9). These results 
indicate that the ATM dependent phosphorylation of BAF180 on S948 after DNA 
damage is dispensable for its accumulation at damage sites. The accumulation of 
BAF180 and subsequently PBAF to DNA damage sites might depend on the BAH 
domains of BAF180 which were recently shown to be required for BAF180 chromatin 
binding (Downs et al unpublished). Phosphorylation of BAF180 by ATM appears to be 
dispensable for its recruitment but this could be a result of currently unidentified 
phosphorylation sites on BAF180. In this case mutation of S948 would not be enough 
as phosphorylation of other sites could still target BAF180 to chromatin. Using ATMi 
treated cells would indicate whether the BAF180 phosphorylation is dispensable for its 
recruitment to DNA damage sites but possible redundancy between ATM and ATR 
would not allow for definitive conclusions. On the other hand, ATM function might be 
required for BAF180 function downstream of its recruitment to DNA damage sites. 
This phosphorylation could lead to conformational changes that regulate the 
nucleosome remodelling activity of the PBAF complex leading to chromatin 
compaction and the inhibition of transcription. 
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Figure 6.8: Production of BAF180 phosphomutant and phosphomimic constructs by site directed mutagenesis. 
The QuikChange® Multi Site-Directed Mutagenesis Kit was used to introduce the indicated mutations in the 
BAF180-GFP construct. Mutagenic primers were used to introduce these mutations and thus create BAF180-GFP 
phosphomutant (S to A) and phosphomimic (S to E) constructs following the manufacturers instructions. The 
successful introduction of the mutations was verified by sequencing. 
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Figure 6.9: BAF180 localisation to UVA laser induced DNA damage regions is not affected by mutating S948. 
HEK293 cells expressing phosphomutant (SèA) and phosphomimic (SèE) BAF180-GFP were preincubated with 10 
µg/ml Hoechst 33258 at 37°C for 30m and irradiated with a 351-nm UVA laser. Images of the irradiated cells were 
taken at 15s intervals up to 200s post irradiation. Neither mutation abrogated the ability of BAF180 to localize to 
laser irradiated tracks. 
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6.2.7: CHD7 is required is for efficient DSB repair in euchromatin. 
 
The proteomics study that identified BAF180 as an ATM phosphorylation target, also 
identified other chromatin remodelling factors. Amongst these was CHD7, a component 
of the 9 member CHD family of ATP-dependent chromatin remodelling enzymes 
(Matsuoka et al, 2007). The CHD family of chromatin remodellers are involved in 
transcriptional regulation and can both activate and repress the process via their 
chromodomains and their SNF-like ATPase domain (Marfella & Imbalzano, 2007). 
Recent studies have indicated that CHD7 plays an important role in embryonic 
development by controlling gene expression in embryonic stem cells (Bajpai et al, 
2010). Loss of CHD7 in mice is embryonic lethal, further demonstrating its importance 
in embryonic development (Janssen et al, 2012). On the other hand, heterozygous 
mutations in CHD7 lead to CHARGE (coloboma of the eye, heart defects, atresia of the 
choanae, retardation of growth and/or development, genital and/or urinary abnormalities 
and ear abnormalities and deafness) syndrome (Vissers et al, 2004).  
 As discussed previously, members of the CHD family of chromatin remodellers 
have been shown to function in the DDR (Polo et al, 2010; Larsen et al, 2010; Smeenk 
et al, 2010; Luijsterburg et al, 2012; Goodarzi et al, 2011). Interestingly, CHD3 has 
been shown to promote HC formation and is therefore inhibitory to repair of DSBs at 
HC regions, whereas CHD4 function was recently identified as a factor that enables 
DSB repair via chromatin decondensation (Goodarzi et al, 2011; Luijsterburg et al, 
2012). Since transcriptional silencing at DSB sites seems to require chromatin 
compaction, it is likely that these chromatin alterations necessitate the function of 
multiple chromatin remodelling factors. Interestingly, CHD7 has been shown to interact 
with PBAF in embryonic development where they control gene expression during 
neuronal crest formation (Bajpai et al, 2010). Given that PBAF is required for 
transcriptional silencing in cis to DSBs and given that CHD7 is phosphorylated by 
ATM on S2255 in response to DNA damage, I decided to investigate whether CHD7 is 
also required for DSB repair at early times post IR. 
  Following depletion of CHD7 by siRNA treatment, !-H2AX foci were 
enumerated in murine NIH3T3 cells  at early and late times post IR. Strikingly, 
depletion of CHD7 led to elevated numbers of !-H2AX foci at early times post IR with 
the most significant difference being observed at 30 minutes post IR (Figure 6.10). 
However, by one hour post IR the number of !-H2AX foci in CHD7 knockdown cells 
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was indistinguishable to that in control cells and no repair defect was observed at late 
time points (Figure 6.10). This phenotype mirrors that of BAF180 and RNF8 depleted 
cells at early time points indicating that CHD7 may also function in the same pathway. 
Distinct to the situation in RNF8 depleted cells however, no repair defect was observed 
at late time points indicating that CHD7 is dispensable for chromatin remodelling at HC 
DSBs. 
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Figure 6.10: The chromatin remodeller CHD7 is required for DSB repair at early times post IR. 
NIH3T3 cells were transfected with control and CHD7 siRNA and then allowed to enter G0 by contact inhibition 
(48h). The cells were then irradiated with 1.5Gy IR and harvested at the indicated time points. Fixed cells were then 
immunostained with a !-H2AX antibody and DAPI and imaged on a fluorescent microscope. !-H2AX foci were 
enumerated in 30 cells per time-point and the data represent the mean and standard deviation of three independent 
experiments. 
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6.2.8: CHD7 is required for transcriptional repression in cis to DNA DSBs. 
 
Following the finding that CHD7 knockdown leads to a DSB repair defect at early times 
post IR, I investigated whether this coincides with a defect in transcriptional silencing 
after DSB induction. To test this, I used the U2OS transcription reporter system and 
monitored nascent transcript formation in the presence and absence of FOK1 induced 
DSBs. The level of doxycycline driven transcription was not affected by CHD7 
knockdown as no reduction in nascent transcript levels compared to control cells was 
observed (Figure 6.11). Remarkably however, CHD7 knockdown lead to a defect in 
transcriptional silencing in cis to the FOK1 induced DSBs and nascent transcripts were 
observed in the majority of FOK1 transfected cells.  
 The defect in transcriptional silencing at DSB sites following CHD7 knockdown 
is identical in magnitude to that observed after PBAF knockdown (or either of its 
subunits). This finding raises the possibility that these chromatin remodellers function 
in the same pathway leading to transcriptional silencing following DSB induction. 
There are several lines of evidence supporting the notion that these factors are involved 
in the regulation of gene transcription via their chromatin remodelling activities 
(Murawska, 2011; Morrison & Shen, 2009; Clapier & Cairns, 2009). Moreover, a direct 
interaction between CHD7 and the PBAF complex has been demonstrated in neural 
crest cells. During the formation of the neural crest, CHD7 and PBAF function together 
to promote neural crest gene expression (Bajpai et al, 2010). Both these chromatin 
remodellers have been implicated in both the activation and repression of transcription 
but how this occurs mechanistically is currently unclear. 
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Figure 6.11: CHD7 as well as the PBAF complex are required for transcriptional silencing in cis to DSBs. 
Transcription reporter U2OS cells were treated with control, CHD7, BRG1, BAF180 or combined BRG1 and 
BAF180 (PBAF) siRNA. 48h later, the cells were transfected, or not, with the mCherry-FOK1 endonuclease. 24h 
later, doxycycline was added to the cells to drive transcription and the cells were harvested 4h later. The cells were 
then visualized on a fluorescent microscope. Doxycycline driven transcription was visualized as YFP-MS2 protein 
binding to MS2 nascent transcript. In cells expressing FOK1, DSBs were visualized by FOK1 focal accumulation and 
transcription in these cells was monitored by YPF-MS2. Where indicated, ATMi was added 30m prior to doxycycline 
treatment. Y-axis indicates the fraction of YFP positive cells where 1=100%. The presence or absence of nascent 
transcripts was analysed in a minimum of 30 cells per condition and the data represent the mean and standard 
deviation of three independent experiments. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
!"
!#$"
!#%"
!#&"
!#'"
!#("
!#)"
!#*"
!#+"
!#,"
$"
-./" -./"0"1.2$" -./"0"1.2$"0"3456"
789:;8<"
=6>?@$"
=6>31$+!"
=6A>31"
=67B-*"
C"
!!
"#&!
6.3: Discussion 
 
In recent years, an ever-expanding body of evidence has emerged indicating that 
chromatin remodelling plays an important role in the DDR (Misteli & Soutoglou, 2009). 
Work from our laboratory has primarily focused on DSB repair of lesions at HC 
regions. Published work and data presented in chapter 3 of this thesis demonstrate that 
DSBs that are repaired with slow kinetics following exposure to X or !- rays correspond 
to DSBs at HC. The accurate repair of these lesions requires ATM and the mediator 
proteins, which function in a pathway that culminates with the phosphorylation of KAP-
1. This modification leads to localised chromatin relaxation, which is essential for 
access to damaged chromatin. More recently prolonged KAP-1 phosphorylation was 
found to be required to maintain a relaxed chromatin state by inhibiting the 
heterochromatin building function of the chromatin remodeller, CHD3. The 
phosphorylation of KAP-1 is dispensable for DSB repair in EU and this is thought to be 
because the relatively relaxed conformation of EU does not pose a barrier to repair. 
 As part of the DDR, cells have evolved cell cycle checkpoints that delay the 
progression from one cell cycle to the next while repair is on-going. This is vital, as 
attempts to carry out processes such as DNA replication or cell division in presence of 
DNA damage could have devastating consequences for genomic integrity (Ulrich & 
Walden, 2010). However, there are also inter-phase metabolic processes that require 
access to DNA and chromatin remodelling that cannot be inhibited by cell cycle 
checkpoints. The process of transcription requires localised chromatin decondensation 
in order for the transcription machinery to access the required region of DNA. One 
model is that if a DSB arises in a transcriptionally active region, then transcription is 
inhibited in order to prevent erroneous repair. Recent work from the Greenberg 
laboratory demonstrated that this indeed the case (Shanbhag et al, 2010).  They found 
that transcription is silenced at least up to 13kb from a DSB site and that histone H2A 
ubiquitylation is necessary for this process. Strikingly, they demonstrated that ATM 
kinase activity is also required. However how ATM achieves this mechanistically is still 
unclear. 
 In this chapter I aimed to build on these findings and investigate how ATM 
kinase activity leads to transcriptional silencing in cis to DSBs. In addition, I assessed 
the role of the chromatin remodellers BAF180 and CHD7 since they are both ATM 
!!
"#'!
substrates. Finally, I investigated the impact of deficient transcriptional silencing on the 
overall fidelity of DSB repair. 
 The original publication investigating transcriptional silencing in cis to DSBs 
demonstrated that H2A ubiquitylation is required for this process (Shanbhag et al, 
2010). This modification is carried out by the ubiquitin ligases RNF8 and RNF168 and 
loss of these leads to deficient transcriptional silencing. In addition, ATM kinase 
activity is required for the maintenance of ubiquitin chains on histone H2A and for the 
inhibition of transcription associated chromatin decondensation. Here I wanted to ask 
whether loss of ATM activity leads to deficient DSB repair as a result of deficient 
transcriptional silencing. Previous work from our laboratory has demonstrated that loss 
of ATM leads to a DSB repair defect at late repairing DSBs that repair at early time 
points is normal. However, due to ATMs role in !-H2AX phosphorylation IRIF are 
smaller in ATMi treated cells at early times and comparison to control cells is difficult. 
To overcome this limitation, I tested the impact of RNF8 knockdown on DSB repair at 
very early time points. I reasoned that since RNF8 functions in the same pathway as 
ATM in transcriptional silencing, depletion of RNF8 would have the same impact on 
repair as the inhibition of ATM. RNF8 status does not impact on !-H2AX IRIF, thus 
allowing direct comparison to control cells. Interestingly, I observed that RNF8 
knockdown leads to a defect/delay in the repair of DSBs within the first hour post IR 
when only EU DSBs undergo repair (Figure 6.1-6.2). One interpretation of this result is 
that the defect in transcriptional silencing in cis to DSBs following RNF8 depletion 
(Figure 6.3) has a direct impact on DSB repair in EU. However, in light of recent 
findings indicating that RNF8 promotes chromatin decondensation at DSBs via its 
interaction with CHD4, it is also possible that the repair defect observed at early times 
post IR results from a failure to carry out this process (Luijsterburg et al, 2012). An 
interesting future experiment will be to use a transcription marker such as antibodies 
towards the 7- methylguanosine (m7G) cap structure present on nascent transcripts, to 
investigate whether the !-H2AX foci in RNF8 depleted cells colocalise with 
transcription sites.  
 Chromatin remodellers carry out changes in the organisation of chromatin to 
facilitate important cellular processes. In the case of transcription, chromatin 
decondensation is required to allow access to the transcription machinery. However in 
the presence of DNA damage, chromatin decondensation must be prevented so that 
transcription is not initiated in the presence of damage. ATM and RNF8 are clearly 
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required for this process but as neither protein is an ATP-dependent chromatin 
remodeller they cannot directly manipulate nucleosomes.  Here I have identified the 
PBAF chromatin-remodelling complex as a key component of the transcriptional 
silencing response in cis to DSBs.  I investigated the role of this complex since the 
homologous complex in yeast (RSC) has a direct role in both transcription and DSB 
repair. Moreover, RSC is able to manipulate the position of nucleosomes in the vicinity 
of DSBs via its chromatin remodelling activity. Finally, the PBAF complex seemed a 
good candidate since the BAF180 subunit had previously been identified as an ATM 
DNA damage dependent phosphorylation substrate. 
Depletion of PBAF or either of its subunits (BRG1, BAF180), led to deficient 
transcriptional silencing following DSB induction (Figure 6.4). This result strongly 
suggests that PBAF is the chromatin-remodelling complex, or one of them, carrying out 
the chromatin changes leading to transcriptional repression after DSB induction. 
Moreover, depletion of BRG1 or BAF180 also led to a DSB repair defect in early 
repairing DSBs supporting the notion that DSBs at transcriptionally active regions are 
rapidly repaired (Figure 6.5). Importantly, the repair defect of PBAF knockdown cells at 
early time points was similar in magnitude to RNF8 knockdown cells. These results 
indicate that PBAF functions in the same pathway as ATM and RNF8 leading to 
transcriptional repression in cis to DSBs. 
 Several studies have investigated the recruitment of DDR factors to DNA 
damage sites as the recruitment kinetics of a particular factor can provide clues as to its 
position in the cascade of events. For example the recruitment of MDC1 and 
RNF8/RNF168 to DSBs are dependent on ATM phosphorylation events and are 
recruited with faster kinetics than 53BP1 and BRCA1 which are recruited by 
ubiquitylation events (Bekker-Jensen & Mailand, 2010). In order to gain insight into 
where PBAF functions in the cascade of events leading to transcriptional silencing, I 
monitored its recruitment to laser damaged chromatin (Figures 6.6-6.7). When BAF180-
GFP was expressed in cells that were exposed to laser micro irradiation, it initially 
dispersed from the irradiated region but then quickly returned and accumulated along 
the DNA damaged track (Figures 6.6-6.7). Interestingly, BAF180-GFP was recruited 
with fast kinetics and reached maximum intensity along the damaged region within 60s. 
This result is consistent with the notion that BAF180 might be remodelling chromatin 
into a configuration favourable for the RNF8/RNF168 ubiquitylation events leading to 
transcriptional silencing.  
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 ATM phosphorylates BAF180 on S948 in a DNA damage dependent manner. 
To assess the significance of this phosphorylation event on the recruitment of BAF180 
to DNA damage sites, I mutated this residue to either and Alanine or a Glutamic acid 
thus creating a phosphomutant and phosphomimic version of the protein. However 
these mutations did not effect the recruitment of BAF180 and normal recruitment was 
seen in both cases (Figure 6.9). This result indicates that this modification is 
dispensable for BAF180 recruitment to damaged chromatin. Treating BAF180-GFP 
expressing cells with ATMi and repeating these tracking experiments might be 
informative but redundancy amongst ATM, ATR and DNA-PK in phosphorylating 
downstream targets can make interpretation difficult. A recent study from the Downs 
laboratory demonstrated that BAF180 chromatin binding is compromised in vivo when 
its two BAH domains are mutated. It will be interesting to see whether these mutations 
will also abrogate the ability of BAF180 to accumulate at DNA damage tracks.  
If the phosphorylation of BAF180 by ATM proves to be dispensable for its 
recruitment to DNA damage sites, then this modification might regulate its function 
downstream of its recruitment. Future experiments using the phosphomimic and 
phosphomutant BAF180 constructs will address these questions by monitoring 
transcriptional silencing and DSB repair. These experiments entail depleting 
endogenous BAF180 by siRNA treatment and then reconstituting with siRNA resistant 
versions of the BAF180 phosphomimic and phosphomutant constructs. If these 
endpoints are affected by these mutations then the phosphorylation of BAF180 might be 
required to regulate its function downstream of its recruitment to DSBs. These 
endpoints must also be investigated in cells expressing the mutated BAH domain 
version of BAF810. 
Overall, these findings support the notion that RNF8 and PBAF function in the 
ATM pathway leading to transcriptional silencing in cis to DSBs. Moreover, I provide 
evidence showing that defective inhibition of transcription via RNF8 or PBAF depletion 
leads to a DSB repair defect affecting breaks in EU. However it is not yet clear how 
these factors co-operate in this process and where they are positioned in the cascade of 
events. A recent study looking at the role the SWI/SNF complexes in DSB repair, 
described a role for p400 in promoting RNF8 dependent histone ubiquitylation (Xu et 
al, 2010). Interestingly, in this study the authors demonstrated that p400 functions 
upstream of RNF8 in the DDR and destabilises nucleosomes (Xu et al, 2010). This 
destabilisation was shown to be a pre-requisite for RNF8 dependent histone H2A 
!!
"$+!
ubiquitylation and the subsequent recruitment of 53BP1 and BRCA1. Similarly, a 
separate study demonstrated that CHD4 directly interacts with RNF8 and via its ATPase 
activity promotes RNF8 catalysed histone ubiquitylation leading to chromatin 
decondensation (Luijsterburg et al, 2012). BRG1, like p400 and CHD4 is a chromatin 
remodeller with ATPase activity. It is therefore possible that BRG1 like p400 and 
CHD4, acts upstream of RNF8 to remodel nucleosomes into a confirmation that is 
favourable for histone H2A ubiquitylation and the associated transcriptional silencing. 
Conversely, PBAF might function downstream of RNF8 to directly mediate 
transcriptional silencing via nucleosome compaction. Deciphering how RNF8 and 
PBAF co-operate in the ATM dependent transcriptional silencing pathway in response 
to DSBs is an important future question.  
CHD7 is a member of the CHD family of chromatin remodellers that are 
involved in transcriptional regulation (Murawska, 2011). In addition, CHD7 has been 
shown to interact with PBAF during neural crest development where they control gene 
expression. CHD7 has not been reported to play a role in the DDR but ATM 
phosphorylates it on S2255 in response to DNA damage. Given this, I investigated the 
role of CHD7 in transcriptional silencing in cis to DSBs but also in DSB repair. 
Surprisingly, depletion of CHD7 led to a delay in the repair of DSBs at very early times 
post IR and similar to the situation following PBAF or RNF8 depletion this could only 
be detected up to 60m post IR (Figure 6.10). This result indicates that CHD7 might play 
a role in transcriptional silencing following DNA damage. Importantly, no repair defect 
was observed at late time points indicating that CHD7 is dispensable for HC DBS 
repair.  
 CHD7 siRNA treatment led to defective transcriptional silencing in cis to DSBs 
(Figure 6.11). This defect was similar in magnitude to that seen following PBAF 
depletion indicating that these chromatin remodellers function in the same pathway.  
CHD7 localises to genomic regions enriched for H3K4me3 that are associated with the 
up-regulation of transcription (Schnetz et al, 2009). Interestingly in yeast, H3K4me3 
has been demonstrated to be required for a proficient response to DSBs (Faucher & 
Wellinger, 2010). Moreover, RSC was shown to be required for this modification via its 
role in the recruitment of Set1p, the H3 specific mehtyltransferase responsible for 
H3K4me3 (Faucher & Wellinger, 2010). Genomic regions with high levels of 
H3K4me3 are described as transcriptionally active where as regions that are 
permanently silenced, such as HC, are enriched for H3K9 (Seiler et al, 2011). 
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Surprisingly in yeast, the ‘pro-transcriptional’ modification of H3K4me3 is enriched at 
DSBs and required for efficient repair by NHEJ. On the other hand, the ‘anti-
transcriptional modification’ of H2B ubiquitylation is also enriched at DSBs indicating 
that a balancing act takes place. Consistent with this notion, RNF8 has been shown to 
promote both chromatin decondensation and compaction via histone ubiquitylation 
(Shanbhag et al, 2010; Luijsterburg et al, 2012). It appears that a delicate equilibrium 
needs to be achieved whereby chromatin is sufficiently relaxed to facilitate repair and 
sufficiently compact to inhibit transcription.  
 It is thought that CHD7 functions in transcriptional regulation although how this 
is achieved is unclear. CHD7 is able to bind to H3K4me2/3 in vitro via its 
chromodomains (Schnetz et al, 2009). This histone modification is frequently found at 
enhancer sequences that regulate the expression of specific genes. CHD7 was found to 
directly bind to these enhancer regions via its interaction with H3K4 and this directly 
impacted on the transcription of the associated genes (Schnetz et al, 2009). There is 
therefore ample evidence indicating that CHD7 is required for transcriptional regulation 
and this appears to be important also in regions in cis to DSBs.  
 The data showing that CHD7 directly interacts with enhancers via H3K4 
binding suggest that CHD7 is a ‘pro-transcriptional’ factor. Following the observation 
that transcription in not efficiently silenced in the absence of CHD7, I postulated that 
this might be a result of defective loss of pro-transcriptional histone modifications. 
Indeed, a recent study demonstrated that DSB induced transcriptional silencing is 
associated with loss of H3K4me3. This group used a microscopy based approach and 
reported that H3K4me3 is lost from !-H2AX sites and that this loss depends on the 
function of the JARID1A demethylase (Seiler et al, 2011). An important future question 
is whether ATM and CHD7 are also required for these histone modifications in cis to 
DSBs and whether ATM regulates CHD7 function. It is becoming evident that post-
translational modifications such as ubiquitylation and methylation play a key role in the 
regulation of transcription in cis to DSBs. ATM and the chromatin remodellers CHD7 
and BAF180 play an important role in this process but their detailed functions are yet to 
be determined. 
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7   Discussion 
 
 
7.1: Chapter 3: Investigating the role of the mediator proteins in HR 
 
7.1.1: Major conclusions from Chapter 3 
 
 
• DSBs induced by !-radiation G2 phase co-localise with pKAP1 foci and are 
repaired by HR.  
 
• The mediator proteins 53BP1, MDC1 and H2AX promote the repair of these 
DSBs by enabling chromatin relaxation through KAP1 phosphorylation. 
 
• In addition to mediating pKAP1 formation, MDC1 function is required for 
Rad51 foci formation in G2 phase. 
 
• The role of 53BP1 in G2 phase HR, but not that of MDC1, can be overcome via 
KAP1 depletion. 
 
• CtIP is required for resection in S-phase following CPT treatment but the 
mediator proteins are dispensable. 
 
Previous work from our laboratory, demonstrated that in G1 phase cells, DSBs repaired 
with slow kinetics following exposure to X or !-radiation are those located at HC 
regions (Noon et al, 2010). In order for such lesions to be repaired, ATM, Artemis and 
the mediator proteins are required to remodel chromatin into a relaxed configuration 
through robust localised KAP1 phosphorylation (Noon et al, 2010). Subsequent 
experiments revealed that the slow component of repair in G2 phase cells also requires 
ATM and Artemis for efficient repair but that these DBSs are repaired by HR (Beucher 
et al, 2009). 
In chapter 3, I demonstrated that DSBs that are repaired with slow kinetics in G2 phase, 
undergo resection and co-localise with pKAP1 IRIF (Figure 3.1). Moreover, I showed 
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that pATM and 53BP1 IRIF overlap with pKAP1 IRIF suggesting that as in G1, they 
are required for pKAP1 IRIF also in G2 phase (Figure 3.1). Since pKAP1 IRIF are 
thought to depict HC regions, I propose that slowly repaired DSBs in G2 are located at 
HC regions and are repaired by HR (Noon et al, 2010). In support of this model, when I 
inhibited NHEJ by depleting Ku80 and DNA-PKcs, I observed more RPA and Rad51 
foci as well as more SCEs compared to control cells indicating that HR was repairing a 
greater fraction of DSBs (Figure 3.2). Importantly, under these conditions there was a 
reduction in the fraction of RPA foci that co-localised with pKAP1 foci indicating that 
resection of DSBs in EU was taking place in contrast to control cells where resection is 
limited to pKAP1 enriched regions.   
 Following the observation that 53BP1 foci co-localise with pATM, pKAP1, and 
RPA IRIF in G2 phase, I investigated whether the mediator proteins are required for G2 
phase DSB repair (Figure 3.3). I observed a requirement for 53BP1, MDC1 and H2AX 
in the repair of a subset of induced DSBs in G2 phase cells (Figure 3.3). The repair 
defect following the depletion of these proteins affected the slow component of repair 
and was epistatic to ATMi treated cells indicating that these proteins are required for 
efficient HR repair in G2 phase (Figure 3.3). I verified this by showing that RPA and 
Rad51 foci formation are partially defective following depletion of these proteins, while 
IR induced SCEs are completely abolished indicating deficient HR in the absence of 
these factors (Figures 3.4-3.6). 
 The requirement of 53BP1 in G2 phase DSB repair was overcome by KAP1 
depletion as was its requirement for RPA IRIF, Rad51 IRIF and SCEs. This finding 
indicates that in G2 phase, 53BP1 promotes HR via pKAP1 mediated HC relaxation but 
does not have a direct role in the HR process. In support of this conclusion, 53BP1 is 
dispensable for resection in EU as well as for resection in S-phase cells following 
exposure to CPT, where chromatin structure is believed to be less inhibitory to repair 
(Figure 3.10 and 3.16). 53BP1 has previously been portrayed as a pro-NHEJ factor 
while recent studies have indicated that it actively inhibits resection and therefore HR 
(Xie et al, 2007; Bunting et al, 2010; Bouwman et al, 2010). In contrast to these 
findings, my results indicate that 53BP1 function is required for HR specifically in G2 
phase cells and that as in G1, it mediates repair via localised KAP1 phosphorylation. 
 In contrast to 53BP1, the requirement for MDC1 in G2 phase HR goes beyond 
mediating KAP1 phosphorylation and thus cannot be overcome by KAP1 depletion 
(Figure 3.7). By monitoring different HR intermediates I observed that MDC1 is 
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dispensable for resection (RPA foci) but required for Rad51 loading (Rad51 foci) when 
KAP1 is depleted (Figures 3.8-3.9). Consistent with MDC1 playing a direct role in 
Rad51 loading, MDC1 depletion perturbs Rad51 foci in EU as well as in S-phase 
following CPT treatment (Figure 11 and Lobrich et al unpublished). It is not currently 
clear how MDC1 enables Rad51 loading. There is evidence that MDC1 directly 
interacts with Rad51 and that this interaction is required for HR through the retention of 
Rad51 in chromatin (Zhang et al, 2005). Another possibility is that MDC1 mediates 
Rad51 loading via the recruitment of downstream factors such as Rad18 that has been 
shown to be required for Rad51 loading through its interaction with Rad51c (Huang et 
al, 2009). Future experiments are required to determine the exact role of MDC1 in 
Rad51 filament formation during HR in both the S and G2 phases. 
 ATM and CtIP have previously been shown to be required for the initiation of 
resection in G2 phase (Shibata et al, 2011). In this chapter, using a flow cytometry 
approach, I investigated the requirement of ATM, CtIP and the mediator proteins in 
RPA retention in S-phase cells following CPT treatment (Figure 3.16). Although no 
RPA foci are observed in ATMi treated G2 phase cells following IR, ATMi treated S-
phase cells showed normal RPA retention after CPT treatment (Figure 3.16). In 
contrast, CtIP depletion led to a significant reduction in RPA retention in S-phase cells 
following CPT treatment. These results indicate that CtIP is required for resection in 
both the S and G2 phases, but that its phosphorylation by ATM is only required for 
resection in G2 phase (Li et al, 2000). I propose that the phosphorylation of CtIP by 
ATM functions to target CtIP to DSBs where it functions in the initiation of resection. 
Consistent with this, ATMi treated cells or cells expressing phosho-mutant CtIP fail to 
form CtIP foci in G2 phase following IR (Shibata et al, 2011). In S-phase, when a 
replication fork stall/collapses, ssDNA forms that becomes coated by RPA and leads to 
ATR activation (Shechter et al, 2004). It is possible that ssDNA at these regions leads 
to the recruitment of CtIP independently of ATM, where it then functions in the 
elongation of ssDNA. It is also possible that another kinase such as ATR or DNA-PK 
can redundantly phosphorylate CtIP following its recruitment to stalled/collapsed 
replication forks. To gain insight into this process, I inhibited the function of ATM, 
ATR and DNA-PK individually and in conjunction (Figure 3.15). By using a 
combination of inhibitors and caffeine, I observed that while inhibition of ATM or 
DNA-PK alone does not impact on RPA retention after CPT, combined inhibitor 
treatment led to a reduction in RPA retention that became greater still by the addition of 
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caffeine to inhibit ATR (Figure 3.15). These findings indicate that the PIKK kinases 
ATM, DNA-PK and ATR are required for ssDNA formation during HR repair/recovery 
of stalled/collapsed replication forks. Further experiments are required to address how 
they regulate this process. Monitoring CtIP foci in S-phase cells following CPT 
treatment can provide insight into whether they regulate the process via CtIP 
recruitment. It is possible that they are dispensable for CtIP recruitment but that their 
function is required for the recruitment of other factors important for this process, as has 
previously been shown for MRE11 (Trenz et al, 2006). Although further work is needed 
to elucidate how resection is controlled in S-phase, the mediator proteins 53BP1, MDC1 
and H2AX appear to be dispensable for this process since RPA retention after CPT is 
not affected by their depletion (Figure 3.16). 
   One-ended DSBs arising from collapsed replication forks are preferentially 
repaired by HR and lead to replication fork restoration (Roseaulin et al, 2008; Hanada et 
al, 2007; Helleday et al, 2007). It is thought that NHEJ can not accurately repair these 
lesions as they are one-ended and cannot be repaired in the same way as two-ended 
DSBs in the G1 and G2 phases (Helleday et al, 2007). One model is that the sensitivity 
of HR and FA mutant cells to S-phase induced DNA damage, is due to erroneous repair 
of one-ended DSBs by NHEJ resulting in ligation to distant one-ended DSBs and 
therefore genomic rearrangements (D'Andrea & Grompe, 2003; Helleday et al, 2007). 
There is evidence from several metabolic processes that 53BP1 function is required for 
long-range re-joining events (Difilippantonio et al, 2008; Dimitrova et al, 2008; 
Bothmer et al, 2011). In this chapter I attempted to assess whether long-range re-joining 
events could be observed in BRCA1 depleted cells exposed to MMS. To achieve this I 
used a construct containing a 53BP1 fragment required for its focal accumulation fused 
to an mCherry fluorescent tag (Dimitrova et al, 2008). MMS treatment led to DSBs 
specifically in S-phase cells, and the mCherry-BP1 construct localised to these regions 
(Figure 3.18). However, under these experimental conditions, BRCA1 depletion did not 
lead to an increase in long-range fusion events or to an increase in the mobility of the 
mCherry-BP1 IRIF as assessed by LCI. Caution must be taken when interpreting these 
findings as further validation and analysis of this experimental system is required.  
 Aberrant repair of one-ended DSBs arising from DNA damage in S-phase, is an 
attractive model for the genomic instability of BRCA and FA mutant cells. Moreover, if 
re-joining of distant one-ended DSBs does take place it will be interesting to address 
whether 53BP1 is required for this process. Recent studies in which the HR defect of 
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BRCA1 deficient cells is overcome by 53BP1 depletion indicate that 53BP1 blocks HR 
by inhibiting resection and that BRCA1 function is required to overcome this (Bunting 
et al, 2010; Bouwman et al, 2010). It is therefore possible that 53BP1 inhibits HR and 
promotes erroneous NHEJ in S-phase in BRCA1 deficient cells, thus contributing to the 
genomic instability of these cells.  
 
 
 
7.2: Chapter 4: The role of ubiquitin signalling in Homologous Recombination 
 
 
7.2.1: Major conclusions from Chapter 4 
 
 
• RIDDLE patient cells are defective in G2 phase HR. 
 
• RNF8 and RNF168 have distinct roles in G2 phase HR. 
 
• Proteasome inhibition affects G2 phase resection. 
 
• RNF8/RNF168 depletion or proteasome inhibition does not affect S-phase 
resection. 
 
• BRCA1 is required for G2 phase HR. 
 
• The BRCT domain but not the RING domain of BRCA1 is required for G2 
phase HR. 
 
 
In chapter 4, I investigated the role of ubiquitin signalling in HR. By using cultured 
fibroblasts isolated from a RIDDLE syndrome patient, I demonstrated that RNF168 is 
required for DSB repair also in G2 phase (Figure 4.1) (Stewart et al, 2007; 2009). The 
repair defect in G2 phase affected DSBs repaired with slow kinetics, which in chapter 3, 
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I demonstrated represent DSBs that are repaired by HR. Consistent with this, using 
RIDDLE patient cells I observed an RPA and Rad51 foci formation defect in G2 phase, 
indicating that RNF168 is required for efficient repair by HR (Figure 4.1). In G1, 
RNF168 mediates the repair of DSBs located at HC regions by ubiquitylating 
downstream targets leading to 53BP1 recruitment and subsequently the localised KAP1 
phosphorylation necessary for repair (Noon et al, 2010). Similarly in G2, when KAP1 
was depleted in RIDDLE cells, I observed normal RPA and Rad51 foci formation as 
well as normal !-H2AX foci clearance (Figure 4.2). In summary, RNF168 mediates HR 
in G2 by promoting KAP1 dependent HC relaxation but has no direct role in the HR 
pathway. 
 The amplification of ubiquitin signals at DSBs that are required for 53BP1 and 
BRCA1 retention are carried out by RNF168, but the initial ubiquitin modification of 
histones at DSBs is carried out by RNF8 (Mailand et al, 2007; Doil et al, 2009). In G1, 
RNF8 is required for 53BP1 recruitment and therefore for HC DSB repair by mediating 
HC relaxation via KAP1 phosphorylation (Noon et al, 2010). Here, I have demonstrated 
that RNF8 is also required for HC DSB repair in G2 phase, but that in G2 the 
requirement for RNF8 cannot be overcome by KAP1 depletion (Figure 4.3). Moreover, 
I demonstrated that RNF8 depletion leads to a severe defect in RPA and Rad51 foci 
formation thus revealing an important role for RNF8 in these processes (Figure 4.3). To 
investigate whether ubiquitin signalling is required for HR, I used the proteasome 
inhibitor epoxomicin and observed deficient RPA foci formation in G2 (Figure 4.8). 
Importantly, neither RNF8 knockdown nor epoxomicin treatment affected RPA 
retention in S-phase cells after CPT treatment, indicating that ubiquitin signalling is 
dispensable for resection in S-phase (Figure 4.8).  
  In summary, my data demonstrate a requirement for ubiquitin signalling in 
resection and Rad51 loading during DSB repair by HR in G2 phase. Surprisingly, there 
is a differential requirement between RNF8 and RNF168 for the formation of these HR 
intermediates. Whereas the role of RNF168 can be overcome by KAP1 depletion, that 
of RNF8 cannot (Figures 4.2-4.3). How RNF8 promotes resection is unclear but its 
ubiquitin ligase function is likely to be required. Two independent studies have 
demonstrated that RNF8 but not RNF168 is required for the formation of K48 linked 
ubiquitin chain IRIF at DSB sites and for the accumulation of these ubiquitin conjugates 
at laser induced DNA damage tracks (Feng & Chen, 2012; Meerang et al, 2011). The 
formation of K48 linked ubiquitin chains on a target substrate target it for degradation 
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by the 26S proteasome. (Ramadan & Meerang, 2011). RNF8 was recently shown to 
target Ku80 for proteasomal degradation through K48 ubiquitylation (Feng & Chen, 
2012). The removal of factors modified by K48 linked ubiquitin chains from DSB sites 
by the proteasome appears to be important for 53BP1, BRCA1 and Rad51 recruitment 
(Meerang et al, 2011; Mallette & Richard, 2012). Consistent with the notion that the 
formation of K48 linked ubiquitin chains are important for HR, the depletion of RNF8 
but not RNF168 supresses HR also when measured by a GFP-reporter assay, supporting 
the data from this chapter depicting distinct roles for RNF8 and RNF168 in HR 
(Ramadan & Meerang, 2011). Based on these findings and my data from this chapter, I 
propose a model whereby RNF8 promotes resection in G2 phase HR by ubiquitylating 
downstream targets and regulating the formation of K48 ubiquitin chains. RNF168 is 
dispensable for this process but is required for the amplification of K63 linked ubiquitin 
modifications that are required for 53BP1 recruitment/retention and therefore localised 
KAP1 phosphorylation. 
 BRCA1 is another ubiquitin ligase that has been implicated in HR (Moynahan et 
al, 1999; Schlegel et al, 2006). However there is conflicting evidence as to whether the 
ubiquitin ligase activity of BRCA1 is required for its role in HR. It was previously 
suggested that BRCA1 ubiquitylates its binding partner CtIP and that this is required for 
the association of CtIP with chromatin and therefore for ssDNA formation (Yu et al, 
2006). However, another study indicated that the ubiquitin ligase activity of BRCA1 is 
dispensable for HR (Reid et al, 2008). A more recent study supported the notion that 
BRCA1 E3 ligase activity is dispensable for HR and went on to show that it is also 
dispensable for the tumour suppressor function of BRCA1 (Shakya et al, 2011; 
Greenberg, 2011). Here, I demonstrate that BRCA1 activity is required for slowly 
repaired DSBs in G2 and that its requirement cannot be overcome by KAP1 depletion 
(Figure 4.9). Moreover, I showed that BRCA1 depletion also leads to an RPA and 
Rad51 foci formation defect in G2 that cannot be overcome by KAP1 depletion (Figure 
4.9). Finally, I demonstrated the E3 ubiquitin ligase activity of BRCA1 is dispensable 
for G2 phase HR whereas it BRCT domain is required. Deciphering how BRCA1 
facilitates these processes was the main focus of my work in chapter 5. 
 
7.3: Chapter 5: BRCA1 repositions 53BP1 during homologous recombination in 
G2 to enable resection at heterochromatin 
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7.3.1 Major conclusions from Chapter 5 
 
 
• BRCA1 is required for HR at HC-DSBs in G2 but is dispensable for HC 
relaxation. 
 
• BRCA1 functions in HR downstream of CtIP/MRE11 in resection. 
 
• 53BP1 depletion rescues the HR defect of BRCA1 knockdown cells in G2. 
 
• 53BP1 pATM and ubiquitin chains undergo BRCA1 dependent repositioning in 
G2. 
 
• The BRCT but not the RING domain of BRCA1 is required for 53BP1 
repositioning during HR. 
 
• The deubiquitinating enzyme POH1 is required for resection and 53BP1 
dissociation from chromatin in G2. 
 
 
In chapter 4, I demonstrated that BRCA1 is required for RPA and Rad51 foci formation 
in G2 phase cells following IR treatment. In this chapter, I aimed to gain insight into the 
role of BRCA1 in these processes. First, I tested whether BRCA1 depletion affects !-
H2AX foci clearance following IR in G1 and G2 (Figure 5.1). Consistent with previous 
studies and my data showing a role for BRCA1 in HR, I observed a DSB repair defect 
in late repairing DSBs in G2. Importantly, no repair defect was observed in G1 phase 
cells indicating that BRCA1 is dispensable for NHEJ but also for KAP1 mediated HC 
relaxation. I confirmed this by showing that BRCA1 is dispensable for pKAP1 foci 
formation, indicating a distinct role to the mediator proteins in HR (Figure 5.2). 
 Previous work from out laboratory has demonstrated that CtIP is required for the 
initiation of resection and commitment to repair by HR (Shibata et al, 2011). In 
addition, the nuclease activity of MRE11 is also required for the initiation of resection 
and is thought to achieve this by removing Ku from DNA ends (Mimitou & Symington, 
2011). In the absence of either of these factors, resection fails to initiate and repair by 
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HR cannot ensue. Interestingly, when cells fail to initiate resection they can return to 
NHEJ and repair the lesions via this pathway and no DSB repair defect is observed 
(Figures 5.3-5.4). Here, I demonstrate that BRCA1 functions in a DNA resection step 
that is downstream of the CtIP/MRE11 dependent initiation of resection. Consequently, 
when BRCA1 is depleted HR cannot progress, and since resection is initiated, NHEJ 
can no longer repair the lesions thus leading to a DSB repair defect (Figure 5.3). The 
notion that BRCA1 functions downstream of CtIP and MRE11 in resection is supported 
by the fact that CtIP or MRE11 depletion can rescue the repair defect of BRCA1 
depleted cells (Figure 5.3-5.4). Under these conditions, resection fails to initiate and 
repair ensues by NHEJ thus making BRCA1 function dispensable (Figures 5.3-5.5).  
 Recent studies have indicated that BRCA1 functions in HR to overcome an 
inhibitory barrier posed by 53BP1 on DNA resection (Bunting et al, 2010; Bouwman et 
al, 2010). However, my data from chapter 3, suggest that in G2 phase HR, 53BP1 does 
not inhibit HR but rather facilitates the process by mediating the KAP1 dependent 
chromatin relaxation required for HR repair of DSBs at HC regions. Here I asked 
whether 53BP1 depletion could rescue the requirement for BRCA1 in HR also in G2 
phase. Surprisingly, I observed that when KAP1 is depleted, thus making 53BP1 
dispensable for HR, depletion of 53BP1 did rescue the HR defect of BRCA1 depleted 
cells (Figure 5.6). These results indicate that 53BP1 has dual roles in G2 phase HR. It 
promotes HR by mediating KAP1 phosphorylation but it also inhibits HR by blocking 
the initiation of resection.  
 A recent study demonstrated that RNF169 antagonises the recruitment of 53BP1 
and BRCA1 to DSBs by binding to ubiquitylated histones (Poulsen et al, 2012). One 
possibility is that by delaying the recruitment of 53BP1 to DSBs, RNF169 promotes the 
CtIP/MRE11 dependent initiation of resection. Once 53BP1 is recruited, BRCA1 is then 
required to promote the elongation step of resection by overcoming the inhibitory role 
of 53BP1 on this process. It is currently unclear how BRCA1 achieves this. In this 
chapter, I observed that 53BP1 becomes repositioned in G2 phase in a BRCA1 
dependent manner (Figure 5.8). Moreover, using enhanced resolution microscopy and 
3D modelling, I observed that 53BP1 disassociates from chromatin in the IRIF core, 
leading to an inner region devoid of 53BP1 (Figure 5.9). Importantly, I demonstrated 
that BRCA1 forms IRIF internally to 53BP1 and is required for the formation of this 
region devoid of 53BP1 where RPA foci form (Figure 5.10 and 5.15). One 
interpretation of these findings is that BRCA1 overcomes the inhibitory function of 
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53BP1 on resection by repositioning 53BP1 away from the DSB ends and by promoting 
its dissociation from chromatin regions where resection takes place.  
 Histone H2A ubiquitylation is required for the recruitment of 53BP1 to DSB 
sites (Huen et al, 2007; Mailand et al, 2007; Doil et al, 2009). Given this, I investigated 
whether 53BP1 repositioning coincided with the repositioning of FK2 IRIF, which 
depict ubiquitin chains. I observed that FK2 IRIF become repositioned in a BRCA1 
dependent manner and that they strongly co-localise with 53BP1 foci up to 8 hours post 
IR (Figures 5.13-5.15). Moreover, pATM foci also become repositioned and strongly 
co-localise with 53BP1 foci, consistent with the role of 53BP1 in tethering activated 
ATM at DSBs to maintain chromatin relaxation via pKAP1 (Figures 5.14-5.15) (Noon 
et al, 2010). These results suggest that on-going ubiquitylation events away from the 
DSB ends might be driving the repositioning of 53BP1. Since BRCA1 is required for 
this process, I tested whether its ubiquitin ligase activity is required to reposition 
53BP1. However, MEFs expressing ubiquitin ligase mutant BRCA1 indicated that this 
isn’t the case since 53BP1 is repositioned normally in these cells following IR treatment  
(Figure 5.16).  
 Since the BRCT domain of BRCA1 is required for its tumour suppressor 
function and for efficient RPA foci formation (Figure 3.9), I tested whether it is 
required for 53BP1 repositioning (Shakya et al, 2011). Using MEFs with mutated 
BRCT domains, I demonstrated that the BRCT domain of BRCA1 is required for 
53BP1 repositioning in G2 (Figure 5.16). BRCA1 forms several complexes via its 
BRCT domains, with varying roles in the DDR (Huen et al, 2009). To test whether 
BRCA1 repositions 53BP1 via its BRCT binding partners, I monitored 53BP1 foci 
volume in G2 following depletion of BACH1, BRCC36 or RAP80 but observed normal 
53BP1 volume expansion (Figure 5.17).  
 The expansion of 53BP1 away from DSB ends is likely to be driven by on-going 
histone ubiquitylation but 53BP1 also needs to disassociate from the inner region of the 
IRIF to allow resection to. I reasoned that this might require the function of a DUB 
since a hollow core also forms in FK2 IRIF suggesting that DUBing takes place (Figure 
5.15). I first tested whether BRCC36 is required for this since it possesses DUB 
enzymatic activity and is a member of the BRCA1a complex (Diagram 5.1). However, 
BRCC36 did not impact on 53BP1 repositioning or disassociation from chromatin while 
depletion of BRCC36 has been shown to lead to more resection rather than less (Figure 
5.17) (Hu et al, 2011). 
!!
"%#!
 The DUB enzyme, POH1, is a component of the 19S subunit of the proteasome, 
but recent findings indicate it also functions in the DDR (Morris et al unpublished). I 
tested whether POH1 is required for 53BP1 disassociation from chromatin and therefore 
for resection. Strikingly, POH1 depletion led to a severe RPA and Rad51 foci formation 
defect and a failure to form a hollow core in 53BP1 IRIF despite normal IRIF expansion 
(Figure 5.18). Moreover, POH1 depleted cells failed to form a hollow core in FK2 IRIF 
indicating that POH1 is required for this process. One interpretation of these results is 
that the DUB activity of POH1 is required to remove ubiquitin modifications from DSB 
ends thus leading to the disassociation of 53BP1, which is required for resection. In 
support of such a model, ubiquitin modifications have previously been found to be 
inhibitory to resection as they are bound by RAP80 in order to prevent excessive 
resection. Consequently, depletion of RAP80 or its binding partners BRCC36 and 
Abraxas, leads to increased resection. It appears that POH1 functions to overcome the 
inhibitory function of RAP80 on resection by DUBing ubiquitylated histones at DSB 
ends. This model is supported by the fact that depletion of RAP80, BRCC36 or 
Abraxas, overcomes the requirement for POH1 in resection and in the disassociation of 
53BP1 from DSB ends (Figures 5.18). However, the Rad51 foci formation defect of 
POH1 depleted cells could not be rescued by RAP80 or BRCC36 co-depletion 
indicating that POH1 might also have a direct downstream role in Rad51 loading 
(Figure 5.18c). Consistent with this, unpublished work from the Morris laboratory has 
shown that POH1 is required for the recruitment of the BRCA2-co-factor DSS1 to DSB 
sites. Moreover, POH1 was shown to form a complex with BRCA2 and BRCA1 
following hydroxyurea treatment. These findings suggest that the 19S proteasome, 
which contains POH1, interacts with factors that promote Rad51 loading. 
 My data from this chapter looking at the interplay of BRCA1 and 53BP1during 
G2 phase HR have revealed a complex regulatory system involving on-going 
ubiquitylation and de-ubiquitylation events. 53BP1 seems to protect DNA ends from 
resection by binding to methylated histones following its recruitment by histone 
ubiquitylation. The amplification of ubiquitin modifications at DSBs acts as a binding 
platform for the RAP80 complex that in turn protects these regions from rampant 
resection (Sobhian et al, 2007; Hu et al, 2011). At the subset of DSBs that are to be 
repaired by HR, BRCA1 and POH1 co-operate to overcome the barriers posed to 
resection by RAP80 and 53BP1. The BRCT domain of BRCA1 is required to drive 
53BP1 repositioning away from DSB ends in a process likely to be dependent on novel 
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ubiquitylation events even if BRCA1 is not the E3 ligase carrying out these 
modifications.  In conjunction, POH1 is required for the formation of a hollow inner 
core in FK2 and 53BP1 IRIF that is required for RPA foci formation. This is likely to be 
achieved by DUBing ubiquitylating histones leading to the disassociation of 53BP1 and 
RAP80 from chromatin and thus overcoming their inhibitory role on resection. It is not 
currently clear how BRCA1 and POH1 co-operate in this process. Future experiments 
investigating functional interactions between these factors should provide valuable 
information. Moreover, further experiments are required to demonstrate that POH1 
DUB enzymatic activity is indeed required for G2 phase resection and HR. 
 
 
 
7.4: Chapter 6: Transcriptional silencing at DSBs requires ATM and RNF8 as well 
as the chromatin remodellers BAF180 and CHD7. 
 
 
7.4.1: Major conclusions from Chapter 6. 
 
• RNF8 is required is for efficient DSB repair in EU and functions in the same 
pathway as ATM leading to transcriptional silencing in cis to DSBs. 
 
• The PBAF chromatin-remodelling complex is required for DSB repair in EU 
and for transcriptional repression in cis to DNA DSBs. 
       
• BAF180 is recruited to DSB containing laser tracks and this does not depend on 
phosphorylation by ATM. 
 
• The chromatin remodeller CHD7 is required for DSB repair in EU and for 
transcriptional repression in cis to DNA DSBs. 
 
In this chapter, I aimed to build on findings by the Greenberg laboratory, which 
previously demonstrated that ATM functions to silence transcription in cis to DSBs by 
maintaining histone ubiquitylation modifications (Shanbhag et al, 2010). These 
modifications inhibit transcription and are carried out by RNF8 and amplified by 
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RNF168 (Doil et al, 2009). Consequently, depletion of RNF8 and RNF168 leads to 
deficient transcriptional silencing is cis to DSBs (Shanbhag et al, 2010). Here, I 
investigated whether deficient transcriptional silencing results in a DSB repair defect. 
However, previous experiments in RNF8 depleted cells did not reveal a repair defect at 
times as early as 1h post IR (Noon et al, 2010). I decided to investigate the role of 
RNF8 in the repair of DSBs at very early times post IR( >1h) when repair takes place 
specifically in EU, which contains transcriptionally active regions (Figure 6.1). RNF8 
depletion led to a repair defect/delay at very early times post IR but this was not 
detectable by 1h post IR (Figure 6.3). This repair defect coincided with a defect in 
transcriptional silencing in cis to DSBs raising the possibility that a failure to carry out 
this process leads to defective/delayed DSB repair (Figure 6.3). Alternatively, this 
repair defect might be the consequence of deficient chromatin decondensation at the 
DSB sites, a process that was recently found to be RNF8 and CHD4 dependent 
(Luijsterburg et al, 2012). 
   Next I investigated whether chromatin remodelling is required to achieve ATM 
dependent transcriptional silencing. By depleting individual components of the PBAF 
chromatin-remodelling complex in the U20S transcription reporter cells, I uncovered a 
role for this complex in transcriptional silencing in cis to DSBs (Figure 6.4). In 
addition, depletion of either the BAF180 or BRG1 subunits led to a repair defect at very 
early times post IR that was identical in magnitude to that observed following RNF8 
depletion (Figure 6.5). My interpretation of these results is that PBAF and RNF8 
function in the same pathway leading to transcriptional silencing in cis to DSBs. 
To gain insight into the role of the PBAF complex in transcriptional silencing I 
monitored its accumulation to laser induced DNA damage tracks containing DSBs. 
BAF180, contains two BAH domains that are important for its association with 
chromatin and likely target the complex to chromatin. Therefore, the BAF180 subunit 
was cloned into a GFP-vector and its recruitment to DNA damage tracks was 
investigated. I observed that BAF180 forms ‘weak’ tracks following laser micro-
irradiation but is recruited with fast kinetics and reaches maximum intensity within 60s 
post IR (Figures 6.6-6.7). ATM phosphorylates BAF180 in response to DNA damage 
but mutating this phosphorylation site did not prevent BAF180 from being recruited 
along the DNA damage tracks. The functional importance of this phosphorylation is 
currently unclear. Future experiments looking at DSB repair and transcriptional 
silencing following DSB induction in cells expressing phosphomutant BAF180 are 
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likely to be informative. It also remains to be seen whether the BAH domains of 
BAF180 are important for its recruitment to laser induced DNA damage tracks. The 
recruitment of BAF180 to DNA damage sites occurs with fast kinetics indicating that it 
is likely to function upstream of the RNF8 dependent ubiquitin modifications. One 
possibility is that PBAF functions upstream of RNF8 to remodel nucleosomes into a 
configuration that is favourable to ubiquitin modification. Further experiments are 
needed to prove or disprove whether this is how PBAF promotes transcriptional 
silencing in cis to DSBs. 
 In this chapter I also investigated the role of the chromatin remodeller CHD7 in 
transcriptional silencing in cis to DSBs. CHD7 co-operates with PBAF in neuronal crest 
formation and is also phosphorylated by ATM after DNA damage (Bajpai et al, 2010; 
Matsuoka et al, 2007). Following CHD7 depletion I observed a DSB repair defect/delay 
at very early times post IR (Figure 6.10). Moreover, I also observed a defect in 
transcriptional silencing following DSB induction that was similar in magnitude to that 
seen after PBAF depletion (Figure 6.11). It remains to be seen whether PBAF and 
CHD7 cooperate to silence transcription in cis to DSBs and how this is achieved. 
Uncovering a role for these chromatin remodellers in DSB repair via transcriptional 
silencing could be significant since CHD7 is mutated in CHARGE syndrome while 
BAF180 is frequently mutated in cancers. 
      
 
7.5: Final summary 
 
In recent years, major discoveries in the DDR field have uncovered a vastly complex 
and multifaceted system that functions to maintain genomic stability. The ‘nuts and 
bolts’ of the DNA DSB repair pathways have been well studied and characterised but 
how these pathways are regulated is now becoming clear. Following the induction of 
DNA damage, the appropriate repair pathway must be deployed, repair must take place 
within the context of chromatin, and it must interface with processes such as replication 
and transcription. Pivotal in the regulation of these processes are post-translational 
modifications, which provide control over function, localisation, interactions and more.  
In this thesis, my work focused on several aspects of the DDR to DSBs. First I 
studied the role of the mediator proteins in HR in the G2 phase of the cell cycle. I 
described roles for these proteins in facilitating the chromatin modifications required for 
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HR to take place at HC regions. Work from our laboratory had previously described the 
importance of modifying chromatin for repair at HC in G1, and here I progressed these 
studies by studying HC repair in G2. Chromatin modifications at DSBs where repair by 
HR takes place are likely to extend onto the undamaged template used for repair. In this 
thesis I have not provided evidence for this model and it remains to be seen if this is the 
case.  
Since the discovery of a non-proteasomal function for the ubiquitin signalling 
pathway, significant discoveries have been made into the role of this modification in the 
DDR. In this thesis I demonstrated that ubiquitin signalling is important for chromatin 
modifications through its role in recruiting factors such as 53BP1. In addition, ubiquitin 
signalling plays a direct role in HR since RNF8 depletion or treatment with a 
proteasome inhibitor leads to defective DNA resection. 
One of the main reasons leading to conflicting data in the literature is that 
factors in the DDR can either inhibit or promote a given process depending on the given 
circumstances. In this thesis I have described a dual role for 53BP1 in HR. 53BP1 can 
promote HR at HC regions by mediating chromatin relaxation, but it also inhibits HR 
by blocking resection. I also provide insight into the intricate mechanisms regulating 
DSB repair pathway choice as well as to how processes such as resection are negatively 
and positively regulated so that a delicate balance is achieved. 
Finally, I have progressed important findings showing that transcriptional 
silencing takes place in cis to DSBs. There are many unresolved questions regarding 
how this is achieved but my data indicate that chromatin remodelling is likely to play a 
key role. Perhaps unsurprisingly, ATM appears to be a key regulatory player in this 
process, adding another dimension to its multifunctional role in the DDR. 
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Abstract. (174) 
Although DNA non-homologous end-joining (NHEJ) repairs most DNA double strand 
breaks (DSBs) in G2 phase, DSBs at heterochromatin (HC) regions undergo repair by 
homologous recombination (HR). Here, we examine roles for 53BP1 and BRCA1 in 
DSB repair in G2. We show that 53BP1 is required for HR at HC regions in G2 by 
promoting phosphorylated KAP1 foci formation but conversely 53BP1 creates a barrier 
to HR. BRCA1 is dispensable for pKAP1 foci formation but promotes resection 
downstream of CtIP/MRN. BRCA1, via its BRCT domain, promotes G2-specific 
repositioning of 53BP1 to the foci periphery and its vacation from the core. Ubiquitin 
modifications but not gH2AX are similarly relocalised. RPA foci form in the 53BP1-
devoid core. Depletion of the deubiquitinating enzyme and proteasome component, 
POH1, allows 53BP1 expansion but prevents formation of the 53BP1-devoid core and 
RPA foci formation. Depletion of RAP80, BRCC36 or Abraxas overcomes the need for 
POH1 for generation of the 53BP1-devoid core. We propose that BRCA1 promotes 
53BP1 repositioning onto the undamaged template relieving the barrier to HR whilst 
enabling HC modifications.  
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Introduction 
Agents such as ionising radiation (IR) generate two-ended DNA double strand breaks 
(DSBs) in all cell cycle phases. Additionally, one-ended DSBs can arise in S phase at 
stalled/collapsed replication forks (Petermann & Helleday, 2010). Cells are equipped 
with two major DSB repair mechanisms, DNA non-homologous end-joining (NHEJ), 
which occurs in all cell cycle phases and homologous recombination (HR), which uses 
sister homologues in late S/G2 phase (Mahaney et al, 2009; Wyman & Kanaar, 2006). 
NHEJ represents the major pathway repairing two-ended DSBs whilst HR exerts its 
main function during replication (Beucher et al, 2009; Zhang & Jasin, 2011).   
 Two related DNA damage response (DDR) signalling pathways respond to 
DSBs (Kurz & Lees-Miller, 2004). Ataxia and telangiectasia mutated (ATM) is 
activated by two-ended DSBs; AT and Rad3 related (ATR), in contrast, responds to 
single stranded (ss) regions of DNA, which arise at stalled/collapsed replication forks or 
following resection of double stranded (ds) DNA ends (Ciccia & Elledge, 2010; Lavin, 
2008). Both kinases orchestrate assembly of DDR proteins at the damage site. ATM-
dependent signalling involves ATM recruitment by the MRE11/RAD50/NBS1 (MRN) 
complex, H2AX phosphorylation and recruitment of the mediator protein, MDC1, 
which provides a step tethering MRN and ATM at the DSB (Jackson & Bartek, 2009). 
The ubiquitin ligases, RNF8 and RNF168, are then recruited (Panier & Durocher, 
2009). Subsequent degradation of methylated histone binding proteins aids the 
localisation of 53BP1, another mediator protein (Acs et al, 2011; Mallette et al, 2012). 
This assembly can be visualised as IR-induced foci (IRIF) at DSBs. In addition to this 
process, which occurs in all cell cycle phases, another branch of recruited proteins that 
include BRCA1, Rap80, Abraxas, and BRCC36, form either uniquely or more robustly 
in G2 phase (Feng et al, 2010).  
DSB repair is influenced by chromatin structure and cell cycle phase. In G0/G1, 
the majority (~ 85 %) of IR-induced DSBs, which are located in euchromatic (EC) 
DNA, are re-joined by NHEJ without requirement for ATM or DDR mediator proteins 
(Riballo et al, 2004). In contrast, the repair of DSBs located in heterochromatic (HC) 
regions (~ 15 %) requires ATM, H2AX, MRN, RNF8, RNF168, and 53BP1 as well as 
NHEJ proteins (Goodarzi et al, 2008; Noon et al, 2010). Current evidence suggests that 
compacted HC impedes DSB repair and that ATM promotes phosphorylation of KAP1 
(pKAP1), an HC-building factor. pKAP1 forms in a pan nuclear manner and as discrete 
foci (pKAP1 foci). Whilst pan nuclear pKAP1 only requires activated ATM, pKAP1 
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foci, which form uniquely at HC-DSBs, additionally require 53BP1 and upstream DDR 
proteins necessary for 53BP1 recruitment (Noon et al, 2010). 53BP1 is proposed to 
tether ATM at DSBs, promoting concentrated pKAP-1 (i.e. pKAP-1 foci) at HC-DSBs, 
release of the chromatin remodelling protein, CHD3, and HC relaxation (Noon et al, 
2010); (Goodarzi et al, 2011). Although ATM localises to all DSBs, it is specifically 
required for HC-DSB repair (although it may also promote repair of other DSB sub-
fractions such as those undergoing transcription) (Shanbhag et al, 2010). In addition to 
these differing genetic requirements for HC versus EC-DSB repair, there are kinetic 
differences; EC-DSBs are repaired rapidly whilst HC-DSBs are repaired with slow 
kinetics (Goodarzi et al, 2008).  
In G2, EC-DSBs are repaired predominantly by NHEJ (as in G1). However, 
HC-DSBs, in contrast to the situation in G1, undergo repair by HR (Beucher et al, 
2009). ATM has at least two functions in HR; it phosphorylates KAP1 promoting HC 
relaxation and phosphorylates and activates CtIP, enabling DNA resection (Shibata et 
al, 2011). Based on these and additional findings, it has been proposed that NHEJ 
makes the first attempt to repair DSBs in G2 but if rapid repair does not ensue then 
resection occurs committing to HR. Thus, HR functions predominantly to repair the 
slow component of DSB repair (HC-DSBs) in G2 phase (Beucher et al, 2009). 
However, little is understood about events regulating the switch from NHEJ to HR. 
There is also interplay between HR and NHEJ at one-ended DSBs in S phase 
with data suggesting that the Fanconi anaemia proteins function to prevent access of 
Ku, an upstream NHEJ component (Adamo et al, 2010; Pace et al, 2010). Additionally, 
evidence has suggested that 53BP1 and BRCA1 regulate DSB repair pathway choice 
(Bothmer et al, 2010; Bouwman et al, 2010; Bunting et al, 2010; Shibata et al, 2011). 
BRCA1 is essential for HR although it may also influence NHEJ (Baldeyron et al, 
2002; Moynahan et al, 1999; Stark et al, 2004; Zhong et al, 2002).  BRCA1 has been 
reported to enhance CtIP recruitment and resection (Chen et al, 2008; Choudhary & Li, 
2002; Schlegel et al, 2006). 53BP1, in contrast, has been considered to promote NHEJ. 
Although 53BP1 is dispensable for most DSB repair by NHEJ, it is required for HC-
DSB repair, telomere fusions, and long range V(D)J recombination re-joining 
(Difilippantonio et al, 2008; Dimitrova et al, 2008; Noon et al, 2010). Importantly, 
whilst deficiency in BRCA1 impairs resection and inhibits HR, both are regained 
following concomitant loss of BRCA1 and 53BP1 (Bouwman et al, 2010; Bunting et al, 
2010). However, the mechanism underlying these provocative findings is unclear. 
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 Here, we examine roles for 53BP1 and BRCA1 in HR at IR-induced two-ended 
DSBs in G2. We exploit G2 phase analysis since transactions at replication forks are 
complex to dissect and since it allows the necessity for additional chromatin 
modifications (e.g. HC relaxation) to be examined. We show that, contrary to previous 
reports, 53BP1 has a pro-HR function at HC-DSBs in G2 via its requirement for pKAP-
1 foci formation. Thus, 53BP1 does not solely promote NHEJ. Next, we show that 
BRCA1 functions downstream of CtIP/MRN to complete resection. As in S phase, loss 
of 53BP1 overcomes the need for BRCA1 for HR. Using enhanced resolution and 3D 
imaging, we show that 53BP1 foci undergo G2-phase specific enlargement via a process 
requiring BRCA1’s BRCT domain. Additionally, a central core devoid of 53BP1 where 
RPA foci form is generated. Moreover, we show that POH1, a recently characterised 
deubiquitinating enzyme and proteasome component, is required for generation of the 
53BP1-devoid core and RPA foci (Cooper et al, 2009; Yao & Cohen, 2002). These 
findings provide mechanistic insight into how BRCA1 modulates 53BP1 to enable HR. 
We propose a model whereby BRCA1 counterbalances two opposing impacts of 
53BP1, repositioning 53BP1 to relieve its barrier to resection whilst enabling 53BP1 to 
effect HC modifications on the undamaged template.  
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Results. 
53BP1 is required for HR at two-ended DSBs in G2 phase. 
The requirement for 53BP1 for DSB repair in G2 was initially examined by 
enumerating gH2AX foci in irradiated 53BP1+/+ and -/- mouse embryo fibroblasts 
(MEFs). DSB repair was normal at 2-4 h but impaired by 6-8 h post IR (Figure 1A), 
which is similar to the defect observed in 53BP1-/- G0/G1 phase MEFs and G2 cells 
lacking Artemis, ATM, BRCA2, RAD51 or RAD54 (Beucher et al, 2009; Riballo et al, 
2004). These findings were verified using siRNA 53BP1 in A549 cells (Figure 1B). 
Enumeration of RPA and Rad51 foci formation as markers of resection and HR repair 
in A549 cells at 2 h post IR revealed modestly diminished resection and more markedly 
impaired RAD51 loading following siRNA 53BP1 (Figure 1C,D).  Examination of 
sister chromatid exchanges (SCEs) in mitotic cells derived from irradiated G2 cells (see 
(Beucher et al, 2009)) showed that siRNA 53BP1 abolished IR-induced SCEs (Figure 
1E).  Addition of an ATM inhibitor (ATMi) demonstrated that 53BP1 functions 
epistatically to ATM to promote HR (Figure 1B-E). We conclude that 53BP1 is 
essential for HR in G2 following IR since SCEs, a direct readout for HR, and gH2AX 
foci loss are similarly diminished by either siRNA 53BP1 or ATMi addition.   
 
53BP1 is specifically required for HR at HC-DSBs. 
We previously suggested that, after g- or X-ray exposure, HR in G2 phase arises 
predominantly at HC-DSBs, which are repaired with slow kinetics due to a barrier 
created by the HC superstructure (Beucher et al, 2009; Shibata et al, 2011). Previous 
studies have shown that densely staining DAPI regions do not efficiently reflect 
chromocentres in late G2 (Goodarzi et al, 2009). To consolidate the notion that HR 
occurs predominantly at HC-DSBs, we used confocal microscopy and 
immunofluorescence staining for the heterochromatic markers, H3K9me3 and 
H4K20me3, to visualise chromocentres in G2. At 8 h post IR in WT cells, >71 % of 
RPA foci overlap with H3K9me3 or H4K20me3 positive chromatin; when both HC 
markers were used (to enhance HC demarcation), >88% of RPA foci co-localise with 
HC (Figure 2A-D). We previously showed that ~15-20% of DSBs undergo resection in 
control G2 cells with the level of resected DSBs increasing following loss of NHEJ 
proteins, demonstrating that HR can occur at EC-DSBs (Shibata et al, 2011). Here, we 
observed that in 2BN cells, which lack the NHEJ component, XLF, the additional RPA 
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foci persisting 8 h post IR (compared to control) predominantly occur in H3K9me3 or 
H4K20me3 negative chromatin (i.e. euchromatin) (Figure 2A-D).  
Next, we examined the relationship between pKAP1 foci and HR in G2 phase. 
In G1 cells, we observed that pKAP1 foci only form at the subset of DSBs repaired with 
slow kinetics, shown to represent HC-DSBs (Noon et al, 2010). Previously, we were 
unable to detect pKAP1 foci in G2 cells due to partial dispersal of KAP1 from 
chromocentres in late G2/mitosis (Goodarzi et al, 2009). Here, using siRNA MeCP2, 
which enhances the size of IRIF (Brunton et al, 2011), we could visualise pKAP1 foci 
in G2 cells and found that RPA foci substantially co-localise with pKAP1 and 53BP1 
foci (Figure 2E). Additionally, following combined Ku80+DNA-PKcs siRNA (siRNA 
DNA-PK) this overlap is greatly diminished. Since RPA foci co-localise with the HC 
markers, H3K9me3/H4K20me3, this supports the notion that pKAP1 foci 
predominantly form at HC-DSBs in G2 (as in G1 phase). Together, this analysis 
strongly suggests that HR occurs primarily at HC-DSBs in WT cells but can arise at 
EC-DSBs when DNA-PK is absent.  We also observed that pKAP1 foci do not form in 
G2 (as in G1) cells following 53BP1+MeCP2 siRNA (Figure 2F). Moreover, we 
observed normal RPA foci and gH2AX foci loss at EC-DSBs following siRNA 53BP1 
providing evidence that 53BP1 is dispensable for HR at EC-DSBs (Supplementary 
Figure 2A). Thus, there is a direct correlation between 53BP1’s requirement for pKAP1 
foci formation and HR consistent with a causal relationship. 
To consolidate the notion that 53BP1 is required for HR via a function in 
promoting HC relaxation, we examined whether HC relaxation (by knockdown of HC 
components) can overcome the requirement for 53BP1 for DSB repair in G2 phase. 
Strikingly, siRNA KAP-1 restored normal gH2AX foci loss, resection (as judged by 
RPA foci numbers), RAD51 loading and SCE formation to 53BP1 depleted G2 cells 
(Supplementary Figure 3). Knockdown of HP1 (a,b+g) similarly overcame the need for 
53BP1 for G2 phase DSB repair (Supplementary Figure 3E).  
Collectively, these findings substantiate and extend previous data suggesting 
that after IR, HR occurs predominantly at HC regions. We propose that HC represents a 
partial barrier to resection and a full barrier to the completion of HR (SCEs) at DSBs in 
G2 and that 53BP1 promotes pKAP-1 foci formation to relieve that barrier. However, 
HR can occur efficiently without 53BP1at HC-DSBs following siRNA of critical HC 
components (KAP1 or HP1) or at EC-DSBs.  Moreover, 53BP1 is dispensable for 
NHEJ since the fast DSB repair process (NHEJ) takes place in 53BP1-/- cells (Figure 
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1A). This strongly suggests that 53BP1 is dispensable for HR and NHEJ but can 
promote either process by impacting on HC.  
 
BRCA1 is required for HR at HC-DSBs in G2. 
Having examined 53BP1’s role in DSB repair, we next examined the requirement for 
BRCA1. Firstly, we observed normal pKAP-1 foci formation in G2 phase cells 
following siRNA BRCA1+MeCP2 in contrast to the defect observed following siRNA 
53BP1 (Figure 2F) suggesting that BRCA1 is dispensable for pKAP1-mediated HC 
relaxation. Next, we examined DSB repair in cells depleted for BRCA1. In G1 cells, we 
observed normal gH2AX foci loss post IR (fast and slow components) following siRNA 
BRCA1 (Figure 3A). In contrast, we reproducibly observed defective DSB repair in 
BRCA1-depleted G2 cells detectable as a failure to undergo the slow DSB repair 
process (Figure 3B). The fact that the slow DSB repair process in G1 (HC-DSB repair) 
is BRCA1 independent is consistent with the finding above that BRCA1 is dispensable 
for pKAP1 foci formation. The failure to repair the slow component of DSB repair in 
G2 (which, we argue, represents HR) is consistent with the substantial evidence that 
BRCA1 is essential for HR (Baldeyron et al, 2002; Moynahan et al, 1999; Stark et al, 
2004; Zhong et al, 2002). Consistent with the notion that BRCA1’s role in DSB repair 
in G2 represents a direct function in HR rather than HC-relaxation, we found that 
combined siRNA BRCA1+KAP1 did not overcome the repair defect caused by siRNA 
BRCA1 (Figure 3B).   
 
BRCA1 functions downstream of CtIP/MRN.   
Previous studies have shown that CtIP is required for resection during HR (Chen et al, 
2008; Choudhary & Li, 2002; Schlegel et al, 2006). We previously observed that in G2, 
CtIP depletion inhibits RPA foci formation and HR but efficient DSB repair ensues by 
NHEJ (Shibata et al, 2011). That repair occurs by NHEJ is demonstrated by its 
dependence on XLF, an NHEJ factor (Shibata et al, 2011) (see also Figure 3C,E). 
However, impaired repair is observed in G2 following siRNA BRCA1 suggesting that 
BRCA1 may function downstream of CtIP, possibly at a stage post commitment to HR. 
To investigate the order of BRCA1 and CtIP function, we examined whether CtIP 
depletion could rescue the G2 repair defect following siRNA BRCA1. As previously, 
we observed normal DSB repair following siRNA CtIP (Shibata et al, 2011) (Figure 
3C). Strikingly, siRNA CtIP+BRCA1 relieved the defect observed following siRNA 
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BRCA1 alone (Figure 3C). We propose that CtIP functions upstream of BRCA1 to 
initiate resection, committing to repair by HR. BRCA1, in contrast, functions to 
complete resection. Since initiation of resection (the step committing to HR) occurs in 
the absence of BRCA1, DSB repair can no longer ensue by NHEJ. 
Next, we examined whether siRNA CtIP or BRCA1 could rescue the repair 
defect in cells lacking BRCA2, a protein required for loading of RAD51, a downstream 
step in HR (Pellegrini et al, 2002). We anticipated that if BRCA1 functions downstream 
of CtIP-dependent initiation of resection, siRNA CtIP but not BRCA1 would rescue the 
BRCA2 repair defect. Consistent with this notion, whilst siRNA CtIP rescued the repair 
defect caused by siRNA BRCA2, joint siRNA BRCA1+BRCA2 showed defective DSB 
repair (Figure 3C).  
We also examined the impact of siRNA MRE11, which, like CtIP, is required 
for the initiation of resection (Mimitou & Symington, 2011).  However, MRE11 has an 
additional downstream role as a component of the MRN complex, promoting HC-DSB 
repair via pKAP-1 foci formation (Noon et al, 2010). Thus, MRN, like 53BP1, is 
required for HC relaxation. We examined how these distinct roles impacted upon 
BRCA1 depletion. In G2, siRNA MRE11 conferred a DSB repair defect similar to that 
observed in HR deficient cells but combined siRNA MRE11+KAP-1 allowed normal 
DSB repair (most likely by NHEJ) (Figure 3D). Support for the notion that DSB repair 
does not occur by HR is provided by the fact that efficient DSB repair was also 
observed following triple siRNA BRCA2, MRE11+KAP-1 (Figure 3C). Thus, if the 
requirement for MRE11 for HC-relaxation is bypassed by KAP1 siRNA, then depletion 
of MRE11 or CtIP yield similar phenotypes. Thus, we conclude that MRE11 has an 
additional role in the initiation of resection. Consistent with this, a normal level of DSB 
repair was also observed following siRNA MRE11+KAP-1+BRCA1 (Figure 3D). 
Collectively these findings strongly suggest that CtIP/MRN functions to initiate 
resection whereas BRCA1 has a downstream role promoting resection post the initiation 
step.  
To gain further insight into the position of BRCA1 function, we examined RPA 
and RAD51 foci formation. Consistent with other findings, siRNA BRCA1 causes a 
modest decrease in RPA and RAD51 foci numbers (Figure 3E-F) (Chen et al, 2008; 
Choudhary & Li, 2002; Schlegel et al, 2006). siRNA CtIP causes a marked decrease in 
both endpoints. As expected, siRNA BRCA2 does not impair resection but prevents 
RAD51 foci formation (Shibata et al, 2011). Importantly, RPA and RAD51 foci 
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numbers remained low following siRNA BRCA1+CtIP or BRCA2+CtIP consistent 
with the evidence that DSB repair ensues by NHEJ and not HR (Shibata et al, 2011), 
and that both BRCA1 and BRCA2 function downstream of CtIP-dependent initiation of 
resection (Figure 3E-F).   
siRNA MRE11 reduced RPA foci numbers although less dramatically than 
observed after siRNA CtIP, which we attribute to inefficient siRNA. Importantly, 
combined siRNA MRE11+KAP-1 did not enhance RPA foci numbers, in contrast to our 
finding with 53BP1, demonstrating an additional role of MRE11 in resection. Further, 
triple siRNA MRE11+KAP-1+BRCA2 conferred reduced RPA foci numbers compared 
to siRNA BRCA2 alone consistent with the notion that the DSB repair observed in 
Figure 3C occurs by NHEJ not HR. Following siRNA BRCA1+BRCA2 the level of 
RPA foci numbers were low compared to siRNA BRCA2 alone arguing that BRCA1 
functions upstream of BRCA2, yet DSB repair is precluded (Figure 3E).  
Collectively, we interpret these findings as showing that MRE11/CtIP has an 
upstream role in initiating resection, which commits to repair by HR. If prevented, DSB 
repair can ensue by NHEJ. In contrast, BRCA1 has a downstream role in HR. Since 
diminished RPA foci numbers are evident following siRNA BRCA1, we propose that 
BRCA1 has a role in completing resection downstream of CtIP/MRN-dependent 
initiation.  
 
Combined siRNA 53BP1+BRCA1 restores HR at two ended DSBs. 
Previous findings have shown that combined depletion of 53BP1 and BRCA1 enables 
resection and HR to proceed following replication stalling (Bouwman et al, 2010; 
Bunting et al, 2010). We examined whether this is similarly observed at IR-induced 
DSBs in G2. Perhaps surprisingly, combined knockdown of 53BP1 and BRCA1 does 
not restore RPA or RAD51 foci formation or DSB repair (Figure 4A-C). However, 
consistent with 53BP1’s role in promoting HC relaxation, triple knockdown of 53BP1, 
BRCA1 and KAP-1 restored all these end points to control levels (NB SCE formation 
was not examined following triple knockdown due to a diminished mitotic index) 
(Figure 4A-C). These findings demonstrate that 53BP1 has two functions in G2; a 
positive role in promoting HC relaxation and an inhibitory function that is overcome by 
BRCA1. Further, they verify that analysis of G2 phase DSB repair is a suitable system 
to probe the role of BRCA1 in overcoming the barrier posed by 53BP1.   
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53BP1 undergoes repositioning at IRIF during HR. 
We observed that 53BP1 IRIF in G2 cells enlarge at later times post IR compared to 
IRIF in G1. We exploited enhanced resolution microscopy and 3D processing to 
quantify IRIF size and organization. In G1 cells, we did not detect any substantial 
increase in IRIF volume post IR using a-53BP1, whereas a doubling in 53BP1 foci 
volume was observed from 0.5 to 8 h in G2 (Figure 5A,C). Importantly, siRNA BRCA1 
did not affect IRIF volume in G1 cells but precluded the enlargement in G2, with IRIF 
volume resembling that observed in G1 (Figure 5B, C). We also observed that, whereas 
53BP1 was localised as a tight sphere in G1 and at 30 min post IR in G2, in striking 
contrast, it became repositioned by 8 h post IR in G2, vacating the central core and 
relocalising to the periphery of enlarged IRIF (Figure 6B and Supplementary Figure 
4A).  Strikingly, 53BP1 repositioning did not occur following siRNA BRCA1 (Figure 
6C). Further, in control cells at both 0.5 and 8 h post IR, BRCA1 localised internally to 
53BP1 (Figure 6A,B). To gain insight into the progression of HR, we next examined the 
relative localisation of RPA. Strikingly, RPA localised to the IRIF core that became 
devoid of 53BP1 with BRCA1 being located between 53BP1 and RPA (Figure 6B). A 
similar relative localisation of 53BP1 to BRCA1 was recently reported and RPA 
localisation to the IRIF core is consistent with a report of a micro compartment of single 
strand DNA binding proteins within the centre of micro irradiated laser tracks (Bekker-
Jensen et al, 2006; Chapman et al, 2012). 
 
Ubiquitin chains but not gH2AX relocalise with 53BP1. 
53BP1 localises to IRIF via RNF8-RNF168-dependent H2A ubiquitylation (Pei et al, 
2011). We predicted that 53BP1 repositioning to IRIF periphery might necessitate 
enlargement of the region encompassing ubiquitin chains.  Using 3D imaging with a-
FK2 antibodies at 8 h post IR in G2 cells, we observed that the IRIF core became 
depleted of the a-FK2 signal, which instead strongly co-localised with 53BP1 (Figure 
6A,B and Supplementary Figure 4B). Thus, FK2 co-localised with 53BP1 at 0.5 and 8 h 
post IR in G2. In stark contrast, whereas gH2AX localises externally to 53BP1 at 0.5h 
post IR, it does not relocalise and hence becomes positioned internally to 53BP1 by 8 h 
post IR in G2 (Figure 6A,B). However, gH2AX is also lost from the core, where RPA 
foci form.  
To assess whether the inability of 53BP1 foci to enlarge in BRCA1 depleted 
cells might be a consequence of the reduced resection (assessed as RPA foci numbers) 
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observed following BRCA1 siRNA, we examined 53BP1 foci in cells depleted for 
Artemis, an endonuclease required for resection in G2 phase, since Artemis siRNA 
results in a similar decrease in RPA foci numbers to that observed following BRCA1 
siRNA (Beucher et al, 2009). Notably, we observed a similar two-fold increase in 
53BP1 foci volume in G2 cells to that seen in control cells (Figure 6D). Additionally, 
53BP1 depletion did not rescue either the diminished RPA foci numbers or DSB repair 
in Artemis-depleted G2 cells (Supplementary Figure 5A-B). This strongly suggests that 
BRCA1 directly promotes 53BP1 relocalisation during HR rather than relocalisation 
being an indirect consequence of impaired resection. 
To gain insight into the domains of BRCA1 required for 53BP1 repositioning, 
we exploited MEFs homozygously expressing WT BRCA1,  BRCA1FH-126A, which 
inactivates the E3 ligase activity, or BRCA1S1598F , which disrupts the BRCT phospho-
recognition domain (Shakya et al, 2011). Analysis using these cells has shown that 
BRCA1’s BRCT domain is required for HR monitored by an I-Sce1 plasmid assay 
(Shakya et al, 2011). Consistent with these findings, we observed that RPA and RAD51 
foci formation is diminished in BRCA1S1598F MEFs but occurs normally in BRCA1FH-
126A MEFs (Figure 7A,B). Furthermore, although foci expansion was less marked in 
MEFs compared to the human cells, expansion was evident and occurs normally in 
MEFs expressing WT or BRCA1FH126A but not in BRCA1S1598F MEFs (Figure 7C). Thus, 
we conclude that BRCA1’s BRCT domain is required for 53BP1 repositioning in G2 
phase. 
 
POH1 is dispensable for 53BP1 repositioning but is required for its vacation from 
the central core; interface with the RAP80/BRCC36/Abraxas complex. 
Several proteins interact with BRCA1’s  BRCT domain including CtIP,  BACH1 and a 
complex encompassing RAP80-BRCC36-Abraxas, (Cantor et al, 2001; Hu et al, 2011; 
Sobhian et al, 2007; Wang et al, 2007; Yu et al, 1998). Since we observed that CtIP 
functions upstream of BRCA1 in the initiation step of HR, we considered it unlikely 
that CtIP is the factor mediating BRCA1 function in 53BP1 repositioning. Normal 
53BP1 foci enlargement and repositioning was observed following siRNA RAP80, 
BRCC36 or BACH1 (Supplementary Figure 6). Since the process involves 
repositioning of ubiquitin chains, we reasoned that it might require the function of a 
deubiquitin ligase (DUB) but surprisingly BRCC36 did not appear to be required. We, 
therefore, examined the requirement for POH1, a recently described component of the 
!!
")#!
DNA damage response required for HR (Butler et al, manuscript submitted). Although 
53BP1 and FK2 chains expanded normally following siRNA POH1, strikingly they did 
not vacate the core region nor were RPA foci observed in the core (Figure 8A,B). 
Consistent with this, RPA foci numbers were markedly reduced following siRNA 
POH1 (Figure 8C). These findings show that POH1 is required for resection. To 
consolidate this using non-foci analysis, we also observed that IR-induced RPA 
phosphorylation is POH1-dependent (Supplementary Figure 7A). Recent studies have 
proposed that RAP80 suppresses resection by binding to and protecting ubiquitin chains 
on chromatin from degradation by DUBs. Since depletion of RAP80, BRCC36 or 
Abraxas leads to enhanced resection, we examined the impact of combined POH1 and 
either siRNA RAP80, BRCC36 or Abraxas (Coleman & Greenberg, 2011; Hu et al, 
2011). In all cases, as expected we observed normal 53BP1 enlargement but 
surprisingly a central core devoid of ubiquitin chains and 53BP1 was now visible 
(Figure 8A,B). Moreover, RPA was detected in the core and RPA foci numbers returned 
to normal levels, although the foci appeared slightly smaller than in control cells (Figure 
8B, C). Additionally, we examined RAD51 foci formation following siRNA POH1. As 
expected from the dramatic reduction in RPA foci, siRNA POH resulted in markedly 
reduced RAD51 foci formation. Unexpectedly, however, siRNA POH1+BRCC36 did 
not restore RAD51 foci formation despite promoting the recovery of RPA foci 
(Supplementary Figure 7B). Thus, we conclude that POH1 has an additional function in 
promoting RAD51 loading that is likely distinct to its role in creating a 53BP1-devoid 
core to IRIF. 
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Discussion. 
 
Here, we gain mechanistic insight into functions of BRCA1 and 53BP1 in HR by 
examining repair of two-ended DSBs in G2 following IR. Previously, we have shown 
that in G1 phase, DSBs are repaired with two component kinetics, that the slow 
component represents the repair of HC-DSBs and that 53BP1 promotes HC-DSB repair 
by enabling pKAP1 foci formation. DSBs are also repaired with fast and slow kinetics 
in G2 phase. However, in G2 the slow component represents HR with evidence 
suggesting that the DSBs repaired by HR are predominantly HC-DSBs. Here, we 
provide further evidence to support that notion. Using H3K9me3 and H4K20me3 to 
identify chromodomains in G2, we show that RPA foci form predominantly at such 
domains. Additionally, visualisation of pKAP1 foci in G2 following siMeCP2 shows 
that they are 53BP1-dependent and predominantly co-localise with RPA foci. However, 
depletion of NHEJ components allows RPA foci to form at non-HC regions; under such 
conditions RPA foci do not co-localise with pKAP1 foci.  
Surprisingly, in contrast to previous suggestions that 53BP1 promotes NHEJ, we 
show that it is required for HR at HC-DSBs in G2 but is dispensable for HR at the non-
HC-DSBs, which arise following depletion of DNA-PK. Further, the role of 53BP1 in 
HR correlates with its requirement for pKAP1 foci formation. Thus, although not a core 
HR protein, we suggest that 53BP1 can indirectly promote HR (in the presence of 
BRCA1) via a role in enabling HC-relaxation. The fact that HR can proceed without 
53BP1 following depletion of HC components (KAP1 or HP1) supports this suggestion. 
This role of 53BP1 may be dispensable during replication, where HC may dismantle. 
 We show that BRCA1 specifically confers a DSB repair defect in G2 but, unlike 
53BP1, is dispensable for pKAP1 foci formation. A recent study reported that BRCA1 
loss impacts upon heterochromatinization (Zhu et al, 2011). We previously observed 
normal DSB repair rates in other human syndromes with disordered heterochromatin 
(e.g. Rett Syndrome) but such cells display a diminished requirement for ATM for HC-
DSB repair (Brunton et al, 2011; Goodarzi et al, 2008). The specific requirement for 
BRCA1 in G2 is, therefore, a distinct phenotype. Further, we have observed that 
BRCA1-depleted cells display the anticipated DSB repair defect following ATMi 
addition in G1 and G2. Thus, any change in HC structure caused by BRCA1 depletion 
does not impact upon the need for ATM for HC-DSB repair.  We reveal that BRCA1 
functions downstream of CtIP/MRN-dependent initiation of resection to promote full 
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resection. In assessing resection, we acknowledge that our resection assay (RPA foci 
formation) has limitations. Surprisingly, following either BRCA1 or 53BP1 siRNA, 
RPA foci numbers are reduced without any detectable change in size. We suggest that 
RPA foci size may not reflect the magnitude of resection but rather there may be a 
threshold size for detection. Notwithstanding this limitation, we interpret reduced RPA 
foci numbers as a read out for impaired resection. Studies with S. cerevisiae have 
revealed that resection occurs in two steps; initially, the yeast homologues of 
CtIP/MRN remove a short oligonucleotide producing an intermediate with a 3’ 
overhang. End processing then occurs by a process involving the yeast homologues of 
ExoI or BLM (Mimitou & Symington, 2011). Our findings support this model and 
suggest that BRCA1 promotes a step downstream of MRN/CtIP.  
We show that MRN has dual roles in end-processing; an upstream role where it 
functions with CtIP and a downstream role as a mediator protein, promoting HC-
relaxation (Mimitou & Symington, 2011; Noon et al, 2010). To examine the upstream 
role, we relieve the need for HC relaxation by depleting KAP1. Importantly, depletion 
of CtIP alone or Mre11+KAP1 reduces RPA foci formation but not DSB repair. We 
recently showed that CtIP depletion allows DSB repair by NHEJ in G2 (Shibata et al, 
2011). Strikingly, depletion of CtIP alone or MRN+KAP1 also rescues the repair defect 
conferred by BRCA2 depletion in G2. In contrast, BRCA1 depletion cannot rescue 
repair in BRCA2-depleted cells. Thus, we propose that the CtIP-MRN initiating step of 
resection that commits to repair by HR is BRCA1-independent and that BRCA1 is 
required for a downstream step completing resection. Interestingly, as shown here and 
previously, BRCA1 is dispensable for resection since resection occurs when BRCA1 
and 53BP1 are concordantly depleted (Bouwman et al, 2010; Bunting et al, 2010).  
 We demonstrate two distinct and somewhat opposing impacts of 53BP1 at IRIF 
in G2. Firstly, as discussed above, 53BP1 promotes HC relaxation, identical to its role 
in G1 phase, although in G2, HC-DSBs undergo repair by HR rather than a process 
involving NHEJ proteins (Beucher et al, 2009; Noon et al, 2010). In contrast to this role 
of 53BP1 in promoting HR, we show that, consistent with findings in S phase cells, 
53BP1 can block HR in the absence of BRCA1 (Bouwman et al, 2010; Bunting et al, 
2010). This impact is distinct to its role in HC relaxation since HR stalls in BRCA1 
depleted cells even following siRNA KAP1. Based on the phenotype of BRCA1 
depleted cells, 53BP1 appears to provide a modest barrier to RPA foci formation, a 
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larger barrier to RAD51 loading but a full barrier to the completion of HR (SCE 
formation and DSB repair). 
 
BRCA1 promotes relocalisation of 53BP1 in G2 creating a core devoid of 53BP1. 
Enhanced imaging analysis has provided mechanistic insight into how BRCA1 
overcomes the barrier posed by 53BP1, namely by promoting 53BP1 relocalisation to 
the periphery of enlarged IRIF and creating a core devoid of 53BP1. Strikingly, 53BP1 
foci at DSBs undergoing HR increase in volume relative to G1 cells. Ubiquitin chains 
detected by FK2 similarly increase in volume but gH2AX does not. Whilst this could 
represent an enlargement along the DNA molecule, the volume increase occurs in three 
dimensions (i.e. spherically) rather than longitudinally raising the possibility that it 
represents 53BP1 repositioning to encompass the undamaged template. Since HC 
confers a barrier to steps of HR, HC changes on the undamaged template will likely be 
required. We propose that BRCA1 promotes 53BP1 repositioning onto the undamaged 
template during HR, enabling the requisite chromatin modifications, including HC 
relaxation (Supplementary Figure 6). However, 53BP1 repositioning also creates a core 
devoid of 53BP1, enabling RPA foci formation and subsequent RAD51 loading. 53BP1, 
therefore, exerts two opposing impacts on HR; promoting HR via HC relaxation and 
inhibiting HR at IRIF. BRCA1 counterbalances these two opposing impacts. 
 We show that this process requires BRCA1 BRCT domain but not the ring 
finger motif. Recent studies have shown that BRCA1 BRCT interacts with a 
RAP80/BRCC36/Abraxas complex. Although it has been proposed that RAP80 helps to 
recruit BRCA1, we observed that loss of RAP80, BRCC36 or Abraxas does not impair 
53BP1 repositioning. This is consistent with other studies showing that loss of these 
proteins does not impair but enhances HR (Coleman & Greenberg, 2011; Hu et al, 
2011). However, we found that the DUB, POH1, is required for formation of the core 
devoid of 53BP1 and ubiquitin chains, and for RPA foci formation. A recent study has 
shown that POH1 and the proteasome are required for HR (Butler et al, manuscript 
submitted). Significantly, the POH1-dependent 53BP1-devoid core also lacks ubiquitin 
moieties and gH2AX suggesting that its generation could require proteasome-dependent 
degradation. Interestingly, 53BP1 expansion to the foci periphery is POH1-independent 
demonstrating that it likely represents new recruitment of 53BP1 and not histone 
shuffling.  
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Our findings demonstrate that BRCA1 BRCT has two distinct functions; (i) it 
promotes new 53BP1 recruitment to the foci periphery and (ii) it creates a core in the 
IRIF devoid of 53BP1 that enables RPA recruitment. This latter process is POH1-
dependent and serves to relieve an inhibitory barrier posed by the 
RAP80/BRCC36/Abraxas complex. One possibility is that BRCA1 serves to recruit 
POH1 and/or other proteasome components. Interestingly, BRCA1 immunoprecipitates 
with BRCA1 although further work is required to assess the significance of this 
interaction (Butler et al. manuscript submitted). Combined loss of POH1 and either 
RAP80, BRCC36 or Abraxas leads to recovery of a 53BP1-devoid core and RPA 
recruitment. Coupled with recent evidence suggesting that RAP80 binds ubiquitin 
chains and protects them from rampant deubiquitylation, we suggest that BRCA1 
regulates a timely switch enabling POH1-dependent deubiquitylation and possibly 
proteasome-mediated degradation (Coleman & Greenberg, 2011; Hu et al, 2011). 
Interestingly, recent work has shown that RNF169, represents a further ubiquitin ligase 
that functions in the DNA damage response (Poulsen et al, 2012). RNF169, however, 
appears to function in an atypical manner and can compete with and limit both 53BP1 
and RAP80 recruitment to RNF8/168-ubiquitylated chromatin. Whether RNF169 
functions to promote access of POH1 to the ubiquitin chains remains to be determined. 
The role that BRCA1 plays in allowing additional 53BP1 recruitment at IRIF periphery 
is unclear but is POH1 independent. 
 
Model for the roles of 53BP1 and BRCA1 in HR. 
We propose that since HR in irradiated G2 cells occurs predominantly at HC-DSBs, 
chromatin modifications (particularly pKAP1 foci) on the undamaged and damaged 
template are required. BRCA1 facilitates this by promoting the repositioning of 
ubiquitin modifications and 53BP1, enabling ATM to remain tethered at DSBs as 
resection ensues (Supplementary Figure 8A). Additionally, 53BP1 repositioning creates 
a core devoid of ubiquitin modifications and 53BP1. Although ubiquitin modifications 
do not appear to restrict HR, the presence of 53BP1 itself is inhibitory. This process 
may occur more dramatically in G2 either because BRCA1 shows greater expression in 
G2 than in G1, because resection is CDK regulated and occurs more readily and/or 
because a sister chromatid is present.  
 In summary, we provide mechanistic insight into events that regulate the 
conversion from NHEJ to HR at two-ended DSBs in G2. We propose that cells counter-
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balance distinct events that restrict resection and Rad51 loading. HC super-structure 
represents one such barrier, which is overcome by 53BP1-dependent KAP1 
phosphorylation (Supplementary Figure 8A). However, 53BP1 and RAP80 also create a 
barrier to resection and RAD51 loading. We propose that BRCA1 promotes 53BP1 
repositioning to the foci periphery enabling continued HC relaxation. Additionally, 
BRCA1 together with POH1 create a core devoid of 53BP1 where RPA loading occurs. 
This latter role relieves the barrier posed by RAP80 since depletion of RAP80 
overcomes the need for POH1 to create the 53BP-devoid core (Supplementary Figure 
8B). 
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Materials and Methods 
 
Cell Culture and irradiation 
A549 and 1BrhTERT cells were cultured in DMEM with 10% FCS, L-glutamine, 
penicillin and streptomycin. Cells were incubated at 37°C in a humidified 95% air and 
5% CO2 atmosphere. 
 
Cells were irradiated by exposure to a 137Cs. For G2 experiments 4µl of 2.95mM 
Aphidicolin was added prior to IR to prevent S-phase cells from progressing into G2. 
ATMi Ku-55933(Calbiochem) was added as indicated. 
 
 
Small interfering RNA (siRNA) knockdown conditions 
siRNA-mediated knockdown was achieved using HiPerFect Transfection Reagent 
(Qiagen, Hilden, Germany) following the manufacturer’s instructions. 100 pmol of 
siRNA duplexes per 2 x 105 of logarithmically growing cells were used. Cells were then 
grown for 72 hours prior to IR. 53BP1(5´-AGAACGAGGAGACGGUA 
AUAGUGGG-3´), KAP-1 (5’CAGUGCUGCACUAGCUGUGA 
GGAUA-3’) BRCA1( 5'-GGAACCUGUCUCCACAAAG-3') POH1(5’- 
AGAGUUGGAUGGAAGGUUU-3’) and Abraxas ( 5’-
CATCGACTGGAACATTCCTTATATA-3’)  siRNA oligonucleotides were StealthTM 
RNAi oligos from Invitrogen. 53BP1,BRCA1, Ku70, DNAPK, Artemis, BRCA2, 
Mre11, BRCC36, RAP80, POH1 and CtiP siRNA oligonucleotides were obtained from 
the Dharmacon SMARTpool.  
 
Immunofluorescence  
Cells plated on glass slides were fixed for 10 min with fixative (3% (w/v) PFA, 2% 
(w/v) sucrose, 1X PBS) and permeabilized for 1 min with 0.2 % Triton X-100 in PBS. 
When staining for RPA and Rad51 foci, pre extraction was performed by treatment with 
0.2 % Triton X-100 in PBS for 0.5-1 min prior to PFA fixation. Cells were rinsed with 
PBS and incubated with primary antibody diluted in PBS + 2% (w/v) BSA for 1 h at 
room temperature (RT). Cells were washed three times, incubated with secondary 
antibody (diluted in PBS + 2% (w/v) BSA) for 30 min at RT in the dark, incubated with 
4’,6-diamidino-2-phenylindole (DAPI) for 10 min and washed three times with PBS. 
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Slides were mounted using Vectashield and visualised/analysed using a Nikon-e400 
microscope and imaged using an Applied Precision® Delta Vision® RT Olympus IX70 
deconvolution microscope and softWoRx® Suite software. In each sample a minimum 
of 30 cells was scored blindly and error bars represent the s.d between three 
experiments.  
 
 
Z stack imaging and 3D modelling 
Z-stack imaging was carried out using an Applied Precision® Delta Vision® RT 
Olympus IX70 deconvolution microscope and softWoRx® Suite software. Z-stacks 
were set at 2 )m and individual nuclei imaged using 100x magnification. Following 
deconvolution by the Huygens Professional image processing software package (PSF- 
Theoretical, Max iterations- 400, Quality change threshold- 0.01), IRIF volume 
quantification was undertaken using the ‘surface’ tool of the BitPlane Imaris software.  
 
Sister Chromatid Exchanges: 
2 x 105 logarithmically cells were grown for 48 h in 10 )M BrdU before IR. 0.2)g/ml 
Colcemid  (plus 1mM caffeine to overcome the G2/M arrest) was added from 8 -12 h 
post-IR to collect mitotic cells. SCEs were scored in > 800 chromosomes from 3  
experiments per data point. Staining was according to standard protocols. Aphidicolin 
(Sigma-Aldrich, Poole, UK) was added at 1 mg/ml immediately before IR. ATM 
inhibitor (KU55933, Calbiochem), was added at 20 mM 20 minutes prior to IR. 
 
Antibodies 
The primary antibodies used were: !H2AX and 53BP1 (Upstate Technology, Billerica, 
USA) at 1:800, 53BP1 (Bethyl, Cambridge, England) at 1:800), RPA (Calbiochem, 
Billerica, USA) at 1:800, RPA (Lifespan Biosciences, Suffolk, UK) at 1:100), Phospho 
RPA32 (S4/S8) (Bethyl, Cambridge, UK), Ku80 (Cell signalling), Rad51( Santa-Cruz 
Biootechnology, Santa Cruz, USA) at 1:200,  p-histone H3 (p-H3) Ser10 ( 
Upstate Biotechnology, Buckingham, UK.) at 1:500; FK2 (Millipore, Billerica, USA.) 
at 1:400; H3K9me3 and H4K20me3 (Abcam, Cambridge, UK), at 1:800). The anti-
rabbit polyclonal BRCA1 antibody was raised against human BRCA1 amino acid 
residues 1250-1650. The corresponding cDNA fragment was cloned into the pET-28 
expression vector (Novagen, Billerica, USA) and the recombinant protein fused to a 
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histidine tag was purified using Ni-NTA resin (Qiagen, Hilden, Germany) following the 
manufacturer's instructions. The following secondary antibodies were: FITC (Sigma 
Aldrich, Poole, UK.) at 1:200, CY3 (Sigma Aldrich, Poole, UK.) at 1:200), Alexa 488, 
Alexa647 and Alexa 555 (Invitrogen, Grand Island, USA.) all at 1:400. 
 
Analysis of RPA foci overlap with HC in G2. 
1BR3 hTERT (WT) and 2BN hTERT (XLF mutated) cells were irradiated with 3 Gy IR 
and maintained in aphidicolin (as above). Cells were harvested 8 hr later, extracted 30s 
with 0.2% triton X100 (in PBS) and fixed and immunostained for RPA (p34 subunit, 
RPA2) and Histone H3 Trimethylated K9 (H3K9me3) or Histone H4 Trimethylated 
K20 (H4K20me3). Z-stacks were captured using a Confocal Zeiss LSM510meta 
microscope. Overlap between RPA foci and HC markers were quantified by ImageJ 
software with the ‘Colocalisation Analysis’ plugin. Mean values represent 15-20 cells in 
each of three experiments for each condition. 
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Figure legends. 
Figure 1. 53BP1 promotes DSB repair by HR in G2 phase. 
A) Wild type (WT), 53BP1-/- and Artemis-/- MEFs were exposed to 3 Gy IR and 
gH2AX  foci enumerated to 8 h post IR. G2 cells were identified by CENPF staining 
(Shibata et al, 2011). Aphidicolin was added prior to IR to prevent S phase cells 
progressing into G2 during analysis in all experiments. Control experiments verified 
that this does not affect HR in G2 phase (Beucher et al, 2009; Shibata et al, 2011). 
B) gH2AX foci were enumerated in A549 cells with or without siRNA 53BP1 
following 3 Gy IR. Similar results to those observed using MEFs were obtained. ATM 
inhibitor (ATMi) was added as indicated. C-D) RPA foci (C), RAD51 foci (D) and 
SCEs generated from G2 phase cells (E). RPA and RAD51 foci were enumerated at 2 h 
and SCEs scored at the first metaphase post 3 Gy IR, either with or without ATMi and 
53BP1 siRNA. Control experiments have shown that RPA and RAD51 foci numbers 
reach a maximum ~ 2 h post IR (Shibata et al, 2011). All results represent the mean and 
s.d. of 3 experiments.  Results shown were obtained using a single 53BP1 
oligonucleotide; identical results were obtained using a pool of 53BP1 oligonucleotides 
distinct to the single oligonucleotide (Supplementary Figure 1). Knockdown efficiency 
is shown in Supplementary Figure 1. Thus, a DSB repair defect in G2 cells lacking 
53BP1 is shown in deficient MEFs and following two siRNA conditions. Direct 
evidence for defective HR is shown by SCE and supported by foci analysis. E-F) 
Representative images of IF analysis. 
 
Figure 2. 53BP1 is specifically required for HR at HC-DSBs. 
A) Visualisation of H3K9me3 and RPA foci in G2 cells.  
Proliferating 1BR3hTERT and 2BN hTERT (XLF deficient) cells were exposed to 3 Gy 
IR in the presence of aphidicolin. 8 h post IR cells were extracted and immunostained 
for RPA2 (green), H3K9me3 (red) and DNA (ToPro03, blue). Slides were imaged in 
3D by confocal microscopy. The figure shows a 2D representation of the 3D images. 
B-D) The experiment in (A) was repeated with either H3K9me3, H4K20me3 or 
H3K9me3+H4K20me3 in the red channel. The overlap between RPA and HC markers 
was quantified by computer analysis and results represent mean values for 3 
experiments for each condition. 
E) Co-localisation of RPA and pKAP1 IRIF in G2 phase. 1BRhTERT cells were 
harvested 8 h post 3 Gy IR in the presence of aphidocolin and immunostained with the 
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indicated antibodies. Analysis was undertaken in G2 cells; S phase cells were excluded 
from analysis by the pan-nuclear RPA staining caused by aphidicolin addition. G1 cells 
do not show RPA foci. G2 phase cells have low chromatin bound KAP-1 making 
pKAP1 foci analysis difficult (Goodarzi et al, 2009). To visualise pKAP-1 in G2 cells, 
cells were subjected to MeCP2 siRNA, which we previously observed caused increased 
foci expansion and visualisation of pKAP1 in G2 (Brunton et al, 2011). Co-localisation 
between pKAP1 and RPA was undertaken using softWoRx® Suite software. The 
Pearson Coefficient of Correlation indicates how closely two intensities colocalise on a 
pixel-by-pixel basis (full colocalisation is 1.0). RPA foci show significant overlap with 
pKAP1. Similar analysis was carried out after combined Ku80+DNA-PKcs siRNA 
(DNA-PK siRNA). Under these conditions the overlap between RPA and pKAP1 was 
substantially reduced. F) 53BP1 but not BRCA1 is required for pKAP1 IRIF in G2 
phase  
F). Analysis was carried out as in 2E following siRNA MeCP2+ 53BP1 or +BRCA1. 
53BP1 is required for pKAP1 foci formation but is dispensable for pan-nuclear KAP1 
phosphorylation (Noon et al, 2010). 
   
Figure 3. BRCA1 is dispensable for HC-DSB repair in G1 phase but functions 
downstream of CtIP/MRN in G2 to promote resection during HR repair of HC-
DSBs.  
A-B) A549 cells were exposed to 3 Gy IR and gH2AX foci enumerated in G1 and G2 
with or without siRNA BRCA1 and KAP-1. G2 and G1 cells were identified as in 
Figure 1. Results shown are with a single BRCA1 oligonucleotide; identical results 
were obtained using a distinct pool of oligonucleotides. Aphidicolin was added as 
previously described. The efficiency of triple knockdown is shown in Supplementary 
Figure 1. The efficacy of CtIP knockdown using three distinct oligonucleotides was 
shown previously (Shibata et al, 2011). Also, using the same conditions, we observed 
that resection and RAD51 foci formation was restored by transfection with CtIP cDNA. 
(C-F) Enumeration of gH2AX (C and D), RPA (E) andRAD51 (F) foci in G2 phase 
A549 cells post 3 Gy IR following treatment with the indicated siRNAs. Results 
represent the mean and s.d. of 3 experiments. 
  
Figure 4. Combined loss of BRCA1, 53BP1 and KAP1 allows DSB repair by HR. 
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A549 cells were treated with the indicated siRNAs, exposed to 3 Gy IR and examined 
for RPA (A), RAD51 (B) or gH2AX (C) foci at the indicated times. Results are shown 
in samples with or without siRNA KAP1 to expose the necessity to have relaxed HC to 
observe HR in G2 phase. Results represent the mean and s.d. of 3 experiments.   
 
Figure 5. Analysis of IRIF in G1 and G2 cells using enhanced resolution 
microscopy. 
A-B) Analysis of 53BP1 foci volume in A549 cells following exposure to 3 Gy IR. The 
53BP1 foci volume was assessed by 3 dimensional imaging using an Applied 
Precision® Delta Vision® RT Olympus IX70 deconvolution microscope and 
softWoRx® Suite software at the indicated times in G1 and G2 phase cells (see 
Materials and Methods for details).  G2 cells were identified by CENPF staining. 
Analysis was undertaken in untreated cells (A) and following treatment with siRNA 
BRCA1 (B). The data represent the median, lower and upper quartiles from at least 10 
nuclei from each of three experiments. Error bars represent the minimum and maximum 
valid values. Maximum valid values, determined as the highest datum still within 1.5 x 
the interquartile range of the upper quartile, were used to eliminate abnormally large 
values arising from foci ‘clumping’ and resolution limitations (depicted as individual 
points). Statistical analysis was carried out using the Mann Whitney Rank Sum test. 
Data were deemed to be significant when a p value < 0.05 was obtained.  BRCA1 
depletion was confirmed by immunostaining. Typical results are shown in 
Supplementary Figure 4A. C) Representative images of nuclei immunostained for 
53BP1 at 8 h after 3 Gy IR in G1 and G2 with or without siRNA BRCA1. Left panels 
are immunofluorescence images; right panels show the computer generated 3D 
structures used for foci volume quantification in panels (A) and (B). We and others have 
observed foci enlargement in G1 phase with time. However, although observed, this did 
not cause a significant increase in the volume assessment made here 
and is distinct (and smaller) than the marked increase in volume observed in G2 phase 
cells. 
 
Figure 6:  BRCA1 promotes relocalisation of 53BP1 in G2 creating a core devoid of 
53BP1 and ubiquitin chains.  
A-B) Analysis of G2 A549 cells at 0.5 (A) and 8 (B) h post 3 Gy IR. Following 
immunostaining with the indicated antibodies (53BP1, BRCA1, RPA, FK2 and 
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gH2AX), 3D IRIF analysis was undertaken using softWoRx® Suite. The red and green 
signals represent 53BP1 and RPA, respectively; the blue signal is as indicated. 
‘Wireframe’ images are displayed allowing 3D visualisation. Foci volume enlarges 
from 0.5- 8 h post IR generating an expanded core lacking 53BP1. BRCA1 localises 
internally to 53BP1 and RPA lies within the core. G1 images are shown in Figure 5C. 
They were indistinguishable from G2 images at 0.5 h. C) Images following siRNA 
BRCA1 8 h post IR. The foci at 0.5 h were similar to those at 8 h. No detectable 
BRCA1 signal was observed following BRCA1 knockdown. D) 53BP1 foci volume 
estimations following siRNA Artemis. Analysis was undertaken as in Figure 5. Artemis 
knockdown was verified by demonstrating a G2 repair defect (Supplementary Figure 
5A).   
 
Figure 7. The BRCT but not the RING domain of BRCA1 is required for 
resection, Rad51 loading and 53BP1 repositioning during HR in G2. 
A) BRCA1FH-WT/FH-WT, BRCA1FH-I26A/FH-I26A and BRCA1S1598F/S1598F MEFs were irradiated 
with 3Gy IR in the presence of aphidocolin. Cells were harvested 8 h post IR and 
immunostained with DAPI, RPA and p-H3 antibodies to identify G2 cells. RPA foci 
were enumerated in p-H3+ cells. B) As for A) but Rad51 foci were enumerated 2 h post 
3Gy IR. In A-B), foci were enumerated in 30 cells per time-point and the data represent 
the mean and s.d. of 3 experiments. C) Analysis of 53BP1 foci volume in G2 phase 
Brca1FH-WT/FH-WT, BRCA1FH-I26A and BRCA1FH-S1598F MEFs 0.5 and 8h following 3Gy 
IR. Analysis was carried out as in Figure 5A. Statistical analysis was carried out using 
the Mann Whitney Rank Sum test. Data were deemed significant when p was < 0.05.   
 
Figure 8. POH1 promotes resection in G2 by overcoming the inhibitory barriers of 
53BP1 and RAP80. 
A) 53BP1 foci volume was estimated in A549 cells treated with the indicated siRNA at 
0.5 and 8 h following 3Gy IR. Statistical analysis was carried out using the Mann-
Whitney rank sum test. Data were deemed to be significant when a p value < 0.05 was 
obtained. B) A549 cells were immunostained with the indicated antibodies 8 h post 3Gy 
IR. G2 cells were selected by CENPF+ staining. The far left panels are a projection of 
the immunofluorescence (IF) Z-stacked images acquired on an Applied Precision® 
Delta Vision® RT Olympus IX70 deconvolution microscope. 3D model conversions of 
these images using the softWoRx® Suite are shown in the subsequent panels. Individual 
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foci from cells treated with the indicated siRNA were magnified and displayed either as 
solid or wireframe structures. Wireframe images allow visualisation of the hollow core 
in 53BP1 and FK2 IRIF where RPA foci form. A devoid core of 53BP1 or FK2 does 
not form following siRNA POH1 but is visible following siRNA BRCC36+POH1. A 
single oligonucleotide to POH1 was used for this experiment but similar results were 
obtained using a pool of siRNA POH1 oligonucleotides. C) A549 cells were treated 
with the indicated siRNA, and exposed to 3 Gy IR. Cells were processed as in Figure 1. 
RPA foci were enumerated in 30 cells per time-point and data represent the mean and 
s.d. of 3 experiments. 
 
  
!!
#"+!
 
  
Supplementary ﬁgure 1!
53BP1! DAPI! Overlay!
Control 
siRNA!
53BP1 
siRNA!
Single 
oligo!
53BP1!
Pool oilgos!
53BP1! DAPI! Overlay!
53BP1! DAPI! Overlay!
A?
BRCA1! DAPI! Overlay!
BRCA1!
Pool oilgos!
BRCA1! DAPI! Overlay!
Control 
siRNA!
B?
D?BRCA1!
MCM6!
C?
KAP1! DAPI! Overlay!
KAP1! DAPI! Overlay!
KAP1! DAPI! Overlay!
KAP1! DAPI! Overlay!
siControl!
siKAP1!
siKAP1 + 
siBRCA2!
siKAP1 + 
siBRCA2 + 
siMRE11!
POH1! DAPI! Overlay!
POH1! DAPI! Overlay!
siControl!
siPOH1!
!!
#"*!
 
  
DNAPK siRNA!
!
2!0! 0.5! 4!
0!
10!
20!
30!
40!
50!
60!
- KAP1 siRNA!
No
. o
f f
oc
i !
Time Post IR (h)!
A? RPA   Foci! "-H2AX    Foci!
Control siRNA!
53BP1 siRNA + Ku80 +!
Ku80 + DNAPK siRNA!
0! 2!0.5! 4!
0!
10!
20!
30!
40!
50!
60!
+ KAP1 siRNA!
Time Post IR (h)!
No
. O
f f
oc
i!
B?
0!
10!
20!
30!
40!
50!
60!
0! 2!0.5! 4!
Time Post IR (h)!
C?
No
. o
f f
oc
i !
0!
10!
20!
30!
40!
50!
60!
0! 2!0.5! 4!
Time Post IR (h)!
D?
No
. o
f f
oc
i!
- KAP1 siRNA! + KAP1 siRNA! Rad51   Foci! "-H2AX    Foci!
Control siRNA!
53BP1 siRNA + Ku80 +!
DNAPK siRNA!
!
Ku80 + DNAPK siRNA!
Supplementary ﬁgure 2!
siControl!
siKu80 + siDNAPK!
siKu80 + siDNAPK !
+ si53BP1!
Dose (Gy)!
SC
Es
 pe
r 1
00
X-
me
s!
0!
5!
10!
15!
20!
25!
30!
0! 2!
E!
RPA   
Foci!
"-H2AX    
Foci!
Control siRNA!
53BP1 siRNA + Ku80 +!
Ku80 + DNAPK siRNA!
DNAPK siRNA!
!
Rad51   
Foci!
"-H2AX    
Foci!
Control siRNA!
53BP1 siRNA + Ku80 +!
DNAPK siRNA!
!
Ku80 + DNAPK siRNA!
!!
#""!
 
  
B?
Control siRNA!
53BP1 siRNA!
KAP-1 siRNA!
Time Post IR (h)!
0!
10!
20!
30!
40!
50!
60!
0! 2! 8!
No
. o
f "
-H
2A
X 
foc
i!
A?
Control siRNA!
53BP1 siRNA!
KAP-1 siRNA!
No
. o
f R
PA
 fo
ci!
Time Post IR (h)!
0!
5!
10!
15!
20!
25!
30!
35!
40!
45!
0! 2!
C?
Control siRNA!
53BP1 siRNA!
KAP-1 siRNA!
No
. o
f R
ad
51
 fo
ci!
Time Post IR (h)!
0!
5!
10!
15!
20!
25!
30!
0! 2!
D? KAP-1 siRNA!Control siRNA!
53BP1 siRNA!
ATMi!
SC
Es
 pe
r 1
00
 X
-m
es!
Dose (Gy)!
0!
5!
10!
15!
20!
25!
30!
0! 2!
Supplementary ﬁgure 3!
!"
#!"
$!"
%!"
&!"
'!"
(!"
)!"
!" $" *"
!"#
$%
&'
!()
*+!
,+-.!/)01!23!456!
Control siRNA!
53BP1 siRNA!
BRCA1 siRNA!
HP1 siRNA !E?
!!
#"#!
 
  
Supplementary ﬁgure 4!
A?
53BP1! 53BP1! 53BP1!RPA! RPA!
B?
RPA! FK2!DAPI! 53BP1!
Pearson Coefﬁcient 
of correlation 0.85!
!!
#"$!
 
  
A?
Time post IR (h)!
No
. o
f "
-H
2A
X 
foc
i!
0!
10!
20!
30!
40!
50!
60!
0! 2! 8!
siControl!
si53BP1!
siArtemis!
si53BP1 + siArtemis + !
siKAP1!
B?
0!
5!
10!
15!
20!
25!
30!
35!
40!
45!
50!
0! 2!
No
. o
f R
PA
 fo
ci!
Time post IR (h)!
siControl!
si53BP1!
si53BP1 + siArtemis + !
siKAP1!
siArtemis!
Supplementary ﬁgure 5!
!!
#"%!
 
  
siControl siBACH1 
53
B
P
1 
fo
ci
 v
ol
um
e 
A
.U
 
0.0 
0.2 
0.4 
0.6 
0.8 
1.0 
siBRCC36 siRAP80 siATR siControl siBACH1 siBRCC36 siRAP80 siATR 
!"#$
Time Post IR (h) 
0.5h 8h 
Supplementary ﬁgure 6!
!!
#"&!
 
 
  
Supplementary ﬁgure 7!
A? B?
pRPA 
RPA 
Ku80 
30 Gy, 2 hr 
!"
#"
$!"
$#"
%!"
%#"
&!"
!" %"
!"
#$
%&'
()
*&
+*,-&.(/0&123&4!&567&
!"#$%&'()*&*8&29&.6"/-&:$;<&)-==/&
'()*+,-*."
'(/01$"
'(/01$"2"'(34/5!"
'(/01$"2"'(63))&7"
!!
#"'!
 
  
Supplementary ﬁgure 8!
A? B?
!!
#"(!
Supplementary Figure 1: Controls for siRNA knockdown efficiencies.  
100 pmol of siRNA duplexes per 2 x 105 logarithmically growing cells were used for 
each knockdown. Cells were then grown for 72 h prior to fixation and 
immunostaining/immunoblotting with the indicated antibodies. A) Knockdown 
efficiency in A549 cells following treatment with either a single or a pool of 53BP1 
siRNA oligonucleotides (the single oligonucleotide was distinct to any in the pool). B) 
As above but knockdown efficiency of KAP-1 siRNA was assessed under single, 
double and triple knockdown conditions. C) BRCA1 single and pool oligonucleotide 
knockdown efficiency was assessed by immunoblotting and immunostaining. For 
immunoblotting, MCM6 was used as a loading control. D) Knockdown efficiency of 
POH1 following treatment with a single POH1 siRNA oligonucleotide. Similar results 
were also obtained using a pool of distinct siRNA POH1 oliognucleotides. 
 
Supplementary Figure 2: 53BP1 is dispensable for resection and RAD51 loading at 
euchromatic DSBs in cells lacking DNA-PK components.   
A-B) RPA and gH2AX foci were enumerated in G2 cells at the indicated times after 
exposure to 1 Gy IR in A549 cells subjected to control siRNA, siRNA Ku80+DNA-
Pkcs or siRNA 53BP1+Ku80+DNA-PKcs either without (A) or with (B) KAP1 siRNA.  
C-D) As shown for panels A-B but RAD51 foci are shown instead of RPA foci. Solid 
and hashed columns represent RPA (or RAD51) and gH2AX foci, respectively. Results 
following 53BP1 siRNA alone are given in Figure 2. Results represent the mean and 
s.d. of 3 experiments. 
Since DNA-PK component proteins (Ku70, Ku80 and DNA-PKcs) are highly 
expressed in human cells, siRNA depletion of these proteins is inefficient. We, 
therefore, carried out combined Ku80 and DNA-PKcs siRNA (labelled Ku80+DNA-PK 
siRNA). Following Ku80+DNA-PKsiRNA, DSB repair is slowed and increased RPA 
and Rad51 foci numbers are observed (A and C) and increased G2 phase SCEs arise (E) 
i.e. euchromatic (EC) DSB repair by HR is increased. siRNA Ku80+DNA-PK+ 53BP1 
compared with to siRNA Ku80+DNA-PK (i.e. without 53BP1 siRNA)  revealed a 
modest reduction in RPA foci (A,B), RAD51 foci (C,D) or SCEs (E). This reduction 
was similar to that observed in cells treated only with siRNA 53BP1 (see Figure 1 main 
text). As in Figure 1, the magnitude of the reduction was greater for RAD51 than for 
RPA foci.  Further, following additional depletion of KAP-1 (i.e. DNA-
PK/53BP1/KAP-1 siRNA) RPA foci numbers were identical to that observed in cells 
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subjected to DNA-PK siRNA alone (B). Similar results were obtained monitoring 
RAD51 foci (C and D). (NB SCE analysis was not carried out following quadruple 
siRNA since this impacted on cell proliferation).  Collectively, these results suggest that 
53BP1 is dispensable for HR at EC-DSBs but promotes HR at HC-DSBs via its role in 
promoting HC relaxation. E) Sister chromatid exchanges in G2 phase A549 cells 
following exposure to 2 Gy IR. Following treatment with the indicated siRNA oligos, 2 
x 105 logarithmically growing cells were cultured for 48 h in 10 )M BrdU before IR. 
0.2)g/ml Colcemid (plus 1mM caffeine to overcome the G2/M arrest) was added from 
8 -12 h post-IR to collect mitotic cells. SCEs were scored in at least 800 chromosomes 
from 3 independent experiments per data point. Staining was according to standard 
protocols. Results represent the mean and s.d of 3 experiments.  These results show a 
small increase in SCEs following siRNA of Ku80+DNA-PKcs demonstrating that some 
DSBs are repaired by HR. SCE frequency is also increased compared following 
Ku80+DNA-PKcs+53BP1 siRNA but the increase is smaller compared to that observed 
in control cells. This is consistent with the notion that 53BP1 is dispensable for HR at 
EC-DSBs but is required for HR at HC-DSBs. SCE formation after quadruple knock-
down that included KAP1siRNA was not pursued since there was a significant impact 
on mitotic frequency. 
 
Figure 3. The defect in HR in 53BP1 siRNA cells can be relieved by KAP1 or HP1 
siRNA. 
gH2AX (A), RPA (B) or RAD51 (C) foci were enumerated at the times indicated 
following exposure of A549 cells to 3 Gy IR with or without siRNA KAP-1. Panel D) 
shows the quantification of SCEs in mitotic cells arising from irradiated G2 phase cells. 
In all panels results represent the mean and s.d. of 3 experiments. All results shown 
were obtained using a pool of 53BP1 oligonucleotides and these are used hereafter as 
substantial protein knockdown was achieved (Supplementary Figure 1A). The 
efficiency of siRNA KAP-1 is shown in Supplementary Figure 1B. E) A549 cells were 
treated with control, 53BP1 or BRCA1 siRNA with or without siRNA to all three 
isoforms of HP1 (%,&,!) and were irradiated with 3Gy IR. Sample preparation and 
gH2AX enumeration was carried out as in A). 
For all endpoints, siRNA KAP1 or HP1 relieved the defects observed by siRNA 53BP1. 
 
Supplementary figure 4: Analysis of 53BP1, RPA and FK2 IRIF. 
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 A) 3D model of G2 phase A549 cell harvested 8h post 3 Gy IR and immunostained 
with the indicated antibodies. The left panel is a ‘solid’ representation of both 53BP1 
and RPA signals. In the middle and right panels, 53BP1 signal is shown as ‘wireframe’ 
depicting the hollow center of 53BP1 foci where RPA foci form. B) A549 Cells were 
immunostained with the indicated antibodies 8 h post 3Gy IR and colocalization 
between 53BP1 and FK2  was carried out using softWoRx® Suite software. The 
Pearson Coefficient of Correlation indicates how closely the two intensities are 
colocalized on a pixel-by-pixel basis (full colocalization is 1.0) 
 
 
Supplementary figure 5: 53BP1 depletion does not alleviate the requirement of 
Artemis in G2 phase DSB repair.  
A549 cells were treated with the indicated siRNA, exposed to 3 Gy IR and examined 
for gH2AX (A) and RPA foci (B) at the indicated times. 53BP1 depletion did not rescue 
either the diminished RPA foci formation or DSB repair in G2 cells depleted for 
Artemis. Results represent the mean and s.d. of 3 experiments. 
 
Supplementary Figure 6. The BRCA1 interacting proteins BACH1, RAP80 and 
BRCC36 as well as ATR function are dispensable for 53BP1 repositioning during 
HR. 
Analysis 53BP1 foci volume in A549 cells treated with the indicated siRNA. The cells 
were irradiated with 3Gy and harvested at 0.5h and 8h post IR. The volume of 53BP1 
foci was assessed by 3 dimensional imaging using an Applied Precision® Delta 
Vision® RT Olympus IX70 deconvolution microscope and softWoRx® Suite software 
at the indicated times (see materials and methods for details of image processing). The 
data represent the median and lower and upper quartiles from at least 10 nuclei from 
each of three experiments. Error bars represent the minimum and maximum valid values 
determined as the highest datum still within 1.5 the interquartile range of the upper 
quartile. These were used to eliminate abnormally large values (depicted as single 
points) arising from foci ‘clumping’ and resolution limitations. Statistical analysis was 
carried out using the Mann Whitney Rank Sum test. Data where deemed to be 
significant when a p value < 0.05 was obtained.   
 
Supplementary Figure 7: POH1 depletion impairs resection and Rad51 foci 
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formation following IR. 
 A) Cells subjected to POH1 siRNA display impaired IR-induced RPA phosphorylation. 
To monitor resection following IR, phosphorylation of RPA on Ser 4 and Ser 8 was 
examined by Western Blotting. A549 cells were irradiated with 30 Gy following siRNA 
transfection, and whole cell extracts were prepared at 2 h post IR. Depletion of siRNA 
POH1 resulted in significantly reduced pRPA formation. The results are shown using a 
single POH1 siRNA oligonucleotide and a pool of POH1 siRNA oligonucleotides (see 
Materials and Methods). 
B) A549 cells were treated with the indicated siRNA and 72 h later were exposed to 
3Gy IR. Rad51 foci were scored in G2 phase cells as determined by CENP-F +ve 
staining. Results represent the mean and s.d. of 2 experiments. siRNA POH1 resulted in 
markedly reduced RAD51 foci but there was only a small rescue following siRNA 
RAP80 or BRCC36 in contrast to the marked rescue of RPA foci (Figure 8C).  
 
Supplementary Figure 8: Model showing the expansion of 53BP1 foci in G2 phase 
and the formation of an IRIF core devoid of 53BP1 and FK2 where RPA foci form. 
A) Model showing the requirement for 53BP1 to affect HC changes on the undamaged 
sister chromatid. The slowly repaired DSBs that arise within regions of heterochromatin 
(HC) undergo resection and repair by HR (HC is depicted in green). In early G2 phase 
(30 min post IR), 53BP1 foci form around the DSB on a single DNA molecule similar 
to the situation in G1 phase. 53BP1 is likely not located at the extreme DNA end. 
53BP1 interacts with RAD50 of the MRN complex; NBS1 of the MRN complex 
interacts with ATM. Thus, ATM tethering at the DSB is enhanced by the presence of 
53BP1 foci (interactions between MRN and MDC1 or H2AX also enhance ATM 
tethering but 53BP1 appears to be critical for the presence of  pATM foci at DSBs). 
ATM phosphorylates KAP-1 located at HC-DSBs in a concentrated manner producing 
pKAP-1 foci (note that pan-nuclear pKAP-1 also occurs at early 
times post IR but this is not 53BP1-dependent; in contrast the formation of pKAP-1 
foci, which only form at HC-DSBs is 53BP1-dependent). This causes HC-relaxation in 
the vicinity of the DSB (not depicted in the figure). HC forms a partial barrier to 
resection that is overcome by 53BP1-ATM pKAP-1 foci formation. The presence of 
53BP1 on the DNA molecule also forms a partial barrier to the completion of resection 
and a bigger barrier to RAD51 loading. However, neither 53BP1 nor KAP1 prevent the 
initiation of resection by CtIP-MRN, since they function downstream of CtIP-MRN 
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dependent commitment to HR and since RPA foci numbers are only partially reduced. 
Later in G2 (evident at 2 h), further resection ensues followed by the single stranded 
DNA overhang with bound RPA and/or RAD51 invading the undamaged sister 
template.  53BP1 foci formation expands to allow further resection and to encompass 
the undamaged DNA molecule, resulting in a two fold expansion in foci volume. The 
expansion of 53BP1 foci requires the BRCT but not the RING finger domain of BRCA1 
and involves repositioning of ubiquitin modifications on histones. Thus, we propose 
that BRCA1 promotes deubiquitination and/or proteasome mediated protein degradation 
in the core region and new ubiquitin events on the damaged and, we propose, the 
undamaged molecule. For simplicity this has not been depicted in the figure. The 
presence of 53BP1 on the undamaged strand allows pKAP1 formation and hence HC 
relaxation on this strand, which promotes the completion of resection and/or RAD51 
loading. We have depicted 53BP1 as entirely encircling the DNA molecule although its 
initial tethering involves interactions with methylated H4. This is consistent with 
evidence that 53BP1 undergoes oligomerisation and has a role in synapsis during long 
range V(D)J recombination (Adams et al, 2005; Difilippantonio et al, 2008). In G2 
phase, 53BP1 may also enhance synapsis but this does not appear to be essential since 
HR can ensue in the absence of 53BP1+BRCA1.  We suggest that the close association 
of sister chromatids in G2 phase via cohesin interactions can function redundantly to 
53BP1-dependent synapsis in G2 phase.  Thus, 53BP1-dependent synapsis is only 
essential for long-range translocation events in G1 phase. 
B) Model showing the role of POH1 in removing 53BP1 from the foci core region. 
Previous studies have demonstrated that 53BP1 and RAP80 form a restrictive barrier to 
resection by binding to methylated and ubiquitylated histones at DSBs. The BRCT 
domain of BRCA1 is required for 53BP1 repositioning away from the DSB ends as well 
as for the formation of an IRIF core devoid of 53BP1 where resection occurs. Similarly, 
the BRCT domain of BRCA1 is also required for the formation of an IRIF central core 
devoid of ubiquitin modifications. We propose that BRCA1 achieves this via the 
recruitment of the deubiquitinating enzyme POH1which functions to promote the 
removal of 53BP1 and ubiquitin chains but is dispensable for 53BP1 repositioning to 
the foci periphery. POH1 DUBing might lead to histone degradation thus exposing 
DNA to the nucleases which carry out the elongation step in resection. 
 
